data_2m0a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m0a _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 2.6 p . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.868 0.366 . . . . 999.99000000000001 110.591 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -103.11 137.81 40.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.313 -0.625 . . . . 999.99000000000001 109.313 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 97.5 mttt -95.53 114.59 26.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.211 0.529 . . . . 999.99000000000001 111.16 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.594 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -100.68 147.1 8.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.268 -0.878 . . . . 999.99000000000001 110.178 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.558 ' N ' HG13 ' A' ' 21' ' ' ILE . 11.7 tttt -134.78 11.72 3.68 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.667 -0.697 . . . . 999.99000000000001 110.783 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.594 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.7 mp -95.85 111.47 26.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.931 0.396 . . . . 999.99000000000001 110.697 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.44 130.68 53.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 999.99000000000001 110.293 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -78.02 113.19 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.099 0.476 . . . . 999.99000000000001 110.41 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.26 107.85 19.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 999.99000000000001 110.756 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.11 -40.06 82.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 999.99000000000001 110.181 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -154.08 170.2 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 999.99000000000001 109.891 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.97 25.23 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.331 -0.395 . . . . 999.99000000000001 110.1 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 32' ' ' ASP . 17.1 m -58.71 -64.68 0.84 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.726 -0.67 . . . . 999.99000000000001 110.405 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 77.9 m-85 -75.93 16.49 0.41 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.357 0.526 . . . . 999.99000000000001 109.967 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.0 t0 -88.51 -65.5 1.01 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.65 -0.87 . . . . 999.99000000000001 108.65 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.2 p -73.1 -33.51 65.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.471 -0.786 . . . . 999.99000000000001 109.7 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.9 -50.1 45.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.077 -0.51 . . . . 999.99000000000001 111.457 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 16.9 tp -64.05 -41.73 97.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 119.91 -0.716 . . . . 892.61000000000001 110.521 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -62.68 -45.65 91.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.353 -0.385 . . . . 999.99000000000001 110.937 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -64.35 -39.69 94.38 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.906 0.335 . . . . 999.99000000000001 111.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.55 -27.33 31.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 999.99000000000001 110.654 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 42' ' ' PHE . 2.9 t -147.78 85.3 1.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 999.99000000000001 111.982 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 p -97.13 -16.28 20.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.878 -0.601 . . . . 999.99000000000001 110.094 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.484 ' CG ' ' HE3' ' A' ' 22' ' ' LYS . 41.4 mt-10 -152.03 144.48 24.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.047 -0.979 . . . . 999.99000000000001 112.067 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CD2' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -142.94 141.76 31.52 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.764 -0.653 . . . . 999.99000000000001 111.564 179.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 16.5 pt-20 -105.91 115.31 30.01 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.814 -0.63 . . . . 999.99000000000001 110.508 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -119.89 111.95 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.854 0.835 . . . . 999.99000000000001 112.644 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 2.2 m-20 -57.73 170.76 0.55 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.014 -1.448 . . . . 999.99000000000001 107.667 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -87.89 31.67 0.77 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.295 1.861 . . . . 999.99000000000001 110.084 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -133.72 -3.9 2.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 999.99000000000001 109.817 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.429 HG12 ' CB ' ' A' ' 52' ' ' GLU . 19.2 t -79.53 126.15 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.877 -0.601 . . . . 999.99000000000001 109.996 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' GLU . 19.8 p -103.18 145.66 29.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.907 -0.588 . . . . 731.38 110.178 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -30.31 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.773 0.671 . . . . 441.33999999999997 110.882 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' THR . 97.6 m-20 -60.22 -49.48 77.45 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.326 -0.397 . . . . 698.47000000000003 110.598 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.3 mt-10 -66.78 -38.95 87.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 999.99000000000001 110.55 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.417 ' O ' HG21 ' A' ' 57' ' ' VAL . 20.4 tp -61.08 -46.02 92.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.695 -0.483 . . . . 717.46000000000004 109.695 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.461 HD21 HG23 ' A' ' 90' ' ' VAL . 1.6 mt -63.32 -40.96 98.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 612.28999999999996 110.432 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -60.64 -51.52 69.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 805.60000000000002 111.064 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.86 -35.8 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.779 0.323 . . . . 999.99000000000001 110.795 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 53' ' ' LEU . 4.6 t -64.28 -48.04 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.06 -0.518 . . . . 556.5 110.653 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.454 ' CD1' ' CD1' ' A' ' 81' ' ' LEU . 30.5 tp -65.1 -43.38 92.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 641.33000000000004 110.136 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -64.62 -42.08 95.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.931 -0.577 . . . . 999.99000000000001 110.78 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . -61.4 -50.95 70.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 848.76999999999998 110.828 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.76 -40.82 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 599.86000000000001 110.555 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -66.35 -36.91 84.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.927 -0.578 . . . . 999.99000000000001 110.36 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -41.78 75.58 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.229 -0.441 . . . . 999.99000000000001 111.221 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -74.22 -48.59 27.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.423 -0.353 . . . . 999.99000000000001 110.871 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.459 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 3.7 tp -106.23 72.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 999.99000000000001 110.438 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.521 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -78.23 -49.3 1.89 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 999.99000000000001 110.678 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 66' ' ' SER . 59.8 Cg_endo -76.53 63.18 7.22 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.859 2.372 . . . . 999.99000000000001 112.423 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -91.86 -31.67 15.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 908.97000000000003 110.518 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -65.69 -16.52 63.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 999.99000000000001 110.873 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.78 -39.81 66.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.401 -0.363 . . . . 999.99000000000001 110.956 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 75' ' ' GLY . 99.0 m-70 -86.73 118.52 26.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 999.99000000000001 110.281 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.06 -40.64 94.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 999.99000000000001 110.947 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -47.24 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 999.99000000000001 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 43.1 mt -83.27 -29.68 8.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.144 -0.48 . . . . 999.99000000000001 110.612 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -21.71 -76.03 0.01 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 110.863 -0.895 . . . . 719.80999999999995 110.863 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -25.0 -35.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.016 0.48 . . . . 989.60000000000002 112.169 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -53.93 -29.75 43.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.267 -0.173 . . . . 999.99000000000001 110.606 179.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.77 -46.9 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.781 0.324 . . . . 999.99000000000001 110.389 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 m -61.79 -44.64 96.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.938 -0.574 . . . . 800.41999999999996 110.228 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.02 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.962 -0.563 . . . . 563.47000000000003 110.224 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.454 ' CD1' ' CD1' ' A' ' 58' ' ' LEU . 58.3 tp -62.67 -45.31 93.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.078 -0.51 . . . . 913.92999999999995 110.479 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.2 -43.32 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 999.99000000000001 110.345 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.3 -40.08 96.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 999.99000000000001 110.43 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 91.7 mtt180 -65.33 -40.0 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 999.99000000000001 110.745 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tp -74.94 -19.37 60.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.947 -0.57 . . . . 999.99000000000001 110.389 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.76 -45.13 94.12 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.364 -0.38 . . . . 999.99000000000001 111.097 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.55 -56.3 0.06 OUTLIER Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.939 -0.648 . . . . 999.99000000000001 111.505 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 92.0 m-20 -84.15 112.81 20.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.34 -0.244 . . . . 999.99000000000001 110.34 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.467 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.2 p90 -108.62 -110.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.323 . . . . 999.99000000000001 110.474 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.467 ' H ' ' HD2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -151.39 115.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.331 -0.618 . . . . 608.69000000000005 109.331 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -73.84 155.27 38.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.262 -0.644 . . . . 586.54999999999995 109.262 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 3.8 tt -142.35 135.19 28.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.723 -0.843 . . . . 364.69 108.723 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.51 163.73 32.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.882 0.372 . . . . 999.99000000000001 111.011 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -79.49 -175.73 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 841.49000000000001 110.36 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.08 50.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.145 -0.479 . . . . 999.99000000000001 110.687 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.39 -55.62 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.778 -0.929 . . . . 951.75999999999999 110.778 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.76 -20.3 2.18 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.572 -1.011 . . . . 744.85000000000002 110.572 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -72.33 136.8 46.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.739 0.304 . . . . 774.99000000000001 110.588 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -74.21 89.83 2.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 691.20000000000005 110.28 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.62 151.13 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 663.89999999999998 110.456 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.45 123.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.546 . . . . 679.55999999999995 110.208 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.44 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . . . -141.28 177.49 1.91 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 660.94000000000005 110.399 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 102' ' ' ALA . 53.2 Cg_exo -51.51 -36.79 60.81 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.704 2.269 . . . . 999.99000000000001 111.979 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -123.21 98.0 5.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.212 -0.449 . . . . 999.99000000000001 110.499 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.403 ' SD ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -116.01 134.84 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.536 . . . . 630.75 110.4 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 70.7 t80 -94.87 106.23 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 807.87 110.147 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.43 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 4.3 t -98.64 120.76 39.63 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.107 -0.497 . . . . 611.89999999999998 110.669 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.493 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 10.4 t -177.38 167.2 2.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.188 0.518 . . . . 710.65999999999997 110.738 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.458 ' N ' HG12 ' A' ' 90' ' ' VAL . 26.0 p90 -85.68 26.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 999.99000000000001 109.982 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.1 m -119.77 121.1 38.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.259 -0.428 . . . . 999.99000000000001 110.552 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.54 161.35 1.56 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.854 -0.612 . . . . 854.05999999999995 110.418 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.58 -47.46 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.558 2.172 . . . . 999.99000000000001 112.324 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 24.7 p-10 -72.95 -38.28 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 999.99000000000001 110.409 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 114.429 -1.259 . . . . 999.99000000000001 110.032 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -113.83 171.3 7.67 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -112.52 147.39 36.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.37 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tp -108.65 134.29 51.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.05 -2.42 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mt -102.52 122.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.41 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -147.41 144.2 28.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.455 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.55 119.61 23.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.29 36.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -64.88 -40.5 95.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.569 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.3 t0 -156.25 -175.82 5.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.478 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -61.1 -42.91 99.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.53 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.3 m -63.12 -47.56 82.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.563 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -65.34 -33.46 76.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.447 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -65.46 -51.49 59.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.826 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 t -63.67 -44.86 92.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.749 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.9 t -62.73 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.84 -43.4 96.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.705 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.27 -45.79 91.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.59 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -65.25 -44.39 88.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.728 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.27 -54.52 14.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.472 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 60.8 m -118.58 79.22 1.35 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.562 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.46 -37.96 89.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.476 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -172.63 150.48 2.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.604 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -142.12 156.94 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.84 124.66 32.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.985 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 m -124.6 135.64 63.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.093 0.473 . . . . 0.0 110.592 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.24 168.57 19.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.145 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -73.7 161.25 30.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 56.96 33.86 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.678 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -75.14 140.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.242 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 20.3 p -90.76 -71.36 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 172.17 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.771 0.669 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 26.5 p-10 -55.88 -44.46 78.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.919 0.39 . . . . 0.0 110.451 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 79.5 tt0 -64.61 -41.24 96.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.419 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.429 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 19.3 mt -62.95 -43.64 98.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.83 -43.21 96.88 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.839 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -67.92 -43.05 80.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.022 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.71 -50.48 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 76.4 t -57.54 -48.21 83.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.92 -55.73 17.52 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.622 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -51.66 -41.82 61.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.304 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.44 99.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.588 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.91 -45.3 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.703 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.59 -42.17 82.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.589 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 t -61.34 -54.37 44.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.794 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.1 p -59.75 -45.42 92.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.152 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -108.01 81.34 1.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.55 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.63 -46.61 4.18 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 66' ' ' SER . 61.1 Cg_endo -81.91 106.4 1.61 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.335 2.023 . . . . 0.0 112.009 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.401 ' SG ' ' CG2' ' A' ' 78' ' ' VAL . 1.4 p -133.25 -42.0 0.88 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.871 0.367 . . . . 0.0 110.208 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -66.9 -22.91 65.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -72.29 -38.64 68.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.732 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 75' ' ' GLY . 77.0 m80 -97.66 125.3 42.36 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.76 -34.98 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.064 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.27 -45.98 95.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.073 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 31.8 mm -88.59 -22.38 6.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.201 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -37.71 -56.18 1.68 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.8 p -46.58 -19.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.722 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 88.9 tttt -62.03 -45.96 91.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.588 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 74.1 t -62.61 -44.53 99.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.57 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 77.9 m -62.0 -49.43 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.78 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.28 -44.53 94.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.72 -43.61 98.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 87' ' ' GLY . 33.2 t70 -62.11 -44.27 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 88' ' ' ASP . 87.5 mtm180 -66.83 -36.99 83.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.816 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.21 -46.33 87.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.406 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.21 -49.85 2.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.46 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -69.23 -95.65 0.05 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 83' ' ' ASP . 99.7 m-20 -68.92 -172.11 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.574 0.226 . . . . 0.0 110.495 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' CE1' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER 173.45 175.06 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.092 0.472 . . . . 0.0 110.322 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.27 138.29 47.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.479 ' OH ' ' CE1' ' A' ' 89' ' ' TYR . 54.5 m-85 -110.11 151.52 27.14 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.48 ' CD1' ' SG ' ' A' ' 107' ' ' CYS . 7.1 tt -131.29 124.6 30.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -132.76 154.68 50.0 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.694 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 97' ' ' GLY . 18.8 p-10 -82.98 177.41 8.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.16 26.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -144.3 -4.6 0.66 Allowed Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.559 ' N ' ' OD1' ' A' ' 94' ' ' ASP . . . 91.75 -6.27 79.73 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 45.1 t0 -86.9 117.19 25.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.791 0.329 . . . . 0.0 110.464 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.6 86.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.521 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 98' ' ' ASP . 67.7 t -156.83 134.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.47 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.513 ' N ' ' CD1' ' A' ' 101' ' ' ILE . 1.6 mp -68.92 131.44 33.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -146.06 172.0 5.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.582 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.46 -35.69 56.1 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.598 2.199 . . . . 0.0 111.812 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -118.63 74.23 0.96 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.002 0.43 . . . . 0.0 110.392 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -104.79 148.69 26.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.165 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.508 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 57.3 t80 -116.82 124.89 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.48 ' SG ' ' CD1' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -123.5 110.36 14.98 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.508 ' OG ' ' CE2' ' A' ' 106' ' ' TYR . 7.1 p -168.38 169.3 10.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.804 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 109' ' ' PHE . 30.1 t80 -62.46 -47.36 84.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -59.34 145.69 42.44 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.403 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.58 170.79 14.26 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.443 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.32 -42.29 55.1 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.526 2.15 . . . . 0.0 111.84 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.05 -41.11 97.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.02 0.438 . . . . 0.0 110.755 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.762 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 110.438 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' OG1' ' A' ' 18' ' ' THR . 33.7 ptt180 -139.24 167.18 22.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.358 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -116.17 146.7 42.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 8.3 tt -130.26 122.4 53.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.36 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -99.42 121.5 41.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.922 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.17 115.0 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.165 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -154.54 117.8 4.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -134.11 138.65 45.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.958 0.409 . . . . 0.0 110.425 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 143.11 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.6 mt -139.78 -79.72 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 21.9 p-10 -156.94 -62.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.583 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.545 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -178.11 -68.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.453 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.02 -51.21 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -69.73 -20.77 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.352 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.89 -52.86 17.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 36' ' ' SER . 78.1 p -68.46 -41.54 80.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.634 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.08 -45.63 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.71 -42.63 99.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 78.3 p -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.484 ' H ' ' HG ' ' A' ' 36' ' ' SER . 98.3 mttt -64.74 -41.2 96.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.678 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -59.31 -24.15 63.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.634 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 38' ' ' ALA . 8.5 m -162.42 63.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.569 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.4 p -68.49 -18.77 64.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.519 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -174.45 139.43 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 156.15 46.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.086 0.469 . . . . 0.0 110.181 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -119.51 113.83 21.34 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.973 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.58 133.82 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.255 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.42 141.1 28.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.317 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 64.3 tttp -47.56 101.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.94 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD2' ' C ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER 163.38 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.712 0.632 . . . . 0.0 110.3 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.76 136.91 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 110.454 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -92.42 155.52 17.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.05 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -42.65 -37.73 1.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.22 -43.59 95.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.211 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -65.61 -35.36 80.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.6 mt -61.53 -46.83 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.444 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.53 -41.58 98.46 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.452 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -43.14 99.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.93 -45.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-O 120.955 0.407 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.04 -48.37 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.894 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.7 -53.67 47.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.98 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -49.86 -42.6 47.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.829 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.93 -49.66 74.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.942 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.59 -48.06 90.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.247 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -45.32 -53.39 8.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.398 0.618 . . . . 0.0 110.414 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 t -60.08 -43.44 95.48 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.5 p -86.04 14.34 6.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.118 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.73 -24.01 23.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 110.212 179.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.479 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -41.33 -49.96 8.82 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.582 -178.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 66' ' ' SER . 50.2 Cg_exo -53.04 -39.75 78.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.149 1.899 . . . . 0.0 112.218 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.8 m -68.02 -34.28 76.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.597 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -60.92 -30.45 70.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.517 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.62 -33.64 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.475 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 75' ' ' GLY . 97.8 m-70 -97.05 118.49 33.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.238 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.0 p-10 -68.5 -35.38 77.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 78.1 t -61.57 -47.85 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 76' ' ' THR . 58.6 mt -88.42 -34.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.391 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -39.89 -21.75 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' ILE . 46.2 p -54.76 -29.73 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.103 0.478 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -32.89 66.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.09 -46.17 97.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.43 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 94.2 m -63.66 -39.13 93.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.8 -43.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.82 -41.45 99.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.4 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.58 -41.9 99.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.566 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 87' ' ' GLY . 40.0 t0 -62.19 -43.11 99.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -69.5 -37.61 77.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.518 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.61 -43.11 99.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.464 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.68 -12.15 22.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.556 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -119.78 57.17 0.57 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 63.51 98.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.086 0.469 . . . . 0.0 110.504 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -55.29 -100.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.12 162.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.157 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -116.29 139.77 50.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.861 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.87 132.58 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -140.98 154.78 46.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.644 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -85.13 -162.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.564 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -73.01 51.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.566 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.43 -90.15 0.08 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.5 -29.07 0.02 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.31 139.93 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -80.96 90.24 5.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -146.61 138.52 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.516 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' A' ' 101' ' ' ILE . 2.5 mp -71.47 131.66 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -145.8 172.56 5.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.631 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.17 -36.29 55.18 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.559 2.173 . . . . 0.0 112.162 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -132.73 103.09 5.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -122.55 148.42 45.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.214 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -101.79 119.9 39.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.06 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.32 112.97 20.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.476 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 t -177.34 168.77 2.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.847 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 -45.48 93.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.6 p -59.14 147.06 36.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.281 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -87.53 170.07 12.75 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.457 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -50.15 -43.97 40.22 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.414 2.076 . . . . 0.0 111.931 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 31.5 p-10 -90.07 -37.84 13.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.97 0.415 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 61.2 t0 . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.545 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 2.3 t . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.778 0.323 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 44' ' ' VAL . 84.8 mtp180 -105.26 140.95 37.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.957 0.408 . . . . 0.0 110.292 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -105.53 148.6 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.133 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.2 tp -127.69 135.12 63.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.307 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -137.8 -35.23 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.817 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.445 ' H ' ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.3 140.52 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.263 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -155.26 144.76 21.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.35 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.39 137.84 55.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 116.11 22.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.584 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.418 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 54.1 mt -62.06 -42.86 99.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.456 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 27' ' ' LEU . 61.8 m-20 -158.77 20.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 73.81 -51.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m -61.36 -53.53 55.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.285 0.565 . . . . 0.0 110.696 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -71.24 -27.33 63.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.922 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.413 ' O ' ' OG ' ' A' ' 36' ' ' SER . 27.3 t70 -60.89 -44.51 97.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.255 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.0 p -70.35 -42.21 72.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.29 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.7 -48.88 86.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.383 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.501 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.3 mp -64.37 -40.73 96.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.498 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 40' ' ' SER . 75.1 m -56.3 -43.38 78.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.09 89.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.502 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.34 2.7 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.861 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.518 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 18.2 p -174.45 54.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.108 0.48 . . . . 0.0 110.286 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 36' ' ' SER . 78.0 p -60.11 -36.97 78.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.754 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -136.59 125.67 24.47 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.453 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -129.82 131.63 46.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.48 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -91.48 126.67 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.15 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.454 ' O ' ' OG1' ' A' ' 18' ' ' THR . 47.1 t -122.48 126.19 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.115 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -48.84 160.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 22.6 pttm -59.72 -50.03 75.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.036 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 49.9 t0 -91.63 90.36 7.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -147.71 128.23 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.275 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -90.48 151.67 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.228 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.69 -32.86 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.375 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -51.11 71.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.289 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.66 -41.71 95.92 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 53' ' ' LEU . 2.8 tm? -61.78 -50.72 71.22 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.8 tp -50.73 -41.72 56.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.14 -35.8 71.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.7 -51.78 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 14.8 p -61.39 -42.7 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.908 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.406 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 57.4 tp -60.45 -54.5 44.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.28 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -53.89 -41.72 67.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.88 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.31 -46.66 82.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.543 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.84 -43.71 97.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.437 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.564 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -62.63 -44.08 97.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.822 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.2 p -68.53 -64.81 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.725 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.41 83.35 2.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.569 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -74.87 -45.73 5.06 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.322 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.8 Cg_endo -83.25 114.32 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.599 2.2 . . . . 0.0 111.987 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.76 -19.39 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.0 -9.84 48.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.759 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.55 -38.5 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.472 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.1 m-70 -103.16 124.58 48.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.3 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.6 p-10 -60.58 -34.98 74.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.353 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.513 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 82.9 t -62.32 -47.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 45.9 mt -82.45 -23.37 9.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -34.91 -61.01 0.64 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -40.05 -24.38 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.95 0.405 . . . . 0.0 110.784 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 66.0 tttm -58.67 -45.39 89.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.213 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.1 t -57.4 -44.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.37 -46.52 88.3 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.73 -38.5 91.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.242 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.39 -42.7 99.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -45.92 91.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 0.0 110.09 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.93 -45.48 94.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -66.08 -39.43 90.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.076 0.465 . . . . 0.0 110.751 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.88 -29.25 69.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.44 59.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.498 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 168.62 -65.35 0.18 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 89' ' ' TYR . 28.0 t70 -173.89 176.0 2.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.548 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.545 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 t80 -175.18 -68.53 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.3 m -66.1 133.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.308 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 65.4 m-85 -116.87 145.89 43.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 tt -117.02 125.73 51.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.509 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -126.37 152.26 46.54 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.284 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 46.6 t0 -74.52 179.16 4.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.165 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.487 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 80.5 mm-40 -65.68 -37.54 86.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.66 -3.47 87.0 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.61 78.97 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.1 t0 -88.5 111.08 21.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -50.62 87.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.306 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 76.0 t -152.87 130.8 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.521 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.59 134.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.031 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.59 171.82 6.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.579 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -50.83 -38.07 56.53 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.414 2.076 . . . . 0.0 111.993 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -130.86 131.79 44.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.315 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.467 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -153.4 173.87 15.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.02 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.522 ' HH ' ' CB ' ' A' ' 108' ' ' SER . 42.0 t80 -117.98 109.73 16.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.343 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.8 t -107.55 115.74 30.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.534 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.522 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . 6.7 t -172.59 177.34 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.527 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -89.72 40.85 1.01 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.617 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.2 m -136.91 116.1 12.54 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.449 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.96 170.38 2.08 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.541 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -54.45 -43.13 61.66 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.428 2.085 . . . . 0.0 112.267 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -93.79 12.73 24.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.583 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.529 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 C--O 1.229 0.025 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' VAL . 62.6 ttp180 -110.53 151.83 27.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -112.42 144.96 40.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.069 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tp -119.32 142.8 32.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -130.74 -15.21 3.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.37 126.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 110.567 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 m -138.13 137.61 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.384 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.8 131.25 50.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.213 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.77 137.1 43.09 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 3.9 mm? -63.89 -41.42 97.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -159.59 179.07 9.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.83 83.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.499 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -63.2 -50.85 68.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.513 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -70.31 -22.69 62.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.65 -52.65 50.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 0.0 110.346 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -67.87 -44.6 76.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.34 -46.45 95.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.27 -43.55 97.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.592 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.3 t -60.58 -42.74 97.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -63.61 -44.47 93.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.549 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.17 -78.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.487 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 31.6 t -87.14 64.34 8.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.5 t -62.33 -41.28 98.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -154.28 148.11 25.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 81.8 t80 -150.28 150.12 31.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.495 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 16.7 pt-20 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.238 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 19' ' ' ARG . 65.4 t -127.89 133.27 67.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.116 0.484 . . . . 0.0 110.472 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -81.2 170.08 16.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.228 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.81 152.23 20.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.086 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.12 41.55 10.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.587 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 49' ' ' THR . 62.7 t -89.22 166.85 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 51' ' ' ASP . 31.0 m -121.71 129.33 52.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.26 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.453 ' H ' HD21 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -37.61 -27.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.697 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 49' ' ' THR . 64.2 t0 -60.03 -46.92 87.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.055 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 49' ' ' THR . 80.7 mm-40 -64.88 -41.95 95.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.367 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.59 -41.36 98.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.213 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -44.61 95.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.754 0.788 . . . . 0.0 110.367 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.36 -42.49 68.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.543 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.0 t -66.72 -51.27 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.071 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 9.3 p -58.17 -43.93 86.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.479 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 58.1 tp -60.06 -52.22 66.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.257 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.79 -31.53 71.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.16 -54.42 41.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.17 -38.58 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.722 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.5 -44.77 81.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.2 p -62.1 -44.8 95.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.434 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.0 p -61.17 -49.21 78.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -101.35 109.49 21.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.254 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.43 -48.11 3.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.5 Cg_endo -80.69 138.04 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.637 2.224 . . . . 0.0 111.881 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.8 m -130.99 -77.79 0.53 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.586 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.2 -5.73 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.466 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -72.36 0.96 8.71 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.342 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -130.26 102.92 6.42 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.269 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -66.17 -39.54 89.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.597 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.01 -47.58 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.731 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 75' ' ' GLY . 97.2 mt -67.42 -56.04 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.911 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . 31.95 -155.93 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m 71.84 -50.62 0.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 110.377 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -63.68 -25.29 68.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.338 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.32 -50.33 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.6 m -69.37 -37.65 77.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.44 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.66 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.955 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.19 -47.26 85.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.876 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.03 -40.29 96.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.12 0.486 . . . . 0.0 110.437 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -61.43 -46.27 90.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.713 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -43.22 97.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.256 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.33 -24.35 64.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.498 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.12 32.87 2.28 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 89' ' ' TYR . 97.7 m-20 -78.69 -53.5 7.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 48.5 p90 42.61 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.653 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.8 m -142.08 168.13 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.158 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.4 137.76 38.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.046 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.57 139.96 45.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.625 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -151.94 164.11 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.819 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.569 ' C ' ' H ' ' A' ' 96' ' ' GLY . 52.4 p-10 -76.58 178.0 7.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.277 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.38 26.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -118.7 -70.07 0.35 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.79 -24.91 0.23 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.97 123.21 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.27 92.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.478 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.94 135.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.655 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.51 132.8 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.339 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -161.27 172.0 6.26 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.663 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.19 -42.97 56.55 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.592 2.195 . . . . 0.0 111.785 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.72 78.24 1.33 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.062 0.458 . . . . 0.0 110.038 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -106.08 134.46 49.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.405 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -104.47 97.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.451 ' O ' ' OG ' ' A' ' 108' ' ' SER . 11.9 t -95.38 124.32 39.35 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.511 0.507 . . . . 0.0 110.597 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 107' ' ' CYS . 69.1 m -168.95 170.21 9.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.56 48.53 1.53 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.97 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 t -140.61 168.58 19.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.115 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.98 170.38 6.63 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.75 -39.3 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.586 2.191 . . . . 0.0 111.837 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -81.47 40.35 0.57 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.982 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 120.708 0.289 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.405 ' NH2' ' NZ ' ' A' ' 46' ' ' LYS . 43.2 ttm180 -127.95 149.23 50.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.229 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.08 135.61 46.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.13 138.5 37.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -95.24 115.35 27.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.768 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.8 mp -94.57 108.64 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.458 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -137.08 102.02 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.507 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -161.06 107.17 1.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.16 151.15 49.45 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.168 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.2 28.09 8.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 33.8 t0 -146.03 -143.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.307 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.526 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -131.52 -64.66 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.439 ' CG2' ' N ' ' A' ' 31' ' ' PHE . 14.7 t -58.03 -42.76 86.02 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.393 0.616 . . . . 0.0 110.399 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.439 ' N ' ' CG2' ' A' ' 30' ' ' THR . 52.2 t80 -68.16 -22.98 64.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.507 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -76.3 -44.42 37.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.993 0.425 . . . . 0.0 111.135 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -63.27 -45.73 90.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.843 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -65.28 -40.19 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.398 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -51.02 70.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.841 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -62.6 -45.34 93.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.04 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.02 -44.56 84.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.91 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 7.5 t -89.31 79.75 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.414 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -82.19 -9.04 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.321 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -172.7 127.97 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.135 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.29 139.84 45.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -119.52 115.89 24.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.267 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.36 156.15 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.768 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -87.57 171.69 10.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.207 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 48' ' ' VAL . 68.6 mttm -60.85 -59.49 5.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 46' ' ' LYS . 98.4 m-20 -34.09 -34.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' LYS . 21.3 t -59.55 133.13 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 p -106.72 147.42 29.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.241 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -38.88 -35.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.55 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.14 -51.83 67.91 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.114 0.483 . . . . 0.0 110.146 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.68 -34.92 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.046 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.68 -40.02 95.78 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.534 0.521 . . . . 0.0 110.442 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.265 0.555 . . . . 0.0 111.077 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -69.4 -46.68 66.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.669 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 57' ' ' VAL . 29.2 m -69.82 -49.72 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 9.8 p -57.39 -45.61 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 55.5 tp -60.94 -53.56 55.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.12 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -53.62 -39.79 65.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.59 -52.05 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.498 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.465 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 66.7 t -64.26 -47.31 90.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.47 -45.29 76.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.352 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.509 ' HG ' ' N ' ' A' ' 64' ' ' THR . 78.0 p -62.46 -45.61 92.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.714 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.509 ' N ' ' HG ' ' A' ' 63' ' ' SER . 74.8 m -53.31 -51.95 60.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.586 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.4 OUTLIER -108.29 68.43 0.7 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.366 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.56 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.94 -47.05 2.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.4 Cg_endo -81.08 85.07 1.86 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.569 2.179 . . . . 0.0 112.333 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.4 m -133.49 -10.04 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.591 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.09 -27.12 68.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.12 -36.75 69.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.579 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 75' ' ' GLY . 80.8 m80 -76.61 126.08 30.36 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.89 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.46 -43.98 92.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.53 -44.68 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.11 17.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.429 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -74.55 -62.13 2.96 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -9.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.95 0.405 . . . . 0.0 110.064 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 75' ' ' GLY . 49.7 tptt -59.7 -51.77 68.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.626 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -57.61 -48.53 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 110.032 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.4 m -57.18 -34.57 68.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.103 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.94 93.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.493 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.04 -44.9 95.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.596 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.76 -44.64 92.83 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.41 -43.86 97.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.416 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mtt180 -67.92 -41.7 82.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.761 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.77 -20.75 66.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.425 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.52 -35.53 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.704 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -63.43 0.04 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' ARG . 67.5 t0 -79.15 119.54 22.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.652 0.263 . . . . 0.0 110.424 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -120.47 -100.25 0.43 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.741 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -144.3 141.92 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 110.501 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -93.54 132.68 37.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.966 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.5 tt -120.8 121.68 38.69 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -154.62 149.54 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.676 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.6 p30 -93.65 -176.56 4.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.522 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.59 42.56 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -139.96 -16.38 0.5 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.65 -7.78 78.06 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 100' ' ' VAL . 51.9 t0 -96.91 111.03 23.41 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 40.3 mp0 -53.66 88.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 98' ' ' ASP . 6.3 p -146.73 153.54 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.8 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.533 ' N ' ' CD1' ' A' ' 101' ' ' ILE . 2.0 mp -77.46 129.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 110.329 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.49 173.6 4.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.738 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -50.49 -38.21 53.45 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.437 2.091 . . . . 0.0 111.807 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 102.56 12.63 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 109.863 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.6 mtp -103.19 137.55 41.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.49 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -138.03 104.09 5.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 28.2 p -111.53 110.62 21.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.463 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 m -158.87 165.62 33.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 95.9 m-85 -61.09 -30.25 70.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -63.56 152.67 38.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.262 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.41 170.62 5.29 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.76 -40.9 64.69 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.63 2.22 . . . . 0.0 112.015 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 67.6 t0 -96.84 45.76 1.05 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.417 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.455 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.908 0.385 . . . . 0.0 110.297 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.594 ' N ' ' OG1' ' A' ' 18' ' ' THR . 15.0 ptm180 -105.84 143.39 34.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.179 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -107.84 146.56 32.1 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.749 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.23 48.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -137.33 -3.11 1.96 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.898 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.42 126.65 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.6 p -149.33 146.28 27.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -62.11 116.58 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.004 0.43 . . . . 0.0 110.171 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.68 112.49 15.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 10.4 mp -67.09 -42.52 84.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.525 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' ASP . 71.4 m-20 -151.82 151.11 30.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.53 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.95 -51.33 66.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.9 m -61.7 -49.03 78.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.726 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -64.96 -30.64 71.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' ASP . 64.8 t0 -64.43 -50.29 68.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.528 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 t -62.46 -44.61 96.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.542 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.3 -44.95 94.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.62 -45.16 94.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.71 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' SER . 44.1 t -61.74 -44.4 96.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.57 -35.48 80.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.672 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.97 87.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.784 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.424 ' O ' ' OG ' ' A' ' 40' ' ' SER . 62.7 m -123.95 -63.07 1.24 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.861 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.6 p 72.92 1.68 4.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.481 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -170.63 146.51 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.88 100.07 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' A' ' 19' ' ' ARG . 10.8 tp10 -77.42 117.81 19.26 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 18' ' ' THR . 75.9 t -127.24 132.43 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.002 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.54 172.28 0.51 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -89.38 19.97 4.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.563 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -148.08 54.69 1.04 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.425 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.58 144.08 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 110.536 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -96.41 146.56 24.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.18 -34.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.411 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -48.64 -47.46 40.37 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -64.07 -36.21 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.546 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.87 -43.92 97.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.325 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 89' ' ' TYR . 10.8 mp -62.35 -44.03 97.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.463 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.61 -34.41 75.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.15 -51.57 25.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.626 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.55 -45.93 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.4 tp -61.69 -55.02 34.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.254 0.549 . . . . 0.0 110.293 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.41 -30.85 65.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.29 -55.45 21.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.345 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -64.34 -40.51 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.844 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.9 t -62.63 -48.46 79.28 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.484 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.9 m -67.26 -71.96 0.18 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.8 tp -101.07 83.09 2.45 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -72.79 -46.04 9.06 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.4 Cg_endo -81.69 104.27 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.619 2.213 . . . . 0.0 111.888 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 2.8 m -133.59 -23.32 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -64.91 -30.69 71.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.396 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -72.0 -37.21 69.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 75' ' ' GLY . 72.2 m80 -78.67 115.74 18.56 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.495 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -60.37 -29.99 69.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.04 -45.57 98.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.7 mt -106.91 -1.71 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 110.344 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -51.87 169.85 0.48 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 m 70.98 -22.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.474 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.575 ' H ' ' C ' ' A' ' 75' ' ' GLY . 50.2 tptt -63.72 -45.81 88.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.22 -45.05 84.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.131 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 84.1 m -63.42 -41.17 98.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.73 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.48 95.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.15 -42.16 96.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.62 -42.93 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.728 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 87' ' ' GLY . 97.8 m-20 -64.15 -42.86 96.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mtt180 -70.36 -38.74 74.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -61.94 -44.51 96.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.671 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.13 -45.47 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -66.46 -74.31 0.55 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 84' ' ' ARG . 44.8 t0 -164.35 165.26 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.098 0.475 . . . . 0.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.435 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 27.3 p90 -132.78 146.4 51.81 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.901 0.381 . . . . 0.0 110.508 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.5 m -53.51 132.08 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.589 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -86.06 144.37 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.116 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tt -117.46 136.37 53.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.622 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 25.9 p90 -155.12 166.45 33.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.767 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 12.3 t70 -73.03 -156.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.561 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 98.5 mt-10 -66.86 -53.0 36.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.601 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.88 -98.15 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.33 22.54 0.18 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -89.22 113.7 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.806 0.336 . . . . 0.0 110.607 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 55.4 mp0 -73.33 89.45 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -164.65 142.65 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.571 ' CD1' ' H ' ' A' ' 101' ' ' ILE . 2.7 mp -59.11 131.79 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.019 0.437 . . . . 0.0 110.01 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.84 173.8 4.47 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.727 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -49.29 -37.85 40.89 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.562 2.175 . . . . 0.0 112.172 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -92.26 121.61 33.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 110.087 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 87.5 mmm -104.12 139.58 39.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.49 96.78 1.07 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.5 t -111.16 118.86 37.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.545 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -164.94 171.45 14.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.697 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 110' ' ' SER . 92.0 m-85 -61.32 -44.67 96.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.287 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' PHE . 70.7 m -37.75 159.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.08 170.26 5.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.668 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -48.54 -42.77 34.91 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.559 2.173 . . . . 0.0 112.158 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 37.1 p-10 -96.75 -32.42 12.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 66.8 t0 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -131.51 165.12 24.29 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -133.03 144.55 50.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.202 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.27 140.67 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 109.996 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -135.82 26.9 3.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.579 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 2.2 mp -97.94 118.63 44.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 146.13 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -91.51 129.38 37.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.364 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.59 113.44 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -149.21 88.07 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.553 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 1.2 m-20 165.25 -20.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.593 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 77.17 -71.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.532 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 m -61.51 -50.03 74.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.372 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -72.63 -23.3 60.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.79 -51.15 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.369 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -65.25 -45.27 85.28 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.393 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.91 -45.47 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.367 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.58 -41.0 98.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -58.5 -42.44 87.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -79.96 -21.02 44.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.744 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.32 67.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.527 ' C ' ' H ' ' A' ' 41' ' ' GLU . 5.9 t -163.44 -84.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.42 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 67.84 -8.99 0.49 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 -179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 39' ' ' CYS . 8.7 tm-20 -146.97 135.51 21.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 64.1 t80 -142.12 146.82 35.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.535 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 56.0 mp0 -86.46 150.97 23.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.359 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.56 124.64 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' ASP . 1.3 m-20 -141.95 139.58 32.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.448 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 70.9 mmtt -50.94 85.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.421 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.6 m-20 173.81 -31.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.386 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 m -106.13 111.63 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 110.333 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 p -86.36 167.32 14.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -41.08 -35.06 0.51 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.531 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.36 -48.72 80.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.414 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' A' ' 52' ' ' GLU . 56.3 mp0 -65.2 -34.4 78.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.79 -40.76 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.148 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.17 -35.88 71.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.542 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.56 -46.17 60.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.625 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 57' ' ' VAL . 28.2 m -68.63 -49.41 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.188 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 8.2 p -59.67 -46.6 93.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.214 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.509 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 52.3 tp -63.28 -57.21 11.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.358 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -51.61 -38.42 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.692 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.1 79.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.61 -46.29 96.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -62.56 -40.06 95.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.297 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.0 t -59.86 -50.28 74.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.548 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.6 p -59.13 -65.75 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.35 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -107.95 80.68 1.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.847 0.356 . . . . 0.0 110.421 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.65 -45.84 12.7 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.426 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.7 Cg_endo -83.81 84.67 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.761 2.307 . . . . 0.0 111.875 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.4 m -87.03 -17.82 32.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.86 -5.44 16.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -72.37 -38.54 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' GLY . 58.2 m-70 -110.13 126.54 54.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.47 -38.74 91.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.72 -48.15 88.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 77' ' ' LYS . 68.5 mt -80.49 -31.04 12.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.163 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 78' ' ' VAL . . . -34.65 -57.47 0.75 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 m -39.43 -28.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.433 0.635 . . . . 0.0 110.945 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 74' ' ' ILE . 27.9 tptp -60.92 -40.27 92.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 75' ' ' GLY . 2.9 p -56.03 -39.61 58.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.433 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 1.2 t -66.26 -48.7 69.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.23 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.41 87.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.282 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.86 -45.48 93.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.45 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -61.82 -43.17 99.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.43 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.49 -42.76 78.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.056 0.455 . . . . 0.0 110.71 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.49 -20.29 64.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.455 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.42 82.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.561 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.34 -54.23 0.09 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.23 117.97 12.46 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.459 ' O ' ' CE1' ' A' ' 91' ' ' TYR . 37.0 p90 -123.53 141.96 51.49 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 110.558 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.5 t -50.89 125.14 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.18 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 3.4 m-85 -82.55 153.89 25.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.285 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.41 130.37 47.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.563 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.87 155.81 42.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 42.6 t0 -73.17 -178.62 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.365 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 24.8 tp10 -74.67 38.45 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.491 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.49 -59.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.63 0.24 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.63 140.69 58.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.625 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.84 88.44 4.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.55 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.3 t -150.07 134.16 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.741 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 86.7 mt -70.7 132.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.314 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.8 170.81 7.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -49.51 -38.82 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.403 2.069 . . . . 0.0 112.305 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -125.16 126.54 45.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -150.81 166.14 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.212 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -113.12 118.54 35.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.431 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.514 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 14.9 p -105.12 122.78 46.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.71 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.496 ' HG ' ' H ' ' A' ' 109' ' ' PHE . 42.0 t -171.98 166.85 6.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.674 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.496 ' H ' ' HG ' ' A' ' 108' ' ' SER . 48.9 p90 -73.44 -26.12 60.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.532 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.8 p -95.27 169.82 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.472 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.83 162.26 22.19 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.266 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.63 -21.59 45.37 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.701 2.267 . . . . 0.0 112.057 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -149.28 65.44 1.02 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.422 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.853 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -105.04 165.18 11.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.117 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -130.95 135.33 47.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.65 133.01 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -119.57 22.13 11.79 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.562 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.9 mp -84.93 136.87 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.481 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -135.86 132.47 36.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.347 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 107' ' ' CYS . 73.6 t80 -109.83 114.7 28.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.209 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.83 147.75 48.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.469 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.0 mt -97.95 -63.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 8.6 t70 -84.68 173.71 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.63 -36.7 84.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 31' ' ' PHE . 1.2 p -61.99 -54.4 42.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.683 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.449 ' N ' ' OG1' ' A' ' 30' ' ' THR . 67.0 m-85 -60.25 -20.03 57.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.544 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.426 ' O ' ' OG ' ' A' ' 36' ' ' SER . 54.0 t0 -76.58 -49.04 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.5 p -73.47 -35.14 65.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.41 -51.81 63.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.58 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.55 -41.93 83.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.749 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 32' ' ' ASP . 69.8 m -61.52 -45.43 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.853 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.84 -45.87 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.979 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 40' ' ' SER . . . -73.66 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 14.5 p -71.33 45.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.592 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 38' ' ' ALA . 4.4 p -59.13 -28.62 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.372 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.78 140.24 19.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.12 137.75 41.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.55 120.07 30.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.266 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.3 m -144.3 162.46 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.369 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 47' ' ' ASP . 45.9 t0 -89.79 170.41 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.628 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -78.65 39.22 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 66.1 t0 -118.22 -25.95 6.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.532 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.03 128.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 0.0 110.709 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.9 p -85.0 158.38 20.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.386 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.443 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -46.98 -38.46 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.243 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.12 -46.75 89.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -68.29 -35.16 77.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.312 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.7 tp -63.46 -43.83 96.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -39.32 87.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 0.0 110.511 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -71.43 -43.55 66.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.775 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.16 -51.48 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.058 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 8.0 p -58.57 -44.71 89.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.476 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 47.5 tp -61.33 -55.6 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.287 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.42 -33.61 65.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.866 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.92 -51.1 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.76 -43.19 93.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -62.75 -46.87 86.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.621 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.1 t -60.2 -49.28 78.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.604 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -58.84 -45.79 89.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.183 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.41 76.47 1.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.991 0.424 . . . . 0.0 110.407 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.59 -43.68 11.95 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.099 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 66' ' ' SER . 37.7 Cg_exo -60.21 110.18 0.74 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.404 2.069 . . . . 0.0 111.835 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 66' ' ' SER . 3.4 m -133.9 -58.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.552 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -68.5 -9.38 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.58 -42.84 61.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.636 ' HD1' ' H ' ' A' ' 73' ' ' VAL . 4.5 t-80 -106.36 134.53 49.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.514 ' N ' ' HD1' ' A' ' 71' ' ' HIS . 53.3 t0 -61.73 -35.54 78.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.545 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.636 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 76.1 t -60.25 -48.0 89.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.449 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.544 ' O ' ' N ' ' A' ' 77' ' ' LYS . 57.4 mt -82.54 -27.01 8.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.933 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -34.05 -59.02 0.62 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -42.7 -23.76 0.05 OUTLIER 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.289 0.566 . . . . 0.0 110.947 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 74' ' ' ILE . 88.7 tttt -58.99 -42.78 90.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.111 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 79' ' ' CYS . 5.2 p -54.75 -37.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.439 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.404 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 77.8 m -70.08 -50.17 43.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.31 84.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.98 -42.51 99.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 tt -60.44 -44.82 95.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -62.42 -43.78 98.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.472 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.77 -42.72 90.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.643 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.69 -11.99 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.53 -37.28 77.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.97 -34.46 0.56 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.04 115.31 24.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.425 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -132.88 146.35 51.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.407 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.6 m -50.51 148.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.068 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.97 164.23 12.62 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.311 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 tt -131.55 128.65 39.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.88 151.73 41.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -77.6 -159.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -72.02 51.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.75 -118.56 0.66 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.29 4.53 2.3 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -90.04 116.38 28.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.748 0.309 . . . . 0.0 110.39 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.31 89.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -135.69 133.4 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.45 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -71.64 127.93 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.03 0.443 . . . . 0.0 109.894 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.65 152.46 16.56 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.633 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.29 -39.86 27.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.31 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 65.1 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.278 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -103.53 135.96 44.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.184 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.523 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 48.1 t80 -99.89 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.118 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.531 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 4.3 t -113.3 115.43 28.14 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.548 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.523 ' OG ' ' CE2' ' A' ' 106' ' ' TYR . 7.2 p -173.53 169.5 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -70.06 -24.42 63.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 m -67.13 143.18 56.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.36 170.5 6.58 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.96 -40.31 67.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.604 2.203 . . . . 0.0 111.855 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -82.63 45.2 0.96 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.19 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.694 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.521 -0.149 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -125.9 176.97 6.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.354 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -135.83 139.73 43.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.237 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.09 136.3 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.56 -7.36 6.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.552 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -118.34 128.02 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.7 p -132.47 146.6 52.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.536 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.26 132.89 55.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.169 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.6 141.34 48.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 10.2 mp -64.56 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -148.92 168.83 22.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.637 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.05 81.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.417 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 m -59.61 -46.83 87.8 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.084 0.469 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -67.64 -28.56 67.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.483 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -64.91 -48.36 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -62.61 -44.89 95.16 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.492 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.68 -45.82 90.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.685 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.98 -44.62 95.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.609 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 m -60.05 -44.71 94.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.327 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.12 -35.84 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.521 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.73 -75.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 40' ' ' SER . 25.4 p -52.59 -43.91 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.789 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 1.4 m 67.73 -63.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.557 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.83 154.55 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.668 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -144.11 148.76 35.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.83 162.21 27.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.63 135.25 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.61 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.12 166.22 17.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.22 -61.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -88.89 84.23 6.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 110.374 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.52 136.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.312 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.561 ' O ' ' N ' ' A' ' 51' ' ' ASP . 20.5 p -108.22 154.27 22.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.406 0.622 . . . . 0.0 109.719 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.824 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -44.13 -12.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.254 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 49' ' ' THR . 87.0 m-20 -68.16 -53.4 25.32 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.268 0.556 . . . . 0.0 110.349 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -65.16 -38.99 92.31 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.328 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.0 mt -61.6 -39.9 92.88 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.031 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 tp -61.07 -45.12 96.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.158 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -71.49 -34.24 69.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.146 0.498 . . . . 0.0 110.744 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.6 t -72.38 -53.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.996 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 9.6 p -60.59 -43.92 95.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.799 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.473 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 46.6 tp -60.21 -56.48 20.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.137 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.16 -41.13 62.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.54 82.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.508 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.6 t -63.41 -45.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.549 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.06 -44.17 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.367 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.4 p -61.66 -42.74 99.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.0 m -67.89 -71.14 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.38 88.21 3.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.382 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.524 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.57 -47.87 2.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 66' ' ' SER . 66.9 Cg_endo -80.52 68.5 8.3 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.68 2.254 . . . . 0.0 112.134 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.53 -32.16 47.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.35 -5.77 15.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -72.27 -38.66 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 75' ' ' GLY . 39.0 m80 -103.71 120.81 41.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.219 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 28.4 p-10 -58.32 -42.38 86.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.712 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.428 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 3.8 p -55.09 -29.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.409 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 49.2 mm -108.49 -12.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -38.35 -62.92 1.03 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.2 p -37.04 -25.06 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.124 0.487 . . . . 0.0 111.006 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' GLY . 63.4 tttm -58.03 -42.71 85.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.139 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 79' ' ' CYS . 5.6 p -56.43 -42.49 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.455 . . . . 0.0 110.314 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.455 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 87.7 m -62.95 -48.55 78.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.162 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.37 82.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.5 tp -53.16 -42.34 66.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tt -60.76 -46.47 90.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.062 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -63.52 -45.49 90.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.52 -25.55 65.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.773 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.78 -44.23 90.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.364 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.34 -39.11 0.67 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.77 127.14 33.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.265 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 90' ' ' VAL . 2.0 p90 -131.73 -127.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.629 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.599 ' O ' ' CD2' ' A' ' 89' ' ' TYR . 29.1 m -134.44 165.03 32.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 121.097 0.475 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -114.01 144.76 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.465 ' CD2' ' C ' ' A' ' 92' ' ' LEU . 1.3 tt -131.13 143.18 50.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.989 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.27 163.25 38.76 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.666 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 96' ' ' GLY . 47.4 p30 -74.5 175.9 7.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.529 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.09 26.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -133.66 -70.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.98 -36.04 0.1 OUTLIER Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.71 140.51 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.78 0.324 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 56.4 mp0 -86.66 88.4 7.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.472 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.79 130.64 26.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.48 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 101' ' ' ILE . 12.9 mm -61.96 131.74 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.08 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.41 170.56 7.47 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.633 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.2 -40.14 60.94 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.517 2.144 . . . . 0.0 112.161 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 97.31 5.85 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -119.41 170.7 8.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.624 ' HH ' ' CB ' ' A' ' 108' ' ' SER . 76.5 t80 -139.68 122.33 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.084 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.5 t -122.83 127.53 49.19 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.752 0.657 . . . . 0.0 110.491 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.624 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . 84.1 p -172.78 -174.88 1.18 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' ' CG1' ' A' ' 90' ' ' VAL . 86.0 m-85 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.136 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -146.95 172.12 14.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . -108.0 169.98 6.03 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.406 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -49.41 -38.28 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.445 2.096 . . . . 0.0 112.054 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 49.2 p-10 -65.6 -30.65 71.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.981 0.419 . . . . 0.0 110.802 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 95.8 m-20 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.8 p . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.566 ' HE ' ' NZ ' ' A' ' 46' ' ' LYS . 43.9 ttm180 -107.7 145.38 33.5 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.297 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.39 137.18 39.16 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.333 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tp -102.92 142.84 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.309 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -138.88 111.41 7.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.566 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 2.5 mp -99.76 125.42 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.396 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.06 96.54 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.558 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -151.16 133.97 15.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.203 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.34 109.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -128.06 -67.21 0.82 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.368 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 27' ' ' LEU . 75.5 m-20 -150.88 163.66 38.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.426 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 -62.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.2 m -60.64 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -42.78 -44.52 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 110.391 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -61.98 -48.05 82.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.158 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.647 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.45 -45.12 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.176 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.04 -42.94 99.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.6 m -61.88 -40.44 95.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.08 -16.14 41.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.459 ' C ' ' SG ' ' A' ' 39' ' ' CYS . . . -93.61 23.62 4.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.611 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 38' ' ' ALA . 2.6 m 75.39 101.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.796 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.45 -34.77 78.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.76 131.22 55.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.684 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -145.19 124.66 13.13 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.46 0.648 . . . . 0.0 110.901 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -63.77 135.84 56.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.504 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.1 134.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 0.0 110.58 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.71 164.9 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.3 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.566 ' NZ ' ' HE ' ' A' ' 19' ' ' ARG . 65.2 mttm -94.11 -11.45 30.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.74 11.83 18.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.88 153.02 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.11 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.592 ' HG1' ' H ' ' A' ' 51' ' ' ASP . 57.2 p -99.25 -160.19 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.544 ' CD2' ' H ' ' A' ' 50' ' ' LEU . 1.9 pt? -63.11 -15.81 57.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.592 ' H ' ' HG1' ' A' ' 49' ' ' THR . 22.0 p-10 -59.99 -52.82 63.76 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.348 0.594 . . . . 0.0 110.589 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -64.03 -40.16 95.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.081 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.43 -45.78 92.86 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.109 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.8 tt -56.39 -43.72 79.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.34 -49.01 78.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.903 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.31 -43.4 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.383 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.77 -46.97 93.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.509 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.09 -41.22 99.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.357 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.91 -44.21 94.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.278 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . -64.43 -37.15 86.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.37 -44.78 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.734 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.11 -44.36 60.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.553 ' HG ' ' N ' ' A' ' 64' ' ' THR . 10.6 p -61.99 -33.35 74.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.553 ' N ' ' HG ' ' A' ' 63' ' ' SER . 41.4 p -86.81 -52.25 5.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.4 tp -95.04 79.21 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.544 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.87 -46.62 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.646 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.6 Cg_endo -80.74 109.95 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.404 2.069 . . . . 0.0 112.31 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.86 -46.28 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.441 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -67.91 -6.47 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.718 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -73.02 -21.49 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -103.12 98.18 8.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.697 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 25.8 p-10 -62.68 -44.59 95.86 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.412 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.456 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 71.2 t -64.42 -44.96 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.263 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 76' ' ' THR . 3.3 mt -93.56 9.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -55.54 -1.28 0.18 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.576 ' H ' ' C ' ' A' ' 74' ' ' ILE . 39.9 p -65.7 -31.78 72.97 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.506 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -58.6 -37.59 76.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.201 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.73 -44.13 93.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.32 -38.92 93.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.253 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.32 -54.03 51.41 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.063 0.458 . . . . 0.0 110.687 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.24 -40.32 97.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.311 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.7 -42.95 99.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.242 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -61.89 -43.4 98.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.217 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.97 -39.96 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.474 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.9 mt -63.83 -37.88 89.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.513 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.4 79.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.69 -18.54 0.58 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -78.26 56.72 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.782 0.325 . . . . 0.0 110.418 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.52 -168.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.281 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 132.08 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.506 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -75.05 153.22 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.223 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tt -142.52 122.51 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.468 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -146.12 151.01 36.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.736 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 96' ' ' GLY . 56.8 p-10 -80.96 175.13 10.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 104' ' ' ARG . 41.7 mp0 -62.3 68.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.473 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 94' ' ' ASP . . . -164.97 -79.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' OD1' ' A' ' 98' ' ' ASP . . . 149.7 40.63 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 97' ' ' GLY . 85.6 m-20 -146.98 169.63 18.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.932 0.396 . . . . 0.0 110.529 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 56.5 mp0 -80.92 91.61 6.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.166 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.432 ' CG1' ' N ' ' A' ' 101' ' ' ILE . 59.8 t -141.92 162.83 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.444 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.432 ' N ' ' CG1' ' A' ' 100' ' ' VAL . 4.9 mp -124.1 129.3 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.8 168.93 10.74 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.456 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.6 -40.2 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.498 2.132 . . . . 0.0 112.203 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.432 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 79.4 mtp180 -113.13 107.12 15.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -139.43 142.99 37.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.214 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -96.98 118.85 34.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.32 116.59 25.11 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 t -173.15 178.08 2.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.689 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -60.48 -44.67 95.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.509 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.1 m -55.86 146.1 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.036 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.498 ' H ' ' CB ' ' A' ' 114' ' ' ASP . . . -105.05 170.37 6.05 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.633 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.51 -41.28 61.14 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 112.031 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 55.4 t0 -85.32 -9.97 56.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.552 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' CB ' ' H ' ' A' ' 111' ' ' ALA . 66.1 t0 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.572 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 120.782 0.325 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -138.27 156.15 47.94 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.148 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -107.97 143.63 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 42' ' ' PHE . 17.5 tt -133.31 140.59 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -126.27 11.77 7.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.554 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.5 mp -88.3 101.41 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.961 0.41 . . . . 0.0 110.707 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.8 p -141.14 145.98 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.399 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -93.85 138.93 31.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.202 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.64 138.14 41.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 mt -63.2 -39.99 96.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -151.91 176.98 10.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 80.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.513 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.5 m -61.34 -47.69 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.585 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -68.72 -26.46 65.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.29 -48.53 56.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.3 m -67.1 -41.8 85.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.618 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.36 -47.29 93.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.495 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -63.5 -42.24 98.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.837 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 40' ' ' SER . 78.5 p -62.66 -35.47 79.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -78.69 -34.45 46.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.926 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.04 -92.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.753 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 40' ' ' SER . 14.2 t -65.59 -96.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.713 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER 77.85 -3.79 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.611 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -140.57 115.62 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.465 ' CZ ' ' SG ' ' A' ' 39' ' ' CYS . 84.4 m-85 -117.92 129.12 55.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.184 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -91.6 142.26 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.02 121.13 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.432 0.634 . . . . 0.0 110.515 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 47' ' ' ASP . 19.3 p30 -155.95 171.29 20.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.793 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.22 11.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 45' ' ' ASP . 87.7 m-20 -107.38 0.18 22.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.67 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 p -141.24 160.44 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 50' ' ' LEU . 5.2 p -129.94 -70.12 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.226 0.536 . . . . 0.0 110.648 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' N ' ' OG1' ' A' ' 49' ' ' THR . 0.4 OUTLIER -163.16 -33.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -50.21 -43.95 52.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.333 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -68.41 -40.91 81.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.633 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.472 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 35.6 mt -62.03 -46.26 89.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.72 -36.39 82.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.456 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.81 -52.25 63.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.182 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.422 ' O ' ' CB ' ' A' ' 60' ' ' ALA . 12.8 p -69.64 -38.59 76.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.532 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 43.7 t -59.29 -50.61 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.276 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.69 -50.47 43.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.184 0.516 . . . . 0.0 110.587 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.26 -32.07 69.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.086 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' VAL . . . -69.71 -56.35 7.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.41 -44.12 87.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -59.35 -46.39 88.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.508 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.504 ' HG ' ' N ' ' A' ' 64' ' ' THR . 77.9 p -61.77 -51.65 67.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.504 ' N ' ' HG ' ' A' ' 63' ' ' SER . 19.6 m -60.48 -46.59 89.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.471 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 10.3 mp -94.36 57.85 2.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.399 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.612 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.15 -44.02 2.74 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.214 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 66' ' ' SER . 21.5 Cg_exo -64.3 107.59 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.5 2.133 . . . . 0.0 111.859 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.522 ' C ' ' H ' ' A' ' 70' ' ' GLU . 22.0 t -133.84 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -48.5 -11.3 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.466 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 68' ' ' CYS . 79.2 tt0 -73.94 -36.89 64.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.607 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 75' ' ' GLY . 67.4 m80 -132.65 138.99 47.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.9 -43.83 97.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -45.69 -31.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.318 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.506 ' O ' ' O ' ' A' ' 75' ' ' GLY . 47.0 mm -108.38 -15.11 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.64 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . -46.68 -177.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m 66.74 -31.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.64 ' H ' ' C ' ' A' ' 75' ' ' GLY . 47.1 tptt -63.19 -39.15 93.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.423 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 7.4 p -59.76 -45.23 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.1 m -64.41 -47.74 78.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.341 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.45 -52.56 64.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.286 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.4 tp -51.29 -40.89 59.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.94 -48.06 82.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.21 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -64.24 -40.96 97.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.355 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.23 -40.63 98.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.89 -19.99 58.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.596 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.64 75.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 88' ' ' ASP . . . 160.33 33.64 0.02 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 80.2 m-20 -149.14 78.03 1.38 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.789 0.328 . . . . 0.0 110.52 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.609 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 1.4 p90 -110.2 -113.34 0.31 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.085 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.4 m -130.8 158.77 43.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.303 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -126.81 157.07 40.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.242 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.17 125.06 24.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.82 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -134.68 153.27 52.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -88.98 -168.31 2.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.431 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 33.2 mp0 -72.93 67.24 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.628 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.23 -59.33 0.21 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.28 -18.79 0.32 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.84 139.71 55.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.672 0.272 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 90.68 6.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.605 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -155.11 135.98 4.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.615 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 49' ' ' THR . 56.6 mt -66.15 132.26 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.27 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.17 173.59 4.11 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.66 -40.59 55.68 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.497 2.131 . . . . 0.0 111.842 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.36 90.13 3.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -103.16 145.24 30.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.159 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.447 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 68.5 t80 -113.15 110.21 20.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.138 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.0 p -110.97 113.15 25.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.437 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.447 ' OG ' ' CE2' ' A' ' 106' ' ' TYR . 9.0 p -167.77 164.9 14.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -72.51 -26.9 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.643 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 p -73.19 154.64 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -90.26 170.12 10.86 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.668 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.44 -35.11 53.81 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.46 2.106 . . . . 0.0 112.128 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -79.16 14.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 . . . . . 0 C--O 1.223 -0.332 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.785 -179.876 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -135.08 171.76 13.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -126.45 146.87 49.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.638 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.7 tp -132.11 141.04 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.317 0.58 . . . . 0.0 110.151 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -138.23 20.05 2.78 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.431 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mt -114.15 97.32 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.87 0.367 . . . . 0.0 110.839 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -116.19 143.68 45.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.141 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.92 118.33 13.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.443 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.79 118.6 36.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.243 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.78 -40.99 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.604 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.2 t0 -153.69 -178.94 7.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.58 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.499 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -62.82 -37.47 86.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.21 -48.03 83.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.188 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.16 -4.13 39.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.405 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -85.2 -59.08 2.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.32 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -68.55 -37.29 79.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.926 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.33 -47.45 87.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.07 -41.81 99.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 9.1 t -58.74 -50.25 74.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.58 -34.13 77.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -25.43 60.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.022 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.599 ' C ' ' H ' ' A' ' 41' ' ' GLU . 4.9 t -173.89 -48.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.47 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 36' ' ' SER . 0.4 OUTLIER 59.45 -3.91 0.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.657 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.599 ' H ' ' C ' ' A' ' 39' ' ' CYS . 75.2 mt-10 -144.26 115.79 8.12 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -121.84 133.57 54.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -95.5 156.68 16.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.975 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 m -134.75 116.7 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.665 0.745 . . . . 0.0 110.775 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 47' ' ' ASP . 50.4 t0 -148.2 159.77 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.3 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 50.9 tttm -60.88 12.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.659 ' H ' ' C ' ' A' ' 45' ' ' ASP . 98.2 m-20 -105.34 -37.07 6.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.711 0.291 . . . . 0.0 110.356 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.93 109.06 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.339 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 51' ' ' ASP . 27.3 p -86.46 166.05 15.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.336 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.441 ' H ' HD21 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -48.29 -44.35 33.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.291 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 49' ' ' THR . 1.5 p-10 -56.82 -44.33 81.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -72.98 -28.59 62.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.289 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.3 -54.34 30.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.216 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.79 -39.93 83.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.896 0.379 . . . . 0.0 110.287 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.32 -44.39 95.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.55 -43.12 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.707 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.98 -47.77 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.455 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.407 ' C ' ' CD2' ' A' ' 58' ' ' LEU . 8.6 tt -64.05 -53.25 52.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.081 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -52.23 -38.97 59.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.745 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.84 75.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.629 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.27 -48.98 85.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.685 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.78 -37.72 85.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.444 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -60.69 -45.16 95.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.49 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.8 p -72.92 -40.66 65.3 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.751 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -108.26 106.77 17.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.482 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.424 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -79.1 -60.8 0.53 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 178.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 66' ' ' SER . 36.9 Cg_endo -63.15 134.48 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.338 2.025 . . . . 0.0 112.297 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.2 p -134.98 -37.38 0.8 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -67.99 -7.96 33.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.759 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -73.59 -30.34 62.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.715 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 75' ' ' GLY . 60.1 m80 -92.13 108.91 20.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 20.8 p-10 -66.1 -49.12 68.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.339 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 t -66.84 -45.1 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.412 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 mm -95.09 18.79 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.09 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -81.29 -170.62 43.93 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.415 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER 78.32 -26.41 0.18 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 110.552 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER -63.62 -11.02 21.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.163 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.472 ' CG1' ' H ' ' A' ' 79' ' ' CYS . 7.1 p -71.31 -54.51 17.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 110.304 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.472 ' H ' ' CG1' ' A' ' 78' ' ' VAL . 98.8 m -69.36 -42.66 74.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.143 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.08 74.63 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.113 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 tt -54.62 -42.15 70.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.166 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.95 -48.71 80.58 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.254 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 87' ' ' GLY . 55.2 t0 -65.52 -43.24 90.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.798 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' ASP . 1.4 mpt_? -62.08 -43.79 98.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.6 -42.84 97.61 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.086 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -9.7 51.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.631 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -154.38 62.45 0.36 Allowed Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 84' ' ' ARG . 96.9 m-20 -36.88 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 110.693 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.503 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 65.5 t80 -87.04 -40.7 14.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.679 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.66 131.52 12.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 98.0 m-85 -109.37 152.25 25.57 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -132.31 122.9 25.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.401 ' CZ ' ' CD2' ' A' ' 106' ' ' TYR . 45.2 p90 -142.79 147.68 35.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.52 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.2 t70 -83.91 177.47 8.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.496 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 95.8 mt-10 -70.77 38.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -146.59 -5.71 0.38 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.92 -2.64 73.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 36.4 t0 -93.87 112.86 24.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 110.471 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -53.45 86.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.098 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 69.7 t -145.4 136.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.9 mm -76.09 130.02 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.125 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.02 172.0 5.74 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.452 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.95 -41.52 63.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.354 2.036 . . . . 0.0 111.894 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 1.8 mpt_? -110.46 83.45 1.76 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.188 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -105.19 165.07 11.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.091 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 93' ' ' PHE . 70.6 t80 -134.2 112.51 11.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 21.7 p -115.52 117.08 29.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.623 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.1 t -171.71 175.41 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -66.4 -27.34 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.357 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -61.86 146.46 49.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.473 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -85.62 170.41 13.14 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.78 -41.28 55.29 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.542 2.161 . . . . 0.0 112.025 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -60.51 -48.26 82.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.101 0.477 . . . . 0.0 110.849 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.547 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.67 0.271 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.45 173.51 8.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.237 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.02 144.17 30.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.053 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.0 pt -136.12 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.753 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.53 121.18 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mm -94.3 115.88 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.166 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -127.92 100.46 5.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.445 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.53 107.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.34 140.79 46.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.747 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 10.9 mp -73.7 -41.19 62.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -127.12 -176.78 3.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.63 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.16 82.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -58.69 -52.7 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.414 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' N ' ' OG1' ' A' ' 30' ' ' THR . 85.5 m-85 -69.39 -11.61 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -77.78 -54.89 5.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 p -69.91 -35.34 74.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.914 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.5 t -64.31 -49.89 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.67 -42.22 91.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.835 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.2 p -63.48 -45.65 89.81 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.541 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -68.34 -47.1 68.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.53 -76.1 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.735 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 7.9 t -83.13 72.27 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.9 p -75.78 -26.97 57.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.633 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -172.83 149.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.281 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -130.97 147.01 52.56 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.241 0.543 . . . . 0.0 110.526 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.44 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.38 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.6 132.26 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.904 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 41.7 t0 -145.44 148.62 33.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 20.0 pttp -73.75 20.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 45' ' ' ASP . 13.3 t70 -122.16 16.53 10.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.706 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.11 161.19 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 109.947 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' ASP . 58.2 p -120.29 134.78 55.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.121 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.86 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.851 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' THR . 63.1 t0 -67.8 -50.6 55.99 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.37 0.605 . . . . 0.0 110.1 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.36 -35.47 79.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.829 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.4 tp -61.39 -45.54 93.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.774 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -43.77 97.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.722 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.99 -42.6 99.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.729 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.66 -45.95 83.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.621 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 64.5 t -59.85 -45.76 94.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.44 -51.43 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.726 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -60.52 -32.92 71.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.44 -54.48 46.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.952 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.22 -39.08 84.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.6 m -61.61 -49.46 76.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -61.36 -48.73 79.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 tt -108.27 82.17 1.59 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.323 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.606 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.45 -43.93 2.05 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.403 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.8 Cg_exo -61.21 115.18 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.783 2.322 . . . . 0.0 112.091 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 p -133.11 -41.86 0.89 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 71' ' ' HIS . 88.6 tttt -62.09 -37.44 85.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.752 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -75.56 28.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' A' ' 69' ' ' LYS . 95.6 m-70 -136.78 143.8 43.4 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.577 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.83 -62.96 1.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.961 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.64 -44.54 89.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.278 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.7 mm -84.51 2.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.971 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.45 -28.4 71.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -8.26 59.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.91 -44.63 94.16 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.409 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 79' ' ' CYS . 11.2 p -57.01 -44.15 82.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.352 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.457 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 73.5 m -67.75 -49.39 62.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.71 97.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.57 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.99 -42.4 99.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.09 -42.74 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.096 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.09 -44.51 96.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.674 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -65.73 -39.7 91.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -37.91 89.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.432 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.91 80.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.604 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.64 62.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -172.59 56.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.502 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -101.65 152.58 20.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.962 0.41 . . . . 0.0 110.482 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 34.7 m -48.36 148.01 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.966 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -106.65 164.19 12.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.175 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.436 ' CD2' ' C ' ' A' ' 92' ' ' LEU . 8.0 tt -127.32 126.82 43.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.845 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -137.15 154.9 50.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 96' ' ' GLY . 47.8 p-10 -84.31 -176.96 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.693 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -71.45 47.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -158.13 -68.17 0.01 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.92 -21.31 0.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -73.78 141.67 46.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.945 0.402 . . . . 0.0 110.62 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.447 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -76.0 93.22 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.403 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.31 153.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.295 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.3 mt -91.47 127.14 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.224 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.02 153.99 19.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.548 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.3 -37.8 25.21 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.181 1.921 . . . . 0.0 112.136 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.63 54.42 2.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 110.334 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -103.51 144.34 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.295 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -117.05 122.13 43.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.263 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.9 t -113.09 115.0 27.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.536 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 t -173.89 175.71 2.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -75.39 -20.64 58.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.362 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -72.78 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.238 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.08 170.68 6.75 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.447 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.62 -42.14 64.16 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.654 2.236 . . . . 0.0 112.076 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 67.6 t0 -96.51 48.1 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.566 179.711 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.231 0.091 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -103.58 136.47 43.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.053 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -104.66 121.92 44.56 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.94 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.03 149.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -130.46 20.22 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.963 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.563 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 mp -93.49 122.3 44.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.11 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.1 m -142.56 134.48 27.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -97.55 120.34 37.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.096 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -103.82 145.55 29.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.447 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.1 mm? -64.92 -41.66 95.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.816 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -150.12 -174.08 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.91 -37.68 87.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -59.79 -48.74 80.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.273 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -66.89 -33.95 76.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.589 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.91 -46.54 87.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.436 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -68.32 -41.99 80.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.91 -49.0 85.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.889 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.38 -41.07 96.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -59.94 -41.93 92.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -75.14 -31.15 60.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.69 -89.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.0 m -108.99 94.89 5.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.475 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 t -89.29 -11.28 43.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 94.5 mt-10 -145.04 156.56 44.0 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.602 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 8.4 m-85 -143.59 122.61 12.82 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.078 0.466 . . . . 0.0 110.598 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.83 135.43 49.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.381 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.03 132.62 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -58.92 172.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -50.83 -38.38 48.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -147.27 113.9 6.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 49' ' ' THR . 86.9 t -127.88 160.93 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -96.75 125.65 41.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -38.35 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.8 m-20 -60.27 -45.94 91.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.216 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -63.96 -43.06 96.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.949 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -40.26 95.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.04 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.1 -42.76 99.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.277 0.56 . . . . 0.0 110.184 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.3 -39.45 68.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.703 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.55 -53.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 8.4 p -55.8 -44.82 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.479 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 58.6 tp -62.04 -52.04 65.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.183 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -54.17 -43.31 70.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.099 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.96 93.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.179 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.23 -43.12 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.252 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -67.53 -36.49 81.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.609 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t -63.03 -52.26 63.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 t -74.75 -38.03 62.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.433 . . . . 0.0 110.547 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -92.79 33.98 1.11 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.914 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.43 -47.14 2.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 66' ' ' SER . 71.8 Cg_endo -82.5 78.3 3.43 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.452 2.101 . . . . 0.0 112.291 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 33.4 m -133.81 -18.06 2.15 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -68.03 -7.43 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.672 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.33 -38.89 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' GLY . 93.7 m-70 -101.7 109.87 21.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.225 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 32.8 p-10 -65.78 -36.44 83.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.726 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.56 -57.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.683 ' O ' ' O ' ' A' ' 75' ' ' GLY . 81.6 mt -68.93 -45.0 81.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.683 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . -43.27 -131.27 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 O-C-N 124.053 0.846 . . . . 0.0 111.521 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.429 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 1.3 m 74.22 -36.09 0.32 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.96 -0.729 . . . . 0.0 110.532 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.2 OUTLIER -58.29 -29.47 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.817 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.4 -48.76 86.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.382 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.13 -37.44 87.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.103 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.42 -43.34 99.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.15 -38.02 89.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.794 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.88 -42.05 99.63 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' TYR . 89.0 mtm-85 -62.35 -48.08 81.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.014 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.56 -29.9 66.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.173 0.511 . . . . 0.0 110.411 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.16 84.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.43 -50.71 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.321 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.86 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.5 ' CE2' ' O ' ' A' ' 90' ' ' VAL . 26.9 t80 64.55 165.37 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.29 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.5 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 2.9 p -125.2 156.47 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.96 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.409 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 11.8 m-85 -122.55 138.51 54.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.077 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -108.85 128.83 55.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.4 154.04 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.793 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 44.6 t0 -73.62 176.83 5.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.467 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 11.3 tm-20 -61.12 -42.7 99.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.533 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.62 60.15 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.2 -0.37 87.31 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.5 t0 -89.13 108.83 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.6 0.238 . . . . 0.0 110.472 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -47.1 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.447 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 98' ' ' ASP . 79.6 t -152.84 131.26 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.663 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.554 ' CD1' ' H ' ' A' ' 101' ' ' ILE . 3.1 mp -60.93 123.88 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.27 170.58 8.01 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.539 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.73 -42.12 58.53 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.269 1.98 . . . . 0.0 112.234 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -105.85 101.5 11.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.226 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 52.1 mtm -104.62 147.05 28.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.324 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.507 ' HH ' ' CB ' ' A' ' 108' ' ' SER . 47.8 t80 -119.02 96.33 5.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.971 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.2 t -90.24 119.82 30.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.263 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.507 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . 47.7 t -161.06 159.74 29.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.608 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 5.5 m-85 -85.52 43.1 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.046 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m -146.6 178.76 8.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.232 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.46 170.69 5.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.518 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.14 -39.53 70.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.598 2.199 . . . . 0.0 112.038 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 p30 -87.31 0.58 55.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--O 1.222 -0.388 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.612 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.217 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.421 ' N ' ' HA ' ' A' ' 45' ' ' ASP . 73.2 ttt180 -126.06 150.7 47.96 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.498 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -145.34 126.71 14.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.799 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 42' ' ' PHE . 49.4 pt -140.91 148.56 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.107 0.48 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -113.43 77.41 1.05 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.791 0.329 . . . . 0.0 110.352 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.41 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.7 mp -110.0 126.42 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.0 m -124.19 126.84 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.364 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 107' ' ' CYS . 85.1 t80 -130.08 134.21 47.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.395 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.84 107.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.441 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.3 -43.59 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.605 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 98.1 m-20 -135.28 -86.36 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.511 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.67 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 31' ' ' PHE . 15.3 t -58.75 -45.55 89.46 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.292 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.474 ' N ' ' CG2' ' A' ' 30' ' ' THR . 51.6 t80 -61.46 -35.93 79.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.387 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.605 ' CG ' ' H ' ' A' ' 28' ' ' ASP . 90.9 m-20 -62.17 -44.63 96.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.293 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 30' ' ' THR . 78.3 p -62.16 -46.94 86.75 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.631 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.38 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.496 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 39' ' ' CYS . 53.6 tp -61.22 -44.68 96.88 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -60.17 -41.74 93.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 110.157 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.76 -32.25 73.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.07 -76.56 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.99 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.7 t -104.47 96.16 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -111.7 -30.19 7.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.37 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -95.27 141.25 29.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.365 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' ILE . 96.4 m-85 -136.55 133.36 36.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.173 0.511 . . . . 0.0 110.526 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -133.83 143.26 48.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.788 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' OG1' ' A' ' 18' ' ' THR . 1.2 m -145.72 -106.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.781 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' N ' ' A' ' 19' ' ' ARG . 43.5 p30 -166.85 161.51 15.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -63.64 163.28 11.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 61.49 37.23 16.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.478 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.69 123.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.13 0.491 . . . . 0.0 110.199 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -83.51 169.92 14.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.375 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.476 ' H ' HD21 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -60.81 -40.13 91.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -53.65 -50.34 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.111 0.482 . . . . 0.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.16 -38.08 89.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.313 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.65 -48.8 77.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.296 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.39 -41.18 68.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -62.15 -47.74 83.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.23 -43.36 95.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.133 0.492 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.69 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.82 -45.24 95.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.913 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -55.3 -43.74 75.08 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . -61.17 -38.97 88.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.465 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.89 -42.02 94.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -69.61 -47.01 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -62.44 -37.1 84.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.76 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 60' ' ' ALA . 19.1 m -73.65 -69.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.2 mt -103.48 98.57 8.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.556 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -77.85 -47.05 2.31 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.773 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.0 Cg_endo -81.39 137.63 10.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.603 2.202 . . . . 0.0 111.89 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.624 ' SG ' ' NZ ' ' A' ' 77' ' ' LYS . 5.8 m -133.22 -40.25 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.516 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.54 -11.08 60.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.39 -39.03 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.678 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.583 ' O ' ' N ' ' A' ' 75' ' ' GLY . 34.3 m170 -102.29 106.13 16.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.51 -37.95 89.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.25 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.19 -46.55 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.359 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 75' ' ' GLY . 95.7 mt -91.6 -13.67 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -53.93 -158.22 0.01 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 75' ' ' GLY . 2.2 p 69.44 -35.63 0.31 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.092 0.472 . . . . 0.0 110.539 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.624 ' NZ ' ' SG ' ' A' ' 68' ' ' CYS . 21.7 pttp -63.08 -20.47 65.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.306 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 79' ' ' CYS . 9.8 p -65.5 -46.15 90.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.304 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.487 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 1.6 t -68.85 -47.03 66.97 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.453 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.23 94.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.461 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.97 -43.27 99.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.45 -41.94 99.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.54 -43.81 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.278 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ASP . 96.1 mtt180 -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.135 0.493 . . . . 0.0 110.378 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.92 -42.9 94.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.33 -13.2 55.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.398 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' TYR . . . -149.89 61.41 0.42 Allowed Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' ARG . 88.8 m-20 -38.74 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.508 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -95.0 63.69 2.72 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.356 0.598 . . . . 0.0 110.373 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.9 t -150.91 137.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.33 132.21 41.04 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.219 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -103.65 136.49 43.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.751 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -157.53 148.83 21.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.832 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.63 -164.94 1.25 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 110.468 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.75 -39.83 82.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.78 -34.78 65.52 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.66 60.01 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 100' ' ' VAL . 47.6 t0 -88.16 113.98 24.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -42.57 89.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.658 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 98' ' ' ASP . 9.2 p -144.04 141.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.39 127.65 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.151 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.21 169.67 9.39 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.55 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -45.51 -42.63 18.24 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.426 2.084 . . . . 0.0 112.228 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -99.96 123.85 44.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.82 0.343 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 68.1 mtp -114.81 142.56 46.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.498 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 87.1 t80 -146.15 97.36 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.158 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.522 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.3 t -98.88 115.46 28.89 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.669 0.606 . . . . 0.0 110.923 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.498 ' OG ' ' CE2' ' A' ' 106' ' ' TYR . 9.1 p -171.03 162.11 7.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.649 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 109' ' ' PHE . 1.0 OUTLIER -61.67 -53.34 57.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.361 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.7 p -41.9 148.95 0.15 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.998 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.61 161.89 21.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -56.62 -31.41 86.99 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.671 2.247 . . . . 0.0 112.081 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -105.02 15.08 28.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.163 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.961 -179.856 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.861 0.363 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -131.53 146.16 52.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.479 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.2 140.24 32.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 pt -131.23 146.84 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.18 89.34 2.97 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.4 128.03 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.278 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -66.91 141.34 57.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.6 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 8.0 m-85 -115.05 135.19 54.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.321 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.79 142.77 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.639 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt 67.26 46.65 1.43 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.97 0.414 . . . . 0.0 111.35 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -128.0 12.15 6.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.154 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 36.94 -120.25 0.17 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.228 0.537 . . . . 0.0 111.698 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.74 -59.77 3.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -40.44 -44.45 2.01 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.838 0.352 . . . . 0.0 110.533 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' O ' ' OG ' ' A' ' 36' ' ' SER . 36.2 t0 -56.42 -52.25 65.36 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -68.55 -40.45 80.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.798 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -52.73 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.266 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.17 -42.2 89.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 32' ' ' ASP . 73.4 m -59.67 -43.52 93.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.74 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -79.26 -26.94 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.69 -72.42 0.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.6 p -152.11 98.91 2.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.531 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 78.4 p -51.39 -30.8 20.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.287 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -85.47 144.95 27.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 40' ' ' SER . 45.6 m-85 -129.6 138.6 51.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.54 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 43.6 tt0 -77.46 136.45 38.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.598 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 p -141.12 155.06 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.454 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' ASP . 45.7 t0 -149.75 146.07 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -40.77 -26.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.607 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' ASP . 11.0 m-20 -138.19 90.99 2.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.441 ' CG2' ' N ' ' A' ' 49' ' ' THR . 5.0 p -139.05 158.8 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.943 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 51' ' ' ASP . 68.0 p -121.81 137.52 54.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 1.7 pt? -37.9 -25.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.432 0.635 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.5 m-20 -58.91 -41.8 88.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.947 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' OE2' ' OE1' ' A' ' 43' ' ' GLU . 80.1 tt0 -64.89 -33.77 76.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.848 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.415 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 42.9 tp -62.31 -42.84 99.7 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 109.806 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.99 -42.26 76.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.617 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.81 -43.87 91.75 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.173 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.46 -40.2 63.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.844 0.354 . . . . 0.0 110.688 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 48.0 t -61.09 -48.19 90.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.77 -54.07 41.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.755 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 63.7 t0 -52.31 -38.65 59.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.825 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.76 99.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.33 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' LEU . 75.2 t -63.15 -46.25 96.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -66.59 -43.69 84.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.578 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -61.15 -47.47 86.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.5 p -75.2 -75.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' VAL . 68.9 mt -109.5 109.67 20.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.452 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.26 -44.04 2.68 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.074 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' SER . 27.1 Cg_exo -61.15 132.19 40.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.568 2.178 . . . . 0.0 112.118 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 66' ' ' SER . 2.3 m -134.83 -55.44 0.82 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 110.277 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 71' ' ' HIS . 21.2 ptmt -67.53 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.742 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -76.17 13.25 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.482 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.441 ' H ' ' C ' ' A' ' 69' ' ' LYS . 97.0 m-70 -126.44 93.4 3.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.442 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -62.12 -34.79 77.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.45 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.07 -45.58 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.287 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 75' ' ' GLY . 51.8 mt -77.72 -60.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.719 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.698 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . 46.22 175.82 0.01 OUTLIER Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m 61.96 -23.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.651 -0.323 . . . . 0.0 110.703 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.698 ' H ' ' C ' ' A' ' 75' ' ' GLY . 8.9 tttm -56.69 -62.76 1.51 Allowed 'General case' 0 C--O 1.225 -0.198 0 CA-C-O 121.367 0.603 . . . . 0.0 109.898 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -52.5 -33.34 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.023 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 t -68.22 -50.84 51.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.551 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.13 93.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.82 -42.15 99.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.034 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.81 -43.99 97.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -58.54 -46.69 86.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -64.94 -36.59 84.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.754 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.34 -37.94 85.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.269 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 -24.99 62.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.344 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.18 -65.1 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -174.5 -179.69 1.59 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -158.31 -68.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.572 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.59 157.0 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.543 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 2.5 p90 -144.31 155.3 43.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.784 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.56 154.64 41.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.236 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.47 147.28 27.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.04 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 96' ' ' GLY . 89.6 m-20 -80.79 167.84 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 104' ' ' ARG . 94.8 mt-10 -52.26 -9.36 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.484 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -90.02 -74.52 1.29 Allowed Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.48 -28.19 0.33 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -69.55 137.9 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -75.35 89.85 2.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -147.87 149.73 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 101' ' ' ILE . 1.8 mp -83.16 129.47 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.079 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.33 169.48 9.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.287 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.23 -45.03 19.1 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.593 2.196 . . . . 0.0 112.601 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 95' ' ' GLU . 74.0 mtp85 -107.31 80.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.508 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -104.23 160.9 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -141.87 114.14 8.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 25' ' ' PHE . 8.9 p -102.7 128.94 49.21 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.964 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 109' ' ' PHE . 40.0 t -175.74 -167.07 0.22 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.223 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.541 ' O ' ' CD2' ' A' ' 109' ' ' PHE . 70.6 t80 -104.12 25.18 10.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.7 m -115.03 160.87 19.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.267 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.25 170.41 5.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.522 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.41 -40.68 70.61 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.459 2.106 . . . . 0.0 112.378 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.4 p30 -114.16 39.41 2.75 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.639 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.778 0.323 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -158.45 177.87 10.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.347 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -117.4 141.17 48.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 110.212 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.0 tt -99.16 141.11 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.127 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -132.07 5.41 4.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.23 125.53 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.7 p -138.76 146.56 41.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.81 136.87 56.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.256 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.44 133.33 43.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.062 0.458 . . . . 0.0 110.558 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 10.3 mp -66.75 -40.39 88.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.716 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 37.0 t0 -159.23 -170.92 3.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.418 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.535 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -59.05 -46.05 89.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.704 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -61.51 -53.21 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.422 ' N ' ' OG1' ' A' ' 30' ' ' THR . 92.7 m-85 -61.42 -27.66 68.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.23 0.538 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.42 -45.0 73.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.975 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -67.98 -36.48 80.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.42 -49.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.467 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.9 -41.62 95.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.99 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 40' ' ' SER . 92.6 p -62.07 -44.46 96.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -75.05 -26.69 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.01 -28.91 69.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.676 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.521 ' C ' ' H ' ' A' ' 41' ' ' GLU . 10.7 p -161.22 -33.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.0 t 69.77 -42.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 39' ' ' CYS . 21.4 pt-20 -154.64 143.16 20.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -134.03 136.07 43.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 110.592 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -67.8 135.85 53.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.433 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.61 134.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.309 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.95 164.37 38.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.615 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 68.9 mmtt -70.66 101.4 2.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 1.5 t70 162.64 -46.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.763 0.665 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -100.14 110.6 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.0 110.597 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -87.53 172.81 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -43.76 -30.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 -51.77 67.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.695 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -39.98 94.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.221 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.61 -38.95 92.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.966 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.88 -44.01 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.471 . . . . 0.0 110.206 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.53 -34.95 70.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.611 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.63 -54.51 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 9.4 p -55.74 -44.66 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.492 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 5.6 tt -61.85 -55.3 31.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.63 -42.71 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.8 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.662 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.92 -46.24 92.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -65.64 -47.19 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.851 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -64.83 -54.03 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.8 m -66.15 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.748 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.3 tp -108.86 81.97 1.53 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.658 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.53 -44.41 2.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.454 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.4 Cg_exo -63.16 119.72 6.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.543 2.162 . . . . 0.0 112.032 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.21 -17.89 2.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 71' ' ' HIS . 26.0 pttm -66.46 -20.23 65.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.49 28.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.555 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.428 ' H ' ' C ' ' A' ' 69' ' ' LYS . 76.7 m80 -126.08 160.75 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.492 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -82.43 -65.3 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.42 -47.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.6 mt -65.47 -16.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.061 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.32 3.33 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -82.53 -14.07 55.55 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.299 0.571 . . . . 0.0 110.829 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.52 -34.38 61.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.294 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.2 t -59.55 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.256 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 85.4 m -61.6 -39.84 92.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.17 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.61 84.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.272 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -50.09 74.98 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 82' ' ' LEU . 4.1 mm? -61.91 -41.74 98.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.399 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -60.89 -47.15 87.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.216 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -65.7 -40.91 92.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.637 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.23 -22.22 66.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.657 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -40.43 80.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.95 -37.39 0.66 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -84.01 116.33 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.559 0.219 . . . . 0.0 110.461 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -130.92 143.75 50.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.425 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 m -51.5 140.9 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.392 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.89 150.35 24.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.311 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -127.95 127.79 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.778 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -148.02 151.6 36.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.67 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 96' ' ' GLY . 54.0 p-10 -78.67 179.51 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.761 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.81 26.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.644 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -130.08 -83.8 0.33 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.43 -26.9 0.12 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -72.46 141.16 48.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.519 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.08 89.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -148.54 136.9 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.559 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mm -77.48 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.483 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -140.46 168.95 12.91 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.4 -37.14 60.59 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.544 2.163 . . . . 0.0 112.166 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -129.36 122.79 30.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.52 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.636 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -153.79 149.23 27.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.428 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -87.55 130.82 34.6 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.5 t -126.05 108.4 11.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.15 179.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.417 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' SER . 50.6 p90 -69.34 -40.48 77.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.539 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 109' ' ' PHE . 9.4 t -57.01 149.56 18.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.331 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.77 170.59 8.68 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.643 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.4 -40.39 62.43 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.459 2.106 . . . . 0.0 112.125 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.44 -47.91 84.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.591 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.5 t0 . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.546 -179.773 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.866 0.365 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -145.65 177.02 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.577 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -145.54 133.72 21.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.452 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.89 149.0 32.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 18.9 mtpp -114.11 68.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.268 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -95.22 125.08 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.268 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 t -161.65 142.37 10.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -129.46 134.19 47.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.404 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.42 143.23 47.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -5.14 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.265 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 28.5 t0 -153.42 163.85 39.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.566 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.14 -38.15 89.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -61.25 -45.77 93.16 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.594 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -66.05 -27.82 68.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.437 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -73.44 -40.55 64.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.864 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -66.89 -48.21 69.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.986 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.33 -42.34 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.94 -43.32 99.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.788 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.5 p -67.6 -43.54 80.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 110.813 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -64.86 -35.52 81.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.65 -58.12 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.805 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.2 m -138.42 94.06 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.686 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.528 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 2.4 p -100.2 -2.73 33.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.342 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -145.75 126.17 14.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -110.94 111.25 22.25 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.159 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.564 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -70.56 156.34 39.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.391 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.04 125.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 47' ' ' ASP . 67.6 m-20 -147.24 149.43 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -72.15 16.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 45' ' ' ASP . 92.4 m-20 -112.07 -3.23 14.79 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -119.19 132.46 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.935 0.398 . . . . 0.0 110.276 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.409 ' OG1' ' OD1' ' A' ' 51' ' ' ASP . 72.6 p -101.84 157.52 16.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -48.9 -41.99 35.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.702 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.409 ' OD1' ' OG1' ' A' ' 49' ' ' THR . 1.4 p-10 -59.54 -49.33 78.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 110.337 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -35.52 81.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.316 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.76 -43.86 98.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.314 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.09 -40.61 98.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.381 0.61 . . . . 0.0 110.073 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.11 -43.61 82.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.855 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.37 -52.38 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.37 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 8.6 p -59.0 -46.09 91.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.977 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.401 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 56.8 tp -65.59 -54.7 24.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.772 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -58.99 -31.69 69.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.845 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.19 -56.46 12.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.366 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -69.1 -43.87 81.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.705 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.06 -44.8 91.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.285 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.7 p -63.05 -45.95 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.67 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -63.34 -52.65 60.91 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.412 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -110.58 73.21 0.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.543 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.01 -46.53 2.8 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.545 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.3 Cg_endo -82.39 107.1 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.353 2.035 . . . . 0.0 111.88 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.569 ' C ' ' H ' ' A' ' 70' ' ' GLU . 2.5 m -133.59 -13.51 2.59 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.252 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -51.02 -6.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.997 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.569 ' H ' ' C ' ' A' ' 68' ' ' CYS . 14.4 pt-20 -72.35 -36.96 68.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.505 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -83.65 156.53 22.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.624 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 19.2 p-10 -76.06 -59.65 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.428 ' H ' ' CG ' ' A' ' 72' ' ' ASP . 27.4 m -95.48 -44.87 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.11 -0.85 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.106 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . -106.17 -41.08 1.85 Allowed Glycine 0 N--CA 1.465 0.616 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.2 m -48.77 -12.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 75' ' ' GLY . 21.4 ptmt -56.42 -37.23 69.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.85 -45.67 94.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.803 0.335 . . . . 0.0 110.228 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 82.1 m -64.39 -48.0 77.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.03 82.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.268 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.53 -43.64 98.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.8 -40.7 92.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.65 -50.92 67.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.23 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 89' ' ' TYR . 36.3 ptt180 -69.67 -40.29 76.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 110.642 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.766 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.9 -40.33 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.29 -81.04 1.37 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 84' ' ' ARG . 99.7 m-20 -135.2 97.6 3.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 84' ' ' ARG . 0.3 OUTLIER -55.36 -100.67 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.436 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.5 m -146.38 162.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.524 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.06 142.15 50.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.941 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.0 tt -122.35 125.63 46.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.306 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -128.09 154.29 45.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.558 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 23.3 t0 -74.88 177.52 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.5 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.543 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 8.5 tm-20 -47.03 -59.77 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.52 -46.86 91.4 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.24 -13.53 0.82 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.64 141.79 58.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 0.0 110.56 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -76.6 88.33 3.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.545 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -151.02 137.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 101' ' ' ILE . 95.3 mt -64.33 132.21 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 110.197 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.63 160.89 30.54 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.31 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.46 -24.69 78.72 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.85 2.367 . . . . 0.0 111.94 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -125.36 57.2 1.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.783 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -102.59 144.65 30.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.012 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.484 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 57.4 t80 -97.34 127.43 43.29 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.308 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.1 p -125.39 112.29 16.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.484 ' OG ' ' CE2' ' A' ' 106' ' ' TYR . 5.4 p -171.46 168.76 6.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.772 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 110' ' ' SER . 44.5 p90 -63.5 -47.16 82.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.52 ' N ' ' CG ' ' A' ' 109' ' ' PHE . 17.1 m -59.43 144.14 47.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.83 170.64 15.3 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.562 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.12 -42.03 54.96 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.383 2.055 . . . . 0.0 111.877 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 46.4 p-10 -88.1 -34.18 18.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 67.7 t0 . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.891 0.377 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -148.81 160.0 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.52 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.63 141.72 33.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 tt -107.33 128.94 61.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.04 16.81 10.84 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.227 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mt -108.05 131.4 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.152 0.501 . . . . 0.0 111.13 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.4 m -141.31 145.25 35.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.474 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 107' ' ' CYS . 87.4 t80 -85.0 114.79 22.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.365 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.95 142.38 46.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.529 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.72 -79.49 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.65 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.73 168.7 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.71 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.762 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -57.7 10.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.582 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -65.95 -23.62 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.288 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.48 -46.31 70.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -71.51 -39.32 70.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.494 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.8 -48.22 89.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.271 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.47 -42.92 91.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.967 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 40' ' ' SER . 10.6 t -62.62 -47.94 81.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.502 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.04 -45.75 92.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.727 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.86 65.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.5 t -164.08 78.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' SER . 61.2 p -83.14 -7.22 59.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.294 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -171.16 127.97 0.7 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 43' ' ' GLU . 21.0 t80 -128.76 158.16 39.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.181 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -109.58 116.79 32.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.42 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.82 129.67 75.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.206 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 47' ' ' ASP . 19.6 p-10 -113.94 169.02 9.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.985 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 55.7 mtpt -52.63 86.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.515 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER 167.8 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.449 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.4 t -76.85 129.84 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.311 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLU . 3.8 p -124.18 157.53 34.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.415 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -36.54 -39.3 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.646 -179.422 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.404 ' H ' ' HG ' ' A' ' 50' ' ' LEU . 99.9 m-20 -63.18 -45.95 89.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.445 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 49' ' ' THR . 46.0 tp10 -66.98 -38.44 86.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.464 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 5.5 mt -62.45 -43.14 99.53 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 121.078 0.466 . . . . 0.0 110.617 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.64 -39.47 84.6 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.315 0.579 . . . . 0.0 110.656 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.24 -44.18 80.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.68 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 57' ' ' VAL . 8.4 p -76.64 -45.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.848 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 54.0 t -58.33 -47.6 87.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.58 -56.47 13.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.311 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.05 -40.48 58.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.186 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.52 89.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.2 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.755 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.75 -42.79 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.601 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -63.23 -54.86 30.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.901 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -62.24 -48.76 78.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.541 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.9 tp -108.54 93.57 4.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -79.15 -46.4 1.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.69 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.1 Cg_endo -83.93 116.39 2.15 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.102 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 m -130.64 -34.09 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.556 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -64.57 -28.03 69.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.589 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 70' ' ' GLU . 57.8 mp0 -73.33 -36.37 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 75' ' ' GLY . 92.7 m-70 -91.4 108.67 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.98 -29.85 70.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -59.66 -45.46 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 75' ' ' GLY . 7.0 mt -103.08 -10.75 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . -48.09 -177.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 75' ' ' GLY . 2.0 p 73.74 -30.93 0.21 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.353 0.597 . . . . 0.0 110.642 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.556 ' CB ' ' HZ1' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -62.24 -33.88 75.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.959 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -59.68 -42.03 87.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 83.2 m -63.43 -50.1 71.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.14 81.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.148 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.8 tp -50.99 -41.53 59.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.73 -49.88 75.72 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.141 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.01 -41.99 99.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.35 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -65.83 -41.02 92.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt -62.56 -29.87 70.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.339 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.51 0.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.459 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . 171.14 -74.2 0.1 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 89' ' ' TYR . 9.9 p-10 176.99 -74.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 1.8 t80 75.81 -71.14 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.1 t -52.9 131.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.337 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.567 ' CZ ' ' O ' ' A' ' 89' ' ' TYR . 37.1 m-85 -120.42 160.41 23.15 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.034 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.401 ' CD2' ' C ' ' A' ' 92' ' ' LEU . 8.6 tt -123.79 126.78 47.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.425 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -130.06 150.54 51.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.767 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -82.82 -158.89 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.457 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.53 -49.69 74.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.437 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.94 -113.22 0.15 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -154.05 45.8 0.56 Allowed Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -124.94 131.39 53.43 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.11 89.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.695 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -158.37 146.52 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 mm -73.45 128.91 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.068 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -144.79 171.27 6.84 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.72 -36.74 42.67 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.542 2.161 . . . . 0.0 111.93 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -130.91 131.29 44.4 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.667 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -162.39 167.82 23.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.387 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -139.21 142.17 37.9 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.501 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.9 t -114.28 113.49 24.66 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.0 p -162.22 170.87 18.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.887 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 110' ' ' SER . 44.9 p90 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.513 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 8.4 t -54.91 148.74 12.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.497 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.34 170.4 6.13 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 114' ' ' ASP . 52.2 Cg_exo -51.32 -40.34 61.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.486 2.124 . . . . 0.0 111.903 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -81.6 35.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.426 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 112' ' ' PRO . 68.2 t0 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.524 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 121.322 0.582 . . . . 999.99000000000001 111.615 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -146.18 169.3 19.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.495 -0.775 . . . . 999.99000000000001 110.835 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -126.18 119.7 28.17 Favored 'General case' 0 C--N 1.267 -2.988 1 O-C-N 114.155 -5.341 . . . . 999.99000000000001 111.2 -174.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.55 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -104.25 145.97 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 114.963 -1.017 . . . . 999.99000000000001 110.443 -179.101 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.513 ' N ' HG13 ' A' ' 21' ' ' ILE . 14.1 tttt -134.85 10.67 3.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.142 -0.935 . . . . 999.99000000000001 110.042 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.55 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.4 mp -94.82 110.73 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.09 0.472 . . . . 999.99000000000001 111.354 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -119.63 137.59 53.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.449 -0.796 . . . . 999.99000000000001 109.66 179.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -86.14 114.9 23.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.101 0.477 . . . . 999.99000000000001 110.272 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.91 107.82 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 999.99000000000001 111.048 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.429 HD13 HH22 ' A' ' 84' ' ' ARG . 6.4 mt -68.95 -40.02 79.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 999.99000000000001 109.536 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -151.62 172.25 16.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.794 -1.093 . . . . 999.99000000000001 109.125 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.2 -26.5 62.87 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.584 -0.447 . . . . 999.99000000000001 109.999 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 32' ' ' ASP . 24.8 m -59.97 -63.89 1.14 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.958 -0.565 . . . . 999.99000000000001 110.287 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 69.5 m-85 -75.68 16.4 0.39 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 119.091 0.859 . . . . 999.99000000000001 109.636 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.5 t0 -88.65 -64.79 1.09 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.07 -1.456 . . . . 999.99000000000001 107.07 177.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.3 p -67.8 -41.37 83.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.256 -0.884 . . . . 999.99000000000001 109.046 177.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.6 t -66.51 -50.3 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 112.787 0.662 . . . . 999.99000000000001 112.787 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 12.9 tp -64.96 -41.73 95.22 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.678 -0.809 . . . . 892.61000000000001 110.448 -178.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.54 -44.64 95.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.978 -0.289 . . . . 999.99000000000001 111.411 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -63.18 -45.57 91.16 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.365 0.506 . . . . 999.99000000000001 112.365 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.35 -28.28 52.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.227 -0.442 . . . . 999.99000000000001 110.758 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.591 ' SG ' ' CD2' ' A' ' 42' ' ' PHE . 6.9 t -147.66 80.83 1.5 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.398 0.888 . . . . 999.99000000000001 113.398 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 p -91.45 -14.96 29.61 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.834 -0.621 . . . . 999.99000000000001 109.609 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -151.33 144.6 24.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.685 0.994 . . . . 999.99000000000001 113.685 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.591 ' CD2' ' SG ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -140.48 147.44 39.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.168 -0.923 . . . . 999.99000000000001 111.23 177.862 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -110.59 119.12 38.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.736 -0.666 . . . . 999.99000000000001 110.207 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.474 ' CG2' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -121.61 111.27 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 114.711 1.374 . . . . 999.99000000000001 114.711 -176.698 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.89 161.11 10.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 105.307 -2.109 . . . . 999.99000000000001 105.307 175.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -83.44 35.99 0.52 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 122.403 2.365 . . . . 999.99000000000001 110.376 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -131.94 2.38 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.883 -0.784 . . . . 999.99000000000001 108.883 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.0 t -88.63 124.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.498 -0.774 . . . . 999.99000000000001 109.62 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 52' ' ' GLU . 35.0 p -103.19 147.82 26.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 731.38 109.888 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -33.77 -34.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 441.33999999999997 110.938 -178.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' THR . 98.3 m-20 -60.7 -48.6 81.04 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 698.47000000000003 110.519 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.9 mt-10 -68.24 -38.14 81.53 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.31 -0.405 . . . . 999.99000000000001 110.385 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.25 -45.83 92.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.142 -0.688 . . . . 717.46000000000004 109.142 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.457 ' CD2' HG23 ' A' ' 90' ' ' VAL . 1.9 mt -63.39 -41.95 98.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.537 -0.756 . . . . 612.28999999999996 110.266 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.37 -50.4 73.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.525 -0.761 . . . . 805.60000000000002 111.285 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.8 -36.45 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.821 0.344 . . . . 999.99000000000001 110.925 -179.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.38 -48.24 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 556.5 110.351 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD1' ' CD1' ' A' ' 81' ' ' LEU . 32.2 tp -63.94 -44.06 93.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.204 -0.907 . . . . 641.33000000000004 109.811 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.71 -43.08 97.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.984 -0.553 . . . . 999.99000000000001 111.211 179.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.79 84.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.748 0.309 . . . . 848.76999999999998 110.972 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.7 t -64.24 -42.01 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 599.86000000000001 110.384 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.16 -39.71 93.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 999.99000000000001 109.968 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -42.07 86.07 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.3 -0.409 . . . . 999.99000000000001 111.69 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -44.88 39.62 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.598 -0.441 . . . . 999.99000000000001 110.895 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.457 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 3.0 tp -108.11 71.7 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 999.99000000000001 110.713 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.532 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -78.14 -45.47 2.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 999.99000000000001 110.82 179.42 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 66' ' ' SER . 72.8 Cg_endo -80.42 56.89 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.884 2.39 . . . . 999.99000000000001 113.365 -179.554 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.55 -33.27 25.49 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.935 0.398 . . . . 908.97000000000003 110.318 179.235 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.93 -20.44 65.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.784 -0.644 . . . . 999.99000000000001 111.587 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.79 -38.36 70.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.646 -0.252 . . . . 999.99000000000001 111.451 -178.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -87.78 120.56 29.23 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.95 -0.3 . . . . 999.99000000000001 110.388 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.83 -41.31 97.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.509 0.195 . . . . 999.99000000000001 111.284 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.85 -47.67 92.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 999.99000000000001 110.252 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 75' ' ' GLY . 30.7 mt -81.62 -26.76 9.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 115.975 -0.557 . . . . 999.99000000000001 110.666 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -22.79 -78.93 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 N-CA-C 111.189 -0.764 . . . . 719.80999999999995 111.189 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -25.85 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.942 0.719 . . . . 989.60000000000002 112.942 -178.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -56.02 -29.59 60.6 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.348 -0.22 . . . . 999.99000000000001 110.941 179.635 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.18 -46.2 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 110.16 -0.311 . . . . 999.99000000000001 110.16 178.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.86 -43.77 97.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.0 -0.545 . . . . 800.41999999999996 110.127 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.08 92.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 563.47000000000003 109.793 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.415 ' CD1' ' CD1' ' A' ' 58' ' ' LEU . 58.1 tp -62.65 -45.0 94.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.798 -0.637 . . . . 913.92999999999995 110.331 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.1 tp -62.95 -43.2 99.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.877 -0.601 . . . . 999.99000000000001 110.137 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -64.44 -38.74 92.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.158 -0.474 . . . . 999.99000000000001 110.143 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 97.0 mtt180 -65.73 -39.87 91.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.999 0.428 . . . . 999.99000000000001 110.531 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tp -73.5 -24.52 60.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 999.99000000000001 110.169 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.8 99.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.108 -0.496 . . . . 999.99000000000001 111.941 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.27 -55.79 0.07 OUTLIER Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.238 -0.982 . . . . 999.99000000000001 112.211 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 99.4 m-20 -87.88 115.81 25.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 999.99000000000001 110.119 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.4 p90 -109.6 -111.36 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.559 -0.291 . . . . 999.99000000000001 110.385 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.463 ' H ' ' HD2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -150.73 115.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.373 -0.973 . . . . 608.69000000000005 108.373 178.423 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.17 160.55 32.24 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.02 -1.104 . . . . 586.54999999999995 108.02 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 3.2 tt -146.49 134.74 21.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 120.002 1.274 . . . . 364.69 107.968 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.08 162.73 37.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.186 -0.606 . . . . 999.99000000000001 112.152 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -77.65 -177.98 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.313 -0.858 . . . . 841.49000000000001 110.719 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -74.69 49.82 0.41 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.06 -0.518 . . . . 999.99000000000001 110.609 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -152.45 -53.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.573 -1.011 . . . . 951.75999999999999 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.49 -19.51 2.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.224 -1.151 . . . . 744.85000000000002 110.224 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -70.78 136.93 49.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.34 -0.244 . . . . 774.99000000000001 110.34 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -74.89 89.93 2.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.898 -0.408 . . . . 691.20000000000005 109.898 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.02 149.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 663.89999999999998 110.502 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.86 123.18 41.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.535 -0.543 . . . . 679.55999999999995 109.535 179.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . . . -139.48 178.15 1.74 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.83 -0.623 . . . . 660.94000000000005 109.653 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 102' ' ' ALA . 50.8 Cg_exo -53.74 -35.87 80.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.317 2.011 . . . . 999.99000000000001 111.603 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -121.97 97.9 5.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.94 -0.573 . . . . 999.99000000000001 110.715 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.31 132.2 56.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.045 -0.525 . . . . 630.75 110.542 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 73.8 t80 -92.73 106.07 18.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.367 -0.379 . . . . 807.87 109.993 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.423 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 4.1 t -98.24 118.57 35.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.187 -0.46 . . . . 611.89999999999998 110.942 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.475 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 11.5 t -174.41 168.45 3.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.149 0.499 . . . . 710.65999999999997 110.856 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.463 ' N ' HG12 ' A' ' 90' ' ' VAL . 25.7 p90 -87.79 25.08 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.201 -0.666 . . . . 999.99000000000001 109.201 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.0 m -117.36 121.65 41.7 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.815 -0.63 . . . . 999.99000000000001 110.021 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.74 162.02 2.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.611 -0.722 . . . . 854.05999999999995 110.985 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -46.04 35.48 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.576 2.184 . . . . 999.99000000000001 112.135 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.5 p-10 -74.65 -36.5 62.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.999 0.904 . . . . 999.99000000000001 109.09 177.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 t0 . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 113.624 -1.626 . . . . 999.99000000000001 110.347 179.523 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.455 -1.458 . . . . 999.99000000000001 109.455 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.624 ' CD ' ' HD2' ' A' ' 3' ' ' LYS . 6.6 tptt 89.11 -77.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.819 0.364 . . . . 999.99000000000001 110.706 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.744 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 128.31 -138.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 O-C-N 124.341 1.025 . . . . 999.99000000000001 109.894 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.654 ' CG1' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 174.89 27.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.574 0 O-C-N 123.838 0.711 . . . . 999.99000000000001 112.399 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.481 ' H ' ' HG2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -152.75 22.11 0.6 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.256 0.55 . . . . 999.99000000000001 110.538 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.2 172.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.936 -1.029 . . . . 999.99000000000001 111.532 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.529 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -115.42 -174.3 2.49 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.441 -1.318 . . . . 999.99000000000001 107.441 178.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.777 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 14.5 m-20 68.54 170.35 0.28 Allowed 'General case' 0 C--O 1.207 -1.146 0 CA-C-O 116.888 -1.529 . . . . 999.99000000000001 107.227 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.933 ' O ' ' C ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -27.22 142.3 0.05 OUTLIER Pre-proline 0 CA--C 1.479 -1.771 0 CA-C-O 113.768 -3.015 . . . . 999.99000000000001 108.609 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 1.591 ' CB ' ' CG ' ' A' ' 10' ' ' PRO 0.432 5.9 Cg_exo -55.08 178.3 0.09 OUTLIER 'Trans proline' 2 N--CA 2.068 35.282 3 C-N-CA 134.299 10.0 . . . . 999.99000000000001 128.721 179.226 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER 42.98 -108.63 0.12 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 109.758 -3.383 . . . . 999.99000000000001 107.648 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.721 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 25.6 t -49.36 -24.25 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 105.611 -1.996 . . . . 999.99000000000001 105.611 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.933 ' C ' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -173.78 114.56 0.21 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 113.722 -3.037 . . . . 999.99000000000001 111.288 178.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.418 ' CB ' ' CA ' ' A' ' 10' ' ' PRO 0.455 0.9 OUTLIER -179.74 -175.77 0.34 Allowed 'General case' 2 N--CA 1.634 8.739 0 O-C-N 127.822 3.201 . . . . 999.99000000000001 113.96 172.029 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.484 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -142.71 163.11 40.6 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 112.743 -2.026 . . . . 999.99000000000001 109.19 173.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.754 ' C ' ' H ' ' A' ' 18' ' ' THR . 86.7 Cg_exo -41.58 146.84 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.361 2.04 . . . . 999.99000000000001 112.346 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.58 17.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.315 0.579 . . . . 999.99000000000001 110.985 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.754 ' H ' ' C ' ' A' ' 16' ' ' PRO . 2.6 p -116.41 158.53 23.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.074 -0.966 . . . . 999.99000000000001 110.591 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -103.11 137.81 40.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.313 -0.625 . . . . 999.99000000000001 109.313 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 97.5 mttt -95.53 114.59 26.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.211 0.529 . . . . 999.99000000000001 111.16 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.594 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -100.68 147.1 8.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.268 -0.878 . . . . 999.99000000000001 110.178 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.558 ' N ' HG13 ' A' ' 21' ' ' ILE . 11.7 tttt -134.78 11.72 3.68 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.667 -0.697 . . . . 999.99000000000001 110.783 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.594 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.7 mp -95.85 111.47 26.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.931 0.396 . . . . 999.99000000000001 110.697 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.44 130.68 53.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 999.99000000000001 110.293 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -78.02 113.19 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.099 0.476 . . . . 999.99000000000001 110.41 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.26 107.85 19.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 999.99000000000001 110.756 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.11 -40.06 82.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 999.99000000000001 110.181 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -154.08 170.2 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 999.99000000000001 109.891 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.97 25.23 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.331 -0.395 . . . . 999.99000000000001 110.1 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 32' ' ' ASP . 17.1 m -58.71 -64.68 0.84 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.726 -0.67 . . . . 999.99000000000001 110.405 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 77.9 m-85 -75.93 16.49 0.41 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.357 0.526 . . . . 999.99000000000001 109.967 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.0 t0 -88.51 -65.5 1.01 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.65 -0.87 . . . . 999.99000000000001 108.65 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.2 p -73.1 -33.51 65.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.471 -0.786 . . . . 999.99000000000001 109.7 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.9 -50.1 45.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.077 -0.51 . . . . 999.99000000000001 111.457 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 16.9 tp -64.05 -41.73 97.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 119.91 -0.716 . . . . 892.61000000000001 110.521 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -62.68 -45.65 91.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.353 -0.385 . . . . 999.99000000000001 110.937 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -64.35 -39.69 94.38 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.906 0.335 . . . . 999.99000000000001 111.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.55 -27.33 31.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 999.99000000000001 110.654 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 42' ' ' PHE . 2.9 t -147.78 85.3 1.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 999.99000000000001 111.982 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 p -97.13 -16.28 20.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.878 -0.601 . . . . 999.99000000000001 110.094 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.484 ' CG ' ' HE3' ' A' ' 22' ' ' LYS . 41.4 mt-10 -152.03 144.48 24.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.047 -0.979 . . . . 999.99000000000001 112.067 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CD2' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -142.94 141.76 31.52 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.764 -0.653 . . . . 999.99000000000001 111.564 179.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 16.5 pt-20 -105.91 115.31 30.01 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.814 -0.63 . . . . 999.99000000000001 110.508 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -119.89 111.95 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.854 0.835 . . . . 999.99000000000001 112.644 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 2.2 m-20 -57.73 170.76 0.55 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.014 -1.448 . . . . 999.99000000000001 107.667 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -87.89 31.67 0.77 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.295 1.861 . . . . 999.99000000000001 110.084 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -133.72 -3.9 2.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 999.99000000000001 109.817 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.429 HG12 ' CB ' ' A' ' 52' ' ' GLU . 19.2 t -79.53 126.15 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.877 -0.601 . . . . 999.99000000000001 109.996 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' GLU . 19.8 p -103.18 145.66 29.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.907 -0.588 . . . . 731.38 110.178 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -30.31 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.773 0.671 . . . . 441.33999999999997 110.882 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' THR . 97.6 m-20 -60.22 -49.48 77.45 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.326 -0.397 . . . . 698.47000000000003 110.598 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.3 mt-10 -66.78 -38.95 87.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 999.99000000000001 110.55 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.417 ' O ' HG21 ' A' ' 57' ' ' VAL . 20.4 tp -61.08 -46.02 92.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.695 -0.483 . . . . 717.46000000000004 109.695 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.461 HD21 HG23 ' A' ' 90' ' ' VAL . 1.6 mt -63.32 -40.96 98.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 612.28999999999996 110.432 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -60.64 -51.52 69.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 805.60000000000002 111.064 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.86 -35.8 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.779 0.323 . . . . 999.99000000000001 110.795 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 53' ' ' LEU . 4.6 t -64.28 -48.04 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.06 -0.518 . . . . 556.5 110.653 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.454 ' CD1' ' CD1' ' A' ' 81' ' ' LEU . 30.5 tp -65.1 -43.38 92.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 641.33000000000004 110.136 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -64.62 -42.08 95.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.931 -0.577 . . . . 999.99000000000001 110.78 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . -61.4 -50.95 70.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 848.76999999999998 110.828 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.76 -40.82 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 599.86000000000001 110.555 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -66.35 -36.91 84.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.927 -0.578 . . . . 999.99000000000001 110.36 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -41.78 75.58 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.229 -0.441 . . . . 999.99000000000001 111.221 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -74.22 -48.59 27.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.423 -0.353 . . . . 999.99000000000001 110.871 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.459 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 3.7 tp -106.23 72.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 999.99000000000001 110.438 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.521 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -78.23 -49.3 1.89 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 999.99000000000001 110.678 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 66' ' ' SER . 59.8 Cg_endo -76.53 63.18 7.22 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.859 2.372 . . . . 999.99000000000001 112.423 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -91.86 -31.67 15.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 908.97000000000003 110.518 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -65.69 -16.52 63.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 999.99000000000001 110.873 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.78 -39.81 66.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.401 -0.363 . . . . 999.99000000000001 110.956 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 75' ' ' GLY . 99.0 m-70 -86.73 118.52 26.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 999.99000000000001 110.281 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.06 -40.64 94.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 999.99000000000001 110.947 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -47.24 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 999.99000000000001 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 43.1 mt -83.27 -29.68 8.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.144 -0.48 . . . . 999.99000000000001 110.612 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -21.71 -76.03 0.01 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 110.863 -0.895 . . . . 719.80999999999995 110.863 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -25.0 -35.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.016 0.48 . . . . 989.60000000000002 112.169 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -53.93 -29.75 43.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.267 -0.173 . . . . 999.99000000000001 110.606 179.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.77 -46.9 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.781 0.324 . . . . 999.99000000000001 110.389 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 m -61.79 -44.64 96.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.938 -0.574 . . . . 800.41999999999996 110.228 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.02 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.962 -0.563 . . . . 563.47000000000003 110.224 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.454 ' CD1' ' CD1' ' A' ' 58' ' ' LEU . 58.3 tp -62.67 -45.31 93.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.078 -0.51 . . . . 913.92999999999995 110.479 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.2 -43.32 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 999.99000000000001 110.345 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.3 -40.08 96.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 999.99000000000001 110.43 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 91.7 mtt180 -65.33 -40.0 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 999.99000000000001 110.745 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tp -74.94 -19.37 60.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.947 -0.57 . . . . 999.99000000000001 110.389 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.76 -45.13 94.12 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.364 -0.38 . . . . 999.99000000000001 111.097 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.55 -56.3 0.06 OUTLIER Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.939 -0.648 . . . . 999.99000000000001 111.505 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 92.0 m-20 -84.15 112.81 20.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.34 -0.244 . . . . 999.99000000000001 110.34 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.467 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.2 p90 -108.62 -110.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.323 . . . . 999.99000000000001 110.474 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.467 ' H ' ' HD2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -151.39 115.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.331 -0.618 . . . . 608.69000000000005 109.331 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -73.84 155.27 38.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.262 -0.644 . . . . 586.54999999999995 109.262 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 3.8 tt -142.35 135.19 28.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.723 -0.843 . . . . 364.69 108.723 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.51 163.73 32.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.882 0.372 . . . . 999.99000000000001 111.011 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -79.49 -175.73 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 841.49000000000001 110.36 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.08 50.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.145 -0.479 . . . . 999.99000000000001 110.687 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.39 -55.62 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.778 -0.929 . . . . 951.75999999999999 110.778 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.76 -20.3 2.18 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.572 -1.011 . . . . 744.85000000000002 110.572 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -72.33 136.8 46.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.739 0.304 . . . . 774.99000000000001 110.588 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -74.21 89.83 2.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 691.20000000000005 110.28 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.62 151.13 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 663.89999999999998 110.456 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.45 123.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.546 . . . . 679.55999999999995 110.208 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.44 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . . . -141.28 177.49 1.91 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 660.94000000000005 110.399 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 102' ' ' ALA . 53.2 Cg_exo -51.51 -36.79 60.81 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.704 2.269 . . . . 999.99000000000001 111.979 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -123.21 98.0 5.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.212 -0.449 . . . . 999.99000000000001 110.499 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.403 ' SD ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -116.01 134.84 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.536 . . . . 630.75 110.4 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 70.7 t80 -94.87 106.23 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 807.87 110.147 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.43 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 4.3 t -98.64 120.76 39.63 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.107 -0.497 . . . . 611.89999999999998 110.669 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.493 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 10.4 t -177.38 167.2 2.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.188 0.518 . . . . 710.65999999999997 110.738 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.458 ' N ' HG12 ' A' ' 90' ' ' VAL . 26.0 p90 -85.68 26.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 999.99000000000001 109.982 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.1 m -119.77 121.1 38.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.259 -0.428 . . . . 999.99000000000001 110.552 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.54 161.35 1.56 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.854 -0.612 . . . . 854.05999999999995 110.418 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.58 -47.46 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.558 2.172 . . . . 999.99000000000001 112.324 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 24.7 p-10 -72.95 -38.28 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 999.99000000000001 110.409 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 114.429 -1.259 . . . . 999.99000000000001 110.032 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -76.54 144.11 39.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.316 . . . . 0.0 110.333 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -133.14 -4.76 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.488 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 5' ' ' GLU . 7.1 p -77.24 -52.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.992 0.425 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.444 ' N ' ' CG1' ' A' ' 4' ' ' VAL . 85.8 mt-10 -153.74 150.82 28.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.771 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -102.38 125.47 49.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -173.18 52.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.553 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 9' ' ' LYS . 35.1 t0 43.97 -167.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.36 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.551 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 2.8 mptm? -46.03 157.32 0.41 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.745 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.22 156.32 62.42 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.325 2.017 . . . . 0.0 112.06 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -128.13 144.58 51.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.105 0.479 . . . . 0.0 110.327 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t 57.67 47.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -152.48 150.62 29.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.422 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -57.68 131.96 51.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.409 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 pt -66.95 154.24 92.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.824 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.44 -164.11 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.593 2.195 . . . . 0.0 111.92 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -74.95 1.36 13.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.49 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.9 p -85.25 169.6 13.64 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.322 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -113.83 171.3 7.67 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -112.52 147.39 36.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.37 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tp -108.65 134.29 51.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.05 -2.42 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mt -102.52 122.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.41 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -147.41 144.2 28.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.455 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.55 119.61 23.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.29 36.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -64.88 -40.5 95.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.569 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.3 t0 -156.25 -175.82 5.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.478 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -61.1 -42.91 99.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.53 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.3 m -63.12 -47.56 82.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.563 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -65.34 -33.46 76.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.447 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -65.46 -51.49 59.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.826 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 t -63.67 -44.86 92.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.749 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.9 t -62.73 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.84 -43.4 96.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.705 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.27 -45.79 91.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.59 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -65.25 -44.39 88.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.728 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.27 -54.52 14.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.472 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 60.8 m -118.58 79.22 1.35 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.562 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.46 -37.96 89.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.476 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -172.63 150.48 2.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.604 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -142.12 156.94 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.84 124.66 32.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.985 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 m -124.6 135.64 63.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.093 0.473 . . . . 0.0 110.592 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.24 168.57 19.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.145 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -73.7 161.25 30.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 56.96 33.86 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.678 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -75.14 140.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.242 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 20.3 p -90.76 -71.36 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 172.17 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.771 0.669 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 26.5 p-10 -55.88 -44.46 78.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.919 0.39 . . . . 0.0 110.451 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 79.5 tt0 -64.61 -41.24 96.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.419 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.429 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 19.3 mt -62.95 -43.64 98.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.83 -43.21 96.88 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.839 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -67.92 -43.05 80.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.022 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.71 -50.48 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 76.4 t -57.54 -48.21 83.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.92 -55.73 17.52 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.622 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -51.66 -41.82 61.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.304 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.44 99.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.588 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.91 -45.3 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.703 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.59 -42.17 82.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.589 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 t -61.34 -54.37 44.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.794 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.1 p -59.75 -45.42 92.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.152 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -108.01 81.34 1.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.55 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.63 -46.61 4.18 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 66' ' ' SER . 61.1 Cg_endo -81.91 106.4 1.61 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.335 2.023 . . . . 0.0 112.009 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.401 ' SG ' ' CG2' ' A' ' 78' ' ' VAL . 1.4 p -133.25 -42.0 0.88 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.871 0.367 . . . . 0.0 110.208 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -66.9 -22.91 65.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -72.29 -38.64 68.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.732 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 75' ' ' GLY . 77.0 m80 -97.66 125.3 42.36 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.76 -34.98 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.064 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.27 -45.98 95.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.073 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 31.8 mm -88.59 -22.38 6.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.201 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -37.71 -56.18 1.68 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.8 p -46.58 -19.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.722 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 88.9 tttt -62.03 -45.96 91.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.588 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 74.1 t -62.61 -44.53 99.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.57 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 77.9 m -62.0 -49.43 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.78 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.28 -44.53 94.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.72 -43.61 98.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 87' ' ' GLY . 33.2 t70 -62.11 -44.27 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 88' ' ' ASP . 87.5 mtm180 -66.83 -36.99 83.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.816 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.21 -46.33 87.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.406 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.21 -49.85 2.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.46 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -69.23 -95.65 0.05 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 83' ' ' ASP . 99.7 m-20 -68.92 -172.11 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.574 0.226 . . . . 0.0 110.495 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' CE1' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER 173.45 175.06 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.092 0.472 . . . . 0.0 110.322 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.27 138.29 47.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.479 ' OH ' ' CE1' ' A' ' 89' ' ' TYR . 54.5 m-85 -110.11 151.52 27.14 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.48 ' CD1' ' SG ' ' A' ' 107' ' ' CYS . 7.1 tt -131.29 124.6 30.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -132.76 154.68 50.0 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.694 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 97' ' ' GLY . 18.8 p-10 -82.98 177.41 8.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.16 26.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -144.3 -4.6 0.66 Allowed Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.559 ' N ' ' OD1' ' A' ' 94' ' ' ASP . . . 91.75 -6.27 79.73 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 45.1 t0 -86.9 117.19 25.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.791 0.329 . . . . 0.0 110.464 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.6 86.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.521 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 98' ' ' ASP . 67.7 t -156.83 134.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.47 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.513 ' N ' ' CD1' ' A' ' 101' ' ' ILE . 1.6 mp -68.92 131.44 33.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -146.06 172.0 5.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.582 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.46 -35.69 56.1 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.598 2.199 . . . . 0.0 111.812 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -118.63 74.23 0.96 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.002 0.43 . . . . 0.0 110.392 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -104.79 148.69 26.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.165 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.508 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 57.3 t80 -116.82 124.89 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.48 ' SG ' ' CD1' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -123.5 110.36 14.98 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.508 ' OG ' ' CE2' ' A' ' 106' ' ' TYR . 7.1 p -168.38 169.3 10.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.804 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 109' ' ' PHE . 30.1 t80 -62.46 -47.36 84.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -59.34 145.69 42.44 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.403 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.58 170.79 14.26 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.443 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.32 -42.29 55.1 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.526 2.15 . . . . 0.0 111.84 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.05 -41.11 97.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.02 0.438 . . . . 0.0 110.755 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.762 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -82.82 159.54 22.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 110.6 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -43.32 -45.08 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.1 p -97.31 126.47 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.337 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.42 179.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.431 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASP . 33.3 m-85 -158.6 60.6 0.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.459 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 6' ' ' PHE . 8.4 m120 32.83 -91.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.083 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' PHE . 52.1 p-10 -143.8 -170.88 3.42 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.742 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -80.84 148.22 64.31 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.666 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.93 76.7 1.19 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.469 2.112 . . . . 0.0 112.327 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.0 -39.28 89.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.32 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -71.66 -73.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.495 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -56.62 171.64 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.527 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.14 139.63 56.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.455 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.3 161.59 62.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.653 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -55.02 144.67 67.45 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.317 2.011 . . . . 0.0 112.088 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.6 t -101.65 9.02 41.45 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.573 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -111.14 -179.94 3.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.438 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' OG1' ' A' ' 18' ' ' THR . 33.7 ptt180 -139.24 167.18 22.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.358 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -116.17 146.7 42.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 8.3 tt -130.26 122.4 53.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.36 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -99.42 121.5 41.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.922 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.17 115.0 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.165 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -154.54 117.8 4.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -134.11 138.65 45.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.958 0.409 . . . . 0.0 110.425 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 143.11 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.6 mt -139.78 -79.72 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 21.9 p-10 -156.94 -62.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.583 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.545 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -178.11 -68.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.453 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.02 -51.21 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -69.73 -20.77 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.352 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.89 -52.86 17.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 36' ' ' SER . 78.1 p -68.46 -41.54 80.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.634 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.08 -45.63 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.71 -42.63 99.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 78.3 p -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.484 ' H ' ' HG ' ' A' ' 36' ' ' SER . 98.3 mttt -64.74 -41.2 96.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.678 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -59.31 -24.15 63.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.634 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 38' ' ' ALA . 8.5 m -162.42 63.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.569 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.4 p -68.49 -18.77 64.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.519 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -174.45 139.43 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 156.15 46.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.086 0.469 . . . . 0.0 110.181 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -119.51 113.83 21.34 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.973 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.58 133.82 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.255 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.42 141.1 28.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.317 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 64.3 tttp -47.56 101.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.94 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD2' ' C ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER 163.38 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.712 0.632 . . . . 0.0 110.3 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.76 136.91 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 110.454 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -92.42 155.52 17.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.05 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -42.65 -37.73 1.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.22 -43.59 95.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.211 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -65.61 -35.36 80.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.6 mt -61.53 -46.83 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.444 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.53 -41.58 98.46 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.452 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -43.14 99.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.93 -45.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-O 120.955 0.407 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.04 -48.37 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.894 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.7 -53.67 47.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.98 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -49.86 -42.6 47.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.829 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.93 -49.66 74.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.942 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.59 -48.06 90.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.247 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -45.32 -53.39 8.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.398 0.618 . . . . 0.0 110.414 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 t -60.08 -43.44 95.48 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.5 p -86.04 14.34 6.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.118 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.73 -24.01 23.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 110.212 179.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.479 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -41.33 -49.96 8.82 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.582 -178.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 66' ' ' SER . 50.2 Cg_exo -53.04 -39.75 78.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.149 1.899 . . . . 0.0 112.218 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.8 m -68.02 -34.28 76.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.597 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -60.92 -30.45 70.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.517 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.62 -33.64 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.475 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 75' ' ' GLY . 97.8 m-70 -97.05 118.49 33.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.238 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.0 p-10 -68.5 -35.38 77.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 78.1 t -61.57 -47.85 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 76' ' ' THR . 58.6 mt -88.42 -34.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.391 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -39.89 -21.75 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' ILE . 46.2 p -54.76 -29.73 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.103 0.478 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -32.89 66.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.09 -46.17 97.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.43 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 94.2 m -63.66 -39.13 93.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.8 -43.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.82 -41.45 99.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.4 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.58 -41.9 99.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.566 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 87' ' ' GLY . 40.0 t0 -62.19 -43.11 99.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -69.5 -37.61 77.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.518 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.61 -43.11 99.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.464 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.68 -12.15 22.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.556 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -119.78 57.17 0.57 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 63.51 98.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.086 0.469 . . . . 0.0 110.504 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -55.29 -100.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.12 162.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.157 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -116.29 139.77 50.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.861 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.87 132.58 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -140.98 154.78 46.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.644 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -85.13 -162.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.564 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -73.01 51.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.566 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.43 -90.15 0.08 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.5 -29.07 0.02 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.31 139.93 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -80.96 90.24 5.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -146.61 138.52 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.516 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' A' ' 101' ' ' ILE . 2.5 mp -71.47 131.66 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -145.8 172.56 5.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.631 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.17 -36.29 55.18 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.559 2.173 . . . . 0.0 112.162 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -132.73 103.09 5.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -122.55 148.42 45.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.214 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -101.79 119.9 39.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.06 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.32 112.97 20.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.476 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 t -177.34 168.77 2.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.847 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 -45.48 93.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.6 p -59.14 147.06 36.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.281 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -87.53 170.07 12.75 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.457 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -50.15 -43.97 40.22 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.414 2.076 . . . . 0.0 111.931 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 31.5 p-10 -90.07 -37.84 13.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.97 0.415 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 61.2 t0 . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.545 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.55 ' C ' ' H ' ' A' ' 4' ' ' VAL . 46.5 mttp -65.26 -76.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? 65.87 -7.82 0.35 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.594 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 2' ' ' LYS . 19.6 m -86.93 -163.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.01 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -109.95 150.99 27.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.04 0.448 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -156.42 81.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.488 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -149.13 85.11 1.46 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.831 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.05 176.83 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.098 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.516 ' CB ' ' HZ1' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -104.58 153.38 39.23 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.557 -179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 12' ' ' VAL . 47.1 Cg_endo -67.94 -93.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.676 2.251 . . . . 0.0 111.991 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 13' ' ' ARG . 65.0 tttm 41.92 -88.46 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.716 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 10' ' ' PRO . 16.1 m -71.21 21.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.532 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.563 ' H ' ' C ' ' A' ' 11' ' ' LYS . 61.1 ttp180 -155.54 156.71 35.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.453 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.03 139.81 58.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 110.499 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.548 ' H ' ' CD1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -74.86 160.47 80.68 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.44 -178.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.55 142.33 60.19 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.129 1.886 . . . . 0.0 112.184 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m -78.6 4.52 13.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.453 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 2.3 t -162.09 153.73 18.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.523 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 44' ' ' VAL . 84.8 mtp180 -105.26 140.95 37.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.957 0.408 . . . . 0.0 110.292 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -105.53 148.6 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.133 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.2 tp -127.69 135.12 63.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.307 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -137.8 -35.23 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.817 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.445 ' H ' ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.3 140.52 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.263 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -155.26 144.76 21.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.35 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.39 137.84 55.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 116.11 22.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.584 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.418 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 54.1 mt -62.06 -42.86 99.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.456 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 27' ' ' LEU . 61.8 m-20 -158.77 20.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 73.81 -51.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m -61.36 -53.53 55.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.285 0.565 . . . . 0.0 110.696 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -71.24 -27.33 63.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.922 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.413 ' O ' ' OG ' ' A' ' 36' ' ' SER . 27.3 t70 -60.89 -44.51 97.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.255 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.0 p -70.35 -42.21 72.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.29 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.7 -48.88 86.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.383 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.501 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.3 mp -64.37 -40.73 96.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.498 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 40' ' ' SER . 75.1 m -56.3 -43.38 78.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.09 89.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.502 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.34 2.7 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.861 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.518 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 18.2 p -174.45 54.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.108 0.48 . . . . 0.0 110.286 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 36' ' ' SER . 78.0 p -60.11 -36.97 78.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.754 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -136.59 125.67 24.47 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.453 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -129.82 131.63 46.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.48 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -91.48 126.67 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.15 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.454 ' O ' ' OG1' ' A' ' 18' ' ' THR . 47.1 t -122.48 126.19 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.115 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -48.84 160.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 22.6 pttm -59.72 -50.03 75.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.036 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 49.9 t0 -91.63 90.36 7.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -147.71 128.23 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.275 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -90.48 151.67 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.228 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.69 -32.86 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.375 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -51.11 71.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.289 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.66 -41.71 95.92 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 53' ' ' LEU . 2.8 tm? -61.78 -50.72 71.22 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.8 tp -50.73 -41.72 56.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.14 -35.8 71.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.7 -51.78 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 14.8 p -61.39 -42.7 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.908 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.406 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 57.4 tp -60.45 -54.5 44.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.28 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -53.89 -41.72 67.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.88 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.31 -46.66 82.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.543 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.84 -43.71 97.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.437 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.564 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -62.63 -44.08 97.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.822 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.2 p -68.53 -64.81 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.725 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.41 83.35 2.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.569 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -74.87 -45.73 5.06 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.322 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.8 Cg_endo -83.25 114.32 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.599 2.2 . . . . 0.0 111.987 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.76 -19.39 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.0 -9.84 48.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.759 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.55 -38.5 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.472 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.1 m-70 -103.16 124.58 48.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.3 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.6 p-10 -60.58 -34.98 74.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.353 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.513 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 82.9 t -62.32 -47.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 45.9 mt -82.45 -23.37 9.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -34.91 -61.01 0.64 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -40.05 -24.38 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.95 0.405 . . . . 0.0 110.784 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 66.0 tttm -58.67 -45.39 89.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.213 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.1 t -57.4 -44.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.37 -46.52 88.3 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.73 -38.5 91.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.242 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.39 -42.7 99.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -45.92 91.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 0.0 110.09 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.93 -45.48 94.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -66.08 -39.43 90.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.076 0.465 . . . . 0.0 110.751 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.88 -29.25 69.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.44 59.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.498 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 168.62 -65.35 0.18 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 89' ' ' TYR . 28.0 t70 -173.89 176.0 2.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.548 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.545 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 t80 -175.18 -68.53 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.3 m -66.1 133.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.308 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 65.4 m-85 -116.87 145.89 43.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 tt -117.02 125.73 51.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.509 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -126.37 152.26 46.54 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.284 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 46.6 t0 -74.52 179.16 4.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.165 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.487 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 80.5 mm-40 -65.68 -37.54 86.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.66 -3.47 87.0 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.61 78.97 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.1 t0 -88.5 111.08 21.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -50.62 87.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.306 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 76.0 t -152.87 130.8 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.521 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.59 134.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.031 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.59 171.82 6.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.579 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -50.83 -38.07 56.53 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.414 2.076 . . . . 0.0 111.993 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -130.86 131.79 44.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.315 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.467 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -153.4 173.87 15.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.02 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.522 ' HH ' ' CB ' ' A' ' 108' ' ' SER . 42.0 t80 -117.98 109.73 16.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.343 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.8 t -107.55 115.74 30.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.534 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.522 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . 6.7 t -172.59 177.34 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.527 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -89.72 40.85 1.01 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.617 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.2 m -136.91 116.1 12.54 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.449 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.96 170.38 2.08 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.541 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -54.45 -43.13 61.66 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.428 2.085 . . . . 0.0 112.267 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -93.79 12.73 24.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.583 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.529 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -69.31 141.03 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.996 0.427 . . . . 0.0 110.209 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -114.48 -12.89 12.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.721 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 5' ' ' GLU . 35.9 m -114.94 -14.34 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.784 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 4' ' ' VAL . 48.0 mp0 43.53 98.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -82.68 138.28 34.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.943 0.401 . . . . 0.0 110.39 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -95.54 13.98 24.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.335 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 50.14 -171.02 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.284 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 pttm -109.31 118.64 50.46 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.563 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.25 65.19 7.93 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.412 2.075 . . . . 0.0 112.151 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -102.85 62.63 0.82 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.931 0.396 . . . . 0.0 110.281 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -168.29 -26.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -146.9 152.25 38.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.574 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -67.64 137.42 55.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.268 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -44.63 157.14 0.32 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.537 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -42.22 129.53 4.57 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.396 2.064 . . . . 0.0 112.031 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 95.6 p -88.29 -4.55 58.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.581 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 p -86.08 167.09 15.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.979 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' VAL . 62.6 ttp180 -110.53 151.83 27.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -112.42 144.96 40.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.069 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tp -119.32 142.8 32.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -130.74 -15.21 3.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.37 126.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 110.567 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 m -138.13 137.61 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.384 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.8 131.25 50.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.213 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.77 137.1 43.09 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 3.9 mm? -63.89 -41.42 97.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -159.59 179.07 9.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.83 83.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.499 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -63.2 -50.85 68.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.513 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -70.31 -22.69 62.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.65 -52.65 50.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 0.0 110.346 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -67.87 -44.6 76.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.34 -46.45 95.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.27 -43.55 97.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.592 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.3 t -60.58 -42.74 97.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -63.61 -44.47 93.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.549 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.17 -78.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.487 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 31.6 t -87.14 64.34 8.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.5 t -62.33 -41.28 98.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -154.28 148.11 25.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 81.8 t80 -150.28 150.12 31.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.495 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 16.7 pt-20 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.238 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 19' ' ' ARG . 65.4 t -127.89 133.27 67.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.116 0.484 . . . . 0.0 110.472 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -81.2 170.08 16.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.228 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.81 152.23 20.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.086 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.12 41.55 10.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.587 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 49' ' ' THR . 62.7 t -89.22 166.85 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 51' ' ' ASP . 31.0 m -121.71 129.33 52.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.26 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.453 ' H ' HD21 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -37.61 -27.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.697 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 49' ' ' THR . 64.2 t0 -60.03 -46.92 87.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.055 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 49' ' ' THR . 80.7 mm-40 -64.88 -41.95 95.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.367 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.59 -41.36 98.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.213 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -44.61 95.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.754 0.788 . . . . 0.0 110.367 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.36 -42.49 68.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.543 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.0 t -66.72 -51.27 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.071 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 9.3 p -58.17 -43.93 86.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.479 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 58.1 tp -60.06 -52.22 66.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.257 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.79 -31.53 71.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.16 -54.42 41.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.17 -38.58 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.722 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.5 -44.77 81.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.2 p -62.1 -44.8 95.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.434 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.0 p -61.17 -49.21 78.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -101.35 109.49 21.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.254 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.43 -48.11 3.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.5 Cg_endo -80.69 138.04 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.637 2.224 . . . . 0.0 111.881 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.8 m -130.99 -77.79 0.53 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.586 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.2 -5.73 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.466 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -72.36 0.96 8.71 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.342 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -130.26 102.92 6.42 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.269 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -66.17 -39.54 89.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.597 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.01 -47.58 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.731 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 75' ' ' GLY . 97.2 mt -67.42 -56.04 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.911 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . 31.95 -155.93 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m 71.84 -50.62 0.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 110.377 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -63.68 -25.29 68.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.338 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.32 -50.33 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.6 m -69.37 -37.65 77.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.44 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.66 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.955 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.19 -47.26 85.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.876 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.03 -40.29 96.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.12 0.486 . . . . 0.0 110.437 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -61.43 -46.27 90.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.713 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -43.22 97.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.256 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.33 -24.35 64.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.498 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.12 32.87 2.28 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 89' ' ' TYR . 97.7 m-20 -78.69 -53.5 7.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 48.5 p90 42.61 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.653 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.8 m -142.08 168.13 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.158 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.4 137.76 38.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.046 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.57 139.96 45.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.625 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -151.94 164.11 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.819 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.569 ' C ' ' H ' ' A' ' 96' ' ' GLY . 52.4 p-10 -76.58 178.0 7.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.277 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.38 26.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -118.7 -70.07 0.35 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.79 -24.91 0.23 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.97 123.21 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.27 92.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.478 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.94 135.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.655 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.51 132.8 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.339 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -161.27 172.0 6.26 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.663 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.19 -42.97 56.55 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.592 2.195 . . . . 0.0 111.785 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.72 78.24 1.33 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.062 0.458 . . . . 0.0 110.038 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -106.08 134.46 49.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.405 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -104.47 97.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.451 ' O ' ' OG ' ' A' ' 108' ' ' SER . 11.9 t -95.38 124.32 39.35 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.511 0.507 . . . . 0.0 110.597 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 107' ' ' CYS . 69.1 m -168.95 170.21 9.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.56 48.53 1.53 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.97 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 t -140.61 168.58 19.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.115 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.98 170.38 6.63 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.75 -39.3 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.586 2.191 . . . . 0.0 111.837 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -81.47 40.35 0.57 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.982 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 3' ' ' LYS . 9.8 tptp -76.71 165.62 24.5 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.346 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 99.2 mttt -133.28 -32.92 1.15 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.621 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.03 -172.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.196 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -116.5 136.97 52.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.264 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -104.07 -173.68 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.089 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -130.67 130.04 43.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.09 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -81.26 83.79 6.77 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.106 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -135.27 146.53 58.45 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.84 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.5 129.73 13.97 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.207 1.938 . . . . 0.0 112.142 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -61.14 -61.2 2.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.537 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 13' ' ' ARG . 16.7 m -82.84 -129.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.337 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' VAL . 39.0 ptt180 -51.95 -172.02 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.247 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -112.7 125.37 54.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.143 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 pt -109.45 156.84 38.82 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -61.18 152.37 72.39 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.524 2.149 . . . . 0.0 112.291 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 m -72.01 -16.94 62.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.293 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.2 p -89.79 -174.51 4.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.338 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.405 ' NH2' ' NZ ' ' A' ' 46' ' ' LYS . 43.2 ttm180 -127.95 149.23 50.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.229 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.08 135.61 46.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.13 138.5 37.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -95.24 115.35 27.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.768 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.8 mp -94.57 108.64 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.458 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -137.08 102.02 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.507 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -161.06 107.17 1.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.16 151.15 49.45 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.168 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.2 28.09 8.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 33.8 t0 -146.03 -143.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.307 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.526 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -131.52 -64.66 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.439 ' CG2' ' N ' ' A' ' 31' ' ' PHE . 14.7 t -58.03 -42.76 86.02 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.393 0.616 . . . . 0.0 110.399 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.439 ' N ' ' CG2' ' A' ' 30' ' ' THR . 52.2 t80 -68.16 -22.98 64.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.507 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -76.3 -44.42 37.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.993 0.425 . . . . 0.0 111.135 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -63.27 -45.73 90.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.843 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -65.28 -40.19 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.398 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -51.02 70.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.841 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -62.6 -45.34 93.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.04 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.02 -44.56 84.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.91 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 7.5 t -89.31 79.75 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.414 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -82.19 -9.04 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.321 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -172.7 127.97 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.135 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.29 139.84 45.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -119.52 115.89 24.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.267 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.36 156.15 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.768 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -87.57 171.69 10.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.207 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 48' ' ' VAL . 68.6 mttm -60.85 -59.49 5.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 46' ' ' LYS . 98.4 m-20 -34.09 -34.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' LYS . 21.3 t -59.55 133.13 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 p -106.72 147.42 29.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.241 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -38.88 -35.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.55 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.14 -51.83 67.91 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.114 0.483 . . . . 0.0 110.146 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.68 -34.92 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.046 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.68 -40.02 95.78 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.534 0.521 . . . . 0.0 110.442 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.265 0.555 . . . . 0.0 111.077 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -69.4 -46.68 66.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.669 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 57' ' ' VAL . 29.2 m -69.82 -49.72 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 9.8 p -57.39 -45.61 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 55.5 tp -60.94 -53.56 55.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.12 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -53.62 -39.79 65.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.59 -52.05 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.498 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.465 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 66.7 t -64.26 -47.31 90.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.47 -45.29 76.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.352 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.509 ' HG ' ' N ' ' A' ' 64' ' ' THR . 78.0 p -62.46 -45.61 92.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.714 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.509 ' N ' ' HG ' ' A' ' 63' ' ' SER . 74.8 m -53.31 -51.95 60.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.586 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.4 OUTLIER -108.29 68.43 0.7 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.366 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.56 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.94 -47.05 2.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.4 Cg_endo -81.08 85.07 1.86 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.569 2.179 . . . . 0.0 112.333 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.4 m -133.49 -10.04 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.591 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.09 -27.12 68.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.12 -36.75 69.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.579 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 75' ' ' GLY . 80.8 m80 -76.61 126.08 30.36 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.89 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.46 -43.98 92.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.53 -44.68 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.11 17.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.429 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -74.55 -62.13 2.96 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -9.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.95 0.405 . . . . 0.0 110.064 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 75' ' ' GLY . 49.7 tptt -59.7 -51.77 68.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.626 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -57.61 -48.53 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 110.032 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.4 m -57.18 -34.57 68.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.103 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.94 93.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.493 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.04 -44.9 95.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.596 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.76 -44.64 92.83 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.41 -43.86 97.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.416 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mtt180 -67.92 -41.7 82.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.761 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.77 -20.75 66.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.425 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.52 -35.53 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.704 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -63.43 0.04 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' ARG . 67.5 t0 -79.15 119.54 22.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.652 0.263 . . . . 0.0 110.424 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -120.47 -100.25 0.43 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.741 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -144.3 141.92 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 110.501 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -93.54 132.68 37.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.966 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.5 tt -120.8 121.68 38.69 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -154.62 149.54 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.676 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.6 p30 -93.65 -176.56 4.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.522 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.59 42.56 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -139.96 -16.38 0.5 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.65 -7.78 78.06 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 100' ' ' VAL . 51.9 t0 -96.91 111.03 23.41 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 40.3 mp0 -53.66 88.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 98' ' ' ASP . 6.3 p -146.73 153.54 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.8 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.533 ' N ' ' CD1' ' A' ' 101' ' ' ILE . 2.0 mp -77.46 129.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 110.329 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.49 173.6 4.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.738 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -50.49 -38.21 53.45 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.437 2.091 . . . . 0.0 111.807 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 102.56 12.63 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 109.863 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.6 mtp -103.19 137.55 41.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.49 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -138.03 104.09 5.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 28.2 p -111.53 110.62 21.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.463 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 m -158.87 165.62 33.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 95.9 m-85 -61.09 -30.25 70.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -63.56 152.67 38.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.262 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.41 170.62 5.29 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.76 -40.9 64.69 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.63 2.22 . . . . 0.0 112.015 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 67.6 t0 -96.84 45.76 1.05 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.417 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.455 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.601 ' C ' ' H ' ' A' ' 4' ' ' VAL . 3.5 mmmm -85.38 -6.81 59.19 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 122.87 -0.194 . . . . 0.0 110.797 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 65.81 -35.6 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.659 0.599 . . . . 0.0 110.54 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.601 ' H ' ' C ' ' A' ' 2' ' ' LYS . 11.9 p -103.36 12.95 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 121.031 0.443 . . . . 0.0 110.587 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 97.8 mt-10 49.94 -111.66 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.364 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 5' ' ' GLU . 96.5 m-85 -158.5 -102.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.592 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 8' ' ' ASP . 14.2 m120 49.5 30.29 3.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.473 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 7' ' ' ASN . 99.6 m-20 37.17 -106.48 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.559 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 11' ' ' LYS . 6.6 ptmt -93.66 152.75 41.03 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.625 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -39.51 -18.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.83 2.353 . . . . 0.0 112.493 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 9' ' ' LYS . 73.7 tttt 71.14 -50.16 0.68 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.83 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' CG2' ' N ' ' A' ' 13' ' ' ARG . 33.7 m -63.93 -46.32 94.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.65 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 88.1 mtm180 -144.4 154.97 43.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.563 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -59.26 145.67 42.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.508 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.8 pt -44.72 150.09 0.73 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.701 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.52 145.76 59.53 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.689 2.259 . . . . 0.0 112.331 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.464 ' HG ' ' N ' ' A' ' 18' ' ' THR . 78.4 p -68.86 -39.47 79.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.716 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -105.79 -175.69 2.87 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.297 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.594 ' N ' ' OG1' ' A' ' 18' ' ' THR . 15.0 ptm180 -105.84 143.39 34.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.179 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -107.84 146.56 32.1 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.749 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.23 48.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -137.33 -3.11 1.96 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.898 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.42 126.65 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.6 p -149.33 146.28 27.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -62.11 116.58 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.004 0.43 . . . . 0.0 110.171 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.68 112.49 15.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 10.4 mp -67.09 -42.52 84.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.525 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' ASP . 71.4 m-20 -151.82 151.11 30.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.53 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.95 -51.33 66.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.9 m -61.7 -49.03 78.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.726 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -64.96 -30.64 71.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' ASP . 64.8 t0 -64.43 -50.29 68.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.528 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 t -62.46 -44.61 96.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.542 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.3 -44.95 94.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.62 -45.16 94.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.71 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' SER . 44.1 t -61.74 -44.4 96.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.57 -35.48 80.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.672 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.97 87.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.784 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.424 ' O ' ' OG ' ' A' ' 40' ' ' SER . 62.7 m -123.95 -63.07 1.24 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.861 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.6 p 72.92 1.68 4.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.481 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -170.63 146.51 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.88 100.07 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' A' ' 19' ' ' ARG . 10.8 tp10 -77.42 117.81 19.26 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 18' ' ' THR . 75.9 t -127.24 132.43 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.002 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.54 172.28 0.51 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -89.38 19.97 4.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.563 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -148.08 54.69 1.04 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.425 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.58 144.08 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 110.536 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -96.41 146.56 24.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.18 -34.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.411 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -48.64 -47.46 40.37 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -64.07 -36.21 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.546 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.87 -43.92 97.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.325 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 89' ' ' TYR . 10.8 mp -62.35 -44.03 97.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.463 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.61 -34.41 75.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.15 -51.57 25.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.626 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.55 -45.93 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.4 tp -61.69 -55.02 34.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.254 0.549 . . . . 0.0 110.293 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.41 -30.85 65.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.29 -55.45 21.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.345 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -64.34 -40.51 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.844 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.9 t -62.63 -48.46 79.28 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.484 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.9 m -67.26 -71.96 0.18 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.8 tp -101.07 83.09 2.45 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -72.79 -46.04 9.06 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.4 Cg_endo -81.69 104.27 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.619 2.213 . . . . 0.0 111.888 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 2.8 m -133.59 -23.32 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -64.91 -30.69 71.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.396 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -72.0 -37.21 69.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 75' ' ' GLY . 72.2 m80 -78.67 115.74 18.56 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.495 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -60.37 -29.99 69.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.04 -45.57 98.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.7 mt -106.91 -1.71 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 110.344 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -51.87 169.85 0.48 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 m 70.98 -22.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.474 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.575 ' H ' ' C ' ' A' ' 75' ' ' GLY . 50.2 tptt -63.72 -45.81 88.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.22 -45.05 84.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.131 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 84.1 m -63.42 -41.17 98.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.73 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.48 95.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.15 -42.16 96.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.62 -42.93 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.728 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 87' ' ' GLY . 97.8 m-20 -64.15 -42.86 96.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mtt180 -70.36 -38.74 74.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -61.94 -44.51 96.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.671 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.13 -45.47 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -66.46 -74.31 0.55 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 84' ' ' ARG . 44.8 t0 -164.35 165.26 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.098 0.475 . . . . 0.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.435 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 27.3 p90 -132.78 146.4 51.81 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.901 0.381 . . . . 0.0 110.508 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.5 m -53.51 132.08 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.589 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -86.06 144.37 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.116 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tt -117.46 136.37 53.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.622 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 25.9 p90 -155.12 166.45 33.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.767 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 12.3 t70 -73.03 -156.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.561 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 98.5 mt-10 -66.86 -53.0 36.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.601 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.88 -98.15 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.33 22.54 0.18 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -89.22 113.7 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.806 0.336 . . . . 0.0 110.607 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 55.4 mp0 -73.33 89.45 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -164.65 142.65 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.571 ' CD1' ' H ' ' A' ' 101' ' ' ILE . 2.7 mp -59.11 131.79 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.019 0.437 . . . . 0.0 110.01 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.84 173.8 4.47 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.727 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -49.29 -37.85 40.89 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.562 2.175 . . . . 0.0 112.172 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -92.26 121.61 33.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 110.087 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 87.5 mmm -104.12 139.58 39.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.49 96.78 1.07 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.5 t -111.16 118.86 37.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.545 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -164.94 171.45 14.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.697 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 110' ' ' SER . 92.0 m-85 -61.32 -44.67 96.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.287 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' PHE . 70.7 m -37.75 159.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.08 170.26 5.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.668 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -48.54 -42.77 34.91 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.559 2.173 . . . . 0.0 112.158 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 37.1 p-10 -96.75 -32.42 12.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 66.8 t0 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 3' ' ' LYS . 6.1 tmtt? -70.16 119.8 14.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.028 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 2' ' ' LYS . 67.9 mttm -43.33 169.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.452 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 3' ' ' LYS . 33.2 m 36.21 -151.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 O-C-N 123.369 0.418 . . . . 0.0 110.481 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -140.32 139.59 35.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -51.71 140.77 18.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.284 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.71 83.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.612 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -117.68 35.76 4.57 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.489 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -132.63 158.91 74.48 Favored Pre-proline 0 N--CA 1.458 -0.061 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' VAL . 60.8 Cg_endo -74.18 -86.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.469 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 tttm 64.67 -70.85 0.08 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.314 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 10' ' ' PRO . 11.3 m -64.11 -35.65 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.297 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -76.44 163.16 27.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.555 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -56.35 141.3 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.222 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 15' ' ' ILE . 43.5 mm -117.73 86.48 24.21 Favored Pre-proline 0 N--CA 1.468 0.457 0 O-C-N 123.41 0.444 . . . . 0.0 110.231 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.55 144.54 84.44 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.728 2.285 . . . . 0.0 111.764 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.0 m -114.63 16.44 17.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.507 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -129.46 167.18 18.22 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.388 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -131.51 165.12 24.29 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -133.03 144.55 50.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.202 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.27 140.67 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 109.996 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -135.82 26.9 3.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.579 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 2.2 mp -97.94 118.63 44.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 146.13 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -91.51 129.38 37.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.364 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.59 113.44 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -149.21 88.07 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.553 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 1.2 m-20 165.25 -20.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.593 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 77.17 -71.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.532 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 m -61.51 -50.03 74.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.372 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -72.63 -23.3 60.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.79 -51.15 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.369 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -65.25 -45.27 85.28 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.393 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.91 -45.47 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.367 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.58 -41.0 98.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -58.5 -42.44 87.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -79.96 -21.02 44.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.744 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.32 67.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.527 ' C ' ' H ' ' A' ' 41' ' ' GLU . 5.9 t -163.44 -84.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.42 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 67.84 -8.99 0.49 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 -179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 39' ' ' CYS . 8.7 tm-20 -146.97 135.51 21.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 64.1 t80 -142.12 146.82 35.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.535 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 56.0 mp0 -86.46 150.97 23.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.359 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.56 124.64 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' ASP . 1.3 m-20 -141.95 139.58 32.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.448 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 70.9 mmtt -50.94 85.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.421 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.6 m-20 173.81 -31.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.386 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 m -106.13 111.63 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 110.333 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 p -86.36 167.32 14.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -41.08 -35.06 0.51 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.531 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.36 -48.72 80.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.414 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' A' ' 52' ' ' GLU . 56.3 mp0 -65.2 -34.4 78.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.79 -40.76 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.148 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.17 -35.88 71.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.542 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.56 -46.17 60.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.625 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 57' ' ' VAL . 28.2 m -68.63 -49.41 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.188 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 8.2 p -59.67 -46.6 93.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.214 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.509 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 52.3 tp -63.28 -57.21 11.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.358 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -51.61 -38.42 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.692 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.1 79.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.61 -46.29 96.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -62.56 -40.06 95.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.297 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.0 t -59.86 -50.28 74.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.548 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.6 p -59.13 -65.75 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.35 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -107.95 80.68 1.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.847 0.356 . . . . 0.0 110.421 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.65 -45.84 12.7 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.426 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.7 Cg_endo -83.81 84.67 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.761 2.307 . . . . 0.0 111.875 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.4 m -87.03 -17.82 32.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.86 -5.44 16.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -72.37 -38.54 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' GLY . 58.2 m-70 -110.13 126.54 54.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.47 -38.74 91.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.72 -48.15 88.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 77' ' ' LYS . 68.5 mt -80.49 -31.04 12.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.163 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 78' ' ' VAL . . . -34.65 -57.47 0.75 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 m -39.43 -28.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.433 0.635 . . . . 0.0 110.945 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 74' ' ' ILE . 27.9 tptp -60.92 -40.27 92.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 75' ' ' GLY . 2.9 p -56.03 -39.61 58.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.433 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 1.2 t -66.26 -48.7 69.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.23 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.41 87.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.282 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.86 -45.48 93.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.45 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -61.82 -43.17 99.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.43 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.49 -42.76 78.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.056 0.455 . . . . 0.0 110.71 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.49 -20.29 64.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.455 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.42 82.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.561 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.34 -54.23 0.09 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.23 117.97 12.46 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.459 ' O ' ' CE1' ' A' ' 91' ' ' TYR . 37.0 p90 -123.53 141.96 51.49 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 110.558 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.5 t -50.89 125.14 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.18 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 3.4 m-85 -82.55 153.89 25.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.285 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.41 130.37 47.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.563 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.87 155.81 42.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 42.6 t0 -73.17 -178.62 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.365 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 24.8 tp10 -74.67 38.45 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.491 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.49 -59.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.63 0.24 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.63 140.69 58.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.625 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.84 88.44 4.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.55 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.3 t -150.07 134.16 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.741 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 86.7 mt -70.7 132.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.314 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.8 170.81 7.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -49.51 -38.82 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.403 2.069 . . . . 0.0 112.305 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -125.16 126.54 45.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -150.81 166.14 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.212 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -113.12 118.54 35.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.431 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.514 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 14.9 p -105.12 122.78 46.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.71 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.496 ' HG ' ' H ' ' A' ' 109' ' ' PHE . 42.0 t -171.98 166.85 6.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.674 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.496 ' H ' ' HG ' ' A' ' 108' ' ' SER . 48.9 p90 -73.44 -26.12 60.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.532 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.8 p -95.27 169.82 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.472 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.83 162.26 22.19 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.266 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.63 -21.59 45.37 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.701 2.267 . . . . 0.0 112.057 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -149.28 65.44 1.02 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.422 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.853 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -69.74 134.77 48.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.99 0.424 . . . . 0.0 110.85 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -103.0 -28.41 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.501 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.58 -42.26 87.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.468 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.52 ' O ' ' C ' ' A' ' 6' ' ' PHE . 98.2 mt-10 58.62 67.8 0.89 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.255 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.52 ' C ' ' O ' ' A' ' 5' ' ' GLU . 74.2 m-85 -19.0 109.46 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.23 0.956 . . . . 0.0 110.702 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -38.46 -50.45 1.53 Allowed 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 123.397 0.435 . . . . 0.0 110.514 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -55.84 118.46 4.61 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.167 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -65.72 144.29 98.83 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.976 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.24 145.18 48.14 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.687 2.258 . . . . 0.0 112.306 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 13' ' ' ARG . 59.3 mttp -94.18 -50.78 5.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.25 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 12' ' ' VAL . 8.4 p -73.13 43.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.045 0.45 . . . . 0.0 110.634 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 11' ' ' LYS . 35.7 ttm180 -157.48 158.17 35.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.436 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -71.43 134.2 46.45 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.012 0.434 . . . . 0.0 110.617 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 pt -82.23 156.46 69.06 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.647 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -44.29 162.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.437 2.091 . . . . 0.0 112.314 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.7 t -63.1 -7.86 6.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.663 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 p -107.17 168.43 9.22 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.332 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -105.04 165.18 11.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.117 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -130.95 135.33 47.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.65 133.01 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -119.57 22.13 11.79 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.562 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.9 mp -84.93 136.87 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.481 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -135.86 132.47 36.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.347 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 107' ' ' CYS . 73.6 t80 -109.83 114.7 28.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.209 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.83 147.75 48.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.469 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.0 mt -97.95 -63.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 8.6 t70 -84.68 173.71 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.63 -36.7 84.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 31' ' ' PHE . 1.2 p -61.99 -54.4 42.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.683 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.449 ' N ' ' OG1' ' A' ' 30' ' ' THR . 67.0 m-85 -60.25 -20.03 57.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.544 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.426 ' O ' ' OG ' ' A' ' 36' ' ' SER . 54.0 t0 -76.58 -49.04 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.5 p -73.47 -35.14 65.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.41 -51.81 63.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.58 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.55 -41.93 83.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.749 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 32' ' ' ASP . 69.8 m -61.52 -45.43 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.853 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.84 -45.87 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.979 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 40' ' ' SER . . . -73.66 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 14.5 p -71.33 45.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.592 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 38' ' ' ALA . 4.4 p -59.13 -28.62 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.372 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.78 140.24 19.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.12 137.75 41.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.55 120.07 30.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.266 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.3 m -144.3 162.46 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.369 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 47' ' ' ASP . 45.9 t0 -89.79 170.41 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.628 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -78.65 39.22 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 66.1 t0 -118.22 -25.95 6.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.532 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.03 128.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 0.0 110.709 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.9 p -85.0 158.38 20.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.386 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.443 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -46.98 -38.46 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.243 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.12 -46.75 89.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -68.29 -35.16 77.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.312 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.7 tp -63.46 -43.83 96.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -39.32 87.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 0.0 110.511 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -71.43 -43.55 66.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.775 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.16 -51.48 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.058 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 8.0 p -58.57 -44.71 89.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.476 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 47.5 tp -61.33 -55.6 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.287 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.42 -33.61 65.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.866 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.92 -51.1 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.76 -43.19 93.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -62.75 -46.87 86.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.621 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.1 t -60.2 -49.28 78.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.604 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -58.84 -45.79 89.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.183 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.41 76.47 1.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.991 0.424 . . . . 0.0 110.407 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.59 -43.68 11.95 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.099 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 66' ' ' SER . 37.7 Cg_exo -60.21 110.18 0.74 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.404 2.069 . . . . 0.0 111.835 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 66' ' ' SER . 3.4 m -133.9 -58.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.552 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -68.5 -9.38 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.58 -42.84 61.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.636 ' HD1' ' H ' ' A' ' 73' ' ' VAL . 4.5 t-80 -106.36 134.53 49.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.514 ' N ' ' HD1' ' A' ' 71' ' ' HIS . 53.3 t0 -61.73 -35.54 78.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.545 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.636 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 76.1 t -60.25 -48.0 89.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.449 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.544 ' O ' ' N ' ' A' ' 77' ' ' LYS . 57.4 mt -82.54 -27.01 8.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.933 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -34.05 -59.02 0.62 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -42.7 -23.76 0.05 OUTLIER 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.289 0.566 . . . . 0.0 110.947 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 74' ' ' ILE . 88.7 tttt -58.99 -42.78 90.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.111 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 79' ' ' CYS . 5.2 p -54.75 -37.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.439 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.404 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 77.8 m -70.08 -50.17 43.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.31 84.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.98 -42.51 99.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 tt -60.44 -44.82 95.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -62.42 -43.78 98.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.472 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.77 -42.72 90.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.643 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.69 -11.99 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.53 -37.28 77.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.97 -34.46 0.56 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.04 115.31 24.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.425 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -132.88 146.35 51.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.407 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.6 m -50.51 148.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.068 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.97 164.23 12.62 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.311 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 tt -131.55 128.65 39.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.88 151.73 41.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -77.6 -159.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -72.02 51.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.75 -118.56 0.66 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.29 4.53 2.3 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -90.04 116.38 28.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.748 0.309 . . . . 0.0 110.39 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.31 89.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -135.69 133.4 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.45 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -71.64 127.93 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.03 0.443 . . . . 0.0 109.894 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.65 152.46 16.56 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.633 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.29 -39.86 27.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.31 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 65.1 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.278 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -103.53 135.96 44.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.184 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.523 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 48.1 t80 -99.89 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.118 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.531 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 4.3 t -113.3 115.43 28.14 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.548 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.523 ' OG ' ' CE2' ' A' ' 106' ' ' TYR . 7.2 p -173.53 169.5 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -70.06 -24.42 63.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 m -67.13 143.18 56.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.36 170.5 6.58 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.96 -40.31 67.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.604 2.203 . . . . 0.0 111.855 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -82.63 45.2 0.96 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.19 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.694 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 3' ' ' LYS . 23.0 ttpt -81.56 120.79 25.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 118.929 -0.557 . . . . 0.0 110.069 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.556 ' C ' ' O ' ' A' ' 2' ' ' LYS . 64.4 tttm -8.39 -81.95 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.341 1.026 . . . . 0.0 111.227 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 2' ' ' LYS . 26.9 m -37.87 134.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 121.222 0.534 . . . . 0.0 110.929 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 7' ' ' ASN . 12.9 pt-20 -80.23 -13.86 58.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.922 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 66.96 -14.11 0.18 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.669 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.589 ' H ' ' C ' ' A' ' 5' ' ' GLU . 41.3 t-20 63.21 41.97 7.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.693 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 9' ' ' LYS . 94.5 m-20 -86.6 -1.83 57.99 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.357 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 10' ' ' PRO . 48.3 tttp -37.5 128.4 0.87 Allowed Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.751 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 9' ' ' LYS . 67.4 Cg_exo -46.9 -172.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.567 2.178 . . . . 0.0 112.132 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.08 -129.23 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.479 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.63 -41.75 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -83.78 145.55 28.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.344 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -95.42 149.99 20.78 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.446 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.5 mt -42.89 106.52 0.48 Allowed Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.48 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.6 147.16 40.31 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.532 2.154 . . . . 0.0 112.035 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -79.07 -7.93 58.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.564 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 p -85.54 164.47 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -125.9 176.97 6.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.354 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -135.83 139.73 43.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.237 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.09 136.3 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.56 -7.36 6.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.552 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -118.34 128.02 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.7 p -132.47 146.6 52.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.536 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.26 132.89 55.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.169 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.6 141.34 48.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 10.2 mp -64.56 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -148.92 168.83 22.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.637 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.05 81.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.417 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 m -59.61 -46.83 87.8 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.084 0.469 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -67.64 -28.56 67.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.483 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -64.91 -48.36 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -62.61 -44.89 95.16 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.492 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.68 -45.82 90.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.685 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.98 -44.62 95.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.609 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 m -60.05 -44.71 94.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.327 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.12 -35.84 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.521 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.73 -75.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 40' ' ' SER . 25.4 p -52.59 -43.91 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.789 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 1.4 m 67.73 -63.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.557 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.83 154.55 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.668 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -144.11 148.76 35.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.83 162.21 27.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.63 135.25 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.61 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.12 166.22 17.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.22 -61.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -88.89 84.23 6.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 110.374 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.52 136.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.312 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.561 ' O ' ' N ' ' A' ' 51' ' ' ASP . 20.5 p -108.22 154.27 22.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.406 0.622 . . . . 0.0 109.719 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.824 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -44.13 -12.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.254 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 49' ' ' THR . 87.0 m-20 -68.16 -53.4 25.32 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.268 0.556 . . . . 0.0 110.349 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -65.16 -38.99 92.31 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.328 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.0 mt -61.6 -39.9 92.88 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.031 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 tp -61.07 -45.12 96.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.158 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -71.49 -34.24 69.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.146 0.498 . . . . 0.0 110.744 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.6 t -72.38 -53.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.996 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 9.6 p -60.59 -43.92 95.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.799 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.473 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 46.6 tp -60.21 -56.48 20.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.137 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.16 -41.13 62.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.54 82.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.508 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.6 t -63.41 -45.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.549 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.06 -44.17 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.367 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.4 p -61.66 -42.74 99.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.0 m -67.89 -71.14 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.38 88.21 3.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.382 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.524 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.57 -47.87 2.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 66' ' ' SER . 66.9 Cg_endo -80.52 68.5 8.3 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.68 2.254 . . . . 0.0 112.134 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.53 -32.16 47.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.35 -5.77 15.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -72.27 -38.66 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 75' ' ' GLY . 39.0 m80 -103.71 120.81 41.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.219 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 28.4 p-10 -58.32 -42.38 86.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.712 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.428 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 3.8 p -55.09 -29.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.409 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 49.2 mm -108.49 -12.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -38.35 -62.92 1.03 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.2 p -37.04 -25.06 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.124 0.487 . . . . 0.0 111.006 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' GLY . 63.4 tttm -58.03 -42.71 85.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.139 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 79' ' ' CYS . 5.6 p -56.43 -42.49 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.455 . . . . 0.0 110.314 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.455 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 87.7 m -62.95 -48.55 78.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.162 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.37 82.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.5 tp -53.16 -42.34 66.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tt -60.76 -46.47 90.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.062 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -63.52 -45.49 90.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.52 -25.55 65.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.773 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.78 -44.23 90.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.364 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.34 -39.11 0.67 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.77 127.14 33.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.265 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 90' ' ' VAL . 2.0 p90 -131.73 -127.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.629 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.599 ' O ' ' CD2' ' A' ' 89' ' ' TYR . 29.1 m -134.44 165.03 32.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 121.097 0.475 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -114.01 144.76 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 ' CD2' ' C ' ' A' ' 92' ' ' LEU . 1.3 tt -131.13 143.18 50.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.989 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.27 163.25 38.76 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.666 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 96' ' ' GLY . 47.4 p30 -74.5 175.9 7.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.529 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.09 26.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -133.66 -70.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.98 -36.04 0.1 OUTLIER Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.71 140.51 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.78 0.324 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 56.4 mp0 -86.66 88.4 7.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.472 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.79 130.64 26.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.48 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 101' ' ' ILE . 12.9 mm -61.96 131.74 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.08 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.41 170.56 7.47 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.633 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.2 -40.14 60.94 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.517 2.144 . . . . 0.0 112.161 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 97.31 5.85 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -119.41 170.7 8.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.624 ' HH ' ' CB ' ' A' ' 108' ' ' SER . 76.5 t80 -139.68 122.33 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.084 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.5 t -122.83 127.53 49.19 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.752 0.657 . . . . 0.0 110.491 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.624 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . 84.1 p -172.78 -174.88 1.18 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' ' CG1' ' A' ' 90' ' ' VAL . 86.0 m-85 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.136 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -146.95 172.12 14.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . -108.0 169.98 6.03 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.406 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -49.41 -38.28 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.445 2.096 . . . . 0.0 112.054 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 49.2 p-10 -65.6 -30.65 71.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.981 0.419 . . . . 0.0 110.802 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 95.8 m-20 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.53 -99.38 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.687 0.28 . . . . 0.0 110.498 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 4' ' ' VAL . 25.8 tttm -173.65 179.89 1.96 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 3' ' ' LYS . 29.0 m 29.52 -139.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 123.864 0.728 . . . . 0.0 110.429 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -137.92 -13.43 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 110.571 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 72.13 61.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.528 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 1.7 m120 64.81 101.02 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.66 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -72.97 144.66 47.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.691 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 10' ' ' PRO . 14.2 ttmm -42.38 118.1 2.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.71 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' LYS . 78.3 Cg_exo -45.36 -179.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.36 2.04 . . . . 0.0 112.591 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -170.38 -87.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.261 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.61 44.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.893 0.378 . . . . 0.0 110.272 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -127.43 165.68 19.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.419 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -62.56 131.18 48.24 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.199 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.497 ' H ' ' CD1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -75.89 157.91 83.14 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.437 -179.15 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -44.04 155.34 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.263 1.975 . . . . 0.0 112.434 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.6 p -64.46 -17.62 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.455 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.8 p -87.06 165.8 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.051 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.566 ' HE ' ' NZ ' ' A' ' 46' ' ' LYS . 43.9 ttm180 -107.7 145.38 33.5 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.297 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.39 137.18 39.16 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.333 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tp -102.92 142.84 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.309 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -138.88 111.41 7.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.566 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 2.5 mp -99.76 125.42 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.396 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.06 96.54 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.558 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -151.16 133.97 15.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.203 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.34 109.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -128.06 -67.21 0.82 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.368 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 27' ' ' LEU . 75.5 m-20 -150.88 163.66 38.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.426 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 -62.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.2 m -60.64 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -42.78 -44.52 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 110.391 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -61.98 -48.05 82.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.158 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.647 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.45 -45.12 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.176 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.04 -42.94 99.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.6 m -61.88 -40.44 95.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.08 -16.14 41.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.459 ' C ' ' SG ' ' A' ' 39' ' ' CYS . . . -93.61 23.62 4.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.611 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 38' ' ' ALA . 2.6 m 75.39 101.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.796 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.45 -34.77 78.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.76 131.22 55.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.684 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -145.19 124.66 13.13 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.46 0.648 . . . . 0.0 110.901 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -63.77 135.84 56.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.504 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.1 134.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 0.0 110.58 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.71 164.9 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.3 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.566 ' NZ ' ' HE ' ' A' ' 19' ' ' ARG . 65.2 mttm -94.11 -11.45 30.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.74 11.83 18.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.88 153.02 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.11 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.592 ' HG1' ' H ' ' A' ' 51' ' ' ASP . 57.2 p -99.25 -160.19 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.544 ' CD2' ' H ' ' A' ' 50' ' ' LEU . 1.9 pt? -63.11 -15.81 57.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.592 ' H ' ' HG1' ' A' ' 49' ' ' THR . 22.0 p-10 -59.99 -52.82 63.76 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.348 0.594 . . . . 0.0 110.589 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -64.03 -40.16 95.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.081 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.43 -45.78 92.86 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.109 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.8 tt -56.39 -43.72 79.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.34 -49.01 78.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.903 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.31 -43.4 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.383 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.77 -46.97 93.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.509 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.09 -41.22 99.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.357 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.91 -44.21 94.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.278 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . -64.43 -37.15 86.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.37 -44.78 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.734 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.11 -44.36 60.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.553 ' HG ' ' N ' ' A' ' 64' ' ' THR . 10.6 p -61.99 -33.35 74.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.553 ' N ' ' HG ' ' A' ' 63' ' ' SER . 41.4 p -86.81 -52.25 5.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.4 tp -95.04 79.21 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.544 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.87 -46.62 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.646 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.6 Cg_endo -80.74 109.95 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.404 2.069 . . . . 0.0 112.31 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.86 -46.28 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.441 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -67.91 -6.47 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.718 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -73.02 -21.49 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -103.12 98.18 8.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.697 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 25.8 p-10 -62.68 -44.59 95.86 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.412 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.456 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 71.2 t -64.42 -44.96 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.263 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 76' ' ' THR . 3.3 mt -93.56 9.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -55.54 -1.28 0.18 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.576 ' H ' ' C ' ' A' ' 74' ' ' ILE . 39.9 p -65.7 -31.78 72.97 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.506 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -58.6 -37.59 76.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.201 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.73 -44.13 93.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.32 -38.92 93.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.253 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.32 -54.03 51.41 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.063 0.458 . . . . 0.0 110.687 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.24 -40.32 97.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.311 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.7 -42.95 99.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.242 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -61.89 -43.4 98.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.217 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.97 -39.96 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.474 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.9 mt -63.83 -37.88 89.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.513 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.4 79.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.69 -18.54 0.58 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -78.26 56.72 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.782 0.325 . . . . 0.0 110.418 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.52 -168.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.281 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 132.08 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.506 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -75.05 153.22 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.223 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tt -142.52 122.51 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.468 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -146.12 151.01 36.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.736 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 96' ' ' GLY . 56.8 p-10 -80.96 175.13 10.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 104' ' ' ARG . 41.7 mp0 -62.3 68.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.473 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 94' ' ' ASP . . . -164.97 -79.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' OD1' ' A' ' 98' ' ' ASP . . . 149.7 40.63 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 97' ' ' GLY . 85.6 m-20 -146.98 169.63 18.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.932 0.396 . . . . 0.0 110.529 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 56.5 mp0 -80.92 91.61 6.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.166 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.432 ' CG1' ' N ' ' A' ' 101' ' ' ILE . 59.8 t -141.92 162.83 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.444 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.432 ' N ' ' CG1' ' A' ' 100' ' ' VAL . 4.9 mp -124.1 129.3 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.8 168.93 10.74 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.456 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.6 -40.2 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.498 2.132 . . . . 0.0 112.203 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.432 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 79.4 mtp180 -113.13 107.12 15.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -139.43 142.99 37.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.214 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -96.98 118.85 34.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.32 116.59 25.11 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 t -173.15 178.08 2.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.689 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -60.48 -44.67 95.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.509 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.1 m -55.86 146.1 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.036 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.498 ' H ' ' CB ' ' A' ' 114' ' ' ASP . . . -105.05 170.37 6.05 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.633 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.51 -41.28 61.14 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 112.031 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 55.4 t0 -85.32 -9.97 56.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.552 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' CB ' ' H ' ' A' ' 111' ' ' ALA . 66.1 t0 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.572 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.532 ' C ' ' H ' ' A' ' 4' ' ' VAL . 42.9 mmtt -66.76 -76.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.724 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 65.65 -6.93 0.37 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.532 ' H ' ' C ' ' A' ' 2' ' ' LYS . 3.4 m -84.25 152.37 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.399 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 1.3 mp0 -76.51 117.13 17.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.587 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -134.73 154.7 51.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.527 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -56.4 107.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.399 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -118.16 -27.2 6.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.473 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -76.27 152.59 83.98 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.484 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.73 151.58 82.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.633 2.222 . . . . 0.0 112.117 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -53.56 -52.0 61.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.343 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.46 ' O ' ' CG1' ' A' ' 12' ' ' VAL . 14.9 p -160.84 70.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.05 0.452 . . . . 0.0 110.387 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -154.43 155.71 35.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.4 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -79.6 140.49 37.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.511 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 pt -83.52 152.09 63.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 18' ' ' THR . 55.6 Cg_endo -69.76 157.16 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.731 2.288 . . . . 0.0 112.236 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -75.44 13.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.378 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 16' ' ' PRO . 74.8 p -130.78 162.46 29.49 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -138.27 156.15 47.94 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.148 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -107.97 143.63 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 42' ' ' PHE . 17.5 tt -133.31 140.59 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -126.27 11.77 7.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.554 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.5 mp -88.3 101.41 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.961 0.41 . . . . 0.0 110.707 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.8 p -141.14 145.98 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.399 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -93.85 138.93 31.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.202 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.64 138.14 41.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 mt -63.2 -39.99 96.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -151.91 176.98 10.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 80.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.513 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.5 m -61.34 -47.69 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.585 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -68.72 -26.46 65.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.29 -48.53 56.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.3 m -67.1 -41.8 85.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.618 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.36 -47.29 93.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.495 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -63.5 -42.24 98.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.837 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 40' ' ' SER . 78.5 p -62.66 -35.47 79.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -78.69 -34.45 46.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.926 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.04 -92.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.753 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 40' ' ' SER . 14.2 t -65.59 -96.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.713 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER 77.85 -3.79 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.611 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -140.57 115.62 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.465 ' CZ ' ' SG ' ' A' ' 39' ' ' CYS . 84.4 m-85 -117.92 129.12 55.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.184 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -91.6 142.26 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.02 121.13 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.432 0.634 . . . . 0.0 110.515 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 47' ' ' ASP . 19.3 p30 -155.95 171.29 20.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.793 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.22 11.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 45' ' ' ASP . 87.7 m-20 -107.38 0.18 22.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.67 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 p -141.24 160.44 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 50' ' ' LEU . 5.2 p -129.94 -70.12 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.226 0.536 . . . . 0.0 110.648 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' N ' ' OG1' ' A' ' 49' ' ' THR . 0.4 OUTLIER -163.16 -33.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -50.21 -43.95 52.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.333 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -68.41 -40.91 81.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.633 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.472 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 35.6 mt -62.03 -46.26 89.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.72 -36.39 82.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.456 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.81 -52.25 63.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.182 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.422 ' O ' ' CB ' ' A' ' 60' ' ' ALA . 12.8 p -69.64 -38.59 76.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.532 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 43.7 t -59.29 -50.61 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.276 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.69 -50.47 43.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.184 0.516 . . . . 0.0 110.587 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.26 -32.07 69.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.086 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' VAL . . . -69.71 -56.35 7.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.41 -44.12 87.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -59.35 -46.39 88.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.508 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.504 ' HG ' ' N ' ' A' ' 64' ' ' THR . 77.9 p -61.77 -51.65 67.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.504 ' N ' ' HG ' ' A' ' 63' ' ' SER . 19.6 m -60.48 -46.59 89.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.471 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 10.3 mp -94.36 57.85 2.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.399 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.612 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.15 -44.02 2.74 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.214 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 66' ' ' SER . 21.5 Cg_exo -64.3 107.59 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.5 2.133 . . . . 0.0 111.859 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.522 ' C ' ' H ' ' A' ' 70' ' ' GLU . 22.0 t -133.84 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -48.5 -11.3 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.466 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 68' ' ' CYS . 79.2 tt0 -73.94 -36.89 64.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.607 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 75' ' ' GLY . 67.4 m80 -132.65 138.99 47.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.9 -43.83 97.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -45.69 -31.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.318 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.506 ' O ' ' O ' ' A' ' 75' ' ' GLY . 47.0 mm -108.38 -15.11 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.64 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . -46.68 -177.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m 66.74 -31.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.64 ' H ' ' C ' ' A' ' 75' ' ' GLY . 47.1 tptt -63.19 -39.15 93.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.423 ' N ' ' SG ' ' A' ' 68' ' ' CYS . 7.4 p -59.76 -45.23 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.1 m -64.41 -47.74 78.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.341 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.45 -52.56 64.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.286 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.4 tp -51.29 -40.89 59.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.94 -48.06 82.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.21 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -64.24 -40.96 97.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.355 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.23 -40.63 98.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.89 -19.99 58.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.596 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.64 75.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 88' ' ' ASP . . . 160.33 33.64 0.02 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 80.2 m-20 -149.14 78.03 1.38 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.789 0.328 . . . . 0.0 110.52 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.609 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 1.4 p90 -110.2 -113.34 0.31 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.085 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.4 m -130.8 158.77 43.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.303 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -126.81 157.07 40.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.242 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.17 125.06 24.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.82 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -134.68 153.27 52.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -88.98 -168.31 2.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.431 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 33.2 mp0 -72.93 67.24 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.628 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.23 -59.33 0.21 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.28 -18.79 0.32 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.84 139.71 55.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.672 0.272 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 90.68 6.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.605 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -155.11 135.98 4.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.615 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 49' ' ' THR . 56.6 mt -66.15 132.26 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.27 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.17 173.59 4.11 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.66 -40.59 55.68 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.497 2.131 . . . . 0.0 111.842 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.36 90.13 3.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -103.16 145.24 30.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.159 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.447 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 68.5 t80 -113.15 110.21 20.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.138 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.0 p -110.97 113.15 25.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.437 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.447 ' OG ' ' CE2' ' A' ' 106' ' ' TYR . 9.0 p -167.77 164.9 14.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -72.51 -26.9 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.643 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 p -73.19 154.64 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -90.26 170.12 10.86 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.668 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.44 -35.11 53.81 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.46 2.106 . . . . 0.0 112.128 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -79.16 14.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 . . . . . 0 C--O 1.223 -0.332 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.785 -179.876 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -109.17 121.33 44.93 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.74 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -109.34 4.25 22.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.365 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.471 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 18.1 m -85.33 15.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.608 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 57.57 -111.63 0.61 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 4' ' ' VAL . 53.1 m-85 51.79 -117.39 1.13 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.796 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -58.02 -40.93 82.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.206 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -82.86 112.97 20.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.837 0.351 . . . . 0.0 110.397 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -66.95 160.25 71.05 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -46.33 130.82 14.53 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.962 1.774 . . . . 0.0 112.062 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -96.97 35.51 1.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.676 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.47 -130.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.236 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -89.32 -172.76 3.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.511 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.29 139.83 57.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.468 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 mm -41.31 102.12 0.26 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.707 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.95 157.19 23.86 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.439 2.092 . . . . 0.0 112.284 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.9 m -61.75 -40.32 94.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.513 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -88.3 -170.21 2.87 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.225 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -135.08 171.76 13.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -126.45 146.87 49.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.638 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.7 tp -132.11 141.04 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.317 0.58 . . . . 0.0 110.151 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -138.23 20.05 2.78 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.431 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mt -114.15 97.32 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.87 0.367 . . . . 0.0 110.839 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -116.19 143.68 45.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.141 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.92 118.33 13.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.443 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.79 118.6 36.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.243 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.78 -40.99 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.604 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.2 t0 -153.69 -178.94 7.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.58 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.499 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -62.82 -37.47 86.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.21 -48.03 83.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.188 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.16 -4.13 39.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.405 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -85.2 -59.08 2.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.32 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -68.55 -37.29 79.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.926 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.33 -47.45 87.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.07 -41.81 99.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 9.1 t -58.74 -50.25 74.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.58 -34.13 77.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -25.43 60.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.022 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.599 ' C ' ' H ' ' A' ' 41' ' ' GLU . 4.9 t -173.89 -48.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.47 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 36' ' ' SER . 0.4 OUTLIER 59.45 -3.91 0.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.657 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.599 ' H ' ' C ' ' A' ' 39' ' ' CYS . 75.2 mt-10 -144.26 115.79 8.12 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -121.84 133.57 54.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -95.5 156.68 16.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.975 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 m -134.75 116.7 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.665 0.745 . . . . 0.0 110.775 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 47' ' ' ASP . 50.4 t0 -148.2 159.77 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.3 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 50.9 tttm -60.88 12.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.659 ' H ' ' C ' ' A' ' 45' ' ' ASP . 98.2 m-20 -105.34 -37.07 6.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.711 0.291 . . . . 0.0 110.356 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.93 109.06 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.339 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 51' ' ' ASP . 27.3 p -86.46 166.05 15.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.336 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.441 ' H ' HD21 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -48.29 -44.35 33.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.291 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 49' ' ' THR . 1.5 p-10 -56.82 -44.33 81.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -72.98 -28.59 62.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.289 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.3 -54.34 30.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.216 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.79 -39.93 83.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.896 0.379 . . . . 0.0 110.287 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.32 -44.39 95.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.55 -43.12 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.707 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.98 -47.77 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.455 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.407 ' C ' ' CD2' ' A' ' 58' ' ' LEU . 8.6 tt -64.05 -53.25 52.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.081 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -52.23 -38.97 59.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.745 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.84 75.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.629 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.27 -48.98 85.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.685 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.78 -37.72 85.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.444 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -60.69 -45.16 95.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.49 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.8 p -72.92 -40.66 65.3 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.751 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -108.26 106.77 17.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.482 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.424 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -79.1 -60.8 0.53 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 178.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 66' ' ' SER . 36.9 Cg_endo -63.15 134.48 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.338 2.025 . . . . 0.0 112.297 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.2 p -134.98 -37.38 0.8 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -67.99 -7.96 33.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.759 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -73.59 -30.34 62.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.715 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 75' ' ' GLY . 60.1 m80 -92.13 108.91 20.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 20.8 p-10 -66.1 -49.12 68.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.339 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 t -66.84 -45.1 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.412 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 mm -95.09 18.79 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.09 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -81.29 -170.62 43.93 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.415 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER 78.32 -26.41 0.18 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 110.552 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER -63.62 -11.02 21.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.163 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.472 ' CG1' ' H ' ' A' ' 79' ' ' CYS . 7.1 p -71.31 -54.51 17.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 110.304 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' H ' ' CG1' ' A' ' 78' ' ' VAL . 98.8 m -69.36 -42.66 74.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.143 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.08 74.63 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.113 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 tt -54.62 -42.15 70.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.166 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.95 -48.71 80.58 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.254 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 87' ' ' GLY . 55.2 t0 -65.52 -43.24 90.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.798 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' ASP . 1.4 mpt_? -62.08 -43.79 98.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.6 -42.84 97.61 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.086 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -9.7 51.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.631 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -154.38 62.45 0.36 Allowed Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 84' ' ' ARG . 96.9 m-20 -36.88 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 110.693 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.503 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 65.5 t80 -87.04 -40.7 14.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.679 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.66 131.52 12.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 98.0 m-85 -109.37 152.25 25.57 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -132.31 122.9 25.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.401 ' CZ ' ' CD2' ' A' ' 106' ' ' TYR . 45.2 p90 -142.79 147.68 35.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.52 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.2 t70 -83.91 177.47 8.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.496 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 95.8 mt-10 -70.77 38.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -146.59 -5.71 0.38 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.92 -2.64 73.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 36.4 t0 -93.87 112.86 24.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 110.471 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -53.45 86.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.098 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 69.7 t -145.4 136.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.9 mm -76.09 130.02 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.125 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.02 172.0 5.74 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.452 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.95 -41.52 63.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.354 2.036 . . . . 0.0 111.894 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 1.8 mpt_? -110.46 83.45 1.76 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.188 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -105.19 165.07 11.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.091 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 93' ' ' PHE . 70.6 t80 -134.2 112.51 11.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 21.7 p -115.52 117.08 29.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.623 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.1 t -171.71 175.41 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -66.4 -27.34 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.357 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -61.86 146.46 49.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.473 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -85.62 170.41 13.14 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.78 -41.28 55.29 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.542 2.161 . . . . 0.0 112.025 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -60.51 -48.26 82.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.101 0.477 . . . . 0.0 110.849 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.547 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -82.58 104.9 13.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.954 0.407 . . . . 0.0 110.665 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.24 -9.38 42.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.183 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.62 -18.14 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.574 ' O ' ' O ' ' A' ' 7' ' ' ASN . 96.6 mt-10 56.42 67.0 1.06 Allowed 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.639 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.535 ' C ' ' O ' ' A' ' 5' ' ' GLU . 75.1 m-85 -8.77 99.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.815 0.697 . . . . 0.0 112.531 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.574 ' O ' ' O ' ' A' ' 5' ' ' GLU . 97.6 m-20 53.85 168.16 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 121.318 0.58 . . . . 0.0 110.738 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -44.83 148.73 0.5 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.506 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -38.01 152.42 0.15 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.03 -80.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.482 2.121 . . . . 0.0 112.244 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 13' ' ' ARG . 12.6 tptp 58.38 110.8 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.946 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 t 67.12 -45.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 123.525 0.515 . . . . 0.0 110.313 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.503 ' H ' ' C ' ' A' ' 11' ' ' LYS . 86.1 mtp180 -57.55 -172.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.543 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -58.11 136.45 57.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.405 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.12 153.11 86.42 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.732 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.569 ' C ' ' H ' ' A' ' 18' ' ' THR . 55.9 Cg_endo -69.57 162.12 43.23 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.642 2.228 . . . . 0.0 112.206 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.9 t -65.93 8.99 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.542 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.569 ' H ' ' C ' ' A' ' 16' ' ' PRO . 47.8 p -109.04 168.47 9.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.291 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.45 173.51 8.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.237 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.02 144.17 30.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.053 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.0 pt -136.12 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.753 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.53 121.18 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mm -94.3 115.88 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.166 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -127.92 100.46 5.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.445 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.53 107.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.34 140.79 46.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.747 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 10.9 mp -73.7 -41.19 62.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -127.12 -176.78 3.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.63 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.16 82.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -58.69 -52.7 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.414 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' N ' ' OG1' ' A' ' 30' ' ' THR . 85.5 m-85 -69.39 -11.61 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -77.78 -54.89 5.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 p -69.91 -35.34 74.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.914 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.5 t -64.31 -49.89 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.67 -42.22 91.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.835 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.2 p -63.48 -45.65 89.81 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.541 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -68.34 -47.1 68.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.53 -76.1 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.735 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 7.9 t -83.13 72.27 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.9 p -75.78 -26.97 57.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.633 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -172.83 149.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.281 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -130.97 147.01 52.56 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.241 0.543 . . . . 0.0 110.526 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.44 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.38 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.6 132.26 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.904 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 41.7 t0 -145.44 148.62 33.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 20.0 pttp -73.75 20.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 45' ' ' ASP . 13.3 t70 -122.16 16.53 10.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.706 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.11 161.19 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 109.947 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' ASP . 58.2 p -120.29 134.78 55.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.121 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.86 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.851 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' THR . 63.1 t0 -67.8 -50.6 55.99 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.37 0.605 . . . . 0.0 110.1 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.36 -35.47 79.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.829 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.4 tp -61.39 -45.54 93.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.774 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -43.77 97.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.722 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.99 -42.6 99.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.729 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.66 -45.95 83.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.621 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 64.5 t -59.85 -45.76 94.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.44 -51.43 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.726 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -60.52 -32.92 71.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.44 -54.48 46.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.952 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.22 -39.08 84.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.6 m -61.61 -49.46 76.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -61.36 -48.73 79.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 tt -108.27 82.17 1.59 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.323 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.606 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.45 -43.93 2.05 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.403 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.8 Cg_exo -61.21 115.18 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.783 2.322 . . . . 0.0 112.091 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 p -133.11 -41.86 0.89 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 71' ' ' HIS . 88.6 tttt -62.09 -37.44 85.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.752 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -75.56 28.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' A' ' 69' ' ' LYS . 95.6 m-70 -136.78 143.8 43.4 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.577 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.83 -62.96 1.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.961 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.64 -44.54 89.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.278 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.7 mm -84.51 2.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.971 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.45 -28.4 71.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -8.26 59.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.91 -44.63 94.16 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.409 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 79' ' ' CYS . 11.2 p -57.01 -44.15 82.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.352 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.457 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 73.5 m -67.75 -49.39 62.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.71 97.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.57 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.99 -42.4 99.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.09 -42.74 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.096 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.09 -44.51 96.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.674 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -65.73 -39.7 91.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -37.91 89.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.432 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.91 80.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.604 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.64 62.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -172.59 56.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.502 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -101.65 152.58 20.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.962 0.41 . . . . 0.0 110.482 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 34.7 m -48.36 148.01 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.966 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -106.65 164.19 12.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.175 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.436 ' CD2' ' C ' ' A' ' 92' ' ' LEU . 8.0 tt -127.32 126.82 43.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.845 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -137.15 154.9 50.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 96' ' ' GLY . 47.8 p-10 -84.31 -176.96 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.693 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -71.45 47.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -158.13 -68.17 0.01 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.92 -21.31 0.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -73.78 141.67 46.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.945 0.402 . . . . 0.0 110.62 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.447 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -76.0 93.22 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.403 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.31 153.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.295 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.3 mt -91.47 127.14 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.224 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.02 153.99 19.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.548 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.3 -37.8 25.21 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.181 1.921 . . . . 0.0 112.136 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.63 54.42 2.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 110.334 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -103.51 144.34 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.295 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -117.05 122.13 43.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.263 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.9 t -113.09 115.0 27.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.536 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 t -173.89 175.71 2.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -75.39 -20.64 58.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.362 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -72.78 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.238 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.08 170.68 6.75 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.447 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.62 -42.14 64.16 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.654 2.236 . . . . 0.0 112.076 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 67.6 t0 -96.51 48.1 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.566 179.711 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -78.93 136.32 37.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 110.645 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -100.34 -0.14 38.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.511 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 4' ' ' VAL . 9.6 p -111.53 36.41 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.536 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 4' ' ' VAL . 98.1 mt-10 55.94 165.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.311 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -94.38 165.24 12.67 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.581 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -52.13 -82.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.808 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 1.1 p30 166.52 126.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.064 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -43.85 155.99 0.31 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.02 110.62 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.618 2.212 . . . . 0.0 111.759 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -82.24 -85.61 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.212 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 t -72.22 52.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.963 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -153.28 120.28 5.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.253 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -70.82 118.87 14.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.375 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.0 mm -122.91 81.89 50.06 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 120.933 0.397 . . . . 0.0 111.093 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.31 111.41 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.683 2.255 . . . . 0.0 111.301 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -77.85 -10.06 59.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.657 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 p -85.63 170.94 12.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -103.58 136.47 43.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.053 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -104.66 121.92 44.56 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.94 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.03 149.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -130.46 20.22 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.963 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.563 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 mp -93.49 122.3 44.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.11 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.1 m -142.56 134.48 27.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -97.55 120.34 37.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.096 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -103.82 145.55 29.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.447 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.1 mm? -64.92 -41.66 95.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.816 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -150.12 -174.08 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.91 -37.68 87.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -59.79 -48.74 80.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.273 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -66.89 -33.95 76.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.589 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.91 -46.54 87.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.436 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -68.32 -41.99 80.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.91 -49.0 85.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.889 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.38 -41.07 96.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -59.94 -41.93 92.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -75.14 -31.15 60.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.69 -89.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.0 m -108.99 94.89 5.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.475 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 t -89.29 -11.28 43.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 94.5 mt-10 -145.04 156.56 44.0 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.602 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 8.4 m-85 -143.59 122.61 12.82 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.078 0.466 . . . . 0.0 110.598 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.83 135.43 49.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.381 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.03 132.62 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -58.92 172.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -50.83 -38.38 48.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -147.27 113.9 6.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 49' ' ' THR . 86.9 t -127.88 160.93 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -96.75 125.65 41.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -38.35 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.8 m-20 -60.27 -45.94 91.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.216 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -63.96 -43.06 96.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.949 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -40.26 95.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.04 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.1 -42.76 99.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.277 0.56 . . . . 0.0 110.184 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.3 -39.45 68.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.703 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.55 -53.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 8.4 p -55.8 -44.82 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.479 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 58.6 tp -62.04 -52.04 65.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.183 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -54.17 -43.31 70.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.099 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.96 93.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.179 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.23 -43.12 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.252 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -67.53 -36.49 81.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.609 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t -63.03 -52.26 63.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 t -74.75 -38.03 62.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.433 . . . . 0.0 110.547 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 tp -92.79 33.98 1.11 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.914 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.43 -47.14 2.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 66' ' ' SER . 71.8 Cg_endo -82.5 78.3 3.43 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.452 2.101 . . . . 0.0 112.291 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 33.4 m -133.81 -18.06 2.15 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -68.03 -7.43 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.672 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.33 -38.89 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' GLY . 93.7 m-70 -101.7 109.87 21.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.225 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 32.8 p-10 -65.78 -36.44 83.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.726 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.56 -57.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.683 ' O ' ' O ' ' A' ' 75' ' ' GLY . 81.6 mt -68.93 -45.0 81.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.683 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . -43.27 -131.27 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 O-C-N 124.053 0.846 . . . . 0.0 111.521 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.429 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 1.3 m 74.22 -36.09 0.32 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.96 -0.729 . . . . 0.0 110.532 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.2 OUTLIER -58.29 -29.47 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.817 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.4 -48.76 86.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.382 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.13 -37.44 87.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.103 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.42 -43.34 99.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.15 -38.02 89.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.794 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.88 -42.05 99.63 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' TYR . 89.0 mtm-85 -62.35 -48.08 81.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.014 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.56 -29.9 66.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.173 0.511 . . . . 0.0 110.411 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.16 84.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.43 -50.71 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.321 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.86 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.5 ' CE2' ' O ' ' A' ' 90' ' ' VAL . 26.9 t80 64.55 165.37 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.29 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.5 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 2.9 p -125.2 156.47 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.96 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.409 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 11.8 m-85 -122.55 138.51 54.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.077 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -108.85 128.83 55.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.4 154.04 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.793 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 44.6 t0 -73.62 176.83 5.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.467 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 11.3 tm-20 -61.12 -42.7 99.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.533 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.62 60.15 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.2 -0.37 87.31 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.5 t0 -89.13 108.83 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.6 0.238 . . . . 0.0 110.472 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -47.1 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.447 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 98' ' ' ASP . 79.6 t -152.84 131.26 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.663 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.554 ' CD1' ' H ' ' A' ' 101' ' ' ILE . 3.1 mp -60.93 123.88 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.27 170.58 8.01 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.539 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.73 -42.12 58.53 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.269 1.98 . . . . 0.0 112.234 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -105.85 101.5 11.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.226 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 52.1 mtm -104.62 147.05 28.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.324 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.507 ' HH ' ' CB ' ' A' ' 108' ' ' SER . 47.8 t80 -119.02 96.33 5.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.971 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.2 t -90.24 119.82 30.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.263 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.507 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . 47.7 t -161.06 159.74 29.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.608 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 5.5 m-85 -85.52 43.1 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.046 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m -146.6 178.76 8.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.232 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.46 170.69 5.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.518 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.14 -39.53 70.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.598 2.199 . . . . 0.0 112.038 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 p30 -87.31 0.58 55.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--O 1.222 -0.388 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.612 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt 41.42 -105.81 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.163 0.506 . . . . 0.0 110.783 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -153.94 2.35 0.25 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.067 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' O ' ' C ' ' A' ' 5' ' ' GLU . 4.5 m -147.74 18.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.477 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 4' ' ' VAL . 5.0 pt-20 30.38 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.83 0.706 . . . . 0.0 110.629 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -130.44 130.98 44.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.255 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 63.33 114.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.506 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -124.68 -179.2 4.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -51.12 151.52 4.71 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.498 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.55 -166.49 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.765 2.31 . . . . 0.0 112.063 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt 75.58 -62.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.995 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 p -70.02 -28.87 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.332 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.53 155.37 47.56 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.753 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -53.56 132.5 40.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.515 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pt -44.5 153.2 0.47 Allowed Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.667 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -44.51 122.84 4.17 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.421 2.081 . . . . 0.0 111.925 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.4 p -108.07 -6.79 16.33 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.519 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -86.43 -176.66 5.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.098 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.421 ' N ' ' HA ' ' A' ' 45' ' ' ASP . 73.2 ttt180 -126.06 150.7 47.96 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.498 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -145.34 126.71 14.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.799 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 42' ' ' PHE . 49.4 pt -140.91 148.56 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.107 0.48 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -113.43 77.41 1.05 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.791 0.329 . . . . 0.0 110.352 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.41 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.7 mp -110.0 126.42 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.0 m -124.19 126.84 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.364 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 107' ' ' CYS . 85.1 t80 -130.08 134.21 47.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.395 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.84 107.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.441 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.3 -43.59 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.605 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 98.1 m-20 -135.28 -86.36 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.511 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.67 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 31' ' ' PHE . 15.3 t -58.75 -45.55 89.46 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.292 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.474 ' N ' ' CG2' ' A' ' 30' ' ' THR . 51.6 t80 -61.46 -35.93 79.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.387 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.605 ' CG ' ' H ' ' A' ' 28' ' ' ASP . 90.9 m-20 -62.17 -44.63 96.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.293 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 30' ' ' THR . 78.3 p -62.16 -46.94 86.75 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.631 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.38 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.496 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 39' ' ' CYS . 53.6 tp -61.22 -44.68 96.88 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -60.17 -41.74 93.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 110.157 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.76 -32.25 73.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.07 -76.56 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.99 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.7 t -104.47 96.16 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -111.7 -30.19 7.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.37 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -95.27 141.25 29.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.365 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' ILE . 96.4 m-85 -136.55 133.36 36.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.173 0.511 . . . . 0.0 110.526 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -133.83 143.26 48.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.788 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' OG1' ' A' ' 18' ' ' THR . 1.2 m -145.72 -106.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.781 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' N ' ' A' ' 19' ' ' ARG . 43.5 p30 -166.85 161.51 15.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -63.64 163.28 11.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 61.49 37.23 16.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.478 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.69 123.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.13 0.491 . . . . 0.0 110.199 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -83.51 169.92 14.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.375 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.476 ' H ' HD21 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -60.81 -40.13 91.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -53.65 -50.34 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.111 0.482 . . . . 0.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.16 -38.08 89.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.313 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.65 -48.8 77.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.296 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.39 -41.18 68.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -62.15 -47.74 83.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.23 -43.36 95.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.133 0.492 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.69 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.82 -45.24 95.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.913 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -55.3 -43.74 75.08 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . -61.17 -38.97 88.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.465 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.89 -42.02 94.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -69.61 -47.01 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -62.44 -37.1 84.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.76 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 60' ' ' ALA . 19.1 m -73.65 -69.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.2 mt -103.48 98.57 8.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.556 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -77.85 -47.05 2.31 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.773 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.0 Cg_endo -81.39 137.63 10.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.603 2.202 . . . . 0.0 111.89 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.624 ' SG ' ' NZ ' ' A' ' 77' ' ' LYS . 5.8 m -133.22 -40.25 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.516 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.54 -11.08 60.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.39 -39.03 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.678 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.583 ' O ' ' N ' ' A' ' 75' ' ' GLY . 34.3 m170 -102.29 106.13 16.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.51 -37.95 89.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.25 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.19 -46.55 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.359 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 75' ' ' GLY . 95.7 mt -91.6 -13.67 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -53.93 -158.22 0.01 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 75' ' ' GLY . 2.2 p 69.44 -35.63 0.31 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.092 0.472 . . . . 0.0 110.539 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.624 ' NZ ' ' SG ' ' A' ' 68' ' ' CYS . 21.7 pttp -63.08 -20.47 65.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.306 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 79' ' ' CYS . 9.8 p -65.5 -46.15 90.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.304 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.487 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 1.6 t -68.85 -47.03 66.97 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.453 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.23 94.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.461 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.97 -43.27 99.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.45 -41.94 99.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.54 -43.81 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.278 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ASP . 96.1 mtt180 -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.135 0.493 . . . . 0.0 110.378 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.92 -42.9 94.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.33 -13.2 55.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.398 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' TYR . . . -149.89 61.41 0.42 Allowed Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' ARG . 88.8 m-20 -38.74 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.508 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -95.0 63.69 2.72 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.356 0.598 . . . . 0.0 110.373 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.9 t -150.91 137.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.33 132.21 41.04 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.219 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -103.65 136.49 43.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.751 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -157.53 148.83 21.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.832 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.63 -164.94 1.25 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 110.468 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.75 -39.83 82.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.78 -34.78 65.52 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.66 60.01 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 100' ' ' VAL . 47.6 t0 -88.16 113.98 24.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -42.57 89.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.658 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 98' ' ' ASP . 9.2 p -144.04 141.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.39 127.65 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.151 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.21 169.67 9.39 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.55 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -45.51 -42.63 18.24 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.426 2.084 . . . . 0.0 112.228 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -99.96 123.85 44.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.82 0.343 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 68.1 mtp -114.81 142.56 46.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.498 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 87.1 t80 -146.15 97.36 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.158 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.522 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.3 t -98.88 115.46 28.89 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.669 0.606 . . . . 0.0 110.923 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.498 ' OG ' ' CE2' ' A' ' 106' ' ' TYR . 9.1 p -171.03 162.11 7.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.649 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 109' ' ' PHE . 1.0 OUTLIER -61.67 -53.34 57.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.361 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.7 p -41.9 148.95 0.15 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.998 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -106.61 161.89 21.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -56.62 -31.41 86.99 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.671 2.247 . . . . 0.0 112.081 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -105.02 15.08 28.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.163 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.961 -179.856 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -67.13 128.49 36.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.731 0.3 . . . . 0.0 110.36 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -74.59 -50.16 18.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.75 154.71 3.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.511 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.42 155.54 38.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -69.7 -156.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.459 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 m120 59.46 68.03 0.84 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.814 0.34 . . . . 0.0 110.251 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.429 ' CG ' ' N ' ' A' ' 9' ' ' LYS . 53.6 p-10 -137.52 -131.81 0.13 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.538 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' N ' ' CG ' ' A' ' 8' ' ' ASP . 17.6 ttmm -45.53 127.06 6.31 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.744 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.29 121.63 6.58 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.976 1.784 . . . . 0.0 112.099 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.629 ' O ' ' N ' ' A' ' 13' ' ' ARG . 70.9 mmtt -87.11 -156.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.934 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t 44.97 -81.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 123.302 0.376 . . . . 0.0 110.795 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.629 ' N ' ' O ' ' A' ' 11' ' ' LYS . 89.1 mtm180 -61.91 162.92 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.546 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.51 175.87 0.96 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.653 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.562 ' H ' ' CD1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -44.57 163.5 0.19 Allowed Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.352 -179.173 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 15' ' ' ILE . 52.8 Cg_exo -54.12 -137.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 122.404 2.069 . . . . 0.0 112.29 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.0 m -85.46 12.41 8.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.856 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p -86.3 143.59 27.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.184 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -131.53 146.16 52.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.479 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.2 140.24 32.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 pt -131.23 146.84 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.18 89.34 2.97 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.4 128.03 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.278 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -66.91 141.34 57.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.6 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 8.0 m-85 -115.05 135.19 54.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.321 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.79 142.77 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.639 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt 67.26 46.65 1.43 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.97 0.414 . . . . 0.0 111.35 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -128.0 12.15 6.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.154 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 36.94 -120.25 0.17 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.228 0.537 . . . . 0.0 111.698 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.74 -59.77 3.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -40.44 -44.45 2.01 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.838 0.352 . . . . 0.0 110.533 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' O ' ' OG ' ' A' ' 36' ' ' SER . 36.2 t0 -56.42 -52.25 65.36 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -68.55 -40.45 80.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.798 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -52.73 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.266 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.17 -42.2 89.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 32' ' ' ASP . 73.4 m -59.67 -43.52 93.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.74 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -79.26 -26.94 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.69 -72.42 0.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.6 p -152.11 98.91 2.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.531 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 78.4 p -51.39 -30.8 20.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.287 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -85.47 144.95 27.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 40' ' ' SER . 45.6 m-85 -129.6 138.6 51.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.54 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 43.6 tt0 -77.46 136.45 38.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.598 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 p -141.12 155.06 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.454 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' ASP . 45.7 t0 -149.75 146.07 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -40.77 -26.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.607 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' ASP . 11.0 m-20 -138.19 90.99 2.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.441 ' CG2' ' N ' ' A' ' 49' ' ' THR . 5.0 p -139.05 158.8 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.943 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 51' ' ' ASP . 68.0 p -121.81 137.52 54.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 1.7 pt? -37.9 -25.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.432 0.635 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.5 m-20 -58.91 -41.8 88.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.947 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' OE2' ' OE1' ' A' ' 43' ' ' GLU . 80.1 tt0 -64.89 -33.77 76.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.848 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.415 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 42.9 tp -62.31 -42.84 99.7 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 109.806 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.99 -42.26 76.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.617 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.81 -43.87 91.75 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.173 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.46 -40.2 63.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.844 0.354 . . . . 0.0 110.688 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 48.0 t -61.09 -48.19 90.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.77 -54.07 41.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.755 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 63.7 t0 -52.31 -38.65 59.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.825 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.76 99.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.33 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' LEU . 75.2 t -63.15 -46.25 96.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -66.59 -43.69 84.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.578 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -61.15 -47.47 86.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.5 p -75.2 -75.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' VAL . 68.9 mt -109.5 109.67 20.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.452 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.26 -44.04 2.68 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.074 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' SER . 27.1 Cg_exo -61.15 132.19 40.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.568 2.178 . . . . 0.0 112.118 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 66' ' ' SER . 2.3 m -134.83 -55.44 0.82 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 110.277 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 71' ' ' HIS . 21.2 ptmt -67.53 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.742 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -76.17 13.25 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.482 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.441 ' H ' ' C ' ' A' ' 69' ' ' LYS . 97.0 m-70 -126.44 93.4 3.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.442 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -62.12 -34.79 77.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.45 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.07 -45.58 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.287 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 75' ' ' GLY . 51.8 mt -77.72 -60.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.719 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.698 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . 46.22 175.82 0.01 OUTLIER Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m 61.96 -23.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.651 -0.323 . . . . 0.0 110.703 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.698 ' H ' ' C ' ' A' ' 75' ' ' GLY . 8.9 tttm -56.69 -62.76 1.51 Allowed 'General case' 0 C--O 1.225 -0.198 0 CA-C-O 121.367 0.603 . . . . 0.0 109.898 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -52.5 -33.34 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.023 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 t -68.22 -50.84 51.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.551 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.13 93.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.82 -42.15 99.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.034 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.81 -43.99 97.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -58.54 -46.69 86.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -64.94 -36.59 84.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.754 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.34 -37.94 85.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.269 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 -24.99 62.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.344 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.18 -65.1 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -174.5 -179.69 1.59 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -158.31 -68.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.572 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.59 157.0 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.543 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 2.5 p90 -144.31 155.3 43.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.784 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.56 154.64 41.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.236 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.47 147.28 27.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.04 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 96' ' ' GLY . 89.6 m-20 -80.79 167.84 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 104' ' ' ARG . 94.8 mt-10 -52.26 -9.36 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.484 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -90.02 -74.52 1.29 Allowed Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.48 -28.19 0.33 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -69.55 137.9 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -75.35 89.85 2.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -147.87 149.73 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 101' ' ' ILE . 1.8 mp -83.16 129.47 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.079 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.33 169.48 9.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.287 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.23 -45.03 19.1 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.593 2.196 . . . . 0.0 112.601 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 95' ' ' GLU . 74.0 mtp85 -107.31 80.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.508 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -104.23 160.9 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -141.87 114.14 8.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 25' ' ' PHE . 8.9 p -102.7 128.94 49.21 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.964 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 109' ' ' PHE . 40.0 t -175.74 -167.07 0.22 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.223 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.541 ' O ' ' CD2' ' A' ' 109' ' ' PHE . 70.6 t80 -104.12 25.18 10.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.7 m -115.03 160.87 19.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.267 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -109.25 170.41 5.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.522 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.41 -40.68 70.61 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.459 2.106 . . . . 0.0 112.378 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.4 p30 -114.16 39.41 2.75 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.639 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -68.33 128.39 36.42 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.668 0.27 . . . . 0.0 110.584 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -81.53 90.6 6.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.315 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.487 ' C ' ' H ' ' A' ' 6' ' ' PHE . 2.7 m -146.63 143.38 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.541 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -57.25 -6.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.596 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.487 ' H ' ' C ' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -44.01 135.05 4.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.34 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 6' ' ' PHE . 1.8 t-20 160.69 -26.15 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 O-C-N 123.818 0.699 . . . . 0.0 110.342 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' ASN . 99.5 m-20 53.85 165.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.025 0.44 . . . . 0.0 110.508 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.72 156.45 80.35 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.798 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.49 14.96 0.88 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.565 2.177 . . . . 0.0 112.172 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.93 -50.46 55.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.57 19.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.151 0.5 . . . . 0.0 110.775 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.4 mtm105 -137.42 150.07 47.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.917 0.389 . . . . 0.0 110.21 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -53.93 98.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.324 0.583 . . . . 0.0 110.447 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.55 154.72 0.33 Allowed Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.746 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.84 -89.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.416 2.077 . . . . 0.0 112.13 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.9 p -112.75 -1.01 14.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.446 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p -87.01 166.94 14.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -158.45 177.87 10.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.347 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -117.4 141.17 48.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 110.212 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.0 tt -99.16 141.11 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.127 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -132.07 5.41 4.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.23 125.53 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.7 p -138.76 146.56 41.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.81 136.87 56.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.256 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.44 133.33 43.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.062 0.458 . . . . 0.0 110.558 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 10.3 mp -66.75 -40.39 88.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.716 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 37.0 t0 -159.23 -170.92 3.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.418 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.535 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -59.05 -46.05 89.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.704 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -61.51 -53.21 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.422 ' N ' ' OG1' ' A' ' 30' ' ' THR . 92.7 m-85 -61.42 -27.66 68.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.23 0.538 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.42 -45.0 73.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.975 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -67.98 -36.48 80.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.42 -49.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.467 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.9 -41.62 95.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.99 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 40' ' ' SER . 92.6 p -62.07 -44.46 96.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -75.05 -26.69 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.01 -28.91 69.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.676 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.521 ' C ' ' H ' ' A' ' 41' ' ' GLU . 10.7 p -161.22 -33.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.0 t 69.77 -42.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 39' ' ' CYS . 21.4 pt-20 -154.64 143.16 20.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -134.03 136.07 43.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 110.592 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -67.8 135.85 53.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.433 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.61 134.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.309 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.95 164.37 38.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.615 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 68.9 mmtt -70.66 101.4 2.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 1.5 t70 162.64 -46.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.763 0.665 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -100.14 110.6 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.0 110.597 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -87.53 172.81 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -43.76 -30.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 -51.77 67.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.695 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -39.98 94.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.221 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.61 -38.95 92.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.966 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.88 -44.01 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.471 . . . . 0.0 110.206 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.53 -34.95 70.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.611 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.63 -54.51 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 9.4 p -55.74 -44.66 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.492 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 5.6 tt -61.85 -55.3 31.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.63 -42.71 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.8 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.662 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.92 -46.24 92.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -65.64 -47.19 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.851 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -64.83 -54.03 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.8 m -66.15 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.748 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.3 tp -108.86 81.97 1.53 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.658 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.53 -44.41 2.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.454 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.4 Cg_exo -63.16 119.72 6.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.543 2.162 . . . . 0.0 112.032 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.21 -17.89 2.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 71' ' ' HIS . 26.0 pttm -66.46 -20.23 65.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.49 28.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.555 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.428 ' H ' ' C ' ' A' ' 69' ' ' LYS . 76.7 m80 -126.08 160.75 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.492 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -82.43 -65.3 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.42 -47.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.6 mt -65.47 -16.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.061 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.32 3.33 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -82.53 -14.07 55.55 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.299 0.571 . . . . 0.0 110.829 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.52 -34.38 61.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.294 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.2 t -59.55 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.256 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 85.4 m -61.6 -39.84 92.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.17 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.61 84.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.272 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -50.09 74.98 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 82' ' ' LEU . 4.1 mm? -61.91 -41.74 98.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.399 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -60.89 -47.15 87.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.216 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -65.7 -40.91 92.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.637 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.23 -22.22 66.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.657 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -40.43 80.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.95 -37.39 0.66 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -84.01 116.33 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.559 0.219 . . . . 0.0 110.461 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -130.92 143.75 50.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.425 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 m -51.5 140.9 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.392 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.89 150.35 24.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.311 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -127.95 127.79 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.778 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -148.02 151.6 36.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.67 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 96' ' ' GLY . 54.0 p-10 -78.67 179.51 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.761 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.81 26.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.644 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -130.08 -83.8 0.33 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.43 -26.9 0.12 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -72.46 141.16 48.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.519 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.08 89.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -148.54 136.9 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.559 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mm -77.48 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.483 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -140.46 168.95 12.91 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.4 -37.14 60.59 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.544 2.163 . . . . 0.0 112.166 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -129.36 122.79 30.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.52 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.636 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -153.79 149.23 27.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.428 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -87.55 130.82 34.6 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.5 t -126.05 108.4 11.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.15 179.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.417 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' SER . 50.6 p90 -69.34 -40.48 77.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.539 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 109' ' ' PHE . 9.4 t -57.01 149.56 18.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.331 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.77 170.59 8.68 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.643 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.4 -40.39 62.43 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.459 2.106 . . . . 0.0 112.125 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.44 -47.91 84.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.591 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.5 t0 . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.546 -179.773 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -77.8 151.43 34.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.616 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -92.5 -4.15 54.03 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.444 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.459 ' C ' ' H ' ' A' ' 6' ' ' PHE . 2.1 t 54.15 21.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.641 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -76.97 38.07 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.489 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.459 ' H ' ' C ' ' A' ' 4' ' ' VAL . 80.0 m-85 -108.17 -164.56 0.97 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 6' ' ' PHE . 11.2 m120 61.19 140.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.111 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 50.7 p-10 -95.21 84.96 4.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.128 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -133.62 145.34 55.85 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.012 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.37 -57.06 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.635 2.224 . . . . 0.0 112.244 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -168.85 -161.9 0.35 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.632 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.2 -53.23 46.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.335 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -42.24 114.36 0.55 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.907 0.385 . . . . 0.0 110.186 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -51.09 175.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.089 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.592 ' H ' ' CD1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -53.4 164.13 0.86 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.557 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.551 ' C ' ' H ' ' A' ' 18' ' ' THR . 34.0 Cg_exo -56.37 148.09 63.88 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.267 1.978 . . . . 0.0 112.119 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.2 p -66.83 8.77 0.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.35 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 16' ' ' PRO . 58.8 p -87.26 160.52 18.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.221 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -145.65 177.02 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.577 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -145.54 133.72 21.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.452 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.89 149.0 32.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 18.9 mtpp -114.11 68.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.268 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -95.22 125.08 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.268 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 t -161.65 142.37 10.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -129.46 134.19 47.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.404 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.42 143.23 47.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -5.14 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.265 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 28.5 t0 -153.42 163.85 39.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.566 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.14 -38.15 89.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -61.25 -45.77 93.16 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.594 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -66.05 -27.82 68.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.437 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -73.44 -40.55 64.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.864 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -66.89 -48.21 69.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.986 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.33 -42.34 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.94 -43.32 99.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.788 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.5 p -67.6 -43.54 80.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 110.813 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -64.86 -35.52 81.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.65 -58.12 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.805 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.2 m -138.42 94.06 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.686 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.528 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 2.4 p -100.2 -2.73 33.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.342 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -145.75 126.17 14.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -110.94 111.25 22.25 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.159 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.564 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -70.56 156.34 39.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.391 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.04 125.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 47' ' ' ASP . 67.6 m-20 -147.24 149.43 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -72.15 16.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 45' ' ' ASP . 92.4 m-20 -112.07 -3.23 14.79 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -119.19 132.46 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.935 0.398 . . . . 0.0 110.276 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.409 ' OG1' ' OD1' ' A' ' 51' ' ' ASP . 72.6 p -101.84 157.52 16.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -48.9 -41.99 35.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.702 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.409 ' OD1' ' OG1' ' A' ' 49' ' ' THR . 1.4 p-10 -59.54 -49.33 78.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 110.337 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -35.52 81.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.316 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.76 -43.86 98.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.314 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.09 -40.61 98.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.381 0.61 . . . . 0.0 110.073 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.11 -43.61 82.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.855 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.37 -52.38 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.37 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 58' ' ' LEU . 8.6 p -59.0 -46.09 91.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.977 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.401 ' N ' ' CG1' ' A' ' 57' ' ' VAL . 56.8 tp -65.59 -54.7 24.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.772 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -58.99 -31.69 69.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.845 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.19 -56.46 12.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.366 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -69.1 -43.87 81.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.705 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.06 -44.8 91.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.285 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.7 p -63.05 -45.95 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.67 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -63.34 -52.65 60.91 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.412 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -110.58 73.21 0.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.543 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.01 -46.53 2.8 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.545 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.3 Cg_endo -82.39 107.1 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.353 2.035 . . . . 0.0 111.88 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.569 ' C ' ' H ' ' A' ' 70' ' ' GLU . 2.5 m -133.59 -13.51 2.59 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.252 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -51.02 -6.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.997 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.569 ' H ' ' C ' ' A' ' 68' ' ' CYS . 14.4 pt-20 -72.35 -36.96 68.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.505 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -83.65 156.53 22.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.624 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 19.2 p-10 -76.06 -59.65 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.428 ' H ' ' CG ' ' A' ' 72' ' ' ASP . 27.4 m -95.48 -44.87 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.11 -0.85 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.106 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . -106.17 -41.08 1.85 Allowed Glycine 0 N--CA 1.465 0.616 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.2 m -48.77 -12.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 75' ' ' GLY . 21.4 ptmt -56.42 -37.23 69.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.85 -45.67 94.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.803 0.335 . . . . 0.0 110.228 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 82.1 m -64.39 -48.0 77.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.03 82.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.268 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.53 -43.64 98.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.8 -40.7 92.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.65 -50.92 67.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.23 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 89' ' ' TYR . 36.3 ptt180 -69.67 -40.29 76.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 110.642 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.766 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.9 -40.33 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.29 -81.04 1.37 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 84' ' ' ARG . 99.7 m-20 -135.2 97.6 3.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 84' ' ' ARG . 0.3 OUTLIER -55.36 -100.67 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.436 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.5 m -146.38 162.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.524 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.06 142.15 50.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.941 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.0 tt -122.35 125.63 46.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.306 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -128.09 154.29 45.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.558 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 23.3 t0 -74.88 177.52 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.5 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.543 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 8.5 tm-20 -47.03 -59.77 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.52 -46.86 91.4 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.24 -13.53 0.82 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.64 141.79 58.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 0.0 110.56 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -76.6 88.33 3.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.545 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -151.02 137.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 101' ' ' ILE . 95.3 mt -64.33 132.21 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 110.197 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.63 160.89 30.54 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.31 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.46 -24.69 78.72 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.85 2.367 . . . . 0.0 111.94 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -125.36 57.2 1.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.783 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -102.59 144.65 30.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.012 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.484 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 57.4 t80 -97.34 127.43 43.29 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.308 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.1 p -125.39 112.29 16.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.484 ' OG ' ' CE2' ' A' ' 106' ' ' TYR . 5.4 p -171.46 168.76 6.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.772 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 110' ' ' SER . 44.5 p90 -63.5 -47.16 82.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.52 ' N ' ' CG ' ' A' ' 109' ' ' PHE . 17.1 m -59.43 144.14 47.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.83 170.64 15.3 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.562 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.12 -42.03 54.96 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.383 2.055 . . . . 0.0 111.877 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 46.4 p-10 -88.1 -34.18 18.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 67.7 t0 . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -72.1 98.95 2.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.824 0.345 . . . . 0.0 110.764 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -61.28 -46.53 89.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.614 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.51 134.88 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.57 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -43.23 150.9 0.17 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.681 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -71.58 -59.58 2.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 p30 176.3 116.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.417 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 9' ' ' LYS . 19.9 p-10 -150.41 -62.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.522 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 20.4 pttm -55.58 147.49 39.57 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.77 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 11' ' ' LYS . 45.2 Cg_endo -70.22 114.21 3.7 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.612 2.208 . . . . 0.0 111.961 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 10' ' ' PRO . 52.9 mtmt 32.38 -112.01 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.476 0.485 . . . . 0.0 110.724 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -133.42 18.71 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.549 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -138.27 137.33 37.36 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.443 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.91 142.43 54.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.501 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.7 mt -110.67 96.78 29.83 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.316 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.1 153.94 32.51 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -72.9 -6.67 46.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.57 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.0 t -129.17 170.19 13.85 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.57 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -148.81 160.0 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.52 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.63 141.72 33.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 tt -107.33 128.94 61.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.04 16.81 10.84 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.227 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mt -108.05 131.4 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.152 0.501 . . . . 0.0 111.13 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.4 m -141.31 145.25 35.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.474 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 107' ' ' CYS . 87.4 t80 -85.0 114.79 22.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.365 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.95 142.38 46.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.529 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.72 -79.49 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.65 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.73 168.7 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.71 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.762 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -57.7 10.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.582 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -65.95 -23.62 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.288 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.48 -46.31 70.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -71.51 -39.32 70.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.494 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.8 -48.22 89.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.271 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.47 -42.92 91.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.967 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 40' ' ' SER . 10.6 t -62.62 -47.94 81.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.502 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.04 -45.75 92.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.727 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.86 65.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.5 t -164.08 78.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' SER . 61.2 p -83.14 -7.22 59.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.294 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -171.16 127.97 0.7 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 43' ' ' GLU . 21.0 t80 -128.76 158.16 39.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.181 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -109.58 116.79 32.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.42 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.82 129.67 75.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.206 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 47' ' ' ASP . 19.6 p-10 -113.94 169.02 9.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.985 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 55.7 mtpt -52.63 86.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.515 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER 167.8 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.449 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.4 t -76.85 129.84 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.311 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLU . 3.8 p -124.18 157.53 34.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.415 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -36.54 -39.3 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.646 -179.422 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' H ' ' HG ' ' A' ' 50' ' ' LEU . 99.9 m-20 -63.18 -45.95 89.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.445 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 49' ' ' THR . 46.0 tp10 -66.98 -38.44 86.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.464 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 5.5 mt -62.45 -43.14 99.53 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 121.078 0.466 . . . . 0.0 110.617 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.64 -39.47 84.6 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.315 0.579 . . . . 0.0 110.656 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.24 -44.18 80.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.68 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 57' ' ' VAL . 8.4 p -76.64 -45.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.848 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 54.0 t -58.33 -47.6 87.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.58 -56.47 13.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.311 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.05 -40.48 58.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.186 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.52 89.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.2 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.755 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.75 -42.79 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.601 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -63.23 -54.86 30.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.901 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -62.24 -48.76 78.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.541 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.9 tp -108.54 93.57 4.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -79.15 -46.4 1.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.69 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.1 Cg_endo -83.93 116.39 2.15 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.102 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 m -130.64 -34.09 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.556 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -64.57 -28.03 69.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.589 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 70' ' ' GLU . 57.8 mp0 -73.33 -36.37 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 75' ' ' GLY . 92.7 m-70 -91.4 108.67 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.98 -29.85 70.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -59.66 -45.46 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 75' ' ' GLY . 7.0 mt -103.08 -10.75 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . -48.09 -177.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 75' ' ' GLY . 2.0 p 73.74 -30.93 0.21 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.353 0.597 . . . . 0.0 110.642 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.556 ' CB ' ' HZ1' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -62.24 -33.88 75.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.959 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -59.68 -42.03 87.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 83.2 m -63.43 -50.1 71.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.14 81.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.148 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.8 tp -50.99 -41.53 59.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.73 -49.88 75.72 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.141 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.01 -41.99 99.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.35 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -65.83 -41.02 92.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt -62.56 -29.87 70.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.339 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.51 0.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.459 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . 171.14 -74.2 0.1 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 89' ' ' TYR . 9.9 p-10 176.99 -74.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 1.8 t80 75.81 -71.14 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.1 t -52.9 131.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.337 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.567 ' CZ ' ' O ' ' A' ' 89' ' ' TYR . 37.1 m-85 -120.42 160.41 23.15 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.034 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.401 ' CD2' ' C ' ' A' ' 92' ' ' LEU . 8.6 tt -123.79 126.78 47.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.425 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -130.06 150.54 51.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.767 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -82.82 -158.89 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.457 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.53 -49.69 74.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.437 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.94 -113.22 0.15 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -154.05 45.8 0.56 Allowed Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -124.94 131.39 53.43 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.11 89.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.695 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -158.37 146.52 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 mm -73.45 128.91 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.068 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -144.79 171.27 6.84 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.72 -36.74 42.67 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.542 2.161 . . . . 0.0 111.93 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -130.91 131.29 44.4 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.667 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -162.39 167.82 23.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.387 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -139.21 142.17 37.9 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.501 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.9 t -114.28 113.49 24.66 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.0 p -162.22 170.87 18.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.887 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 110' ' ' SER . 44.9 p90 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.513 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 8.4 t -54.91 148.74 12.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.497 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.34 170.4 6.13 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 114' ' ' ASP . 52.2 Cg_exo -51.32 -40.34 61.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.486 2.124 . . . . 0.0 111.903 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -81.6 35.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.426 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 112' ' ' PRO . 68.2 t0 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.524 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.815 -1.314 . . . . 999.99000000000001 109.815 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.631 ' NZ ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -40.85 164.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.673 -0.264 . . . . 999.99000000000001 110.506 -179.356 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.992 ' NZ ' ' H ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -58.48 -153.3 0.0 OUTLIER 'General case' 0 C--N 1.343 0.317 0 C-N-CA 120.352 -0.539 . . . . 999.99000000000001 109.779 -179.699 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.893 ' CB ' ' HZ1' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -31.19 -34.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 109.689 -0.485 . . . . 999.99000000000001 109.689 -179.325 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.992 ' H ' ' NZ ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 175.93 21.22 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.268 0.627 . . . . 999.99000000000001 112.064 177.692 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.553 ' CD2' ' OE1' ' A' ' 5' ' ' GLU . 22.2 m-85 -135.73 -39.97 0.7 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.332 1.234 . . . . 999.99000000000001 114.332 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.719 ' H ' ' CG ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -179.64 110.3 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 119.56 1.073 . . . . 999.99000000000001 113.851 -178.208 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 7' ' ' ASN . 7.8 t70 100.74 -132.6 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.418 -0.81 . . . . 999.99000000000001 111.458 178.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.579 ' NZ ' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -116.7 153.34 49.13 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 109.223 -0.658 . . . . 999.99000000000001 109.223 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.579 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 84.8 Cg_exo -39.39 120.79 0.67 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.239 1.959 . . . . 999.99000000000001 114.093 -178.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.614 ' HG3' ' H ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -135.49 -83.77 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.266 -0.424 . . . . 999.99000000000001 110.601 179.134 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.614 ' H ' ' HG3' ' A' ' 11' ' ' LYS . 7.2 m -52.47 -95.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.043 -0.526 . . . . 999.99000000000001 111.378 -179.483 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.614 ' H ' ' CG2' ' A' ' 12' ' ' VAL . 48.2 ttp85 -39.22 172.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.01 0.433 . . . . 999.99000000000001 110.869 -178.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.543 ' H ' ' CG ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -70.84 138.75 50.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 999.99000000000001 110.015 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.6 mt -66.11 133.42 94.69 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.204 -0.453 . . . . 999.99000000000001 109.866 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.664 ' C ' ' H ' ' A' ' 18' ' ' THR . 62.1 Cg_exo -44.81 151.4 0.65 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.615 1.544 . . . . 999.99000000000001 111.526 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 6.0 p -61.47 9.21 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 999.99000000000001 110.025 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.664 ' H ' ' C ' ' A' ' 16' ' ' PRO . 2.9 p -105.41 179.09 4.37 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-O 121.322 0.582 . . . . 999.99000000000001 111.615 -179.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -146.18 169.3 19.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.495 -0.775 . . . . 999.99000000000001 110.835 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -126.18 119.7 28.17 Favored 'General case' 0 C--N 1.267 -2.988 1 O-C-N 114.155 -5.341 . . . . 999.99000000000001 111.2 -174.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.55 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -104.25 145.97 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 114.963 -1.017 . . . . 999.99000000000001 110.443 -179.101 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.513 ' N ' HG13 ' A' ' 21' ' ' ILE . 14.1 tttt -134.85 10.67 3.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.142 -0.935 . . . . 999.99000000000001 110.042 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.55 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.4 mp -94.82 110.73 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.09 0.472 . . . . 999.99000000000001 111.354 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -119.63 137.59 53.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.449 -0.796 . . . . 999.99000000000001 109.66 179.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -86.14 114.9 23.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.101 0.477 . . . . 999.99000000000001 110.272 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.91 107.82 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 999.99000000000001 111.048 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.429 HD13 HH22 ' A' ' 84' ' ' ARG . 6.4 mt -68.95 -40.02 79.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 999.99000000000001 109.536 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -151.62 172.25 16.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.794 -1.093 . . . . 999.99000000000001 109.125 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.2 -26.5 62.87 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.584 -0.447 . . . . 999.99000000000001 109.999 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 32' ' ' ASP . 24.8 m -59.97 -63.89 1.14 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.958 -0.565 . . . . 999.99000000000001 110.287 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 69.5 m-85 -75.68 16.4 0.39 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 119.091 0.859 . . . . 999.99000000000001 109.636 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.5 t0 -88.65 -64.79 1.09 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.07 -1.456 . . . . 999.99000000000001 107.07 177.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.3 p -67.8 -41.37 83.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.256 -0.884 . . . . 999.99000000000001 109.046 177.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.6 t -66.51 -50.3 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 112.787 0.662 . . . . 999.99000000000001 112.787 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 12.9 tp -64.96 -41.73 95.22 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.678 -0.809 . . . . 892.61000000000001 110.448 -178.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.54 -44.64 95.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.978 -0.289 . . . . 999.99000000000001 111.411 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -63.18 -45.57 91.16 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.365 0.506 . . . . 999.99000000000001 112.365 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.35 -28.28 52.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.227 -0.442 . . . . 999.99000000000001 110.758 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.591 ' SG ' ' CD2' ' A' ' 42' ' ' PHE . 6.9 t -147.66 80.83 1.5 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.398 0.888 . . . . 999.99000000000001 113.398 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 p -91.45 -14.96 29.61 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.834 -0.621 . . . . 999.99000000000001 109.609 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -151.33 144.6 24.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.685 0.994 . . . . 999.99000000000001 113.685 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.591 ' CD2' ' SG ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -140.48 147.44 39.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.168 -0.923 . . . . 999.99000000000001 111.23 177.862 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -110.59 119.12 38.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.736 -0.666 . . . . 999.99000000000001 110.207 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.474 ' CG2' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -121.61 111.27 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 114.711 1.374 . . . . 999.99000000000001 114.711 -176.698 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.89 161.11 10.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 105.307 -2.109 . . . . 999.99000000000001 105.307 175.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 17' ' ' SER . 1.2 mtpm? -83.44 35.99 0.52 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 122.403 2.365 . . . . 999.99000000000001 110.376 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -131.94 2.38 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.883 -0.784 . . . . 999.99000000000001 108.883 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.0 t -88.63 124.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.498 -0.774 . . . . 999.99000000000001 109.62 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 52' ' ' GLU . 35.0 p -103.19 147.82 26.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 731.38 109.888 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -33.77 -34.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 441.33999999999997 110.938 -178.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' THR . 98.3 m-20 -60.7 -48.6 81.04 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 698.47000000000003 110.519 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.9 mt-10 -68.24 -38.14 81.53 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.31 -0.405 . . . . 999.99000000000001 110.385 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.25 -45.83 92.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.142 -0.688 . . . . 717.46000000000004 109.142 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.457 ' CD2' HG23 ' A' ' 90' ' ' VAL . 1.9 mt -63.39 -41.95 98.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.537 -0.756 . . . . 612.28999999999996 110.266 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.37 -50.4 73.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.525 -0.761 . . . . 805.60000000000002 111.285 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.8 -36.45 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.821 0.344 . . . . 999.99000000000001 110.925 -179.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.38 -48.24 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 556.5 110.351 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD1' ' CD1' ' A' ' 81' ' ' LEU . 32.2 tp -63.94 -44.06 93.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.204 -0.907 . . . . 641.33000000000004 109.811 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.71 -43.08 97.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.984 -0.553 . . . . 999.99000000000001 111.211 179.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.79 84.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.748 0.309 . . . . 848.76999999999998 110.972 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.7 t -64.24 -42.01 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 599.86000000000001 110.384 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.16 -39.71 93.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 999.99000000000001 109.968 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -42.07 86.07 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.3 -0.409 . . . . 999.99000000000001 111.69 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -44.88 39.62 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.598 -0.441 . . . . 999.99000000000001 110.895 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.457 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 3.0 tp -108.11 71.7 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 999.99000000000001 110.713 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.532 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -78.14 -45.47 2.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 999.99000000000001 110.82 179.42 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 66' ' ' SER . 72.8 Cg_endo -80.42 56.89 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.884 2.39 . . . . 999.99000000000001 113.365 -179.554 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.55 -33.27 25.49 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.935 0.398 . . . . 908.97000000000003 110.318 179.235 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.93 -20.44 65.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.784 -0.644 . . . . 999.99000000000001 111.587 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.79 -38.36 70.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.646 -0.252 . . . . 999.99000000000001 111.451 -178.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -87.78 120.56 29.23 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.95 -0.3 . . . . 999.99000000000001 110.388 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.83 -41.31 97.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.509 0.195 . . . . 999.99000000000001 111.284 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.85 -47.67 92.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 999.99000000000001 110.252 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 75' ' ' GLY . 30.7 mt -81.62 -26.76 9.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 115.975 -0.557 . . . . 999.99000000000001 110.666 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -22.79 -78.93 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 N-CA-C 111.189 -0.764 . . . . 719.80999999999995 111.189 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -25.85 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.942 0.719 . . . . 989.60000000000002 112.942 -178.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -56.02 -29.59 60.6 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.348 -0.22 . . . . 999.99000000000001 110.941 179.635 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.18 -46.2 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 110.16 -0.311 . . . . 999.99000000000001 110.16 178.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.86 -43.77 97.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.0 -0.545 . . . . 800.41999999999996 110.127 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.08 92.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 563.47000000000003 109.793 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.415 ' CD1' ' CD1' ' A' ' 58' ' ' LEU . 58.1 tp -62.65 -45.0 94.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.798 -0.637 . . . . 913.92999999999995 110.331 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.1 tp -62.95 -43.2 99.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.877 -0.601 . . . . 999.99000000000001 110.137 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -64.44 -38.74 92.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.158 -0.474 . . . . 999.99000000000001 110.143 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 97.0 mtt180 -65.73 -39.87 91.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.999 0.428 . . . . 999.99000000000001 110.531 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tp -73.5 -24.52 60.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 999.99000000000001 110.169 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.8 99.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.108 -0.496 . . . . 999.99000000000001 111.941 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.27 -55.79 0.07 OUTLIER Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.238 -0.982 . . . . 999.99000000000001 112.211 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 99.4 m-20 -87.88 115.81 25.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 999.99000000000001 110.119 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.4 p90 -109.6 -111.36 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.559 -0.291 . . . . 999.99000000000001 110.385 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.463 ' H ' ' HD2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -150.73 115.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.373 -0.973 . . . . 608.69000000000005 108.373 178.423 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.17 160.55 32.24 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.02 -1.104 . . . . 586.54999999999995 108.02 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 3.2 tt -146.49 134.74 21.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 120.002 1.274 . . . . 364.69 107.968 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.08 162.73 37.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.186 -0.606 . . . . 999.99000000000001 112.152 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -77.65 -177.98 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.313 -0.858 . . . . 841.49000000000001 110.719 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -74.69 49.82 0.41 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.06 -0.518 . . . . 999.99000000000001 110.609 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -152.45 -53.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.573 -1.011 . . . . 951.75999999999999 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.49 -19.51 2.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.224 -1.151 . . . . 744.85000000000002 110.224 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -70.78 136.93 49.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.34 -0.244 . . . . 774.99000000000001 110.34 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -74.89 89.93 2.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.898 -0.408 . . . . 691.20000000000005 109.898 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.02 149.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 663.89999999999998 110.502 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.86 123.18 41.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.535 -0.543 . . . . 679.55999999999995 109.535 179.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . . . -139.48 178.15 1.74 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.83 -0.623 . . . . 660.94000000000005 109.653 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 102' ' ' ALA . 50.8 Cg_exo -53.74 -35.87 80.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.317 2.011 . . . . 999.99000000000001 111.603 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -121.97 97.9 5.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.94 -0.573 . . . . 999.99000000000001 110.715 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.31 132.2 56.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.045 -0.525 . . . . 630.75 110.542 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 73.8 t80 -92.73 106.07 18.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.367 -0.379 . . . . 807.87 109.993 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.423 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 4.1 t -98.24 118.57 35.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.187 -0.46 . . . . 611.89999999999998 110.942 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.475 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 11.5 t -174.41 168.45 3.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.149 0.499 . . . . 710.65999999999997 110.856 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.463 ' N ' HG12 ' A' ' 90' ' ' VAL . 25.7 p90 -87.79 25.08 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.201 -0.666 . . . . 999.99000000000001 109.201 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.0 m -117.36 121.65 41.7 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.815 -0.63 . . . . 999.99000000000001 110.021 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.74 162.02 2.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.611 -0.722 . . . . 854.05999999999995 110.985 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -46.04 35.48 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.576 2.184 . . . . 999.99000000000001 112.135 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.5 p-10 -74.65 -36.5 62.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.999 0.904 . . . . 999.99000000000001 109.09 177.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 t0 . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 113.624 -1.626 . . . . 999.99000000000001 110.347 179.523 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 2.6 p . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.868 0.366 . . . . 999.99000000000001 110.591 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.409 ' O ' HG23 ' A' ' 44' ' ' VAL . 67.3 mtp180 -103.11 137.81 40.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.313 -0.625 . . . . 999.99000000000001 109.313 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 97.5 mttt -95.53 114.59 26.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.211 0.529 . . . . 999.99000000000001 111.16 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.642 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -100.68 147.1 8.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.268 -0.878 . . . . 885.66999999999996 110.178 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' N ' HG13 ' A' ' 21' ' ' ILE . 11.7 tttt -134.78 11.72 3.68 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.667 -0.697 . . . . 999.99000000000001 110.783 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.642 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.7 mp -95.85 111.47 26.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.931 0.396 . . . . 999.99000000000001 110.697 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.44 130.68 53.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 999.99000000000001 110.293 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -78.02 113.19 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.099 0.476 . . . . 999.99000000000001 110.41 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.26 107.85 19.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 999.99000000000001 110.756 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.4 mt -68.11 -40.06 82.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 999.99000000000001 110.181 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -154.08 170.2 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 999.99000000000001 109.891 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.97 25.23 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.331 -0.395 . . . . 999.99000000000001 110.1 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 32' ' ' ASP . 17.1 m -58.71 -64.68 0.84 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.726 -0.67 . . . . 999.99000000000001 110.405 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.509 ' O ' ' HB3' ' A' ' 35' ' ' LEU . 77.9 m-85 -75.93 16.49 0.41 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.357 0.526 . . . . 999.99000000000001 109.967 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.0 t0 -88.51 -65.5 1.01 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.65 -0.87 . . . . 999.99000000000001 108.65 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.2 p -73.1 -33.51 65.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.471 -0.786 . . . . 999.99000000000001 109.7 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.606 HG11 HD22 ' A' ' 65' ' ' LEU . 66.3 t -70.9 -50.1 45.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.077 -0.51 . . . . 825.48000000000002 111.457 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 31' ' ' PHE . 16.9 tp -64.05 -41.73 97.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 119.91 -0.716 . . . . 715.35000000000002 110.521 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -62.68 -45.65 91.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.353 -0.385 . . . . 999.99000000000001 110.937 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -64.35 -39.69 94.38 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.906 0.335 . . . . 999.99000000000001 111.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.55 -27.33 31.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 999.99000000000001 110.654 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.568 ' HG ' ' HD2' ' A' ' 42' ' ' PHE . 2.9 t -147.78 85.3 1.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 999.99000000000001 111.982 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 p -97.13 -16.28 20.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.878 -0.601 . . . . 999.99000000000001 110.094 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' CG ' ' HE3' ' A' ' 22' ' ' LYS . 41.4 mt-10 -152.03 144.48 24.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.047 -0.979 . . . . 999.99000000000001 112.067 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HD2' ' HG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -142.94 141.76 31.52 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.764 -0.653 . . . . 999.99000000000001 111.564 179.088 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 16.5 pt-20 -105.91 115.31 30.01 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.814 -0.63 . . . . 999.99000000000001 110.508 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.544 HG12 ' CB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -119.89 111.95 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.854 0.835 . . . . 999.99000000000001 112.644 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 2.2 m-20 -57.73 170.76 0.55 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.014 -1.448 . . . . 999.99000000000001 107.667 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -87.89 31.67 0.77 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.295 1.861 . . . . 999.99000000000001 110.084 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -133.72 -3.9 2.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 999.99000000000001 109.817 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.544 ' CB ' HG12 ' A' ' 44' ' ' VAL . 19.2 t -79.53 126.15 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.877 -0.601 . . . . 999.99000000000001 109.996 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' GLU . 19.8 p -103.18 145.66 29.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.907 -0.588 . . . . 533.5 110.178 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.676 ' N ' HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -30.31 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.773 0.671 . . . . 304.88 110.882 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' THR . 97.6 m-20 -60.22 -49.48 77.45 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.326 -0.397 . . . . 698.47000000000003 110.598 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.3 mt-10 -66.78 -38.95 87.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 999.99000000000001 110.55 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.08 -46.02 92.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.695 -0.483 . . . . 499.30000000000001 109.695 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.435 ' CD2' HG23 ' A' ' 90' ' ' VAL . 1.6 mt -63.32 -40.96 98.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 404.06 110.432 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -60.64 -51.52 69.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 805.60000000000002 111.064 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.86 -35.8 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.779 0.323 . . . . 843.98000000000002 110.795 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.28 -48.04 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.06 -0.518 . . . . 353.45999999999998 110.653 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.959 HD11 ' CD1' ' A' ' 81' ' ' LEU . 30.5 tp -65.1 -43.38 92.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 501.13 110.136 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -64.62 -42.08 95.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.931 -0.577 . . . . 999.99000000000001 110.78 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . -61.4 -50.95 70.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 763.22000000000003 110.828 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.76 -40.82 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 599.86000000000001 110.555 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -66.35 -36.91 84.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.927 -0.578 . . . . 999.99000000000001 110.36 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -41.78 75.58 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.229 -0.441 . . . . 999.99000000000001 111.221 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -74.22 -48.59 27.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.423 -0.353 . . . . 999.99000000000001 110.871 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.606 HD22 HG11 ' A' ' 34' ' ' VAL . 3.7 tp -106.23 72.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 999.99000000000001 110.438 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -78.23 -49.3 1.89 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 999.99000000000001 110.678 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 66' ' ' SER . 59.8 Cg_endo -76.53 63.18 7.22 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.859 2.372 . . . . 999.99000000000001 112.423 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -91.86 -31.67 15.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 845.47000000000003 110.518 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HB2' HG21 ' A' ' 78' ' ' VAL . 81.0 tttt -65.69 -16.52 63.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 999.99000000000001 110.873 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.78 -39.81 66.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.401 -0.363 . . . . 999.99000000000001 110.956 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 75' ' ' GLY . 99.0 m-70 -86.73 118.52 26.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 999.99000000000001 110.281 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.06 -40.64 94.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 999.99000000000001 110.947 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -47.24 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 999.99000000000001 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 43.1 mt -83.27 -29.68 8.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.144 -0.48 . . . . 999.99000000000001 110.612 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -21.71 -76.03 0.01 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 110.863 -0.895 . . . . 655.89999999999998 110.863 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -25.0 -35.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.016 0.48 . . . . 866.77999999999997 112.169 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -53.93 -29.75 43.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.267 -0.173 . . . . 999.99000000000001 110.606 179.308 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 69' ' ' LYS . 2.6 t -68.77 -46.9 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.781 0.324 . . . . 812.96000000000004 110.389 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 m -61.79 -44.64 96.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.938 -0.574 . . . . 771.90999999999997 110.228 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.02 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.962 -0.563 . . . . 483.48000000000002 110.224 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.959 ' CD1' HD11 ' A' ' 58' ' ' LEU . 58.3 tp -62.67 -45.31 93.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.078 -0.51 . . . . 703.45000000000005 110.479 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 82' ' ' LEU . 16.0 tp -63.2 -43.32 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 999.99000000000001 110.345 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.3 -40.08 96.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 999.99000000000001 110.43 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 91.7 mtt180 -65.33 -40.0 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 999.99000000000001 110.745 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tp -74.94 -19.37 60.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.947 -0.57 . . . . 985.92999999999995 110.389 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.76 -45.13 94.12 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.364 -0.38 . . . . 999.99000000000001 111.097 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.55 -56.3 0.06 OUTLIER Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.939 -0.648 . . . . 999.99000000000001 111.505 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 92.0 m-20 -84.15 112.81 20.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.34 -0.244 . . . . 999.99000000000001 110.34 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.505 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.2 p90 -108.62 -110.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.323 . . . . 999.99000000000001 110.474 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -151.39 115.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.331 -0.618 . . . . 390.25999999999999 109.331 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -73.84 155.27 38.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.262 -0.644 . . . . 421.31 109.262 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.946 HD12 ' HB2' ' A' ' 107' ' ' CYS . 3.8 tt -142.35 135.19 28.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.723 -0.843 . . . . 247.34 108.723 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.51 163.73 32.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.882 0.372 . . . . 999.99000000000001 111.011 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -79.49 -175.73 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 841.49000000000001 110.36 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.08 50.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.145 -0.479 . . . . 999.99000000000001 110.687 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.39 -55.62 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.778 -0.929 . . . . 951.75999999999999 110.778 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.76 -20.3 2.18 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.572 -1.011 . . . . 633.38 110.572 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -72.33 136.8 46.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.739 0.304 . . . . 774.99000000000001 110.588 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.532 ' HB3' HD21 ' A' ' 50' ' ' LEU . 96.8 mt-10 -74.21 89.83 2.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 691.20000000000005 110.28 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.62 151.13 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 455.33999999999997 110.456 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.676 HD11 ' N ' ' A' ' 50' ' ' LEU . 4.1 mp -90.45 123.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.546 . . . . 501.24000000000001 110.208 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.85 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -141.28 177.49 1.91 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 635.24000000000001 110.399 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.85 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 53.2 Cg_exo -51.51 -36.79 60.81 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.704 2.269 . . . . 999.99000000000001 111.979 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -123.21 98.0 5.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.212 -0.449 . . . . 999.99000000000001 110.499 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.635 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -116.01 134.84 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.536 . . . . 524.37 110.4 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 70.7 t80 -94.87 106.23 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 650.22000000000003 110.147 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.946 ' HB2' HD12 ' A' ' 92' ' ' LEU . 4.3 t -98.64 120.76 39.63 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.107 -0.497 . . . . 456.19999999999999 110.669 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.509 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 10.4 t -177.38 167.2 2.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.188 0.518 . . . . 573.24000000000001 110.738 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.609 ' N ' HG12 ' A' ' 90' ' ' VAL . 26.0 p90 -85.68 26.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 999.99000000000001 109.982 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.1 m -119.77 121.1 38.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.259 -0.428 . . . . 956.63999999999999 110.552 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -53.54 161.35 1.56 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.854 -0.612 . . . . 699.55999999999995 110.418 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.5 Cg_exo -50.58 -47.46 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.558 2.172 . . . . 999.99000000000001 112.324 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 24.7 p-10 -72.95 -38.28 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 999.99000000000001 110.409 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 114.429 -1.259 . . . . 999.99000000000001 110.032 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -113.83 171.3 7.67 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -112.52 147.39 36.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.37 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 21' ' ' ILE . 10.8 tp -108.65 134.29 51.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.05 -2.42 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mt -102.52 122.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.41 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -147.41 144.2 28.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.455 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.55 119.61 23.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.29 36.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -64.88 -40.5 95.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.569 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.3 t0 -156.25 -175.82 5.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -61.1 -42.91 99.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.53 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' VAL . 75.3 m -63.12 -47.56 82.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.563 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.411 ' HB2' ' H ' ' A' ' 28' ' ' ASP . 64.0 m-85 -65.34 -33.46 76.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.447 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -65.46 -51.49 59.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.826 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 t -63.67 -44.86 92.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.749 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 30' ' ' THR . 69.9 t -62.73 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.84 -43.4 96.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.705 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.27 -45.79 91.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.59 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -65.25 -44.39 88.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.728 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.27 -54.52 14.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.472 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 60' ' ' ALA . 60.8 m -118.58 79.22 1.35 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.562 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.46 -37.96 89.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.476 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -172.63 150.48 2.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.604 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -142.12 156.94 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.84 124.66 32.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.985 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 m -124.6 135.64 63.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.093 0.473 . . . . 0.0 110.592 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.24 168.57 19.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.145 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -73.7 161.25 30.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 56.96 33.86 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.678 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -75.14 140.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.242 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 20.3 p -90.76 -71.36 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 172.17 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.771 0.669 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 26.5 p-10 -55.88 -44.46 78.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.919 0.39 . . . . 0.0 110.451 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 79.5 tt0 -64.61 -41.24 96.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.419 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' VAL . 19.3 mt -62.95 -43.64 98.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.83 -43.21 96.88 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.839 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -67.92 -43.05 80.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.022 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.71 -50.48 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 53' ' ' LEU . 76.4 t -57.54 -48.21 83.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 81' ' ' LEU . 54.0 tp -64.92 -55.73 17.52 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.622 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -51.66 -41.82 61.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.304 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.445 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -62.51 -42.44 99.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.588 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 57' ' ' VAL . 53.9 t -63.91 -45.3 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.703 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.59 -42.17 82.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.589 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 t -61.34 -54.37 44.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.794 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.1 p -59.75 -45.42 92.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.152 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -108.01 81.34 1.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.55 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.63 -46.61 4.18 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 66' ' ' SER . 61.1 Cg_endo -81.91 106.4 1.61 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.335 2.023 . . . . 0.0 112.009 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.401 ' SG ' ' CG2' ' A' ' 78' ' ' VAL . 1.4 p -133.25 -42.0 0.88 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.871 0.367 . . . . 0.0 110.208 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -66.9 -22.91 65.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -72.29 -38.64 68.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.732 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 75' ' ' GLY . 77.0 m80 -97.66 125.3 42.36 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.76 -34.98 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.064 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.27 -45.98 95.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.073 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 31.8 mm -88.59 -22.38 6.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.201 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -37.71 -56.18 1.68 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.8 p -46.58 -19.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.722 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 88.9 tttt -62.03 -45.96 91.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.588 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 74.1 t -62.61 -44.53 99.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.57 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 77.9 m -62.0 -49.43 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.78 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 58' ' ' LEU . 5.5 tt -63.28 -44.53 94.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.72 -43.61 98.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 87' ' ' GLY . 33.2 t70 -62.11 -44.27 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 88' ' ' ASP . 87.5 mtm180 -66.83 -36.99 83.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.816 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.21 -46.33 87.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.406 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.21 -49.85 2.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.46 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -69.23 -95.65 0.05 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 83' ' ' ASP . 99.7 m-20 -68.92 -172.11 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.574 0.226 . . . . 0.0 110.495 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CE1' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER 173.45 175.06 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.092 0.472 . . . . 0.0 110.322 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.27 138.29 47.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.436 ' OH ' ' CE1' ' A' ' 89' ' ' TYR . 54.5 m-85 -110.11 151.52 27.14 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.509 HD23 ' C ' ' A' ' 92' ' ' LEU . 7.1 tt -131.29 124.6 30.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.487 ' N ' HD23 ' A' ' 92' ' ' LEU . 82.0 m-85 -132.76 154.68 50.0 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.694 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 97' ' ' GLY . 18.8 p-10 -82.98 177.41 8.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.16 26.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -144.3 -4.6 0.66 Allowed Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.559 ' N ' ' OD1' ' A' ' 94' ' ' ASP . . . 91.75 -6.27 79.73 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 45.1 t0 -86.9 117.19 25.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.791 0.329 . . . . 0.0 110.464 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 100' ' ' VAL . 95.6 mt-10 -55.6 86.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.521 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 99' ' ' GLU . 67.7 t -156.83 134.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.47 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 101' ' ' ILE . 1.6 mp -68.92 131.44 33.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.678 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -146.06 172.0 5.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.582 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.1 Cg_exo -51.46 -35.69 56.1 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.598 2.199 . . . . 0.0 111.812 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' A' ' 103' ' ' PRO . 1.5 mpt_? -118.63 74.23 0.96 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.002 0.43 . . . . 0.0 110.392 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -104.79 148.69 26.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.165 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.485 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 57.3 t80 -116.82 124.89 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.48 ' SG ' ' CD1' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -123.5 110.36 14.98 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.485 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 7.1 p -168.38 169.3 10.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.804 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 109' ' ' PHE . 30.1 t80 -62.46 -47.36 84.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -59.34 145.69 42.44 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.403 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.675 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -80.58 170.79 14.26 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.443 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.675 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.3 Cg_exo -51.32 -42.29 55.1 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.526 2.15 . . . . 0.0 111.84 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.05 -41.11 97.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.02 0.438 . . . . 0.0 110.755 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.762 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 110.438 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' OG1' ' A' ' 18' ' ' THR . 33.7 ptt180 -139.24 167.18 22.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.358 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -116.17 146.7 42.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 21' ' ' ILE . 8.3 tt -130.26 122.4 53.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.36 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -99.42 121.5 41.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.922 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.17 115.0 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.165 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -154.54 117.8 4.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -134.11 138.65 45.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.958 0.409 . . . . 0.0 110.425 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 143.11 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.6 mt -139.78 -79.72 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 21.9 p-10 -156.94 -62.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.583 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.513 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -178.11 -68.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.453 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -62.02 -51.21 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -69.73 -20.77 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.352 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.89 -52.86 17.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 36' ' ' SER . 78.1 p -68.46 -41.54 80.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.634 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 30' ' ' THR . 70.5 t -63.08 -45.63 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.71 -42.63 99.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 78.3 p -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.74 -41.2 96.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.678 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.486 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -59.31 -24.15 63.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.634 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 38' ' ' ALA . 8.5 m -162.42 63.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.569 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.4 p -68.49 -18.77 64.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.519 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -174.45 139.43 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 156.15 46.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.086 0.469 . . . . 0.0 110.181 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -119.51 113.83 21.34 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.973 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.58 133.82 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.255 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.42 141.1 28.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.317 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 64.3 tttp -47.56 101.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.94 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD2' ' C ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER 163.38 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.712 0.632 . . . . 0.0 110.3 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.76 136.91 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 110.454 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -92.42 155.52 17.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.05 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -42.65 -37.73 1.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.22 -43.59 95.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.211 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -65.61 -35.36 80.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 57' ' ' VAL . 18.6 mt -61.53 -46.83 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.53 -41.58 98.46 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.452 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -43.14 99.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.93 -45.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-O 120.955 0.407 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 53' ' ' LEU . 54.6 t -58.04 -48.37 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.894 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.7 -53.67 47.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.98 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -49.86 -42.6 47.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.829 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.93 -49.66 74.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.942 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.59 -48.06 90.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.247 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' HA ' HD23 ' A' ' 65' ' ' LEU . 14.8 mm-40 -45.32 -53.39 8.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.398 0.618 . . . . 0.0 110.414 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 t -60.08 -43.44 95.48 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.5 p -86.04 14.34 6.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.118 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.73 -24.01 23.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 110.212 179.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.479 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -41.33 -49.96 8.82 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.582 -178.607 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 66' ' ' SER . 50.2 Cg_exo -53.04 -39.75 78.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.149 1.899 . . . . 0.0 112.218 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.8 m -68.02 -34.28 76.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.597 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -60.92 -30.45 70.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.517 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.62 -33.64 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.475 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 75' ' ' GLY . 97.8 m-70 -97.05 118.49 33.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.238 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.0 p-10 -68.5 -35.38 77.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 78.1 t -61.57 -47.85 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 76' ' ' THR . 58.6 mt -88.42 -34.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.391 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -39.89 -21.75 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' ILE . 46.2 p -54.76 -29.73 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.103 0.478 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -32.89 66.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 65' ' ' LEU . 91.7 t -62.09 -46.17 97.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.43 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 94.2 m -63.66 -39.13 93.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.8 -43.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.82 -41.45 99.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.4 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.58 -41.9 99.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.566 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 87' ' ' GLY . 40.0 t0 -62.19 -43.11 99.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -69.5 -37.61 77.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.518 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.61 -43.11 99.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.464 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.68 -12.15 22.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.556 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -119.78 57.17 0.57 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 63.51 98.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.086 0.469 . . . . 0.0 110.504 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -55.29 -100.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.12 162.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.157 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -116.29 139.77 50.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.861 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.87 132.58 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -140.98 154.78 46.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.644 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -85.13 -162.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.564 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -73.01 51.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.566 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.43 -90.15 0.08 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.5 -29.07 0.02 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.31 139.93 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -80.96 90.24 5.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -146.61 138.52 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.516 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.749 ' N ' HD12 ' A' ' 101' ' ' ILE . 2.5 mp -71.47 131.66 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -145.8 172.56 5.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.631 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 53.3 Cg_exo -51.17 -36.29 55.18 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.559 2.173 . . . . 0.0 112.162 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -132.73 103.09 5.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -122.55 148.42 45.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.214 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -101.79 119.9 39.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.06 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.32 112.97 20.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.476 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 t -177.34 168.77 2.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.847 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 -45.48 93.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.6 p -59.14 147.06 36.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.281 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -87.53 170.07 12.75 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.457 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 54.8 Cg_exo -50.15 -43.97 40.22 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.414 2.076 . . . . 0.0 111.931 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 31.5 p-10 -90.07 -37.84 13.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.97 0.415 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 61.2 t0 . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.545 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 2.3 t . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.778 0.323 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 44' ' ' VAL . 84.8 mtp180 -105.26 140.95 37.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.957 0.408 . . . . 0.0 110.292 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -105.53 148.6 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.133 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.2 tp -127.69 135.12 63.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.307 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -137.8 -35.23 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.817 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.3 140.52 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.263 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -155.26 144.76 21.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.35 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.39 137.84 55.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 116.11 22.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.584 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.418 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 54.1 mt -62.06 -42.86 99.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.456 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 61.8 m-20 -158.77 20.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 28' ' ' ASP . . . 73.81 -51.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m -61.36 -53.53 55.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.285 0.565 . . . . 0.0 110.696 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -71.24 -27.33 63.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.922 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.89 -44.51 97.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.255 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.0 p -70.35 -42.21 72.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.29 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.7 -48.88 86.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.383 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.37 -40.73 96.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.498 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 40' ' ' SER . 75.1 m -56.3 -43.38 78.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.09 89.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.502 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.34 2.7 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.861 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.518 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 18.2 p -174.45 54.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.108 0.48 . . . . 0.0 110.286 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 36' ' ' SER . 78.0 p -60.11 -36.97 78.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.754 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -136.59 125.67 24.47 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.453 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -129.82 131.63 46.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.48 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -91.48 126.67 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.15 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 19' ' ' ARG . 47.1 t -122.48 126.19 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.115 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -48.84 160.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 22.6 pttm -59.72 -50.03 75.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.036 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 49.9 t0 -91.63 90.36 7.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -147.71 128.23 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.275 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -90.48 151.67 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.228 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -48.69 -32.86 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.375 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -51.11 71.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.289 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 56' ' ' VAL . 82.4 tt0 -64.66 -41.71 95.92 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.71 HD13 ' C ' ' A' ' 53' ' ' LEU . 2.8 tm? -61.78 -50.72 71.22 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.599 HD11 ' NH2' ' A' ' 84' ' ' ARG . 60.8 tp -50.73 -41.72 56.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.14 -35.8 71.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 52' ' ' GLU . 44.4 t -69.7 -51.78 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 58' ' ' LEU . 14.8 p -61.39 -42.7 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.908 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.521 ' N ' HG13 ' A' ' 57' ' ' VAL . 57.4 tp -60.45 -54.5 44.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.28 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -53.89 -41.72 67.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.88 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.31 -46.66 82.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.543 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.84 -43.71 97.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.437 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.564 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -62.63 -44.08 97.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.822 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.2 p -68.53 -64.81 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.725 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.41 83.35 2.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.569 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -74.87 -45.73 5.06 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.322 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.8 Cg_endo -83.25 114.32 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.599 2.2 . . . . 0.0 111.987 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.76 -19.39 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.0 -9.84 48.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.759 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.55 -38.5 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.472 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.1 m-70 -103.16 124.58 48.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.3 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.6 p-10 -60.58 -34.98 74.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.353 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.513 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 82.9 t -62.32 -47.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 45.9 mt -82.45 -23.37 9.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -34.91 -61.01 0.64 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -40.05 -24.38 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.95 0.405 . . . . 0.0 110.784 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 66.0 tttm -58.67 -45.39 89.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.213 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.1 t -57.4 -44.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.37 -46.52 88.3 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.73 -38.5 91.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.242 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.39 -42.7 99.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -62.35 -45.92 91.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 0.0 110.09 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.93 -45.48 94.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.599 ' NH2' HD11 ' A' ' 54' ' ' LEU . 83.1 mtp180 -66.08 -39.43 90.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.076 0.465 . . . . 0.0 110.751 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.88 -29.25 69.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.44 59.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.498 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 168.62 -65.35 0.18 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 89' ' ' TYR . 28.0 t70 -173.89 176.0 2.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.548 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.545 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 t80 -175.18 -68.53 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.3 m -66.1 133.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.308 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 65.4 m-85 -116.87 145.89 43.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.617 HD23 ' C ' ' A' ' 92' ' ' LEU . 7.7 tt -117.02 125.73 51.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.509 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.57 ' N ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -126.37 152.26 46.54 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.284 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 46.6 t0 -74.52 179.16 4.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.165 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 80.5 mm-40 -65.68 -37.54 86.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.66 -3.47 87.0 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.61 78.97 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.1 t0 -88.5 111.08 21.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -50.62 87.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.306 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 76.0 t -152.87 130.8 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.521 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.59 134.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.031 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -155.59 171.82 6.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.579 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 58.0 Cg_exo -50.83 -38.07 56.53 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.414 2.076 . . . . 0.0 111.993 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -130.86 131.79 44.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.315 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.533 ' HB2' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -153.4 173.87 15.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.02 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -117.98 109.73 16.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.343 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.8 t -107.55 115.74 30.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.534 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 t -172.59 177.34 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.527 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -89.72 40.85 1.01 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.617 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.2 m -136.91 116.1 12.54 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.449 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.609 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -61.96 170.38 2.08 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.541 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 49.0 Cg_exo -54.45 -43.13 61.66 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.428 2.085 . . . . 0.0 112.267 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -93.79 12.73 24.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.583 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.529 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 C--O 1.229 0.025 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' VAL . 62.6 ttp180 -110.53 151.83 27.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -112.42 144.96 40.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.069 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tp -119.32 142.8 32.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -130.74 -15.21 3.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.37 126.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 110.567 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 m -138.13 137.61 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.384 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.8 131.25 50.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.213 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.77 137.1 43.09 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.552 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.9 mm? -63.89 -41.42 97.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -159.59 179.07 9.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.83 83.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.499 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -63.2 -50.85 68.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.513 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -70.31 -22.69 62.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.65 -52.65 50.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 0.0 110.346 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -67.87 -44.6 76.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.34 -46.45 95.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.27 -43.55 97.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.592 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.3 t -60.58 -42.74 97.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -63.61 -44.47 93.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.549 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.17 -78.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.487 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 31.6 t -87.14 64.34 8.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.5 t -62.33 -41.28 98.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -154.28 148.11 25.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 81.8 t80 -150.28 150.12 31.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.495 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 16.7 pt-20 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.238 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 19' ' ' ARG . 65.4 t -127.89 133.27 67.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.116 0.484 . . . . 0.0 110.472 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 48' ' ' VAL . 91.5 m-20 -81.2 170.08 16.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.228 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.81 152.23 20.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.086 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.12 41.55 10.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.587 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.625 HG12 ' N ' ' A' ' 49' ' ' THR . 62.7 t -89.22 166.85 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.625 ' N ' HG12 ' A' ' 48' ' ' VAL . 31.0 m -121.71 129.33 52.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.26 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -37.61 -27.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.697 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 49' ' ' THR . 64.2 t0 -60.03 -46.92 87.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.055 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 80.7 mm-40 -64.88 -41.95 95.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.367 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.469 ' O ' HG12 ' A' ' 57' ' ' VAL . 51.2 tp -62.59 -41.36 98.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.213 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.556 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.83 -44.61 95.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.754 0.788 . . . . 0.0 110.367 -178.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.36 -42.49 68.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.543 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' GLU . 56.0 t -66.72 -51.27 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.071 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.549 HG13 ' N ' ' A' ' 58' ' ' LEU . 9.3 p -58.17 -43.93 86.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' N ' HG13 ' A' ' 57' ' ' VAL . 58.1 tp -60.06 -52.22 66.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.257 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.79 -31.53 71.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.16 -54.42 41.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.17 -38.58 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.722 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.5 -44.77 81.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.2 p -62.1 -44.8 95.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.434 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.418 ' C ' HD12 ' A' ' 65' ' ' LEU . 22.0 p -61.17 -49.21 78.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 65' ' ' LEU . 10.8 mp -101.35 109.49 21.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.254 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.43 -48.11 3.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.5 Cg_endo -80.69 138.04 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.637 2.224 . . . . 0.0 111.881 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.8 m -130.99 -77.79 0.53 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.586 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.2 -5.73 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.466 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -72.36 0.96 8.71 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.342 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -130.26 102.92 6.42 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.269 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -66.17 -39.54 89.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.597 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.01 -47.58 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.731 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 75' ' ' GLY . 97.2 mt -67.42 -56.04 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.911 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . 31.95 -155.93 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m 71.84 -50.62 0.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 110.377 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -63.68 -25.29 68.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.338 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.32 -50.33 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.6 m -69.37 -37.65 77.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.44 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.66 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.955 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.19 -47.26 85.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.876 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.03 -40.29 96.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.12 0.486 . . . . 0.0 110.437 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -61.43 -46.27 90.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.713 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -43.22 97.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.256 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.33 -24.35 64.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.498 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.12 32.87 2.28 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 89' ' ' TYR . 97.7 m-20 -78.69 -53.5 7.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 48.5 p90 42.61 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.653 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.8 m -142.08 168.13 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.158 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.4 137.76 38.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.046 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 92' ' ' LEU . 2.5 pp -134.57 139.96 45.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.625 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -151.94 164.11 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.819 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 96' ' ' GLY . 52.4 p-10 -76.58 178.0 7.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.277 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.38 26.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -118.7 -70.07 0.35 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.79 -24.91 0.23 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.97 123.21 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.27 92.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.478 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.94 135.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.655 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.51 132.8 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.339 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -161.27 172.0 6.26 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.663 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 52.2 Cg_exo -52.19 -42.97 56.55 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.592 2.195 . . . . 0.0 111.785 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.72 78.24 1.33 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.062 0.458 . . . . 0.0 110.038 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -106.08 134.46 49.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.405 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -104.47 97.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 108' ' ' SER . 11.9 t -95.38 124.32 39.35 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.511 0.507 . . . . 0.0 110.597 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 107' ' ' CYS . 69.1 m -168.95 170.21 9.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.56 48.53 1.53 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.97 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 t -140.61 168.58 19.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.115 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -100.98 170.38 6.63 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.3 Cg_exo -51.75 -39.3 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.586 2.191 . . . . 0.0 111.837 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -81.47 40.35 0.57 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.982 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.413 HG22 ' OD1' ' A' ' 45' ' ' ASP . 43.2 p . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 120.708 0.289 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.405 ' NH2' ' NZ ' ' A' ' 46' ' ' LYS . 43.2 ttm180 -127.95 149.23 50.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.229 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.08 135.61 46.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.13 138.5 37.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.441 ' C ' HD12 ' A' ' 23' ' ' ILE . 77.0 tttt -95.24 115.35 27.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.768 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.781 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.8 mp -94.57 108.64 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.458 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -137.08 102.02 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.507 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -161.06 107.17 1.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.16 151.15 49.45 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.168 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.2 28.09 8.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 33.8 t0 -146.03 -143.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.307 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.499 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -131.52 -64.66 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.525 HG23 ' N ' ' A' ' 31' ' ' PHE . 14.7 t -58.03 -42.76 86.02 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.393 0.616 . . . . 0.0 110.399 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.525 ' N ' HG23 ' A' ' 30' ' ' THR . 52.2 t80 -68.16 -22.98 64.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.507 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -76.3 -44.42 37.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.993 0.425 . . . . 0.0 111.135 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -63.27 -45.73 90.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.843 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 35' ' ' LEU . 20.6 m -65.28 -40.19 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.398 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -61.72 -51.02 70.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.841 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -62.6 -45.34 93.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.04 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.02 -44.56 84.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.91 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 7.5 t -89.31 79.75 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.414 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -82.19 -9.04 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.321 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -172.7 127.97 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.135 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.29 139.84 45.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -119.52 115.89 24.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.267 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.36 156.15 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.768 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' OD1' HG22 ' A' ' 18' ' ' THR . 92.6 m-20 -87.57 171.69 10.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.207 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 48' ' ' VAL . 68.6 mttm -60.85 -59.49 5.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 46' ' ' LYS . 98.4 m-20 -34.09 -34.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' LYS . 21.3 t -59.55 133.13 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 p -106.72 147.42 29.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.241 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -38.88 -35.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.55 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.14 -51.83 67.91 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.114 0.483 . . . . 0.0 110.146 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.561 ' O ' HG22 ' A' ' 56' ' ' VAL . 85.1 tt0 -63.68 -34.92 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.046 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.47 ' O ' HG12 ' A' ' 57' ' ' VAL . 54.6 tp -62.68 -40.02 95.78 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.534 0.521 . . . . 0.0 110.442 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.265 0.555 . . . . 0.0 111.077 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -69.4 -46.68 66.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.669 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.644 HG23 ' N ' ' A' ' 57' ' ' VAL . 29.2 m -69.82 -49.72 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.644 ' N ' HG23 ' A' ' 56' ' ' VAL . 9.8 p -57.39 -45.61 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.569 ' N ' HG13 ' A' ' 57' ' ' VAL . 55.5 tp -60.94 -53.56 55.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.12 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -53.62 -39.79 65.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.59 -52.05 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.498 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.465 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 66.7 t -64.26 -47.31 90.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.47 -45.29 76.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.352 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.0 p -62.46 -45.61 92.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.714 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.8 m -53.31 -51.95 60.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.586 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.4 OUTLIER -108.29 68.43 0.7 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.366 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.56 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.94 -47.05 2.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.4 Cg_endo -81.08 85.07 1.86 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.569 2.179 . . . . 0.0 112.333 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.4 m -133.49 -10.04 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.591 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.09 -27.12 68.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.12 -36.75 69.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.579 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 75' ' ' GLY . 80.8 m80 -76.61 126.08 30.36 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.89 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.46 -43.98 92.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.53 -44.68 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.11 17.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.429 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -74.55 -62.13 2.96 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -57.12 -9.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.95 0.405 . . . . 0.0 110.064 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' GLY . 49.7 tptt -59.7 -51.77 68.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.626 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -57.61 -48.53 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 110.032 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.4 m -57.18 -34.57 68.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.103 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.94 93.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.493 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.04 -44.9 95.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.596 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.76 -44.64 92.83 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.41 -43.86 97.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.416 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mtt180 -67.92 -41.7 82.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.761 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.77 -20.75 66.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.425 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.52 -35.53 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.704 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -63.43 0.04 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' ARG . 67.5 t0 -79.15 119.54 22.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.652 0.263 . . . . 0.0 110.424 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -120.47 -100.25 0.43 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.741 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -144.3 141.92 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 110.501 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -93.54 132.68 37.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.966 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 92' ' ' LEU . 6.5 tt -120.8 121.68 38.69 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.534 ' N ' HD23 ' A' ' 92' ' ' LEU . 53.2 p90 -154.62 149.54 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.676 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.6 p30 -93.65 -176.56 4.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.522 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.59 42.56 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -139.96 -16.38 0.5 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.65 -7.78 78.06 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 100' ' ' VAL . 51.9 t0 -96.91 111.03 23.41 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 40.3 mp0 -53.66 88.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 98' ' ' ASP . 6.3 p -146.73 153.54 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.8 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 101' ' ' ILE . 2.0 mp -77.46 129.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 110.329 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.679 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.49 173.6 4.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.738 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.679 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 66.5 Cg_exo -50.49 -38.21 53.45 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.437 2.091 . . . . 0.0 111.807 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 102.56 12.63 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 109.863 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.6 mtp -103.19 137.55 41.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.49 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -138.03 104.09 5.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 28.2 p -111.53 110.62 21.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.463 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 m -158.87 165.62 33.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 95.9 m-85 -61.09 -30.25 70.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -63.56 152.67 38.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.262 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.41 170.62 5.29 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.0 Cg_exo -51.76 -40.9 64.69 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.63 2.22 . . . . 0.0 112.015 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 67.6 t0 -96.84 45.76 1.05 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.417 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.455 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.908 0.385 . . . . 0.0 110.297 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.594 ' N ' ' OG1' ' A' ' 18' ' ' THR . 15.0 ptm180 -105.84 143.39 34.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.179 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -107.84 146.56 32.1 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.749 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.23 48.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -137.33 -3.11 1.96 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.898 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.42 126.65 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.6 p -149.33 146.28 27.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -62.11 116.58 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.004 0.43 . . . . 0.0 110.171 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.68 112.49 15.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.4 mp -67.09 -42.52 84.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.525 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' ASP . 71.4 m-20 -151.82 151.11 30.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.53 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.95 -51.33 66.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.9 m -61.7 -49.03 78.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.726 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -64.96 -30.64 71.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' ASP . 64.8 t0 -64.43 -50.29 68.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.528 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 t -62.46 -44.61 96.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.542 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.3 -44.95 94.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.62 -45.16 94.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.71 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' SER . 44.1 t -61.74 -44.4 96.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.57 -35.48 80.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.672 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.97 87.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.784 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.4 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 62.7 m -123.95 -63.07 1.24 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.861 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.6 p 72.92 1.68 4.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.481 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -170.63 146.51 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.88 100.07 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' A' ' 19' ' ' ARG . 10.8 tp10 -77.42 117.81 19.26 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 18' ' ' THR . 75.9 t -127.24 132.43 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.002 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.54 172.28 0.51 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HZ2' ' C ' ' A' ' 18' ' ' THR . 60.1 mttp -89.38 19.97 4.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.563 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -148.08 54.69 1.04 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.425 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.58 144.08 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 110.536 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -96.41 146.56 24.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -43.18 -34.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.411 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -48.64 -47.46 40.37 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 56' ' ' VAL . 30.4 tp10 -64.07 -36.21 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.546 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 57' ' ' VAL . 39.9 tp -60.87 -43.92 97.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.325 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 89' ' ' TYR . 10.8 mp -62.35 -44.03 97.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.463 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.61 -34.41 75.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 52' ' ' GLU . 40.7 t -73.15 -51.57 25.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.626 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 53' ' ' LEU . 72.4 t -55.55 -45.93 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 58' ' ' LEU . 59.4 tp -61.69 -55.02 34.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.254 0.549 . . . . 0.0 110.293 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.41 -30.85 65.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.4 ' HB1' ' SG ' ' A' ' 39' ' ' CYS . . . -64.29 -55.45 21.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.345 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 62' ' ' GLU . 5.3 p -64.34 -40.51 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.844 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 61' ' ' VAL . 44.4 tt0 -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.9 t -62.63 -48.46 79.28 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.484 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.9 m -67.26 -71.96 0.18 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.8 tp -101.07 83.09 2.45 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -72.79 -46.04 9.06 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.4 Cg_endo -81.69 104.27 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.619 2.213 . . . . 0.0 111.888 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 2.8 m -133.59 -23.32 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -64.91 -30.69 71.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.396 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -72.0 -37.21 69.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 75' ' ' GLY . 72.2 m80 -78.67 115.74 18.56 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.495 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -60.37 -29.99 69.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.04 -45.57 98.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 74' ' ' ILE . 28.7 mt -106.91 -1.71 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 110.344 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -51.87 169.85 0.48 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 m 70.98 -22.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.474 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 75' ' ' GLY . 50.2 tptt -63.72 -45.81 88.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.22 -45.05 84.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.131 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 84.1 m -63.42 -41.17 98.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.73 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.48 95.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.15 -42.16 96.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.62 -42.93 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.728 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 87' ' ' GLY . 97.8 m-20 -64.15 -42.86 96.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mtt180 -70.36 -38.74 74.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -61.94 -44.51 96.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.671 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.13 -45.47 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -66.46 -74.31 0.55 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 84' ' ' ARG . 44.8 t0 -164.35 165.26 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.098 0.475 . . . . 0.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.435 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 27.3 p90 -132.78 146.4 51.81 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.901 0.381 . . . . 0.0 110.508 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.5 m -53.51 132.08 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.589 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -86.06 144.37 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.116 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tt -117.46 136.37 53.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.622 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 25.9 p90 -155.12 166.45 33.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.767 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 12.3 t70 -73.03 -156.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.531 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 98.5 mt-10 -66.86 -53.0 36.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.601 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.88 -98.15 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.33 22.54 0.18 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -89.22 113.7 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.806 0.336 . . . . 0.0 110.607 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 55.4 mp0 -73.33 89.45 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -164.65 142.65 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.777 ' H ' HD12 ' A' ' 101' ' ' ILE . 2.7 mp -59.11 131.79 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.019 0.437 . . . . 0.0 110.01 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -154.84 173.8 4.47 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.727 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 61.4 Cg_exo -49.29 -37.85 40.89 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.562 2.175 . . . . 0.0 112.172 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -92.26 121.61 33.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 110.087 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 87.5 mmm -104.12 139.58 39.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.49 96.78 1.07 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.5 t -111.16 118.86 37.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.545 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -164.94 171.45 14.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.697 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 110' ' ' SER . 92.0 m-85 -61.32 -44.67 96.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.287 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' PHE . 70.7 m -37.75 159.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -109.08 170.26 5.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.668 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 61.2 Cg_exo -48.54 -42.77 34.91 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.559 2.173 . . . . 0.0 112.158 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 37.1 p-10 -96.75 -32.42 12.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 66.8 t0 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -131.51 165.12 24.29 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -133.03 144.55 50.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.202 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.27 140.67 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 109.996 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.473 ' H ' HD12 ' A' ' 23' ' ' ILE . 74.3 tttt -135.82 26.9 3.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.579 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.816 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.2 mp -97.94 118.63 44.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 146.13 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -91.51 129.38 37.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.364 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.59 113.44 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -149.21 88.07 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.553 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.2 m-20 165.25 -20.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.593 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 28' ' ' ASP . . . 77.17 -71.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.532 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 34' ' ' VAL . 12.8 m -61.51 -50.03 74.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.372 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -72.63 -23.3 60.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.79 -51.15 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.369 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -65.25 -45.27 85.28 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.393 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 30' ' ' THR . 91.4 t -61.91 -45.47 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.367 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.58 -41.0 98.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -58.5 -42.44 87.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -79.96 -21.02 44.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.744 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.32 67.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 41' ' ' GLU . 5.9 t -163.44 -84.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.42 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 67.84 -8.99 0.49 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 -179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 8.7 tm-20 -146.97 135.51 21.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 64.1 t80 -142.12 146.82 35.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.535 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 56.0 mp0 -86.46 150.97 23.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.359 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.56 124.64 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' ASP . 1.3 m-20 -141.95 139.58 32.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.448 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 70.9 mmtt -50.94 85.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.421 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.6 m-20 173.81 -31.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.386 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 m -106.13 111.63 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 110.333 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 p -86.36 167.32 14.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -41.08 -35.06 0.51 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.531 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.36 -48.72 80.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.414 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.553 ' O ' HG22 ' A' ' 56' ' ' VAL . 56.3 mp0 -65.2 -34.4 78.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 53' ' ' LEU . 1.3 tt -60.79 -40.76 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.148 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.17 -35.88 71.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.542 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.56 -46.17 60.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.625 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.637 HG23 ' N ' ' A' ' 57' ' ' VAL . 28.2 m -68.63 -49.41 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.188 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.637 ' N ' HG23 ' A' ' 56' ' ' VAL . 8.2 p -59.67 -46.6 93.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.214 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' N ' HG13 ' A' ' 57' ' ' VAL . 52.3 tp -63.28 -57.21 11.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.358 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -51.61 -38.42 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.692 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.1 79.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.61 -46.29 96.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -62.56 -40.06 95.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.297 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.0 t -59.86 -50.28 74.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.548 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.6 p -59.13 -65.75 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.35 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -107.95 80.68 1.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.847 0.356 . . . . 0.0 110.421 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.65 -45.84 12.7 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.426 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.7 Cg_endo -83.81 84.67 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.761 2.307 . . . . 0.0 111.875 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.4 m -87.03 -17.82 32.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.86 -5.44 16.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -72.37 -38.54 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' GLY . 58.2 m-70 -110.13 126.54 54.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.47 -38.74 91.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.72 -48.15 88.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' ' C ' ' A' ' 75' ' ' GLY . 68.5 mt -80.49 -31.04 12.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.163 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 78' ' ' VAL . . . -34.65 -57.47 0.75 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 m -39.43 -28.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.433 0.635 . . . . 0.0 110.945 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 75' ' ' GLY . 27.9 tptp -60.92 -40.27 92.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 75' ' ' GLY . 2.9 p -56.03 -39.61 58.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.433 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 1.2 t -66.26 -48.7 69.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.23 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.41 87.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.282 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.86 -45.48 93.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.45 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -61.82 -43.17 99.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.43 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.49 -42.76 78.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.056 0.455 . . . . 0.0 110.71 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.49 -20.29 64.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.455 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.42 82.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.561 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.34 -54.23 0.09 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.23 117.97 12.46 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.459 ' O ' ' CE1' ' A' ' 91' ' ' TYR . 37.0 p90 -123.53 141.96 51.49 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 110.558 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 90' ' ' VAL . 4.5 t -50.89 125.14 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.18 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 3.4 m-85 -82.55 153.89 25.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.285 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.41 130.37 47.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.563 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.87 155.81 42.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 42.6 t0 -73.17 -178.62 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.365 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.484 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 24.8 tp10 -74.67 38.45 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.491 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.49 -59.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.63 0.24 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.63 140.69 58.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.625 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.84 88.44 4.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.55 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.3 t -150.07 134.16 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.741 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 86.7 mt -70.7 132.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.314 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.8 170.81 7.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 60.0 Cg_exo -49.51 -38.82 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.403 2.069 . . . . 0.0 112.305 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -125.16 126.54 45.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -150.81 166.14 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.212 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -113.12 118.54 35.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.431 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.514 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 14.9 p -105.12 122.78 46.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.71 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.0 t -171.98 166.85 6.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.674 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.431 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 48.9 p90 -73.44 -26.12 60.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.532 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.8 p -95.27 169.82 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.472 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -98.83 162.26 22.19 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.266 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 40.6 Cg_endo -67.63 -21.59 45.37 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.701 2.267 . . . . 0.0 112.057 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -149.28 65.44 1.02 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.422 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.853 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -105.04 165.18 11.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.117 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -130.95 135.33 47.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.65 133.01 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -119.57 22.13 11.79 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.779 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 mp -84.93 136.87 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.481 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -135.86 132.47 36.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.347 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 107' ' ' CYS . 73.6 t80 -109.83 114.7 28.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.209 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.83 147.75 48.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.469 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.0 mt -97.95 -63.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 8.6 t70 -84.68 173.71 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.63 -36.7 84.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 34' ' ' VAL . 1.2 p -61.99 -54.4 42.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.683 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.449 ' N ' ' OG1' ' A' ' 30' ' ' THR . 67.0 m-85 -60.25 -20.03 57.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.544 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -76.58 -49.04 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.5 p -73.47 -35.14 65.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 30' ' ' THR . 85.1 t -64.41 -51.81 63.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.58 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.55 -41.93 83.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.749 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -61.52 -45.43 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.853 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.84 -45.87 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.979 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 40' ' ' SER . . . -73.66 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 14.5 p -71.33 45.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.592 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 38' ' ' ALA . 4.4 p -59.13 -28.62 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.372 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.78 140.24 19.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.12 137.75 41.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.55 120.07 30.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.266 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.3 m -144.3 162.46 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.369 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -89.79 170.41 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.628 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -78.65 39.22 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 66.1 t0 -118.22 -25.95 6.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.532 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 48' ' ' VAL . 3.8 m -79.03 128.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 0.0 110.709 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.9 p -85.0 158.38 20.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.386 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -46.98 -38.46 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.243 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.12 -46.75 89.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 56' ' ' VAL . 95.6 mt-10 -68.29 -35.16 77.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.312 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 57' ' ' VAL . 58.7 tp -63.46 -43.83 96.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -39.32 87.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 0.0 110.511 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -71.43 -43.55 66.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.775 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 52' ' ' GLU . 55.2 t -67.16 -51.48 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.058 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.0 p -58.57 -44.71 89.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' HG13 ' A' ' 57' ' ' VAL . 47.5 tp -61.33 -55.6 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.287 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.42 -33.61 65.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.866 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.92 -51.1 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.76 -43.19 93.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -62.75 -46.87 86.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.621 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.1 t -60.2 -49.28 78.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.604 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -58.84 -45.79 89.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.183 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.41 76.47 1.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.991 0.424 . . . . 0.0 110.407 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.59 -43.68 11.95 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.099 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 66' ' ' SER . 37.7 Cg_exo -60.21 110.18 0.74 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.404 2.069 . . . . 0.0 111.835 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 66' ' ' SER . 3.4 m -133.9 -58.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.552 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -68.5 -9.38 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.58 -42.84 61.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.421 ' O ' ' N ' ' A' ' 75' ' ' GLY . 4.5 t-80 -106.36 134.53 49.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -61.73 -35.54 78.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.545 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.25 -48.0 89.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.449 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 77' ' ' LYS . 57.4 mt -82.54 -27.01 8.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.933 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -34.05 -59.02 0.62 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -42.7 -23.76 0.05 OUTLIER 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.289 0.566 . . . . 0.0 110.947 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 74' ' ' ILE . 88.7 tttt -58.99 -42.78 90.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.111 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 75' ' ' GLY . 5.2 p -54.75 -37.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.439 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.404 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 77.8 m -70.08 -50.17 43.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.31 84.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.98 -42.51 99.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 tt -60.44 -44.82 95.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -62.42 -43.78 98.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.472 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.77 -42.72 90.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.643 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.482 ' O ' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -76.69 -11.99 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.53 -37.28 77.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.97 -34.46 0.56 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.04 115.31 24.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.425 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -132.88 146.35 51.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.407 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.6 m -50.51 148.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.068 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.97 164.23 12.62 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.311 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 tt -131.55 128.65 39.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.88 151.73 41.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -77.6 -159.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -72.02 51.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.75 -118.56 0.66 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.29 4.53 2.3 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -90.04 116.38 28.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.748 0.309 . . . . 0.0 110.39 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.31 89.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -135.69 133.4 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.45 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -71.64 127.93 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.03 0.443 . . . . 0.0 109.894 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.65 152.46 16.56 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.633 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.29 -39.86 27.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.31 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 65.1 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.278 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -103.53 135.96 44.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.184 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.467 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 48.1 t80 -99.89 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.118 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.531 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 4.3 t -113.3 115.43 28.14 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.548 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.467 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 7.2 p -173.53 169.5 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -70.06 -24.42 63.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 m -67.13 143.18 56.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -100.36 170.5 6.58 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.3 Cg_exo -51.96 -40.31 67.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.604 2.203 . . . . 0.0 111.855 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -82.63 45.2 0.96 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.19 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.694 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.521 -0.149 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -125.9 176.97 6.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.354 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -135.83 139.73 43.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.237 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.09 136.3 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.56 -7.36 6.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.552 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -118.34 128.02 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.7 p -132.47 146.6 52.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.536 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.26 132.89 55.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.169 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.6 141.34 48.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.2 mp -64.56 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -148.92 168.83 22.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.637 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.05 81.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.417 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 m -59.61 -46.83 87.8 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.084 0.469 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -67.64 -28.56 67.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.483 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -64.91 -48.36 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -62.61 -44.89 95.16 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.492 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.68 -45.82 90.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.685 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.98 -44.62 95.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.609 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 m -60.05 -44.71 94.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.327 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.12 -35.84 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.521 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.73 -75.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 40' ' ' SER . 25.4 p -52.59 -43.91 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.789 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 1.4 m 67.73 -63.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.557 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.83 154.55 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.668 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -144.11 148.76 35.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.83 162.21 27.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.63 135.25 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.61 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.12 166.22 17.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.22 -61.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -88.89 84.23 6.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 110.374 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.52 136.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.312 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.561 ' O ' ' N ' ' A' ' 51' ' ' ASP . 20.5 p -108.22 154.27 22.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.406 0.622 . . . . 0.0 109.719 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.047 ' H ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -44.13 -12.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.254 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.651 ' N ' HD22 ' A' ' 50' ' ' LEU . 87.0 m-20 -68.16 -53.4 25.32 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.268 0.556 . . . . 0.0 110.349 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 56' ' ' VAL . 83.2 mt-10 -65.16 -38.99 92.31 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.328 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 57' ' ' VAL . 32.0 mt -61.6 -39.9 92.88 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.031 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.494 HD22 ' CD2' ' A' ' 89' ' ' TYR . 6.6 tp -61.07 -45.12 96.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.158 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -71.49 -34.24 69.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.146 0.498 . . . . 0.0 110.744 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 52' ' ' GLU . 49.6 t -72.38 -53.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.996 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 58' ' ' LEU . 9.6 p -60.59 -43.92 95.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.799 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.538 ' N ' HG13 ' A' ' 57' ' ' VAL . 46.6 tp -60.21 -56.48 20.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.137 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.16 -41.13 62.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.54 82.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.508 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.6 t -63.41 -45.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.549 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.06 -44.17 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.367 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.4 p -61.66 -42.74 99.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.0 m -67.89 -71.14 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.38 88.21 3.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.382 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.524 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.57 -47.87 2.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 66' ' ' SER . 66.9 Cg_endo -80.52 68.5 8.3 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.68 2.254 . . . . 0.0 112.134 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.53 -32.16 47.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.35 -5.77 15.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -72.27 -38.66 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 75' ' ' GLY . 39.0 m80 -103.71 120.81 41.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.219 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 28.4 p-10 -58.32 -42.38 86.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.712 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.693 HG13 HG12 ' A' ' 74' ' ' ILE . 3.8 p -55.09 -29.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.409 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.693 HG12 HG13 ' A' ' 73' ' ' VAL . 49.2 mm -108.49 -12.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -38.35 -62.92 1.03 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.2 p -37.04 -25.06 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.124 0.487 . . . . 0.0 111.006 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' GLY . 63.4 tttm -58.03 -42.71 85.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.139 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 79' ' ' CYS . 5.6 p -56.43 -42.49 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.455 . . . . 0.0 110.314 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.479 ' N ' HG13 ' A' ' 78' ' ' VAL . 87.7 m -62.95 -48.55 78.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.162 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.37 82.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 58' ' ' LEU . 56.5 tp -53.16 -42.34 66.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 82' ' ' LEU . 3.0 tt -60.76 -46.47 90.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.062 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -63.52 -45.49 90.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.52 ' CD2' HD21 ' A' ' 58' ' ' LEU . 3.7 mm? -67.52 -25.55 65.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.773 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.78 -44.23 90.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.364 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.34 -39.11 0.67 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.77 127.14 33.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.265 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 90' ' ' VAL . 2.0 p90 -131.73 -127.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.629 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.599 ' O ' ' CD2' ' A' ' 89' ' ' TYR . 29.1 m -134.44 165.03 32.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 121.097 0.475 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -114.01 144.76 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.677 HD23 ' C ' ' A' ' 92' ' ' LEU . 1.3 tt -131.13 143.18 50.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.989 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.27 163.25 38.76 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.666 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 96' ' ' GLY . 47.4 p30 -74.5 175.9 7.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.529 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.09 26.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -133.66 -70.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.98 -36.04 0.1 OUTLIER Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.71 140.51 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.78 0.324 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 56.4 mp0 -86.66 88.4 7.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.472 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.79 130.64 26.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.48 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.9 mm -61.96 131.74 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.08 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -149.41 170.56 7.47 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.633 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.674 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 50.6 Cg_exo -51.2 -40.14 60.94 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.517 2.144 . . . . 0.0 112.161 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 97.31 5.85 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.573 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -119.41 170.7 8.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.483 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 76.5 t80 -139.68 122.33 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.084 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.536 ' HB2' HD12 ' A' ' 92' ' ' LEU . 12.5 t -122.83 127.53 49.19 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.752 0.657 . . . . 0.0 110.491 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.483 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 84.1 p -172.78 -174.88 1.18 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' ' CG1' ' A' ' 90' ' ' VAL . 86.0 m-85 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.136 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -146.95 172.12 14.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.0 169.98 6.03 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.406 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 63.1 Cg_exo -49.41 -38.28 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.445 2.096 . . . . 0.0 112.054 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 49.2 p-10 -65.6 -30.65 71.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.981 0.419 . . . . 0.0 110.802 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 95.8 m-20 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.8 p . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.593 ' HE ' ' NZ ' ' A' ' 46' ' ' LYS . 43.9 ttm180 -107.7 145.38 33.5 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.297 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.39 137.18 39.16 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.333 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 42' ' ' PHE . 10.9 tp -102.92 142.84 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.309 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -138.88 111.41 7.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.83 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.5 mp -99.76 125.42 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.396 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.06 96.54 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.558 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -151.16 133.97 15.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.203 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 27' ' ' LEU . . . -59.34 109.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -128.06 -67.21 0.82 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.368 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 27' ' ' LEU . 75.5 m-20 -150.88 163.66 38.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.426 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 -62.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.2 m -60.64 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.522 ' CE2' HD11 ' A' ' 35' ' ' LEU . 37.1 t80 -42.78 -44.52 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 110.391 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -61.98 -48.05 82.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.158 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.647 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.45 -45.12 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.176 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 31' ' ' PHE . 84.2 mt -63.04 -42.94 99.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.6 m -61.88 -40.44 95.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.08 -16.14 41.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.459 ' C ' ' SG ' ' A' ' 39' ' ' CYS . . . -93.61 23.62 4.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.611 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 38' ' ' ALA . 2.6 m 75.39 101.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.796 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.45 -34.77 78.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.76 131.22 55.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.684 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.697 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -145.19 124.66 13.13 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.46 0.648 . . . . 0.0 110.901 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.649 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -63.77 135.84 56.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.504 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.1 134.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 0.0 110.58 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.71 164.9 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.3 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.593 ' NZ ' ' HE ' ' A' ' 19' ' ' ARG . 65.2 mttm -94.11 -11.45 30.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.74 11.83 18.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.88 153.02 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.11 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.435 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 57.2 p -99.25 -160.19 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 50' ' ' LEU . 1.9 pt? -63.11 -15.81 57.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 22.0 p-10 -59.99 -52.82 63.76 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.348 0.594 . . . . 0.0 110.589 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -64.03 -40.16 95.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.081 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.43 -45.78 92.86 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.109 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 54' ' ' LEU . 1.8 tt -56.39 -43.72 79.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.34 -49.01 78.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.903 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.31 -43.4 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.383 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 61' ' ' VAL . 76.0 t -63.77 -46.97 93.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.509 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.09 -41.22 99.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.357 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.91 -44.21 94.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.278 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 64' ' ' THR . . . -64.43 -37.15 86.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 57' ' ' VAL . 55.5 t -63.37 -44.78 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.734 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.11 -44.36 60.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.6 p -61.99 -33.35 74.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 60' ' ' ALA . 41.4 p -86.81 -52.25 5.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.434 HD21 ' CE ' ' A' ' 77' ' ' LYS . 34.4 tp -95.04 79.21 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.544 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.87 -46.62 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.646 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.6 Cg_endo -80.74 109.95 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.404 2.069 . . . . 0.0 112.31 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.86 -46.28 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.441 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -67.91 -6.47 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.718 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -73.02 -21.49 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -103.12 98.18 8.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.697 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 25.8 p-10 -62.68 -44.59 95.86 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.412 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.456 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 71.2 t -64.42 -44.96 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.263 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.543 ' C ' ' H ' ' A' ' 76' ' ' THR . 3.3 mt -93.56 9.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -55.54 -1.28 0.18 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.543 ' H ' ' C ' ' A' ' 74' ' ' ILE . 39.9 p -65.7 -31.78 72.97 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.506 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.434 ' CE ' HD21 ' A' ' 65' ' ' LEU . 17.8 ptmt -58.6 -37.59 76.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.201 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.73 -44.13 93.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.32 -38.92 93.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.253 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.32 -54.03 51.41 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.063 0.458 . . . . 0.0 110.687 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.2 mm? -63.24 -40.32 97.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.311 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.7 -42.95 99.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.242 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -61.89 -43.4 98.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.217 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.97 -39.96 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.474 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.9 mt -63.83 -37.88 89.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.513 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.4 79.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.69 -18.54 0.58 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -78.26 56.72 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.782 0.325 . . . . 0.0 110.418 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.52 -168.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.281 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 132.08 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.506 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -75.05 153.22 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.223 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 92' ' ' LEU . 6.6 tt -142.52 122.51 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.468 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.602 ' N ' HD23 ' A' ' 92' ' ' LEU . 41.1 p90 -146.12 151.01 36.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.736 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 96' ' ' GLY . 56.8 p-10 -80.96 175.13 10.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.474 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 41.7 mp0 -62.3 68.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.473 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 94' ' ' ASP . . . -164.97 -79.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' OD1' ' A' ' 98' ' ' ASP . . . 149.7 40.63 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 97' ' ' GLY . 85.6 m-20 -146.98 169.63 18.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.932 0.396 . . . . 0.0 110.529 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.5 mp0 -80.92 91.61 6.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.166 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 101' ' ' ILE . 59.8 t -141.92 162.83 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.444 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.581 ' N ' HG12 ' A' ' 100' ' ' VAL . 4.9 mp -124.1 129.3 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.8 168.93 10.74 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.456 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 81.9 Cg_exo -46.6 -40.2 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.498 2.132 . . . . 0.0 112.203 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.432 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 79.4 mtp180 -113.13 107.12 15.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.473 ' HB2' HD21 ' A' ' 92' ' ' LEU . 11.8 ptt? -139.43 142.99 37.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -96.98 118.85 34.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.32 116.59 25.11 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 t -173.15 178.08 2.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.689 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -60.48 -44.67 95.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.509 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.1 m -55.86 146.1 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.036 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -105.05 170.37 6.05 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.633 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.8 Cg_exo -51.51 -41.28 61.14 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 112.031 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 55.4 t0 -85.32 -9.97 56.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.552 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.539 ' CB ' ' H ' ' A' ' 111' ' ' ALA . 66.1 t0 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.572 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 120.782 0.325 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -138.27 156.15 47.94 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.148 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -107.97 143.63 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 23' ' ' ILE . 17.5 tt -133.31 140.59 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -126.27 11.77 7.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.5 mp -88.3 101.41 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.961 0.41 . . . . 0.0 110.707 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.516 HG21 ' CD2' ' A' ' 42' ' ' PHE . 75.8 p -141.14 145.98 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.399 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -93.85 138.93 31.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.202 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.64 138.14 41.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 mt -63.2 -39.99 96.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -151.91 176.98 10.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 80.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.513 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 34' ' ' VAL . 97.5 m -61.34 -47.69 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.585 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -68.72 -26.46 65.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.29 -48.53 56.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.3 m -67.1 -41.8 85.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.618 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 30' ' ' THR . 76.3 t -62.36 -47.29 93.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.495 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -63.5 -42.24 98.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.837 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 40' ' ' SER . 78.5 p -62.66 -35.47 79.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -78.69 -34.45 46.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.926 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.04 -92.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.753 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 40' ' ' SER . 14.2 t -65.59 -96.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.713 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER 77.85 -3.79 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.611 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -140.57 115.62 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.516 ' CD2' HG21 ' A' ' 24' ' ' THR . 84.4 m-85 -117.92 129.12 55.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.184 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -91.6 142.26 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.02 121.13 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.432 0.634 . . . . 0.0 110.515 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.476 ' OD1' HG12 ' A' ' 48' ' ' VAL . 19.3 p30 -155.95 171.29 20.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.793 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.22 11.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 45' ' ' ASP . 87.7 m-20 -107.38 0.18 22.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.67 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 49' ' ' THR . 13.5 p -141.24 160.44 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 50' ' ' LEU . 5.2 p -129.94 -70.12 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.226 0.536 . . . . 0.0 110.648 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' N ' ' OG1' ' A' ' 49' ' ' THR . 0.4 OUTLIER -163.16 -33.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -50.21 -43.95 52.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.333 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -68.41 -40.91 81.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.633 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 57' ' ' VAL . 35.6 mt -62.03 -46.26 89.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.72 -36.39 82.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.456 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.81 -52.25 63.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.182 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 57' ' ' VAL . 12.8 p -69.64 -38.59 76.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.532 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 53' ' ' LEU . 43.7 t -59.29 -50.61 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.276 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.69 -50.47 43.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.184 0.516 . . . . 0.0 110.587 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.26 -32.07 69.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.086 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 56' ' ' VAL . . . -69.71 -56.35 7.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 62' ' ' GLU . 30.8 m -67.41 -44.12 87.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.53 ' N ' HG23 ' A' ' 61' ' ' VAL . 8.5 tm-20 -59.35 -46.39 88.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.508 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.9 p -61.77 -51.65 67.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.6 m -60.48 -46.59 89.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.471 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 65' ' ' LEU . 10.3 mp -94.36 57.85 2.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.399 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.612 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.15 -44.02 2.74 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.214 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 66' ' ' SER . 21.5 Cg_exo -64.3 107.59 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.5 2.133 . . . . 0.0 111.859 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.505 ' C ' ' H ' ' A' ' 70' ' ' GLU . 22.0 t -133.84 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -48.5 -11.3 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.466 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 68' ' ' CYS . 79.2 tt0 -73.94 -36.89 64.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.607 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HB3' HG12 ' A' ' 73' ' ' VAL . 96.7 m-70 -132.65 138.99 47.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.9 -43.83 97.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.676 HG13 HG12 ' A' ' 74' ' ' ILE . 2.8 p -45.69 -31.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.318 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.676 HG12 HG13 ' A' ' 73' ' ' VAL . 47.0 mm -108.38 -15.11 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . -46.68 -177.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m 66.74 -31.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 75' ' ' GLY . 47.1 tptt -63.19 -39.15 93.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 79' ' ' CYS . 7.4 p -59.76 -45.23 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.525 ' N ' HG13 ' A' ' 78' ' ' VAL . 75.1 m -64.41 -47.74 78.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.341 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.45 -52.56 64.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.286 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.4 tp -51.29 -40.89 59.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.94 -48.06 82.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.21 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -64.24 -40.96 97.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.355 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.23 -40.63 98.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.89 -19.99 58.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.596 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.64 75.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 88' ' ' ASP . . . 160.33 33.64 0.02 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 80.2 m-20 -149.14 78.03 1.38 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.789 0.328 . . . . 0.0 110.52 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.609 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 1.4 p90 -110.2 -113.34 0.31 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.085 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.447 ' H ' ' HD2' ' A' ' 89' ' ' TYR . 29.4 m -130.8 158.77 43.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.303 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -126.81 157.07 40.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.242 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.17 125.06 24.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.82 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -134.68 153.27 52.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -88.98 -168.31 2.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.431 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 33.2 mp0 -72.93 67.24 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.628 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.23 -59.33 0.21 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.28 -18.79 0.32 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.84 139.71 55.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.672 0.272 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 90.68 6.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.605 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -155.11 135.98 4.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.615 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 49' ' ' THR . 56.6 mt -66.15 132.26 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.27 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.709 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -149.17 173.59 4.11 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.709 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 54.2 Cg_exo -50.66 -40.59 55.68 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.497 2.131 . . . . 0.0 111.842 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.36 90.13 3.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -103.16 145.24 30.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.159 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -113.15 110.21 20.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.138 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.0 p -110.97 113.15 25.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.437 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 p -167.77 164.9 14.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.764 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -72.51 -26.9 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.643 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 p -73.19 154.64 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -90.26 170.12 10.86 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.668 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.3 Cg_exo -51.44 -35.11 53.81 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.46 2.106 . . . . 0.0 112.128 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -79.16 14.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 . . . . . 0 C--O 1.223 -0.332 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.785 -179.876 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -135.08 171.76 13.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -126.45 146.87 49.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.638 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.413 HG13 ' H ' ' A' ' 23' ' ' ILE . 10.7 tp -132.11 141.04 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.317 0.58 . . . . 0.0 110.151 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -138.23 20.05 2.78 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.431 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.413 ' H ' HG13 ' A' ' 21' ' ' ILE . 23.9 mt -114.15 97.32 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.87 0.367 . . . . 0.0 110.839 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -116.19 143.68 45.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.141 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.92 118.33 13.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.443 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.79 118.6 36.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.243 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.78 -40.99 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.604 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.2 t0 -153.69 -178.94 7.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.58 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -62.82 -37.47 86.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -59.21 -48.03 83.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.188 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.16 -4.13 39.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.405 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -85.2 -59.08 2.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.32 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -68.55 -37.29 79.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.926 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 30' ' ' THR . 73.1 t -65.33 -47.45 87.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.07 -41.81 99.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 9.1 t -58.74 -50.25 74.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.58 -34.13 77.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -25.43 60.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.022 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.568 ' C ' ' H ' ' A' ' 41' ' ' GLU . 4.9 t -173.89 -48.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.47 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 36' ' ' SER . 0.4 OUTLIER 59.45 -3.91 0.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.657 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.568 ' H ' ' C ' ' A' ' 39' ' ' CYS . 75.2 mt-10 -144.26 115.79 8.12 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CE1' HG22 ' A' ' 57' ' ' VAL . 80.4 m-85 -121.84 133.57 54.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -95.5 156.68 16.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.975 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 m -134.75 116.7 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.665 0.745 . . . . 0.0 110.775 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' A' ' 47' ' ' ASP . 50.4 t0 -148.2 159.77 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.3 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 50.9 tttm -60.88 12.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.626 ' H ' ' C ' ' A' ' 45' ' ' ASP . 98.2 m-20 -105.34 -37.07 6.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.711 0.291 . . . . 0.0 110.356 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.93 109.06 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.339 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.512 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 27.3 p -86.46 166.05 15.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.336 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -48.29 -44.35 33.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.291 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.512 ' CG ' ' HG1' ' A' ' 49' ' ' THR . 1.5 p-10 -56.82 -44.33 81.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 56' ' ' VAL . 94.9 mt-10 -72.98 -28.59 62.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.289 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.687 ' O ' HG23 ' A' ' 57' ' ' VAL . 55.5 tp -65.3 -54.34 30.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.216 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 55' ' ' ASP . 3.1 pp -67.79 -39.93 83.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.896 0.379 . . . . 0.0 110.287 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 54' ' ' LEU . 16.6 t70 -63.32 -44.39 95.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 52' ' ' GLU . 60.7 t -69.55 -43.12 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.707 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 53' ' ' LEU . 72.1 t -61.98 -47.77 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.455 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 81' ' ' LEU . 8.6 tt -64.05 -53.25 52.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.081 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -52.23 -38.97 59.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.745 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.84 75.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.629 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.27 -48.98 85.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.685 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.78 -37.72 85.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.444 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -60.69 -45.16 95.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.49 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.8 p -72.92 -40.66 65.3 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.751 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -108.26 106.77 17.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.482 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.447 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -79.1 -60.8 0.53 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 178.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 66' ' ' SER . 36.9 Cg_endo -63.15 134.48 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.338 2.025 . . . . 0.0 112.297 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.2 p -134.98 -37.38 0.8 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -67.99 -7.96 33.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.759 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -73.59 -30.34 62.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.715 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 75' ' ' GLY . 60.1 m80 -92.13 108.91 20.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 20.8 p-10 -66.1 -49.12 68.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.339 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 t -66.84 -45.1 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.412 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 mm -95.09 18.79 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.09 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -81.29 -170.62 43.93 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.415 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER 78.32 -26.41 0.18 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 110.552 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER -63.62 -11.02 21.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.163 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.662 HG13 ' N ' ' A' ' 79' ' ' CYS . 7.1 p -71.31 -54.51 17.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 110.304 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.662 ' N ' HG13 ' A' ' 78' ' ' VAL . 98.8 m -69.36 -42.66 74.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.143 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.08 74.63 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.113 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 58' ' ' LEU . 4.7 tt -54.62 -42.15 70.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.166 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.95 -48.71 80.58 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.254 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 87' ' ' GLY . 55.2 t0 -65.52 -43.24 90.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.798 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' ASP . 1.4 mpt_? -62.08 -43.79 98.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.6 -42.84 97.61 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.086 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -9.7 51.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.631 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -154.38 62.45 0.36 Allowed Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 84' ' ' ARG . 96.9 m-20 -36.88 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 110.693 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.503 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 65.5 t80 -87.04 -40.7 14.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.679 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.66 131.52 12.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 98.0 m-85 -109.37 152.25 25.57 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 93' ' ' PHE . 6.1 tt -132.31 122.9 25.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.621 ' N ' HD23 ' A' ' 92' ' ' LEU . 45.2 p90 -142.79 147.68 35.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.52 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.2 t70 -83.91 177.47 8.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.466 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 95.8 mt-10 -70.77 38.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -146.59 -5.71 0.38 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.92 -2.64 73.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 36.4 t0 -93.87 112.86 24.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 110.471 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -53.45 86.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.098 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 69.7 t -145.4 136.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.9 mm -76.09 130.02 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.125 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -150.02 172.0 5.74 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.452 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 52.0 Cg_exo -51.95 -41.52 63.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.354 2.036 . . . . 0.0 111.894 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 1.8 mpt_? -110.46 83.45 1.76 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.188 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -105.19 165.07 11.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.091 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 93' ' ' PHE . 70.6 t80 -134.2 112.51 11.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 21.7 p -115.52 117.08 29.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.623 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.1 t -171.71 175.41 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -66.4 -27.34 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.357 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -61.86 146.46 49.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.473 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -85.62 170.41 13.14 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.1 Cg_exo -50.78 -41.28 55.29 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.542 2.161 . . . . 0.0 112.025 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -60.51 -48.26 82.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.101 0.477 . . . . 0.0 110.849 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.547 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.67 0.271 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.45 173.51 8.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.237 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.02 144.17 30.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.053 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.0 pt -136.12 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.753 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.53 121.18 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 23' ' ' ILE . 4.2 mm -94.3 115.88 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.166 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -127.92 100.46 5.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.445 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.53 107.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.34 140.79 46.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.747 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.9 mp -73.7 -41.19 62.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -127.12 -176.78 3.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.63 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.16 82.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -58.69 -52.7 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.414 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' N ' ' OG1' ' A' ' 30' ' ' THR . 85.5 m-85 -69.39 -11.61 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -77.78 -54.89 5.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 p -69.91 -35.34 74.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.914 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' THR . 73.5 t -64.31 -49.89 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.67 -42.22 91.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.835 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.2 p -63.48 -45.65 89.81 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.541 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -68.34 -47.1 68.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.53 -76.1 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.735 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 7.9 t -83.13 72.27 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.9 p -75.78 -26.97 57.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.633 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -172.83 149.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.281 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.507 ' CE2' HG22 ' A' ' 57' ' ' VAL . 6.0 m-85 -130.97 147.01 52.56 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.241 0.543 . . . . 0.0 110.526 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.44 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.38 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.6 132.26 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.904 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 41.7 t0 -145.44 148.62 33.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 20.0 pttp -73.75 20.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 45' ' ' ASP . 13.3 t70 -122.16 16.53 10.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.706 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 101' ' ' ILE . 3.0 m -134.11 161.19 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 109.947 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' ASP . 58.2 p -120.29 134.78 55.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.121 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.679 HD22 ' C ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.86 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.851 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.659 ' N ' HD22 ' A' ' 50' ' ' LEU . 63.1 t0 -67.8 -50.6 55.99 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.37 0.605 . . . . 0.0 110.1 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 56' ' ' VAL . 97.3 mt-10 -67.36 -35.47 79.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.829 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 57' ' ' VAL . 61.4 tp -61.39 -45.54 93.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.774 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.547 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.99 -43.77 97.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.722 -179.525 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.99 -42.6 99.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.729 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 52' ' ' GLU . 66.2 t -67.66 -45.95 83.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.621 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 53' ' ' LEU . 64.5 t -59.85 -45.76 94.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.44 -51.43 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.726 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -60.52 -32.92 71.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.44 -54.48 46.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.952 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.22 -39.08 84.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.6 m -61.61 -49.46 76.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -61.36 -48.73 79.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 65' ' ' LEU . 5.0 tt -108.27 82.17 1.59 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.323 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.606 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.45 -43.93 2.05 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.403 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.8 Cg_exo -61.21 115.18 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.783 2.322 . . . . 0.0 112.091 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 p -133.11 -41.86 0.89 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 71' ' ' HIS . 88.6 tttt -62.09 -37.44 85.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.752 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -75.56 28.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.465 ' H ' ' C ' ' A' ' 69' ' ' LYS . 95.6 m-70 -136.78 143.8 43.4 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.577 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.83 -62.96 1.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.961 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.64 -44.54 89.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.278 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.7 mm -84.51 2.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.971 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.45 -28.4 71.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -8.26 59.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.91 -44.63 94.16 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.409 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 ' N ' ' A' ' 79' ' ' CYS . 11.2 p -57.01 -44.15 82.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.352 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.567 ' N ' HG13 ' A' ' 78' ' ' VAL . 73.5 m -67.75 -49.39 62.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -62.26 -40.71 97.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.57 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.99 -42.4 99.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.09 -42.74 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.096 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.09 -44.51 96.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.674 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.679 HH12 ' HB1' ' A' ' 80' ' ' ALA . 96.4 mtm-85 -65.73 -39.7 91.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -64.64 -37.91 89.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.432 -179.396 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.91 80.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.604 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.64 62.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -172.59 56.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.502 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -101.65 152.58 20.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.962 0.41 . . . . 0.0 110.482 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 34.7 m -48.36 148.01 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.966 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -106.65 164.19 12.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.175 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 92' ' ' LEU . 8.0 tt -127.32 126.82 43.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.845 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.573 ' N ' HD23 ' A' ' 92' ' ' LEU . 31.6 m-85 -137.15 154.9 50.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -84.31 -176.96 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.693 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -71.45 47.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -158.13 -68.17 0.01 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.92 -21.31 0.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -73.78 141.67 46.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.945 0.402 . . . . 0.0 110.62 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.447 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -76.0 93.22 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.403 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.31 153.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.295 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' A' ' 48' ' ' VAL . 77.3 mt -91.47 127.14 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.224 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.02 153.99 19.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.548 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.3 -37.8 25.21 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.181 1.921 . . . . 0.0 112.136 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.425 ' CD ' ' H ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -92.63 54.42 2.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 110.334 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.546 ' HB2' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -103.51 144.34 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.295 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -117.05 122.13 43.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.263 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.432 ' SG ' HD21 ' A' ' 54' ' ' LEU . 12.9 t -113.09 115.0 27.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.536 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 t -173.89 175.71 2.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -75.39 -20.64 58.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.362 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -72.78 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.238 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -98.08 170.68 6.75 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.447 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.9 Cg_exo -52.62 -42.14 64.16 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.654 2.236 . . . . 0.0 112.076 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 67.6 t0 -96.51 48.1 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.566 179.711 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.231 0.091 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -103.58 136.47 43.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.053 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -104.66 121.92 44.56 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.94 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.03 149.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.431 ' C ' HD12 ' A' ' 23' ' ' ILE . 18.3 ptmt -130.46 20.22 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.963 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.735 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.6 mp -93.49 122.3 44.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.11 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.1 m -142.56 134.48 27.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -97.55 120.34 37.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.096 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -103.82 145.55 29.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.447 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.1 mm? -64.92 -41.66 95.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.816 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -150.12 -174.08 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.91 -37.68 87.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 30' ' ' THR . 1.3 p -59.79 -48.74 80.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.273 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -66.89 -33.95 76.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.589 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.91 -46.54 87.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.436 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -68.32 -41.99 80.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.91 -49.0 85.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.889 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.617 HD11 HG22 ' A' ' 61' ' ' VAL . 4.0 mm? -64.38 -41.07 96.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -59.94 -41.93 92.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -75.14 -31.15 60.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.69 -89.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.0 m -108.99 94.89 5.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.475 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 t -89.29 -11.28 43.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 94.5 mt-10 -145.04 156.56 44.0 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.602 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 8.4 m-85 -143.59 122.61 12.82 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.078 0.466 . . . . 0.0 110.598 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.83 135.43 49.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.381 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.03 132.62 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -58.92 172.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -50.83 -38.38 48.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -147.27 113.9 6.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 49' ' ' THR . 86.9 t -127.88 160.93 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.546 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -96.75 125.65 41.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.658 ' H ' HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -38.35 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.8 m-20 -60.27 -45.94 91.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.216 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 56' ' ' VAL . 37.8 tp10 -63.96 -43.06 96.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.949 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.456 ' O ' HG12 ' A' ' 57' ' ' VAL . 61.9 tp -62.02 -40.26 95.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.04 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.1 -42.76 99.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.277 0.56 . . . . 0.0 110.184 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.3 -39.45 68.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.703 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 52' ' ' GLU . 54.5 t -69.55 -53.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.4 p -55.8 -44.82 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' HG13 ' A' ' 57' ' ' VAL . 58.6 tp -62.04 -52.04 65.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.183 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -54.17 -43.31 70.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.099 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.96 93.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.179 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.617 HG22 HD11 ' A' ' 35' ' ' LEU . 53.1 t -63.23 -43.12 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.252 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -67.53 -36.49 81.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.609 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t -63.03 -52.26 63.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 65' ' ' LEU . 12.1 t -74.75 -38.03 62.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.433 . . . . 0.0 110.547 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.427 ' N ' HG23 ' A' ' 64' ' ' THR . 11.2 tp -92.79 33.98 1.11 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.914 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.43 -47.14 2.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 66' ' ' SER . 71.8 Cg_endo -82.5 78.3 3.43 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.452 2.101 . . . . 0.0 112.291 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 33.4 m -133.81 -18.06 2.15 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -68.03 -7.43 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.672 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.33 -38.89 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -101.7 109.87 21.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.225 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 32.8 p-10 -65.78 -36.44 83.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.726 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.56 -57.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.683 ' O ' ' O ' ' A' ' 75' ' ' GLY . 81.6 mt -68.93 -45.0 81.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.683 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . -43.27 -131.27 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 O-C-N 124.053 0.846 . . . . 0.0 111.521 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.429 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 1.3 m 74.22 -36.09 0.32 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.96 -0.729 . . . . 0.0 110.532 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.2 OUTLIER -58.29 -29.47 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.817 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.412 ' O ' HD13 ' A' ' 82' ' ' LEU . 93.6 t -62.4 -48.76 86.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.382 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.13 -37.44 87.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.103 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.42 -43.34 99.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 78' ' ' VAL . 7.7 mp -63.15 -38.02 89.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.794 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.88 -42.05 99.63 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' TYR . 89.0 mtm-85 -62.35 -48.08 81.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.014 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.584 ' O ' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -70.56 -29.9 66.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.173 0.511 . . . . 0.0 110.411 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.16 84.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.43 -50.71 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.321 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.86 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.5 ' CE2' ' O ' ' A' ' 90' ' ' VAL . 26.9 t80 64.55 165.37 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.29 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.5 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 2.9 p -125.2 156.47 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.96 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.445 ' N ' HG22 ' A' ' 90' ' ' VAL . 11.8 m-85 -122.55 138.51 54.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.077 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -108.85 128.83 55.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.4 154.04 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.793 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 44.6 t0 -73.62 176.83 5.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.437 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 11.3 tm-20 -61.12 -42.7 99.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.533 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.62 60.15 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.2 -0.37 87.31 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.5 t0 -89.13 108.83 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.6 0.238 . . . . 0.0 110.472 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -47.1 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.447 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 98' ' ' ASP . 79.6 t -152.84 131.26 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.663 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.781 ' H ' HD12 ' A' ' 101' ' ' ILE . 3.1 mp -60.93 123.88 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.27 170.58 8.01 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.539 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.632 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.3 Cg_exo -51.73 -42.12 58.53 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.269 1.98 . . . . 0.0 112.234 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -105.85 101.5 11.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.226 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 52.1 mtm -104.62 147.05 28.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.324 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -119.02 96.33 5.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.971 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 90' ' ' VAL . 49.2 t -90.24 119.82 30.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.263 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.7 t -161.06 159.74 29.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.608 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 5.5 m-85 -85.52 43.1 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.046 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m -146.6 178.76 8.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.232 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.46 170.69 5.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.518 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.7 Cg_exo -52.14 -39.53 70.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.598 2.199 . . . . 0.0 112.038 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 p30 -87.31 0.58 55.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--O 1.222 -0.388 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.612 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.217 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.497 ' N ' HG23 ' A' ' 18' ' ' THR . 73.2 ttt180 -126.06 150.7 47.96 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.498 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -145.34 126.71 14.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.799 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 42' ' ' PHE . 49.4 pt -140.91 148.56 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.107 0.48 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.602 ' C ' HD12 ' A' ' 23' ' ' ILE . 62.9 mttp -113.43 77.41 1.05 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.791 0.329 . . . . 0.0 110.352 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 22' ' ' LYS . 1.7 mp -110.0 126.42 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.0 m -124.19 126.84 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.364 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 107' ' ' CYS . 85.1 t80 -130.08 134.21 47.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.395 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.84 107.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.441 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.3 -43.59 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.658 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 98.1 m-20 -135.28 -86.36 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.511 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.67 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.582 HG23 ' N ' ' A' ' 31' ' ' PHE . 15.3 t -58.75 -45.55 89.46 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.292 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.582 ' N ' HG23 ' A' ' 30' ' ' THR . 51.6 t80 -61.46 -35.93 79.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.387 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.658 ' CG ' ' H ' ' A' ' 28' ' ' ASP . 90.9 m-20 -62.17 -44.63 96.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.293 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 30' ' ' THR . 78.3 p -62.16 -46.94 86.75 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.631 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.38 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.496 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 39' ' ' CYS . 53.6 tp -61.22 -44.68 96.88 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -60.17 -41.74 93.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 110.157 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.76 -32.25 73.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.07 -76.56 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.99 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.7 t -104.47 96.16 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -111.7 -30.19 7.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.37 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -95.27 141.25 29.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.365 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' ILE . 96.4 m-85 -136.55 133.36 36.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.173 0.511 . . . . 0.0 110.526 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -133.83 143.26 48.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.788 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' OG1' ' A' ' 18' ' ' THR . 1.2 m -145.72 -106.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.781 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.44 ' HA ' ' N ' ' A' ' 19' ' ' ARG . 43.5 p30 -166.85 161.51 15.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -63.64 163.28 11.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 61.49 37.23 16.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.478 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 48' ' ' VAL . 11.0 p -113.69 123.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.13 0.491 . . . . 0.0 110.199 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -83.51 169.92 14.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.375 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -60.81 -40.13 91.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -53.65 -50.34 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.111 0.482 . . . . 0.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.16 -38.08 89.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.313 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.65 -48.8 77.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.296 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.39 -41.18 68.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -62.15 -47.74 83.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.23 -43.36 95.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.133 0.492 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.69 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.82 -45.24 95.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.913 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -55.3 -43.74 75.08 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.97 88.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.465 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.89 -42.02 94.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -69.61 -47.01 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -62.44 -37.1 84.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.76 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -73.65 -69.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.2 mt -103.48 98.57 8.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.556 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -77.85 -47.05 2.31 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.773 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.0 Cg_endo -81.39 137.63 10.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.603 2.202 . . . . 0.0 111.89 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.624 ' SG ' ' NZ ' ' A' ' 77' ' ' LYS . 5.8 m -133.22 -40.25 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.516 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.54 -11.08 60.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.39 -39.03 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.678 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.576 ' O ' ' N ' ' A' ' 75' ' ' GLY . 34.3 m170 -102.29 106.13 16.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.51 -37.95 89.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.25 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.19 -46.55 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.359 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 75' ' ' GLY . 95.7 mt -91.6 -13.67 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -53.93 -158.22 0.01 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.548 HG23 ' C ' ' A' ' 75' ' ' GLY . 2.2 p 69.44 -35.63 0.31 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.092 0.472 . . . . 0.0 110.539 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.624 ' NZ ' ' SG ' ' A' ' 68' ' ' CYS . 21.7 pttp -63.08 -20.47 65.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.306 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 79' ' ' CYS . 9.8 p -65.5 -46.15 90.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.304 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.576 ' N ' HG13 ' A' ' 78' ' ' VAL . 1.6 t -68.85 -47.03 66.97 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.453 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.23 94.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.461 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.97 -43.27 99.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.45 -41.94 99.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.54 -43.81 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.278 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ASP . 96.1 mtt180 -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.135 0.493 . . . . 0.0 110.378 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.92 -42.9 94.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.33 -13.2 55.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.398 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' TYR . . . -149.89 61.41 0.42 Allowed Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' ARG . 88.8 m-20 -38.74 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.508 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -95.0 63.69 2.72 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.356 0.598 . . . . 0.0 110.373 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.9 t -150.91 137.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.33 132.21 41.04 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.219 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -103.65 136.49 43.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.751 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -157.53 148.83 21.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.832 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.63 -164.94 1.25 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 110.468 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.75 -39.83 82.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.78 -34.78 65.52 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.66 60.01 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 100' ' ' VAL . 47.6 t0 -88.16 113.98 24.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -42.57 89.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.658 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 98' ' ' ASP . 9.2 p -144.04 141.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.39 127.65 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.151 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.21 169.67 9.39 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.55 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.684 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 75.5 Cg_exo -45.51 -42.63 18.24 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.426 2.084 . . . . 0.0 112.228 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -99.96 123.85 44.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.82 0.343 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 68.1 mtp -114.81 142.56 46.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -146.15 97.36 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.158 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.522 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.3 t -98.88 115.46 28.89 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.669 0.606 . . . . 0.0 110.923 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 p -171.03 162.11 7.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.649 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 109' ' ' PHE . 1.0 OUTLIER -61.67 -53.34 57.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.361 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.7 p -41.9 148.95 0.15 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.998 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -106.61 161.89 21.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 17.5 Cg_endo -56.62 -31.41 86.99 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.671 2.247 . . . . 0.0 112.081 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -105.02 15.08 28.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.163 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.961 -179.856 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.861 0.363 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.509 ' O ' HG12 ' A' ' 44' ' ' VAL . 96.7 mtt180 -131.53 146.16 52.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.479 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.2 140.24 32.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 pt -131.23 146.84 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.18 89.34 2.97 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.4 128.03 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.278 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -66.91 141.34 57.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 8.0 m-85 -115.05 135.19 54.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.321 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.79 142.77 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.639 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt 67.26 46.65 1.43 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.97 0.414 . . . . 0.0 111.35 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -128.0 12.15 6.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.154 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 36.94 -120.25 0.17 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.228 0.537 . . . . 0.0 111.698 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -49.74 -59.77 3.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -40.44 -44.45 2.01 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.838 0.352 . . . . 0.0 110.533 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -56.42 -52.25 65.36 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -68.55 -40.45 80.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.798 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -52.73 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.266 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.17 -42.2 89.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -59.67 -43.52 93.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.74 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -79.26 -26.94 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.69 -72.42 0.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.6 p -152.11 98.91 2.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.531 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 78.4 p -51.39 -30.8 20.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.287 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -85.47 144.95 27.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 40' ' ' SER . 45.6 m-85 -129.6 138.6 51.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.54 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 43.6 tt0 -77.46 136.45 38.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.598 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 19' ' ' ARG . 3.6 p -141.12 155.06 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.454 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' ASP . 45.7 t0 -149.75 146.07 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -40.77 -26.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.607 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' ASP . 11.0 m-20 -138.19 90.99 2.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 49' ' ' THR . 5.0 p -139.05 158.8 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.943 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 51' ' ' ASP . 68.0 p -121.81 137.52 54.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.739 HD23 ' N ' ' A' ' 50' ' ' LEU . 1.7 pt? -37.9 -25.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.432 0.635 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.5 m-20 -58.91 -41.8 88.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.947 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' OE2' ' OE1' ' A' ' 43' ' ' GLU . 80.1 tt0 -64.89 -33.77 76.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.848 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.636 ' O ' HG23 ' A' ' 57' ' ' VAL . 42.9 tp -62.31 -42.84 99.7 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 109.806 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.99 -42.26 76.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.617 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.81 -43.87 91.75 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.173 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 57' ' ' VAL . 8.5 p -72.46 -40.2 63.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.844 0.354 . . . . 0.0 110.688 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 53' ' ' LEU . 48.0 t -61.09 -48.19 90.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.77 -54.07 41.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.755 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 63.7 t0 -52.31 -38.65 59.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.825 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.76 99.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.33 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' LEU . 75.2 t -63.15 -46.25 96.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -66.59 -43.69 84.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.578 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -61.15 -47.47 86.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.5 p -75.2 -75.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' VAL . 68.9 mt -109.5 109.67 20.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.452 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.26 -44.04 2.68 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.074 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' SER . 27.1 Cg_exo -61.15 132.19 40.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.568 2.178 . . . . 0.0 112.118 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 66' ' ' SER . 2.3 m -134.83 -55.44 0.82 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 110.277 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 71' ' ' HIS . 21.2 ptmt -67.53 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.742 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -76.17 13.25 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.482 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' H ' ' C ' ' A' ' 69' ' ' LYS . 97.0 m-70 -126.44 93.4 3.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.442 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -62.12 -34.79 77.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.45 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.07 -45.58 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.287 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 75' ' ' GLY . 51.8 mt -77.72 -60.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.719 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . 46.22 175.82 0.01 OUTLIER Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m 61.96 -23.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.651 -0.323 . . . . 0.0 110.703 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.676 ' H ' ' C ' ' A' ' 75' ' ' GLY . 8.9 tttm -56.69 -62.76 1.51 Allowed 'General case' 0 C--O 1.225 -0.198 0 CA-C-O 121.367 0.603 . . . . 0.0 109.898 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -52.5 -33.34 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.023 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 t -68.22 -50.84 51.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.551 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.13 93.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.82 -42.15 99.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.034 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.81 -43.99 97.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -58.54 -46.69 86.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -64.94 -36.59 84.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.754 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.34 -37.94 85.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.269 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 -24.99 62.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.344 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.18 -65.1 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -174.5 -179.69 1.59 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -158.31 -68.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.572 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.59 157.0 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.543 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 2.5 p90 -144.31 155.3 43.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.784 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.56 154.64 41.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.236 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.47 147.28 27.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.04 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.46 ' C ' ' N ' ' A' ' 96' ' ' GLY . 89.6 m-20 -80.79 167.84 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 104' ' ' ARG . 94.8 mt-10 -52.26 -9.36 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.484 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.46 ' N ' ' C ' ' A' ' 94' ' ' ASP . . . -90.02 -74.52 1.29 Allowed Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.48 -28.19 0.33 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -69.55 137.9 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.412 ' HB3' HD22 ' A' ' 50' ' ' LEU . 97.6 mt-10 -75.35 89.85 2.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -147.87 149.73 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.772 ' N ' HD12 ' A' ' 101' ' ' ILE . 1.8 mp -83.16 129.47 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.079 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -148.33 169.48 9.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.287 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 88.2 Cg_exo -46.23 -45.03 19.1 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.593 2.196 . . . . 0.0 112.601 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 95' ' ' GLU . 74.0 mtp85 -107.31 80.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.508 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -104.23 160.9 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -141.87 114.14 8.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.568 ' SG ' ' CE1' ' A' ' 25' ' ' PHE . 8.9 p -102.7 128.94 49.21 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.964 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 109' ' ' PHE . 40.0 t -175.74 -167.07 0.22 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.223 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.541 ' O ' ' CD2' ' A' ' 109' ' ' PHE . 70.6 t80 -104.12 25.18 10.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.7 m -115.03 160.87 19.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.267 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -109.25 170.41 5.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.522 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.9 Cg_exo -52.41 -40.68 70.61 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.459 2.106 . . . . 0.0 112.378 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.4 p30 -114.16 39.41 2.75 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.639 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.778 0.323 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -158.45 177.87 10.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.347 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -117.4 141.17 48.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 110.212 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.0 tt -99.16 141.11 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.127 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -132.07 5.41 4.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.23 125.53 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.7 p -138.76 146.56 41.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.81 136.87 56.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.256 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.44 133.33 43.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.062 0.458 . . . . 0.0 110.558 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.3 mp -66.75 -40.39 88.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.716 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 37.0 t0 -159.23 -170.92 3.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.418 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.505 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -59.05 -46.05 89.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.704 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -61.51 -53.21 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.422 ' N ' ' OG1' ' A' ' 30' ' ' THR . 92.7 m-85 -61.42 -27.66 68.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.23 0.538 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.42 -45.0 73.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.975 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -67.98 -36.48 80.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.546 HG21 HD13 ' A' ' 74' ' ' ILE . 76.9 t -62.42 -49.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.467 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.9 -41.62 95.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.99 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 40' ' ' SER . 92.6 p -62.07 -44.46 96.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -75.05 -26.69 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB1' HG22 ' A' ' 61' ' ' VAL . . . -61.01 -28.91 69.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.676 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' GLU . 10.7 p -161.22 -33.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.0 t 69.77 -42.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 39' ' ' CYS . 21.4 pt-20 -154.64 143.16 20.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -134.03 136.07 43.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 110.592 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -67.8 135.85 53.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.433 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.61 134.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.309 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.95 164.37 38.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.615 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 68.9 mmtt -70.66 101.4 2.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 1.5 t70 162.64 -46.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.763 0.665 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -100.14 110.6 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.0 110.597 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -87.53 172.81 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -43.76 -30.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 -51.77 67.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.695 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' VAL . 80.9 mm-40 -65.02 -39.98 94.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.221 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 57' ' ' VAL . 60.1 tp -62.61 -38.95 92.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.966 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.88 -44.01 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.471 . . . . 0.0 110.206 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.53 -34.95 70.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.611 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 52' ' ' GLU . 53.6 t -73.63 -54.51 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 61' ' ' VAL . 9.4 p -55.74 -44.66 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.552 ' N ' HG13 ' A' ' 57' ' ' VAL . 5.6 tt -61.85 -55.3 31.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.63 -42.71 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.8 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.662 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 57' ' ' VAL . 57.8 t -64.92 -46.24 92.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -65.64 -47.19 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.851 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -64.83 -54.03 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.8 m -66.15 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.748 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.3 tp -108.86 81.97 1.53 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.658 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.53 -44.41 2.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.454 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.4 Cg_exo -63.16 119.72 6.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.543 2.162 . . . . 0.0 112.032 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.518 ' SG ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -134.21 -17.89 2.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -66.46 -20.23 65.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.49 28.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.555 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -126.08 160.75 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.492 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -82.43 -65.3 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.42 -47.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.546 HD13 HG21 ' A' ' 34' ' ' VAL . 12.6 mt -65.47 -16.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.061 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.32 3.33 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -82.53 -14.07 55.55 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.299 0.571 . . . . 0.0 110.829 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.434 ' HZ2' HG11 ' A' ' 34' ' ' VAL . 87.1 tttt -54.52 -34.38 61.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.294 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.518 HG22 ' SG ' ' A' ' 68' ' ' CYS . 65.2 t -59.55 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.256 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 85.4 m -61.6 -39.84 92.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.17 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.61 84.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.272 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -60.36 -50.09 74.98 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 -178.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 82' ' ' LEU . 4.1 mm? -61.91 -41.74 98.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.399 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -60.89 -47.15 87.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.216 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -65.7 -40.91 92.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.637 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.23 -22.22 66.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.657 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -40.43 80.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.95 -37.39 0.66 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -84.01 116.33 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.559 0.219 . . . . 0.0 110.461 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -130.92 143.75 50.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.425 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 m -51.5 140.9 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.392 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.89 150.35 24.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.311 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -127.95 127.79 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.778 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -148.02 151.6 36.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.67 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 96' ' ' GLY . 54.0 p-10 -78.67 179.51 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.761 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.81 26.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -130.08 -83.8 0.33 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.43 -26.9 0.12 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -72.46 141.16 48.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.519 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.08 89.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -148.54 136.9 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.559 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mm -77.48 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.483 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -140.46 168.95 12.91 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.8 Cg_exo -51.4 -37.14 60.59 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.544 2.163 . . . . 0.0 112.166 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -129.36 122.79 30.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.52 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.636 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -153.79 149.23 27.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.428 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -87.55 130.82 34.6 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.5 t -126.05 108.4 11.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.15 179.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.417 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' SER . 50.6 p90 -69.34 -40.48 77.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.539 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 109' ' ' PHE . 9.4 t -57.01 149.56 18.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.331 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.683 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -92.77 170.59 8.68 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.643 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.683 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.7 Cg_exo -51.4 -40.39 62.43 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.459 2.106 . . . . 0.0 112.125 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.44 -47.91 84.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.591 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.5 t0 . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.546 -179.773 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.866 0.365 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -145.65 177.02 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.577 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -145.54 133.72 21.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.452 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.89 149.0 32.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 18.9 mtpp -114.11 68.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.268 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -95.22 125.08 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.268 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 t -161.65 142.37 10.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -129.46 134.19 47.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.404 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.42 143.23 47.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -97.59 -5.14 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.265 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 28.5 t0 -153.42 163.85 39.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.566 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.14 -38.15 89.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -61.25 -45.77 93.16 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.594 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -66.05 -27.82 68.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.437 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -73.44 -40.55 64.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.864 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -66.89 -48.21 69.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.986 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.512 HG23 ' N ' ' A' ' 35' ' ' LEU . 30.8 m -65.33 -42.34 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.513 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.512 ' N ' HG23 ' A' ' 34' ' ' VAL . 37.5 mt -62.94 -43.32 99.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.788 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.5 p -67.6 -43.54 80.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 110.813 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -64.86 -35.52 81.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.65 -58.12 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.805 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.2 m -138.42 94.06 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.686 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.528 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 2.4 p -100.2 -2.73 33.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.342 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -145.75 126.17 14.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -110.94 111.25 22.25 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.159 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.649 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -70.56 156.34 39.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.391 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.04 125.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 47' ' ' ASP . 67.6 m-20 -147.24 149.43 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -72.15 16.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 45' ' ' ASP . 92.4 m-20 -112.07 -3.23 14.79 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -119.19 132.46 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.935 0.398 . . . . 0.0 110.276 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.603 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 72.6 p -101.84 157.52 16.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 51' ' ' ASP . 2.1 pp -48.9 -41.99 35.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.702 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.603 ' CG ' ' HG1' ' A' ' 49' ' ' THR . 1.4 p-10 -59.54 -49.33 78.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 110.337 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -35.52 81.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.316 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.474 ' O ' HG12 ' A' ' 57' ' ' VAL . 44.0 tp -61.76 -43.86 98.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.314 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.09 -40.61 98.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.381 0.61 . . . . 0.0 110.073 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.11 -43.61 82.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.855 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.37 -52.38 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.37 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.578 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.6 p -59.0 -46.09 91.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.977 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.578 ' N ' HG13 ' A' ' 57' ' ' VAL . 56.8 tp -65.59 -54.7 24.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.772 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -58.99 -31.69 69.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.845 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.19 -56.46 12.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.366 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.5 HG23 ' N ' ' A' ' 62' ' ' GLU . 34.0 m -69.1 -43.87 81.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.705 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.5 ' N ' HG23 ' A' ' 61' ' ' VAL . 81.6 tt0 -59.06 -44.8 91.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.285 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.7 p -63.05 -45.95 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.67 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -63.34 -52.65 60.91 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.412 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -110.58 73.21 0.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.543 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.01 -46.53 2.8 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.545 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.3 Cg_endo -82.39 107.1 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.353 2.035 . . . . 0.0 111.88 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.538 ' C ' ' H ' ' A' ' 70' ' ' GLU . 2.5 m -133.59 -13.51 2.59 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.252 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -51.02 -6.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.997 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.538 ' H ' ' C ' ' A' ' 68' ' ' CYS . 14.4 pt-20 -72.35 -36.96 68.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.505 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -83.65 156.53 22.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.624 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 19.2 p-10 -76.06 -59.65 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 74' ' ' ILE . 27.4 m -95.48 -44.87 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.554 ' N ' HG23 ' A' ' 73' ' ' VAL . 4.2 mt -70.11 -0.85 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.106 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.472 ' C ' ' N ' ' A' ' 77' ' ' LYS . . . -106.17 -41.08 1.85 Allowed Glycine 0 N--CA 1.465 0.616 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 76' ' ' THR . 55.2 m -48.77 -12.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.472 ' N ' ' C ' ' A' ' 75' ' ' GLY . 21.4 ptmt -56.42 -37.23 69.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.85 -45.67 94.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.803 0.335 . . . . 0.0 110.228 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 82.1 m -64.39 -48.0 77.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.03 82.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.268 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.53 -43.64 98.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.8 -40.7 92.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.65 -50.92 67.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.23 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 89' ' ' TYR . 36.3 ptt180 -69.67 -40.29 76.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 110.642 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.766 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.9 -40.33 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.29 -81.04 1.37 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 84' ' ' ARG . 99.7 m-20 -135.2 97.6 3.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 84' ' ' ARG . 0.3 OUTLIER -55.36 -100.67 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.436 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.5 m -146.38 162.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.524 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.06 142.15 50.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.941 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 93' ' ' PHE . 7.0 tt -122.35 125.63 46.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.306 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.548 ' N ' HD23 ' A' ' 92' ' ' LEU . 91.9 m-85 -128.09 154.29 45.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 23.3 t0 -74.88 177.52 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.5 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.508 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 8.5 tm-20 -47.03 -59.77 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.52 -46.86 91.4 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.24 -13.53 0.82 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.64 141.79 58.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 0.0 110.56 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -76.6 88.33 3.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.545 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -151.02 137.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.33 132.21 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 110.197 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.63 160.89 30.54 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.31 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 22.4 Cg_endo -61.46 -24.69 78.72 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.85 2.367 . . . . 0.0 111.94 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -125.36 57.2 1.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.783 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -102.59 144.65 30.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.012 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.466 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 57.4 t80 -97.34 127.43 43.29 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.308 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.1 p -125.39 112.29 16.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.466 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 5.4 p -171.46 168.76 6.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.772 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 110' ' ' SER . 44.5 p90 -63.5 -47.16 82.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.52 ' N ' ' CG ' ' A' ' 109' ' ' PHE . 17.1 m -59.43 144.14 47.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -77.83 170.64 15.3 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.562 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.5 Cg_exo -51.12 -42.03 54.96 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.383 2.055 . . . . 0.0 111.877 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 46.4 p-10 -88.1 -34.18 18.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 67.7 t0 . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.412 ' HG1' ' HA ' ' A' ' 45' ' ' ASP . 3.0 t . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.891 0.377 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -148.81 160.0 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.52 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.63 141.72 33.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 21' ' ' ILE . 12.8 tt -107.33 128.94 61.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.04 16.81 10.84 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.227 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mt -108.05 131.4 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.152 0.501 . . . . 0.0 111.13 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.4 m -141.31 145.25 35.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.474 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 107' ' ' CYS . 87.4 t80 -85.0 114.79 22.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.365 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.95 142.38 46.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.529 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.72 -79.49 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.65 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.73 168.7 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.71 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.762 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.414 ' H ' HG22 ' A' ' 30' ' ' THR . 0.2 OUTLIER -55.85 -57.7 10.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.582 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -65.95 -23.62 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.288 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.48 -46.31 70.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -71.51 -39.32 70.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.494 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' THR . 71.4 t -61.8 -48.22 89.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.271 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.47 -42.92 91.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.967 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 40' ' ' SER . 10.6 t -62.62 -47.94 81.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.502 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.04 -45.75 92.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.727 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.86 65.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.5 t -164.08 78.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' SER . 61.2 p -83.14 -7.22 59.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.294 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -171.16 127.97 0.7 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 43' ' ' GLU . 21.0 t80 -128.76 158.16 39.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.181 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -109.58 116.79 32.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.42 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.82 129.67 75.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.206 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 47' ' ' ASP . 19.6 p-10 -113.94 169.02 9.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.985 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 55.7 mtpt -52.63 86.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.515 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER 167.8 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.449 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.4 t -76.85 129.84 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.311 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLU . 3.8 p -124.18 157.53 34.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -36.54 -39.3 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.646 -179.422 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -63.18 -45.95 89.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.445 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 49' ' ' THR . 46.0 tp10 -66.98 -38.44 86.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 57' ' ' VAL . 5.5 mt -62.45 -43.14 99.53 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 121.078 0.466 . . . . 0.0 110.617 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.619 HD23 ' O ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -67.64 -39.47 84.6 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.315 0.579 . . . . 0.0 110.656 -179.155 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.24 -44.18 80.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.68 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.553 HG13 ' N ' ' A' ' 57' ' ' VAL . 8.4 p -76.64 -45.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.848 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 53' ' ' LEU . 54.0 t -58.33 -47.6 87.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.499 HD21 ' CD1' ' A' ' 81' ' ' LEU . 19.9 tp -64.58 -56.47 13.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.311 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.05 -40.48 58.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.186 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.52 89.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 57' ' ' VAL . 75.7 t -62.2 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.755 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.75 -42.79 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.601 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -63.23 -54.86 30.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.901 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -62.24 -48.76 78.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.541 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.9 tp -108.54 93.57 4.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -79.15 -46.4 1.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.69 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.1 Cg_endo -83.93 116.39 2.15 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.102 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 m -130.64 -34.09 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.556 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -64.57 -28.03 69.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.589 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 70' ' ' GLU . 57.8 mp0 -73.33 -36.37 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 75' ' ' GLY . 92.7 m-70 -91.4 108.67 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.98 -29.85 70.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -59.66 -45.46 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 75' ' ' GLY . 7.0 mt -103.08 -10.75 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.602 ' C ' HG23 ' A' ' 76' ' ' THR . . . -48.09 -177.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.602 HG23 ' C ' ' A' ' 75' ' ' GLY . 2.0 p 73.74 -30.93 0.21 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.353 0.597 . . . . 0.0 110.642 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -62.24 -33.88 75.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.959 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 79' ' ' CYS . 11.3 p -59.68 -42.03 87.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.516 ' N ' HG13 ' A' ' 78' ' ' VAL . 83.2 m -63.43 -50.1 71.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.14 81.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.148 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.499 ' CD1' HD21 ' A' ' 58' ' ' LEU . 37.8 tp -50.99 -41.53 59.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.73 -49.88 75.72 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.141 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.01 -41.99 99.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.35 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -65.83 -41.02 92.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.539 ' C ' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt -62.56 -29.87 70.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.339 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.51 0.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.459 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . 171.14 -74.2 0.1 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 9.9 p-10 176.99 -74.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 1.8 t80 75.81 -71.14 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.1 t -52.9 131.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.337 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.567 ' CZ ' ' O ' ' A' ' 89' ' ' TYR . 37.1 m-85 -120.42 160.41 23.15 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.034 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.651 HD23 ' C ' ' A' ' 92' ' ' LEU . 8.6 tt -123.79 126.78 47.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.425 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.522 ' N ' HD23 ' A' ' 92' ' ' LEU . 62.0 m-85 -130.06 150.54 51.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.767 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -82.82 -158.89 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.457 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.53 -49.69 74.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.437 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.94 -113.22 0.15 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -154.05 45.8 0.56 Allowed Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -124.94 131.39 53.43 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.11 89.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.695 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -158.37 146.52 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 50' ' ' LEU . 13.1 mm -73.45 128.91 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.068 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -144.79 171.27 6.84 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.667 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 76.4 Cg_exo -49.72 -36.74 42.67 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.542 2.161 . . . . 0.0 111.93 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -130.91 131.29 44.4 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.667 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -162.39 167.82 23.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.387 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -139.21 142.17 37.9 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.501 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.9 t -114.28 113.49 24.66 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.0 p -162.22 170.87 18.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.887 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 110' ' ' SER . 44.9 p90 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.513 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 8.4 t -54.91 148.74 12.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.497 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -104.34 170.4 6.13 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.2 Cg_exo -51.32 -40.34 61.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.486 2.124 . . . . 0.0 111.903 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -81.6 35.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.426 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.524 -179.874 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 121.322 0.582 . . . . 999.99000000000001 111.615 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -146.18 169.3 19.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.495 -0.775 . . . . 999.99000000000001 110.835 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -126.18 119.7 28.17 Favored 'General case' 0 C--N 1.267 -2.988 1 O-C-N 114.155 -5.341 . . . . 999.99000000000001 111.2 -174.186 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.585 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -104.25 145.97 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 114.963 -1.017 . . . . 885.66999999999996 110.443 -179.101 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.536 ' N ' HG13 ' A' ' 21' ' ' ILE . 14.1 tttt -134.85 10.67 3.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.142 -0.935 . . . . 999.99000000000001 110.042 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.585 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.4 mp -94.82 110.73 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.09 0.472 . . . . 999.99000000000001 111.354 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -119.63 137.59 53.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.449 -0.796 . . . . 999.99000000000001 109.66 179.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -86.14 114.9 23.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.101 0.477 . . . . 999.99000000000001 110.272 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.91 107.82 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 999.99000000000001 111.048 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.456 HD23 ' N ' ' A' ' 27' ' ' LEU . 6.4 mt -68.95 -40.02 79.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 999.99000000000001 109.536 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -151.62 172.25 16.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.794 -1.093 . . . . 999.99000000000001 109.125 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 32' ' ' ASP . . . -58.2 -26.5 62.87 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.584 -0.447 . . . . 999.99000000000001 109.999 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 32' ' ' ASP . 24.8 m -59.97 -63.89 1.14 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.958 -0.565 . . . . 999.99000000000001 110.287 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.493 ' O ' ' HB3' ' A' ' 35' ' ' LEU . 69.5 m-85 -75.68 16.4 0.39 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 119.091 0.859 . . . . 999.99000000000001 109.636 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.5 t0 -88.65 -64.79 1.09 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.07 -1.456 . . . . 999.99000000000001 107.07 177.038 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.3 p -67.8 -41.37 83.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.256 -0.884 . . . . 999.99000000000001 109.046 177.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.497 HG11 HD22 ' A' ' 65' ' ' LEU . 66.6 t -66.51 -50.3 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 112.787 0.662 . . . . 825.48000000000002 112.787 -178.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 31' ' ' PHE . 12.9 tp -64.96 -41.73 95.22 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.678 -0.809 . . . . 715.35000000000002 110.448 -178.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.54 -44.64 95.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.978 -0.289 . . . . 999.99000000000001 111.411 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -63.18 -45.57 91.16 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.365 0.506 . . . . 999.99000000000001 112.365 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 64' ' ' THR . . . -77.35 -28.28 52.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.227 -0.442 . . . . 999.99000000000001 110.758 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 42' ' ' PHE . 6.9 t -147.66 80.83 1.5 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.398 0.888 . . . . 999.99000000000001 113.398 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 p -91.45 -14.96 29.61 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.834 -0.621 . . . . 999.99000000000001 109.609 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -151.33 144.6 24.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.685 0.994 . . . . 999.99000000000001 113.685 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.581 ' CD2' ' SG ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -140.48 147.44 39.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.168 -0.923 . . . . 999.99000000000001 111.23 177.862 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -110.59 119.12 38.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.736 -0.666 . . . . 999.99000000000001 110.207 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.643 HG12 ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -121.61 111.27 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 114.711 1.374 . . . . 999.99000000000001 114.711 -176.698 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.89 161.11 10.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 105.307 -2.109 . . . . 999.99000000000001 105.307 175.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -83.44 35.99 0.52 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 122.403 2.365 . . . . 999.99000000000001 110.376 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -131.94 2.38 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.883 -0.784 . . . . 999.99000000000001 108.883 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.643 ' HB ' HG12 ' A' ' 44' ' ' VAL . 19.0 t -88.63 124.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.498 -0.774 . . . . 999.99000000000001 109.62 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 52' ' ' GLU . 35.0 p -103.19 147.82 26.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 533.5 109.888 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.657 ' N ' HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -33.77 -34.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 304.88 110.938 -178.844 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' THR . 98.3 m-20 -60.7 -48.6 81.04 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 698.47000000000003 110.519 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.9 mt-10 -68.24 -38.14 81.53 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.31 -0.405 . . . . 999.99000000000001 110.385 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.25 -45.83 92.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.142 -0.688 . . . . 499.30000000000001 109.142 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.476 ' CD2' HG23 ' A' ' 90' ' ' VAL . 1.9 mt -63.39 -41.95 98.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.537 -0.756 . . . . 404.06 110.266 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.37 -50.4 73.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.525 -0.761 . . . . 805.60000000000002 111.285 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.8 -36.45 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.821 0.344 . . . . 843.98000000000002 110.925 -179.219 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.38 -48.24 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 353.45999999999998 110.351 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.931 HD11 ' CD1' ' A' ' 81' ' ' LEU . 32.2 tp -63.94 -44.06 93.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.204 -0.907 . . . . 501.13 109.811 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.71 -43.08 97.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.984 -0.553 . . . . 999.99000000000001 111.211 179.545 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.79 84.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.748 0.309 . . . . 763.22000000000003 110.972 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.7 t -64.24 -42.01 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 599.86000000000001 110.384 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.16 -39.71 93.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 999.99000000000001 109.968 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -42.07 86.07 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.3 -0.409 . . . . 999.99000000000001 111.69 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -75.73 -44.88 39.62 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.598 -0.441 . . . . 999.99000000000001 110.895 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 34' ' ' VAL . 3.0 tp -108.11 71.7 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 999.99000000000001 110.713 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.532 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -78.14 -45.47 2.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 999.99000000000001 110.82 179.42 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 66' ' ' SER . 72.8 Cg_endo -80.42 56.89 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.884 2.39 . . . . 999.99000000000001 113.365 -179.554 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.55 -33.27 25.49 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.935 0.398 . . . . 845.47000000000003 110.318 179.235 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.93 -20.44 65.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.784 -0.644 . . . . 999.99000000000001 111.587 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.79 -38.36 70.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.646 -0.252 . . . . 999.99000000000001 111.451 -178.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -87.78 120.56 29.23 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.95 -0.3 . . . . 999.99000000000001 110.388 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.83 -41.31 97.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.509 0.195 . . . . 999.99000000000001 111.284 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.85 -47.67 92.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 999.99000000000001 110.252 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 75' ' ' GLY . 30.7 mt -81.62 -26.76 9.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 115.975 -0.557 . . . . 999.99000000000001 110.666 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -22.79 -78.93 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 N-CA-C 111.189 -0.764 . . . . 655.89999999999998 111.189 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -25.85 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.942 0.719 . . . . 866.77999999999997 112.942 -178.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -56.02 -29.59 60.6 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.348 -0.22 . . . . 999.99000000000001 110.941 179.635 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 68' ' ' CYS . 2.6 t -68.18 -46.2 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 110.16 -0.311 . . . . 812.96000000000004 110.16 178.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.86 -43.77 97.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.0 -0.545 . . . . 771.90999999999997 110.127 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.08 92.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 483.48000000000002 109.793 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.931 ' CD1' HD11 ' A' ' 58' ' ' LEU . 58.1 tp -62.65 -45.0 94.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.798 -0.637 . . . . 703.45000000000005 110.331 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 82' ' ' LEU . 16.1 tp -62.95 -43.2 99.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.877 -0.601 . . . . 999.99000000000001 110.137 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -64.44 -38.74 92.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.158 -0.474 . . . . 999.99000000000001 110.143 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 97.0 mtt180 -65.73 -39.87 91.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.999 0.428 . . . . 999.99000000000001 110.531 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tp -73.5 -24.52 60.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 985.92999999999995 110.169 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.8 99.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.108 -0.496 . . . . 999.99000000000001 111.941 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.27 -55.79 0.07 OUTLIER Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.238 -0.982 . . . . 999.99000000000001 112.211 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 99.4 m-20 -87.88 115.81 25.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 999.99000000000001 110.119 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.473 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.4 p90 -109.6 -111.36 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.559 -0.291 . . . . 999.99000000000001 110.385 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -150.73 115.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.373 -0.973 . . . . 390.25999999999999 108.373 178.423 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.17 160.55 32.24 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.02 -1.104 . . . . 421.31 108.02 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.938 HD12 ' HB2' ' A' ' 107' ' ' CYS . 3.2 tt -146.49 134.74 21.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 120.002 1.274 . . . . 247.34 107.968 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.08 162.73 37.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.186 -0.606 . . . . 999.99000000000001 112.152 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -77.65 -177.98 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.313 -0.858 . . . . 841.49000000000001 110.719 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -74.69 49.82 0.41 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.06 -0.518 . . . . 999.99000000000001 110.609 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -152.45 -53.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.573 -1.011 . . . . 951.75999999999999 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.49 -19.51 2.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.224 -1.151 . . . . 633.38 110.224 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -70.78 136.93 49.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.34 -0.244 . . . . 774.99000000000001 110.34 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.526 ' HB3' HD21 ' A' ' 50' ' ' LEU . 96.7 mt-10 -74.89 89.93 2.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.898 -0.408 . . . . 691.20000000000005 109.898 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.02 149.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 455.33999999999997 110.502 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.657 HD11 ' N ' ' A' ' 50' ' ' LEU . 4.1 mp -89.86 123.18 41.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.535 -0.543 . . . . 501.24000000000001 109.535 179.131 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -139.48 178.15 1.74 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.83 -0.623 . . . . 635.24000000000001 109.653 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 50.8 Cg_exo -53.74 -35.87 80.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.317 2.011 . . . . 999.99000000000001 111.603 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -121.97 97.9 5.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.94 -0.573 . . . . 999.99000000000001 110.715 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.593 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -116.31 132.2 56.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.045 -0.525 . . . . 524.37 110.542 -179.83 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.489 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 73.8 t80 -92.73 106.07 18.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.367 -0.379 . . . . 650.22000000000003 109.993 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.938 ' HB2' HD12 ' A' ' 92' ' ' LEU . 4.1 t -98.24 118.57 35.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.187 -0.46 . . . . 456.19999999999999 110.942 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.489 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 11.5 t -174.41 168.45 3.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.149 0.499 . . . . 573.24000000000001 110.856 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.588 ' N ' HG12 ' A' ' 90' ' ' VAL . 25.7 p90 -87.79 25.08 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.201 -0.666 . . . . 999.99000000000001 109.201 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.0 m -117.36 121.65 41.7 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.815 -0.63 . . . . 956.63999999999999 110.021 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.74 162.02 2.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.611 -0.722 . . . . 699.55999999999995 110.985 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -46.04 35.48 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.576 2.184 . . . . 999.99000000000001 112.135 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.5 p-10 -74.65 -36.5 62.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.999 0.904 . . . . 999.99000000000001 109.09 177.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 t0 . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 113.624 -1.626 . . . . 999.99000000000001 110.347 179.523 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.455 -1.458 . . . . 999.99000000000001 109.455 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.671 ' CD ' ' HD2' ' A' ' 3' ' ' LYS . 6.6 tptt 89.11 -77.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.819 0.364 . . . . 999.99000000000001 110.706 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 1.056 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER 128.31 -138.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 O-C-N 124.341 1.025 . . . . 999.99000000000001 109.894 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.056 HG13 ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 174.89 27.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.574 0 O-C-N 123.838 0.711 . . . . 999.99000000000001 112.399 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.526 ' H ' ' HG2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -152.75 22.11 0.6 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.256 0.55 . . . . 999.99000000000001 110.538 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.2 172.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.936 -1.029 . . . . 999.99000000000001 111.532 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.42 -174.3 2.49 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.441 -1.318 . . . . 999.99000000000001 107.441 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.76 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 14.5 m-20 68.54 170.35 0.28 Allowed 'General case' 0 C--O 1.207 -1.146 0 CA-C-O 116.888 -1.529 . . . . 999.99000000000001 107.227 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.933 ' O ' ' C ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -27.22 142.3 0.05 OUTLIER Pre-proline 0 CA--C 1.479 -1.771 0 CA-C-O 113.768 -3.015 . . . . 999.99000000000001 108.609 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 1.591 ' CB ' ' CG ' ' A' ' 10' ' ' PRO 0.432 5.9 Cg_exo -55.08 178.3 0.09 OUTLIER 'Trans proline' 2 N--CA 2.068 35.282 3 C-N-CA 134.299 10.0 . . . . 999.99000000000001 128.721 179.226 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.729 ' HD3' ' N ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER 42.98 -108.63 0.12 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 109.758 -3.383 . . . . 999.99000000000001 107.648 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.729 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 25.6 t -49.36 -24.25 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 105.611 -1.996 . . . . 999.99000000000001 105.611 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.933 ' C ' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -173.78 114.56 0.21 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 113.722 -3.037 . . . . 999.99000000000001 111.288 178.526 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.418 ' CB ' ' CA ' ' A' ' 10' ' ' PRO 0.455 0.9 OUTLIER -179.74 -175.77 0.34 Allowed 'General case' 2 N--CA 1.634 8.739 0 O-C-N 127.822 3.201 . . . . 999.99000000000001 113.96 172.029 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.495 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -142.71 163.11 40.6 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 112.743 -2.026 . . . . 999.99000000000001 109.19 173.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.673 ' C ' ' H ' ' A' ' 18' ' ' THR . 86.7 Cg_exo -41.58 146.84 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.361 2.04 . . . . 999.99000000000001 112.346 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.58 17.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.315 0.579 . . . . 999.99000000000001 110.985 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.673 ' H ' ' C ' ' A' ' 16' ' ' PRO . 2.6 p -116.41 158.53 23.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.074 -0.966 . . . . 999.99000000000001 110.591 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.409 ' O ' HG23 ' A' ' 44' ' ' VAL . 67.3 mtp180 -103.11 137.81 40.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.313 -0.625 . . . . 999.99000000000001 109.313 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 97.5 mttt -95.53 114.59 26.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.211 0.529 . . . . 999.99000000000001 111.16 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.642 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -100.68 147.1 8.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.268 -0.878 . . . . 885.66999999999996 110.178 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' N ' HG13 ' A' ' 21' ' ' ILE . 11.7 tttt -134.78 11.72 3.68 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.667 -0.697 . . . . 999.99000000000001 110.783 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.642 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.7 mp -95.85 111.47 26.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.931 0.396 . . . . 999.99000000000001 110.697 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.44 130.68 53.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 999.99000000000001 110.293 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -78.02 113.19 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.099 0.476 . . . . 999.99000000000001 110.41 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.26 107.85 19.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 999.99000000000001 110.756 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.4 mt -68.11 -40.06 82.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 999.99000000000001 110.181 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -154.08 170.2 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 999.99000000000001 109.891 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.97 25.23 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.331 -0.395 . . . . 999.99000000000001 110.1 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 32' ' ' ASP . 17.1 m -58.71 -64.68 0.84 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.726 -0.67 . . . . 999.99000000000001 110.405 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.509 ' O ' ' HB3' ' A' ' 35' ' ' LEU . 77.9 m-85 -75.93 16.49 0.41 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.357 0.526 . . . . 999.99000000000001 109.967 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.0 t0 -88.51 -65.5 1.01 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.65 -0.87 . . . . 999.99000000000001 108.65 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.2 p -73.1 -33.51 65.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.471 -0.786 . . . . 999.99000000000001 109.7 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.606 HG11 HD22 ' A' ' 65' ' ' LEU . 66.3 t -70.9 -50.1 45.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.077 -0.51 . . . . 825.48000000000002 111.457 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 31' ' ' PHE . 16.9 tp -64.05 -41.73 97.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 119.91 -0.716 . . . . 715.35000000000002 110.521 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -62.68 -45.65 91.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.353 -0.385 . . . . 999.99000000000001 110.937 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -64.35 -39.69 94.38 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.906 0.335 . . . . 999.99000000000001 111.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.55 -27.33 31.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 999.99000000000001 110.654 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.568 ' HG ' ' HD2' ' A' ' 42' ' ' PHE . 2.9 t -147.78 85.3 1.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 999.99000000000001 111.982 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 p -97.13 -16.28 20.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.878 -0.601 . . . . 999.99000000000001 110.094 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' CG ' ' HE3' ' A' ' 22' ' ' LYS . 41.4 mt-10 -152.03 144.48 24.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.047 -0.979 . . . . 999.99000000000001 112.067 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HD2' ' HG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -142.94 141.76 31.52 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.764 -0.653 . . . . 999.99000000000001 111.564 179.088 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 16.5 pt-20 -105.91 115.31 30.01 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.814 -0.63 . . . . 999.99000000000001 110.508 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.544 HG12 ' CB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -119.89 111.95 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.854 0.835 . . . . 999.99000000000001 112.644 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 2.2 m-20 -57.73 170.76 0.55 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.014 -1.448 . . . . 999.99000000000001 107.667 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -87.89 31.67 0.77 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.295 1.861 . . . . 999.99000000000001 110.084 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -133.72 -3.9 2.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 999.99000000000001 109.817 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.544 ' CB ' HG12 ' A' ' 44' ' ' VAL . 19.2 t -79.53 126.15 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.877 -0.601 . . . . 999.99000000000001 109.996 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' GLU . 19.8 p -103.18 145.66 29.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.907 -0.588 . . . . 533.5 110.178 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.676 ' N ' HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -30.31 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.773 0.671 . . . . 304.88 110.882 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' THR . 97.6 m-20 -60.22 -49.48 77.45 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.326 -0.397 . . . . 698.47000000000003 110.598 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.3 mt-10 -66.78 -38.95 87.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 999.99000000000001 110.55 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.08 -46.02 92.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.695 -0.483 . . . . 499.30000000000001 109.695 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.435 ' CD2' HG23 ' A' ' 90' ' ' VAL . 1.6 mt -63.32 -40.96 98.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 404.06 110.432 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -60.64 -51.52 69.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 805.60000000000002 111.064 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.86 -35.8 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.779 0.323 . . . . 843.98000000000002 110.795 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.28 -48.04 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.06 -0.518 . . . . 353.45999999999998 110.653 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.959 HD11 ' CD1' ' A' ' 81' ' ' LEU . 30.5 tp -65.1 -43.38 92.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 501.13 110.136 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -64.62 -42.08 95.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.931 -0.577 . . . . 999.99000000000001 110.78 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . -61.4 -50.95 70.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 763.22000000000003 110.828 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.76 -40.82 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 599.86000000000001 110.555 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -66.35 -36.91 84.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.927 -0.578 . . . . 999.99000000000001 110.36 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -41.78 75.58 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.229 -0.441 . . . . 999.99000000000001 111.221 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -74.22 -48.59 27.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.423 -0.353 . . . . 999.99000000000001 110.871 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.606 HD22 HG11 ' A' ' 34' ' ' VAL . 3.7 tp -106.23 72.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 999.99000000000001 110.438 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -78.23 -49.3 1.89 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 999.99000000000001 110.678 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 66' ' ' SER . 59.8 Cg_endo -76.53 63.18 7.22 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.859 2.372 . . . . 999.99000000000001 112.423 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -91.86 -31.67 15.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 845.47000000000003 110.518 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HB2' HG21 ' A' ' 78' ' ' VAL . 81.0 tttt -65.69 -16.52 63.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 999.99000000000001 110.873 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.78 -39.81 66.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.401 -0.363 . . . . 999.99000000000001 110.956 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 75' ' ' GLY . 99.0 m-70 -86.73 118.52 26.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 999.99000000000001 110.281 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.06 -40.64 94.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 999.99000000000001 110.947 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -47.24 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 999.99000000000001 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 43.1 mt -83.27 -29.68 8.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.144 -0.48 . . . . 999.99000000000001 110.612 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -21.71 -76.03 0.01 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 110.863 -0.895 . . . . 655.89999999999998 110.863 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -25.0 -35.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.016 0.48 . . . . 866.77999999999997 112.169 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -53.93 -29.75 43.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.267 -0.173 . . . . 999.99000000000001 110.606 179.308 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 69' ' ' LYS . 2.6 t -68.77 -46.9 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.781 0.324 . . . . 812.96000000000004 110.389 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 m -61.79 -44.64 96.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.938 -0.574 . . . . 771.90999999999997 110.228 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.02 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.962 -0.563 . . . . 483.48000000000002 110.224 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.959 ' CD1' HD11 ' A' ' 58' ' ' LEU . 58.3 tp -62.67 -45.31 93.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.078 -0.51 . . . . 703.45000000000005 110.479 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 82' ' ' LEU . 16.0 tp -63.2 -43.32 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 999.99000000000001 110.345 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.3 -40.08 96.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 999.99000000000001 110.43 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 91.7 mtt180 -65.33 -40.0 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 999.99000000000001 110.745 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tp -74.94 -19.37 60.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.947 -0.57 . . . . 985.92999999999995 110.389 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.76 -45.13 94.12 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.364 -0.38 . . . . 999.99000000000001 111.097 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.55 -56.3 0.06 OUTLIER Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.939 -0.648 . . . . 999.99000000000001 111.505 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 92.0 m-20 -84.15 112.81 20.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.34 -0.244 . . . . 999.99000000000001 110.34 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.505 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.2 p90 -108.62 -110.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.323 . . . . 999.99000000000001 110.474 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -151.39 115.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.331 -0.618 . . . . 390.25999999999999 109.331 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -73.84 155.27 38.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.262 -0.644 . . . . 421.31 109.262 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.946 HD12 ' HB2' ' A' ' 107' ' ' CYS . 3.8 tt -142.35 135.19 28.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.723 -0.843 . . . . 247.34 108.723 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.51 163.73 32.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.882 0.372 . . . . 999.99000000000001 111.011 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -79.49 -175.73 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 841.49000000000001 110.36 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.08 50.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.145 -0.479 . . . . 999.99000000000001 110.687 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.39 -55.62 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.778 -0.929 . . . . 951.75999999999999 110.778 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.76 -20.3 2.18 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.572 -1.011 . . . . 633.38 110.572 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -72.33 136.8 46.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.739 0.304 . . . . 774.99000000000001 110.588 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.532 ' HB3' HD21 ' A' ' 50' ' ' LEU . 96.8 mt-10 -74.21 89.83 2.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 691.20000000000005 110.28 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.62 151.13 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 455.33999999999997 110.456 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.676 HD11 ' N ' ' A' ' 50' ' ' LEU . 4.1 mp -90.45 123.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.546 . . . . 501.24000000000001 110.208 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.85 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -141.28 177.49 1.91 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 635.24000000000001 110.399 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.85 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 53.2 Cg_exo -51.51 -36.79 60.81 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.704 2.269 . . . . 999.99000000000001 111.979 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -123.21 98.0 5.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.212 -0.449 . . . . 999.99000000000001 110.499 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.635 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -116.01 134.84 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.536 . . . . 524.37 110.4 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 70.7 t80 -94.87 106.23 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 650.22000000000003 110.147 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.946 ' HB2' HD12 ' A' ' 92' ' ' LEU . 4.3 t -98.64 120.76 39.63 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.107 -0.497 . . . . 456.19999999999999 110.669 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.509 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 10.4 t -177.38 167.2 2.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.188 0.518 . . . . 573.24000000000001 110.738 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.609 ' N ' HG12 ' A' ' 90' ' ' VAL . 26.0 p90 -85.68 26.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 999.99000000000001 109.982 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.1 m -119.77 121.1 38.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.259 -0.428 . . . . 956.63999999999999 110.552 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -53.54 161.35 1.56 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.854 -0.612 . . . . 699.55999999999995 110.418 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.5 Cg_exo -50.58 -47.46 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.558 2.172 . . . . 999.99000000000001 112.324 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 24.7 p-10 -72.95 -38.28 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 999.99000000000001 110.409 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 114.429 -1.259 . . . . 999.99000000000001 110.032 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -76.54 144.11 39.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.316 . . . . 0.0 110.333 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -133.14 -4.76 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.488 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.635 HG13 ' N ' ' A' ' 5' ' ' GLU . 7.1 p -77.24 -52.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.992 0.425 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.635 ' N ' HG13 ' A' ' 4' ' ' VAL . 85.8 mt-10 -153.74 150.82 28.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.771 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -102.38 125.47 49.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -173.18 52.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.553 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 9' ' ' LYS . 35.1 t0 43.97 -167.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.36 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 2.8 mptm? -46.03 157.32 0.41 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.745 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.22 156.32 62.42 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.325 2.017 . . . . 0.0 112.06 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -128.13 144.58 51.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.105 0.479 . . . . 0.0 110.327 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t 57.67 47.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -152.48 150.62 29.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.422 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -57.68 131.96 51.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.409 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 pt -66.95 154.24 92.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.824 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.44 -164.11 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.593 2.195 . . . . 0.0 111.92 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -74.95 1.36 13.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.49 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.9 p -85.25 169.6 13.64 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.322 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -113.83 171.3 7.67 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -112.52 147.39 36.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.37 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 21' ' ' ILE . 10.8 tp -108.65 134.29 51.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.05 -2.42 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mt -102.52 122.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.41 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -147.41 144.2 28.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.455 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.55 119.61 23.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.29 36.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -64.88 -40.5 95.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.569 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.3 t0 -156.25 -175.82 5.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -61.1 -42.91 99.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.53 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' VAL . 75.3 m -63.12 -47.56 82.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.563 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.411 ' HB2' ' H ' ' A' ' 28' ' ' ASP . 64.0 m-85 -65.34 -33.46 76.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.447 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -65.46 -51.49 59.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.826 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 t -63.67 -44.86 92.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.749 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 30' ' ' THR . 69.9 t -62.73 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.84 -43.4 96.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.705 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.27 -45.79 91.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.59 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -65.25 -44.39 88.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.728 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.27 -54.52 14.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.472 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 60' ' ' ALA . 60.8 m -118.58 79.22 1.35 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.562 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.46 -37.96 89.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.476 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -172.63 150.48 2.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.604 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -142.12 156.94 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.84 124.66 32.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.985 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 m -124.6 135.64 63.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.093 0.473 . . . . 0.0 110.592 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.24 168.57 19.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.145 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -73.7 161.25 30.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 56.96 33.86 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.678 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -75.14 140.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.242 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 20.3 p -90.76 -71.36 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 172.17 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.771 0.669 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 26.5 p-10 -55.88 -44.46 78.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.919 0.39 . . . . 0.0 110.451 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 79.5 tt0 -64.61 -41.24 96.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.419 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' VAL . 19.3 mt -62.95 -43.64 98.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.83 -43.21 96.88 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.839 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -67.92 -43.05 80.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.022 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.71 -50.48 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 53' ' ' LEU . 76.4 t -57.54 -48.21 83.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 81' ' ' LEU . 54.0 tp -64.92 -55.73 17.52 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.622 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -51.66 -41.82 61.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.304 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.445 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -62.51 -42.44 99.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.588 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 57' ' ' VAL . 53.9 t -63.91 -45.3 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.703 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.59 -42.17 82.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.589 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 t -61.34 -54.37 44.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.794 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.1 p -59.75 -45.42 92.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.152 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -108.01 81.34 1.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.55 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.63 -46.61 4.18 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 66' ' ' SER . 61.1 Cg_endo -81.91 106.4 1.61 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.335 2.023 . . . . 0.0 112.009 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.401 ' SG ' ' CG2' ' A' ' 78' ' ' VAL . 1.4 p -133.25 -42.0 0.88 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.871 0.367 . . . . 0.0 110.208 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -66.9 -22.91 65.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -72.29 -38.64 68.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.732 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 75' ' ' GLY . 77.0 m80 -97.66 125.3 42.36 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.76 -34.98 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.064 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.27 -45.98 95.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.073 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 31.8 mm -88.59 -22.38 6.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.201 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -37.71 -56.18 1.68 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.8 p -46.58 -19.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.722 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 88.9 tttt -62.03 -45.96 91.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.588 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 74.1 t -62.61 -44.53 99.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.57 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 77.9 m -62.0 -49.43 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.78 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 58' ' ' LEU . 5.5 tt -63.28 -44.53 94.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.72 -43.61 98.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 87' ' ' GLY . 33.2 t70 -62.11 -44.27 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 88' ' ' ASP . 87.5 mtm180 -66.83 -36.99 83.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.816 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.21 -46.33 87.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.406 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.21 -49.85 2.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.46 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -69.23 -95.65 0.05 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 83' ' ' ASP . 99.7 m-20 -68.92 -172.11 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.574 0.226 . . . . 0.0 110.495 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CE1' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER 173.45 175.06 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.092 0.472 . . . . 0.0 110.322 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.27 138.29 47.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.436 ' OH ' ' CE1' ' A' ' 89' ' ' TYR . 54.5 m-85 -110.11 151.52 27.14 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.509 HD23 ' C ' ' A' ' 92' ' ' LEU . 7.1 tt -131.29 124.6 30.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.487 ' N ' HD23 ' A' ' 92' ' ' LEU . 82.0 m-85 -132.76 154.68 50.0 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.694 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 97' ' ' GLY . 18.8 p-10 -82.98 177.41 8.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.16 26.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -144.3 -4.6 0.66 Allowed Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.559 ' N ' ' OD1' ' A' ' 94' ' ' ASP . . . 91.75 -6.27 79.73 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 45.1 t0 -86.9 117.19 25.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.791 0.329 . . . . 0.0 110.464 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 100' ' ' VAL . 95.6 mt-10 -55.6 86.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.521 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 99' ' ' GLU . 67.7 t -156.83 134.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.47 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 101' ' ' ILE . 1.6 mp -68.92 131.44 33.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.678 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -146.06 172.0 5.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.582 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.1 Cg_exo -51.46 -35.69 56.1 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.598 2.199 . . . . 0.0 111.812 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' A' ' 103' ' ' PRO . 1.5 mpt_? -118.63 74.23 0.96 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.002 0.43 . . . . 0.0 110.392 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -104.79 148.69 26.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.165 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.485 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 57.3 t80 -116.82 124.89 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.48 ' SG ' ' CD1' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -123.5 110.36 14.98 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.485 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 7.1 p -168.38 169.3 10.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.804 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 109' ' ' PHE . 30.1 t80 -62.46 -47.36 84.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -59.34 145.69 42.44 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.403 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.675 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -80.58 170.79 14.26 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.443 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.675 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.3 Cg_exo -51.32 -42.29 55.1 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.526 2.15 . . . . 0.0 111.84 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.05 -41.11 97.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.02 0.438 . . . . 0.0 110.755 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.762 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -82.82 159.54 22.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 110.6 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -43.32 -45.08 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 4' ' ' VAL . 8.1 p -97.31 126.47 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.337 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.42 179.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.431 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASP . 33.3 m-85 -158.6 60.6 0.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.459 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 6' ' ' PHE . 87.6 m-20 32.83 -91.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.083 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' PHE . 52.1 p-10 -143.8 -170.88 3.42 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.742 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -80.84 148.22 64.31 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.666 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.93 76.7 1.19 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.469 2.112 . . . . 0.0 112.327 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.0 -39.28 89.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.32 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -71.66 -73.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.495 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -56.62 171.64 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.527 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.14 139.63 56.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.455 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.3 161.59 62.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.653 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -55.02 144.67 67.45 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.317 2.011 . . . . 0.0 112.088 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.6 t -101.65 9.02 41.45 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.573 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -111.14 -179.94 3.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.438 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' OG1' ' A' ' 18' ' ' THR . 33.7 ptt180 -139.24 167.18 22.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.358 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -116.17 146.7 42.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 21' ' ' ILE . 8.3 tt -130.26 122.4 53.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.36 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -99.42 121.5 41.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.922 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.17 115.0 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.165 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -154.54 117.8 4.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -134.11 138.65 45.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.958 0.409 . . . . 0.0 110.425 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 143.11 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.6 mt -139.78 -79.72 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 21.9 p-10 -156.94 -62.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.583 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.513 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -178.11 -68.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.453 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -62.02 -51.21 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -69.73 -20.77 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.352 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.89 -52.86 17.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 36' ' ' SER . 78.1 p -68.46 -41.54 80.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.634 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 30' ' ' THR . 70.5 t -63.08 -45.63 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.71 -42.63 99.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 78.3 p -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.74 -41.2 96.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.678 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.486 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -59.31 -24.15 63.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.634 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 38' ' ' ALA . 8.5 m -162.42 63.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.569 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.4 p -68.49 -18.77 64.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.519 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -174.45 139.43 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 156.15 46.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.086 0.469 . . . . 0.0 110.181 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -119.51 113.83 21.34 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.973 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.58 133.82 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.255 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.42 141.1 28.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.317 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 64.3 tttp -47.56 101.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.94 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD2' ' C ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER 163.38 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.712 0.632 . . . . 0.0 110.3 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.76 136.91 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 110.454 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -92.42 155.52 17.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.05 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -42.65 -37.73 1.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.22 -43.59 95.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.211 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -65.61 -35.36 80.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 57' ' ' VAL . 18.6 mt -61.53 -46.83 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.53 -41.58 98.46 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.452 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -43.14 99.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.93 -45.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-O 120.955 0.407 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 53' ' ' LEU . 54.6 t -58.04 -48.37 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.894 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.7 -53.67 47.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.98 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -49.86 -42.6 47.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.829 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.93 -49.66 74.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.942 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.59 -48.06 90.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.247 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' HA ' HD23 ' A' ' 65' ' ' LEU . 14.8 mm-40 -45.32 -53.39 8.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.398 0.618 . . . . 0.0 110.414 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 t -60.08 -43.44 95.48 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.5 p -86.04 14.34 6.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.118 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.73 -24.01 23.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 110.212 179.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.479 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -41.33 -49.96 8.82 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.582 -178.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 66' ' ' SER . 50.2 Cg_exo -53.04 -39.75 78.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.149 1.899 . . . . 0.0 112.218 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.8 m -68.02 -34.28 76.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.597 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -60.92 -30.45 70.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.517 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.62 -33.64 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.475 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 75' ' ' GLY . 97.8 m-70 -97.05 118.49 33.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.238 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.0 p-10 -68.5 -35.38 77.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 78.1 t -61.57 -47.85 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 76' ' ' THR . 58.6 mt -88.42 -34.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.391 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -39.89 -21.75 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' ILE . 46.2 p -54.76 -29.73 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.103 0.478 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -32.89 66.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 65' ' ' LEU . 91.7 t -62.09 -46.17 97.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.43 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 94.2 m -63.66 -39.13 93.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.8 -43.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.82 -41.45 99.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.4 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.58 -41.9 99.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.566 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 87' ' ' GLY . 40.0 t0 -62.19 -43.11 99.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -69.5 -37.61 77.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.518 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.61 -43.11 99.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.464 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.68 -12.15 22.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.556 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -119.78 57.17 0.57 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 63.51 98.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.086 0.469 . . . . 0.0 110.504 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -55.29 -100.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.12 162.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.157 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -116.29 139.77 50.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.861 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.87 132.58 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -140.98 154.78 46.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.644 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -85.13 -162.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.564 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -73.01 51.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.566 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.43 -90.15 0.08 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.5 -29.07 0.02 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.31 139.93 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -80.96 90.24 5.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -146.61 138.52 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.516 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.749 ' N ' HD12 ' A' ' 101' ' ' ILE . 2.5 mp -71.47 131.66 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -145.8 172.56 5.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.631 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 53.3 Cg_exo -51.17 -36.29 55.18 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.559 2.173 . . . . 0.0 112.162 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -132.73 103.09 5.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -122.55 148.42 45.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.214 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -101.79 119.9 39.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.06 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.32 112.97 20.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.476 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 t -177.34 168.77 2.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.847 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 -45.48 93.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.6 p -59.14 147.06 36.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.281 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -87.53 170.07 12.75 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.457 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 54.8 Cg_exo -50.15 -43.97 40.22 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.414 2.076 . . . . 0.0 111.931 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 31.5 p-10 -90.07 -37.84 13.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.97 0.415 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 61.2 t0 . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.545 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 4' ' ' VAL . 46.5 mttp -65.26 -76.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? 65.87 -7.82 0.35 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.594 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' A' ' 2' ' ' LYS . 19.6 m -86.93 -163.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.01 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -109.95 150.99 27.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.04 0.448 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -156.42 81.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.488 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -149.13 85.11 1.46 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.831 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.05 176.83 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.098 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.58 153.38 39.23 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.557 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 12' ' ' VAL . 47.1 Cg_endo -67.94 -93.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.676 2.251 . . . . 0.0 111.991 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ARG . 65.0 tttm 41.92 -88.46 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.716 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 10' ' ' PRO . 16.1 m -71.21 21.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.532 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' LYS . 61.1 ttp180 -155.54 156.71 35.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.453 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.03 139.81 58.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 110.499 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.596 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -74.86 160.47 80.68 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.44 -178.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.55 142.33 60.19 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.129 1.886 . . . . 0.0 112.184 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m -78.6 4.52 13.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.453 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 2.3 t -162.09 153.73 18.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.523 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 44' ' ' VAL . 84.8 mtp180 -105.26 140.95 37.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.957 0.408 . . . . 0.0 110.292 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -105.53 148.6 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.133 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.2 tp -127.69 135.12 63.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.307 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -137.8 -35.23 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.817 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.3 140.52 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.263 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -155.26 144.76 21.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.35 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.39 137.84 55.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 116.11 22.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.584 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.418 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 54.1 mt -62.06 -42.86 99.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.456 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 61.8 m-20 -158.77 20.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 28' ' ' ASP . . . 73.81 -51.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m -61.36 -53.53 55.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.285 0.565 . . . . 0.0 110.696 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -71.24 -27.33 63.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.922 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.89 -44.51 97.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.255 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.0 p -70.35 -42.21 72.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.29 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.7 -48.88 86.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.383 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.37 -40.73 96.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.498 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 40' ' ' SER . 75.1 m -56.3 -43.38 78.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.09 89.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.502 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.34 2.7 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.861 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.518 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 18.2 p -174.45 54.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.108 0.48 . . . . 0.0 110.286 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 36' ' ' SER . 78.0 p -60.11 -36.97 78.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.754 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -136.59 125.67 24.47 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.453 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -129.82 131.63 46.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.48 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -91.48 126.67 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.15 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 19' ' ' ARG . 47.1 t -122.48 126.19 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.115 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -48.84 160.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 22.6 pttm -59.72 -50.03 75.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.036 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 49.9 t0 -91.63 90.36 7.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -147.71 128.23 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.275 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -90.48 151.67 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.228 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -48.69 -32.86 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.375 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -51.11 71.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.289 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 56' ' ' VAL . 82.4 tt0 -64.66 -41.71 95.92 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.71 HD13 ' C ' ' A' ' 53' ' ' LEU . 2.8 tm? -61.78 -50.72 71.22 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.599 HD11 ' NH2' ' A' ' 84' ' ' ARG . 60.8 tp -50.73 -41.72 56.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.14 -35.8 71.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 52' ' ' GLU . 44.4 t -69.7 -51.78 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 58' ' ' LEU . 14.8 p -61.39 -42.7 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.908 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.521 ' N ' HG13 ' A' ' 57' ' ' VAL . 57.4 tp -60.45 -54.5 44.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.28 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -53.89 -41.72 67.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.88 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.31 -46.66 82.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.543 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.84 -43.71 97.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.437 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.564 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -62.63 -44.08 97.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.822 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.2 p -68.53 -64.81 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.725 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.41 83.35 2.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.569 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -74.87 -45.73 5.06 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.322 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.8 Cg_endo -83.25 114.32 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.599 2.2 . . . . 0.0 111.987 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.76 -19.39 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.0 -9.84 48.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.759 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.55 -38.5 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.472 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.1 m-70 -103.16 124.58 48.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.3 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.6 p-10 -60.58 -34.98 74.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.353 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.513 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 82.9 t -62.32 -47.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 45.9 mt -82.45 -23.37 9.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -34.91 -61.01 0.64 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -40.05 -24.38 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.95 0.405 . . . . 0.0 110.784 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 66.0 tttm -58.67 -45.39 89.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.213 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.1 t -57.4 -44.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.37 -46.52 88.3 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.73 -38.5 91.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.242 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.39 -42.7 99.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -62.35 -45.92 91.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 0.0 110.09 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.93 -45.48 94.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.599 ' NH2' HD11 ' A' ' 54' ' ' LEU . 83.1 mtp180 -66.08 -39.43 90.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.076 0.465 . . . . 0.0 110.751 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.88 -29.25 69.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.44 59.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.498 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 168.62 -65.35 0.18 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 89' ' ' TYR . 28.0 t70 -173.89 176.0 2.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.548 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.545 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 t80 -175.18 -68.53 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.3 m -66.1 133.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.308 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 65.4 m-85 -116.87 145.89 43.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.617 HD23 ' C ' ' A' ' 92' ' ' LEU . 7.7 tt -117.02 125.73 51.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.509 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.57 ' N ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -126.37 152.26 46.54 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.284 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 46.6 t0 -74.52 179.16 4.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.165 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 80.5 mm-40 -65.68 -37.54 86.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.66 -3.47 87.0 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.61 78.97 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.1 t0 -88.5 111.08 21.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -50.62 87.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.306 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 76.0 t -152.87 130.8 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.521 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.59 134.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.031 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -155.59 171.82 6.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.579 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 58.0 Cg_exo -50.83 -38.07 56.53 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.414 2.076 . . . . 0.0 111.993 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -130.86 131.79 44.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.315 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.533 ' HB2' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -153.4 173.87 15.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.02 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -117.98 109.73 16.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.343 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.8 t -107.55 115.74 30.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.534 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 t -172.59 177.34 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.527 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -89.72 40.85 1.01 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.617 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.2 m -136.91 116.1 12.54 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.449 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.609 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -61.96 170.38 2.08 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.541 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 49.0 Cg_exo -54.45 -43.13 61.66 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.428 2.085 . . . . 0.0 112.267 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -93.79 12.73 24.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.583 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.529 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -69.31 141.03 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.996 0.427 . . . . 0.0 110.209 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -114.48 -12.89 12.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.721 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 5' ' ' GLU . 35.9 m -114.94 -14.34 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.784 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 4' ' ' VAL . 48.0 mp0 43.53 98.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -82.68 138.28 34.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.943 0.401 . . . . 0.0 110.39 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -95.54 13.98 24.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.335 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 50.14 -171.02 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.284 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 pttm -109.31 118.64 50.46 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.563 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.25 65.19 7.93 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.412 2.075 . . . . 0.0 112.151 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -102.85 62.63 0.82 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.931 0.396 . . . . 0.0 110.281 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -168.29 -26.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -146.9 152.25 38.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.574 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -67.64 137.42 55.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.268 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -44.63 157.14 0.32 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.537 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -42.22 129.53 4.57 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.396 2.064 . . . . 0.0 112.031 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 95.6 p -88.29 -4.55 58.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.581 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 p -86.08 167.09 15.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.979 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' VAL . 62.6 ttp180 -110.53 151.83 27.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -112.42 144.96 40.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.069 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tp -119.32 142.8 32.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -130.74 -15.21 3.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.37 126.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 110.567 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 m -138.13 137.61 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.384 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.8 131.25 50.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.213 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.77 137.1 43.09 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.552 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.9 mm? -63.89 -41.42 97.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -159.59 179.07 9.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.83 83.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.499 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -63.2 -50.85 68.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.513 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -70.31 -22.69 62.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.65 -52.65 50.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 0.0 110.346 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -67.87 -44.6 76.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.34 -46.45 95.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.27 -43.55 97.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.592 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.3 t -60.58 -42.74 97.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -63.61 -44.47 93.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.549 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.17 -78.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.487 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 31.6 t -87.14 64.34 8.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.5 t -62.33 -41.28 98.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -154.28 148.11 25.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 81.8 t80 -150.28 150.12 31.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.495 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 16.7 pt-20 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.238 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 19' ' ' ARG . 65.4 t -127.89 133.27 67.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.116 0.484 . . . . 0.0 110.472 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 48' ' ' VAL . 91.5 m-20 -81.2 170.08 16.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.228 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.81 152.23 20.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.086 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.12 41.55 10.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.587 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.625 HG12 ' N ' ' A' ' 49' ' ' THR . 62.7 t -89.22 166.85 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.625 ' N ' HG12 ' A' ' 48' ' ' VAL . 31.0 m -121.71 129.33 52.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.26 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -37.61 -27.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.697 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 49' ' ' THR . 64.2 t0 -60.03 -46.92 87.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.055 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 80.7 mm-40 -64.88 -41.95 95.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.367 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.469 ' O ' HG12 ' A' ' 57' ' ' VAL . 51.2 tp -62.59 -41.36 98.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.213 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.556 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.83 -44.61 95.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.754 0.788 . . . . 0.0 110.367 -178.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.36 -42.49 68.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.543 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' GLU . 56.0 t -66.72 -51.27 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.071 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.549 HG13 ' N ' ' A' ' 58' ' ' LEU . 9.3 p -58.17 -43.93 86.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' N ' HG13 ' A' ' 57' ' ' VAL . 58.1 tp -60.06 -52.22 66.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.257 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.79 -31.53 71.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.16 -54.42 41.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.17 -38.58 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.722 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.5 -44.77 81.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.2 p -62.1 -44.8 95.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.434 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.418 ' C ' HD12 ' A' ' 65' ' ' LEU . 22.0 p -61.17 -49.21 78.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 65' ' ' LEU . 10.8 mp -101.35 109.49 21.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.254 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.43 -48.11 3.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.5 Cg_endo -80.69 138.04 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.637 2.224 . . . . 0.0 111.881 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.8 m -130.99 -77.79 0.53 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.586 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.2 -5.73 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.466 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -72.36 0.96 8.71 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.342 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -130.26 102.92 6.42 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.269 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -66.17 -39.54 89.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.597 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.01 -47.58 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.731 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 75' ' ' GLY . 97.2 mt -67.42 -56.04 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.911 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . 31.95 -155.93 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m 71.84 -50.62 0.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 110.377 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -63.68 -25.29 68.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.338 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.32 -50.33 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.6 m -69.37 -37.65 77.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.44 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.66 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.955 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.19 -47.26 85.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.876 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.03 -40.29 96.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.12 0.486 . . . . 0.0 110.437 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -61.43 -46.27 90.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.713 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -43.22 97.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.256 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.33 -24.35 64.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.498 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.12 32.87 2.28 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 89' ' ' TYR . 97.7 m-20 -78.69 -53.5 7.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 48.5 p90 42.61 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.653 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.8 m -142.08 168.13 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.158 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.4 137.76 38.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.046 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 92' ' ' LEU . 2.5 pp -134.57 139.96 45.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.625 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -151.94 164.11 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.819 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 96' ' ' GLY . 52.4 p-10 -76.58 178.0 7.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.277 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.38 26.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -118.7 -70.07 0.35 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.79 -24.91 0.23 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.97 123.21 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.27 92.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.478 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.94 135.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.655 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.51 132.8 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.339 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -161.27 172.0 6.26 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.663 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 52.2 Cg_exo -52.19 -42.97 56.55 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.592 2.195 . . . . 0.0 111.785 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.72 78.24 1.33 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.062 0.458 . . . . 0.0 110.038 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -106.08 134.46 49.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.405 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -104.47 97.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 108' ' ' SER . 11.9 t -95.38 124.32 39.35 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.511 0.507 . . . . 0.0 110.597 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 107' ' ' CYS . 69.1 m -168.95 170.21 9.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.56 48.53 1.53 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.97 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 t -140.61 168.58 19.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.115 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -100.98 170.38 6.63 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.3 Cg_exo -51.75 -39.3 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.586 2.191 . . . . 0.0 111.837 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -81.47 40.35 0.57 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.982 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 3' ' ' LYS . 9.8 tptp -76.71 165.62 24.5 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.346 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 99.2 mttt -133.28 -32.92 1.15 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.621 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.03 -172.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.196 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -116.5 136.97 52.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.264 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -104.07 -173.68 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.089 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -130.67 130.04 43.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.09 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -81.26 83.79 6.77 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.106 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -135.27 146.53 58.45 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.84 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.5 129.73 13.97 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.207 1.938 . . . . 0.0 112.142 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -61.14 -61.2 2.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.537 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 12' ' ' VAL . 16.7 m -82.84 -129.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.337 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' VAL . 39.0 ptt180 -51.95 -172.02 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.247 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -112.7 125.37 54.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.143 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 pt -109.45 156.84 38.82 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -61.18 152.37 72.39 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.524 2.149 . . . . 0.0 112.291 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 m -72.01 -16.94 62.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.293 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.413 HG22 ' OD1' ' A' ' 45' ' ' ASP . 43.2 p -89.79 -174.51 4.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.338 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.405 ' NH2' ' NZ ' ' A' ' 46' ' ' LYS . 43.2 ttm180 -127.95 149.23 50.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.229 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.08 135.61 46.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.13 138.5 37.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' C ' HD12 ' A' ' 23' ' ' ILE . 77.0 tttt -95.24 115.35 27.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.768 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.781 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.8 mp -94.57 108.64 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.458 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -137.08 102.02 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.507 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -161.06 107.17 1.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.16 151.15 49.45 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.168 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.2 28.09 8.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 33.8 t0 -146.03 -143.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.307 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.499 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -131.52 -64.66 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.525 HG23 ' N ' ' A' ' 31' ' ' PHE . 14.7 t -58.03 -42.76 86.02 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.393 0.616 . . . . 0.0 110.399 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.525 ' N ' HG23 ' A' ' 30' ' ' THR . 52.2 t80 -68.16 -22.98 64.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.507 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -76.3 -44.42 37.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.993 0.425 . . . . 0.0 111.135 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -63.27 -45.73 90.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.843 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 35' ' ' LEU . 20.6 m -65.28 -40.19 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.398 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -61.72 -51.02 70.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.841 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -62.6 -45.34 93.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.04 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.02 -44.56 84.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.91 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 7.5 t -89.31 79.75 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.414 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -82.19 -9.04 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.321 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -172.7 127.97 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.135 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.29 139.84 45.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -119.52 115.89 24.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.267 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.36 156.15 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.768 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' OD1' HG22 ' A' ' 18' ' ' THR . 92.6 m-20 -87.57 171.69 10.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.207 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 48' ' ' VAL . 68.6 mttm -60.85 -59.49 5.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 46' ' ' LYS . 98.4 m-20 -34.09 -34.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' LYS . 21.3 t -59.55 133.13 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 p -106.72 147.42 29.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.241 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -38.88 -35.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.55 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.14 -51.83 67.91 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.114 0.483 . . . . 0.0 110.146 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.561 ' O ' HG22 ' A' ' 56' ' ' VAL . 85.1 tt0 -63.68 -34.92 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.046 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.47 ' O ' HG12 ' A' ' 57' ' ' VAL . 54.6 tp -62.68 -40.02 95.78 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.534 0.521 . . . . 0.0 110.442 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.265 0.555 . . . . 0.0 111.077 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -69.4 -46.68 66.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.669 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.644 HG23 ' N ' ' A' ' 57' ' ' VAL . 29.2 m -69.82 -49.72 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.644 ' N ' HG23 ' A' ' 56' ' ' VAL . 9.8 p -57.39 -45.61 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.569 ' N ' HG13 ' A' ' 57' ' ' VAL . 55.5 tp -60.94 -53.56 55.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.12 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -53.62 -39.79 65.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.59 -52.05 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.498 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.465 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 66.7 t -64.26 -47.31 90.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.47 -45.29 76.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.352 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.0 p -62.46 -45.61 92.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.714 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.8 m -53.31 -51.95 60.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.586 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.4 OUTLIER -108.29 68.43 0.7 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.366 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.56 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.94 -47.05 2.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.4 Cg_endo -81.08 85.07 1.86 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.569 2.179 . . . . 0.0 112.333 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.4 m -133.49 -10.04 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.591 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.09 -27.12 68.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.12 -36.75 69.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.579 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 75' ' ' GLY . 80.8 m80 -76.61 126.08 30.36 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.89 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.46 -43.98 92.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.53 -44.68 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.11 17.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.429 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -74.55 -62.13 2.96 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -57.12 -9.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.95 0.405 . . . . 0.0 110.064 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' GLY . 49.7 tptt -59.7 -51.77 68.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.626 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -57.61 -48.53 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 110.032 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.4 m -57.18 -34.57 68.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.103 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.94 93.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.493 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.04 -44.9 95.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.596 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.76 -44.64 92.83 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.41 -43.86 97.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.416 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mtt180 -67.92 -41.7 82.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.761 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.77 -20.75 66.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.425 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.52 -35.53 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.704 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -63.43 0.04 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' ARG . 67.5 t0 -79.15 119.54 22.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.652 0.263 . . . . 0.0 110.424 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -120.47 -100.25 0.43 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.741 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -144.3 141.92 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 110.501 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -93.54 132.68 37.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.966 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 92' ' ' LEU . 6.5 tt -120.8 121.68 38.69 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.534 ' N ' HD23 ' A' ' 92' ' ' LEU . 53.2 p90 -154.62 149.54 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.676 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.6 p30 -93.65 -176.56 4.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.522 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.59 42.56 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -139.96 -16.38 0.5 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.65 -7.78 78.06 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 100' ' ' VAL . 51.9 t0 -96.91 111.03 23.41 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 40.3 mp0 -53.66 88.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 98' ' ' ASP . 6.3 p -146.73 153.54 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.8 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 101' ' ' ILE . 2.0 mp -77.46 129.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 110.329 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.679 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.49 173.6 4.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.738 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.679 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 66.5 Cg_exo -50.49 -38.21 53.45 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.437 2.091 . . . . 0.0 111.807 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 102.56 12.63 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 109.863 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.6 mtp -103.19 137.55 41.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.49 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -138.03 104.09 5.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 28.2 p -111.53 110.62 21.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.463 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 m -158.87 165.62 33.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 95.9 m-85 -61.09 -30.25 70.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -63.56 152.67 38.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.262 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.41 170.62 5.29 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.0 Cg_exo -51.76 -40.9 64.69 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.63 2.22 . . . . 0.0 112.015 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 67.6 t0 -96.84 45.76 1.05 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.417 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.455 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' C ' ' H ' ' A' ' 4' ' ' VAL . 3.5 mmmm -85.38 -6.81 59.19 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 122.87 -0.194 . . . . 0.0 110.797 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 65.81 -35.6 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.659 0.599 . . . . 0.0 110.54 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 4' ' ' VAL . 11.9 p -103.36 12.95 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 121.031 0.443 . . . . 0.0 110.587 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 97.8 mt-10 49.94 -111.66 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.364 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 5' ' ' GLU . 96.5 m-85 -158.5 -102.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.592 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 8' ' ' ASP . 90.4 m-20 49.5 30.29 3.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.473 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 7' ' ' ASN . 99.6 m-20 37.17 -106.48 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.559 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 11' ' ' LYS . 6.6 ptmt -93.66 152.75 41.03 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.625 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -39.51 -18.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.83 2.353 . . . . 0.0 112.493 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 9' ' ' LYS . 73.7 tttt 71.14 -50.16 0.68 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.83 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 13' ' ' ARG . 33.7 m -63.93 -46.32 94.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.65 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.564 ' N ' HG23 ' A' ' 12' ' ' VAL . 88.1 mtm180 -144.4 154.97 43.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.563 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -59.26 145.67 42.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.508 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.8 pt -44.72 150.09 0.73 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.701 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.52 145.76 59.53 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.689 2.259 . . . . 0.0 112.331 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.4 p -68.86 -39.47 79.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.716 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -105.79 -175.69 2.87 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.297 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.594 ' N ' ' OG1' ' A' ' 18' ' ' THR . 15.0 ptm180 -105.84 143.39 34.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.179 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -107.84 146.56 32.1 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.749 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.23 48.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -137.33 -3.11 1.96 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.898 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.42 126.65 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.6 p -149.33 146.28 27.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -62.11 116.58 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.004 0.43 . . . . 0.0 110.171 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.68 112.49 15.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.4 mp -67.09 -42.52 84.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.525 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' ASP . 71.4 m-20 -151.82 151.11 30.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.53 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.95 -51.33 66.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.9 m -61.7 -49.03 78.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.726 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -64.96 -30.64 71.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' ASP . 64.8 t0 -64.43 -50.29 68.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.528 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 t -62.46 -44.61 96.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.542 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.3 -44.95 94.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.62 -45.16 94.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.71 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' SER . 44.1 t -61.74 -44.4 96.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.57 -35.48 80.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.672 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.97 87.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.784 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.4 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 62.7 m -123.95 -63.07 1.24 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.861 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.6 p 72.92 1.68 4.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.481 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -170.63 146.51 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.88 100.07 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' A' ' 19' ' ' ARG . 10.8 tp10 -77.42 117.81 19.26 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 18' ' ' THR . 75.9 t -127.24 132.43 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.002 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.54 172.28 0.51 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HZ2' ' C ' ' A' ' 18' ' ' THR . 60.1 mttp -89.38 19.97 4.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.563 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -148.08 54.69 1.04 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.425 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.58 144.08 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 110.536 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -96.41 146.56 24.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -43.18 -34.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.411 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -48.64 -47.46 40.37 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 56' ' ' VAL . 30.4 tp10 -64.07 -36.21 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.546 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 57' ' ' VAL . 39.9 tp -60.87 -43.92 97.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.325 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 89' ' ' TYR . 10.8 mp -62.35 -44.03 97.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.463 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.61 -34.41 75.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 52' ' ' GLU . 40.7 t -73.15 -51.57 25.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.626 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 53' ' ' LEU . 72.4 t -55.55 -45.93 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 58' ' ' LEU . 59.4 tp -61.69 -55.02 34.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.254 0.549 . . . . 0.0 110.293 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.41 -30.85 65.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.4 ' HB1' ' SG ' ' A' ' 39' ' ' CYS . . . -64.29 -55.45 21.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.345 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 62' ' ' GLU . 5.3 p -64.34 -40.51 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.844 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 61' ' ' VAL . 44.4 tt0 -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.9 t -62.63 -48.46 79.28 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.484 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.9 m -67.26 -71.96 0.18 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.8 tp -101.07 83.09 2.45 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -72.79 -46.04 9.06 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.4 Cg_endo -81.69 104.27 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.619 2.213 . . . . 0.0 111.888 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 2.8 m -133.59 -23.32 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -64.91 -30.69 71.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.396 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -72.0 -37.21 69.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 75' ' ' GLY . 72.2 m80 -78.67 115.74 18.56 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.495 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -60.37 -29.99 69.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.04 -45.57 98.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 74' ' ' ILE . 28.7 mt -106.91 -1.71 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 110.344 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -51.87 169.85 0.48 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 m 70.98 -22.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.474 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 75' ' ' GLY . 50.2 tptt -63.72 -45.81 88.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.22 -45.05 84.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.131 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 84.1 m -63.42 -41.17 98.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.73 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.48 95.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.15 -42.16 96.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.62 -42.93 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.728 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 87' ' ' GLY . 97.8 m-20 -64.15 -42.86 96.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mtt180 -70.36 -38.74 74.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -61.94 -44.51 96.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.671 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.13 -45.47 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -66.46 -74.31 0.55 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 84' ' ' ARG . 44.8 t0 -164.35 165.26 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.098 0.475 . . . . 0.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.435 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 27.3 p90 -132.78 146.4 51.81 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.901 0.381 . . . . 0.0 110.508 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.5 m -53.51 132.08 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.589 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -86.06 144.37 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.116 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tt -117.46 136.37 53.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.622 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 25.9 p90 -155.12 166.45 33.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.767 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 12.3 t70 -73.03 -156.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.531 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 98.5 mt-10 -66.86 -53.0 36.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.601 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.88 -98.15 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.33 22.54 0.18 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -89.22 113.7 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.806 0.336 . . . . 0.0 110.607 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 55.4 mp0 -73.33 89.45 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -164.65 142.65 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.777 ' H ' HD12 ' A' ' 101' ' ' ILE . 2.7 mp -59.11 131.79 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.019 0.437 . . . . 0.0 110.01 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -154.84 173.8 4.47 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.727 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 61.4 Cg_exo -49.29 -37.85 40.89 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.562 2.175 . . . . 0.0 112.172 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -92.26 121.61 33.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 110.087 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 87.5 mmm -104.12 139.58 39.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.49 96.78 1.07 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.5 t -111.16 118.86 37.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.545 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -164.94 171.45 14.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.697 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 110' ' ' SER . 92.0 m-85 -61.32 -44.67 96.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.287 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' PHE . 70.7 m -37.75 159.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -109.08 170.26 5.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.668 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 61.2 Cg_exo -48.54 -42.77 34.91 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.559 2.173 . . . . 0.0 112.158 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 37.1 p-10 -96.75 -32.42 12.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 66.8 t0 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 3' ' ' LYS . 6.1 tmtt? -70.16 119.8 14.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.028 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 2' ' ' LYS . 67.9 mttm -43.33 169.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.452 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 3' ' ' LYS . 33.2 m 36.21 -151.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 O-C-N 123.369 0.418 . . . . 0.0 110.481 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -140.32 139.59 35.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -51.71 140.77 18.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.284 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 60.71 83.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.612 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -117.68 35.76 4.57 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.489 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -132.63 158.91 74.48 Favored Pre-proline 0 N--CA 1.458 -0.061 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' VAL . 60.8 Cg_endo -74.18 -86.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.469 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 tttm 64.67 -70.85 0.08 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.314 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 10' ' ' PRO . 11.3 m -64.11 -35.65 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.297 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -76.44 163.16 27.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.555 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -56.35 141.3 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.222 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.73 86.48 24.21 Favored Pre-proline 0 N--CA 1.468 0.457 0 O-C-N 123.41 0.444 . . . . 0.0 110.231 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.55 144.54 84.44 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.728 2.285 . . . . 0.0 111.764 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.0 m -114.63 16.44 17.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.507 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -129.46 167.18 18.22 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.388 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -131.51 165.12 24.29 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -133.03 144.55 50.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.202 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.27 140.67 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 109.996 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.473 ' H ' HD12 ' A' ' 23' ' ' ILE . 74.3 tttt -135.82 26.9 3.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.579 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.816 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.2 mp -97.94 118.63 44.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 146.13 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -91.51 129.38 37.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.364 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.59 113.44 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -149.21 88.07 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.553 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.2 m-20 165.25 -20.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.593 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 28' ' ' ASP . . . 77.17 -71.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.532 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 34' ' ' VAL . 12.8 m -61.51 -50.03 74.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.372 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -72.63 -23.3 60.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.79 -51.15 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.369 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -65.25 -45.27 85.28 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.393 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 30' ' ' THR . 91.4 t -61.91 -45.47 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.367 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.58 -41.0 98.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -58.5 -42.44 87.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -79.96 -21.02 44.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.744 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.32 67.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 41' ' ' GLU . 5.9 t -163.44 -84.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.42 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 67.84 -8.99 0.49 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 -179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 8.7 tm-20 -146.97 135.51 21.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 64.1 t80 -142.12 146.82 35.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.535 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 56.0 mp0 -86.46 150.97 23.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.359 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.56 124.64 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' ASP . 1.3 m-20 -141.95 139.58 32.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.448 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 70.9 mmtt -50.94 85.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.421 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.6 m-20 173.81 -31.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.386 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 m -106.13 111.63 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 110.333 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 p -86.36 167.32 14.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -41.08 -35.06 0.51 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.531 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.36 -48.72 80.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.414 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.553 ' O ' HG22 ' A' ' 56' ' ' VAL . 56.3 mp0 -65.2 -34.4 78.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 53' ' ' LEU . 1.3 tt -60.79 -40.76 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.148 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.17 -35.88 71.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.542 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.56 -46.17 60.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.625 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.637 HG23 ' N ' ' A' ' 57' ' ' VAL . 28.2 m -68.63 -49.41 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.188 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.637 ' N ' HG23 ' A' ' 56' ' ' VAL . 8.2 p -59.67 -46.6 93.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.214 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' N ' HG13 ' A' ' 57' ' ' VAL . 52.3 tp -63.28 -57.21 11.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.358 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -51.61 -38.42 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.692 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.1 79.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.61 -46.29 96.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -62.56 -40.06 95.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.297 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.0 t -59.86 -50.28 74.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.548 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.6 p -59.13 -65.75 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.35 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -107.95 80.68 1.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.847 0.356 . . . . 0.0 110.421 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.65 -45.84 12.7 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.426 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.7 Cg_endo -83.81 84.67 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.761 2.307 . . . . 0.0 111.875 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.4 m -87.03 -17.82 32.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.86 -5.44 16.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -72.37 -38.54 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' GLY . 58.2 m-70 -110.13 126.54 54.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.47 -38.74 91.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.72 -48.15 88.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' ' C ' ' A' ' 75' ' ' GLY . 68.5 mt -80.49 -31.04 12.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.163 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 78' ' ' VAL . . . -34.65 -57.47 0.75 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 m -39.43 -28.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.433 0.635 . . . . 0.0 110.945 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 75' ' ' GLY . 27.9 tptp -60.92 -40.27 92.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 75' ' ' GLY . 2.9 p -56.03 -39.61 58.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.433 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 1.2 t -66.26 -48.7 69.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.23 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.41 87.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.282 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.86 -45.48 93.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.45 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -61.82 -43.17 99.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.43 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.49 -42.76 78.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.056 0.455 . . . . 0.0 110.71 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.49 -20.29 64.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.455 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.42 82.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.561 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.34 -54.23 0.09 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.23 117.97 12.46 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.459 ' O ' ' CE1' ' A' ' 91' ' ' TYR . 37.0 p90 -123.53 141.96 51.49 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 110.558 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 90' ' ' VAL . 4.5 t -50.89 125.14 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.18 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 3.4 m-85 -82.55 153.89 25.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.285 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.41 130.37 47.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.563 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.87 155.81 42.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 42.6 t0 -73.17 -178.62 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.365 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.484 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 24.8 tp10 -74.67 38.45 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.491 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.49 -59.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.63 0.24 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.63 140.69 58.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.625 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.84 88.44 4.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.55 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.3 t -150.07 134.16 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.741 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 86.7 mt -70.7 132.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.314 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.8 170.81 7.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 60.0 Cg_exo -49.51 -38.82 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.403 2.069 . . . . 0.0 112.305 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -125.16 126.54 45.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -150.81 166.14 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.212 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -113.12 118.54 35.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.431 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.514 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 14.9 p -105.12 122.78 46.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.71 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.0 t -171.98 166.85 6.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.674 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.431 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 48.9 p90 -73.44 -26.12 60.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.532 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.8 p -95.27 169.82 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.472 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -98.83 162.26 22.19 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.266 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 40.6 Cg_endo -67.63 -21.59 45.37 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.701 2.267 . . . . 0.0 112.057 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -149.28 65.44 1.02 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.422 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.853 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -69.74 134.77 48.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.99 0.424 . . . . 0.0 110.85 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -103.0 -28.41 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.501 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.58 -42.26 87.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.468 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.52 ' O ' ' C ' ' A' ' 6' ' ' PHE . 98.2 mt-10 58.62 67.8 0.89 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.255 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.52 ' C ' ' O ' ' A' ' 5' ' ' GLU . 74.2 m-85 -19.0 109.46 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.23 0.956 . . . . 0.0 110.702 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -38.46 -50.45 1.53 Allowed 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 123.397 0.435 . . . . 0.0 110.514 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -55.84 118.46 4.61 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.167 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -65.72 144.29 98.83 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.976 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.24 145.18 48.14 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.687 2.258 . . . . 0.0 112.306 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 13' ' ' ARG . 59.3 mttp -94.18 -50.78 5.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.25 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 12' ' ' VAL . 8.4 p -73.13 43.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.045 0.45 . . . . 0.0 110.634 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 11' ' ' LYS . 35.7 ttm180 -157.48 158.17 35.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.436 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -71.43 134.2 46.45 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.012 0.434 . . . . 0.0 110.617 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 pt -82.23 156.46 69.06 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.647 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -44.29 162.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.437 2.091 . . . . 0.0 112.314 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.7 t -63.1 -7.86 6.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.663 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 p -107.17 168.43 9.22 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.332 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -105.04 165.18 11.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.117 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -130.95 135.33 47.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.65 133.01 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -119.57 22.13 11.79 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.779 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 mp -84.93 136.87 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.481 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -135.86 132.47 36.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.347 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 107' ' ' CYS . 73.6 t80 -109.83 114.7 28.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.209 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.83 147.75 48.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.469 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.0 mt -97.95 -63.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 8.6 t70 -84.68 173.71 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.63 -36.7 84.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 34' ' ' VAL . 1.2 p -61.99 -54.4 42.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.683 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.449 ' N ' ' OG1' ' A' ' 30' ' ' THR . 67.0 m-85 -60.25 -20.03 57.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.544 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -76.58 -49.04 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.5 p -73.47 -35.14 65.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 30' ' ' THR . 85.1 t -64.41 -51.81 63.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.58 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.55 -41.93 83.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.749 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -61.52 -45.43 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.853 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.84 -45.87 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.979 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 40' ' ' SER . . . -73.66 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 14.5 p -71.33 45.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.592 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 38' ' ' ALA . 4.4 p -59.13 -28.62 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.372 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.78 140.24 19.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.12 137.75 41.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.55 120.07 30.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.266 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.3 m -144.3 162.46 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.369 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -89.79 170.41 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.628 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -78.65 39.22 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 66.1 t0 -118.22 -25.95 6.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.532 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 48' ' ' VAL . 3.8 m -79.03 128.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 0.0 110.709 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.9 p -85.0 158.38 20.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.386 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -46.98 -38.46 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.243 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.12 -46.75 89.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 56' ' ' VAL . 95.6 mt-10 -68.29 -35.16 77.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.312 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 57' ' ' VAL . 58.7 tp -63.46 -43.83 96.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -39.32 87.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 0.0 110.511 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -71.43 -43.55 66.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.775 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 52' ' ' GLU . 55.2 t -67.16 -51.48 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.058 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.0 p -58.57 -44.71 89.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' HG13 ' A' ' 57' ' ' VAL . 47.5 tp -61.33 -55.6 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.287 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.42 -33.61 65.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.866 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.92 -51.1 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.76 -43.19 93.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -62.75 -46.87 86.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.621 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.1 t -60.2 -49.28 78.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.604 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -58.84 -45.79 89.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.183 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.41 76.47 1.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.991 0.424 . . . . 0.0 110.407 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.59 -43.68 11.95 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.099 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 66' ' ' SER . 37.7 Cg_exo -60.21 110.18 0.74 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.404 2.069 . . . . 0.0 111.835 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 66' ' ' SER . 3.4 m -133.9 -58.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.552 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -68.5 -9.38 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.58 -42.84 61.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.421 ' O ' ' N ' ' A' ' 75' ' ' GLY . 4.5 t-80 -106.36 134.53 49.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -61.73 -35.54 78.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.545 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.25 -48.0 89.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.449 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 77' ' ' LYS . 57.4 mt -82.54 -27.01 8.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.933 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -34.05 -59.02 0.62 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -42.7 -23.76 0.05 OUTLIER 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.289 0.566 . . . . 0.0 110.947 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 74' ' ' ILE . 88.7 tttt -58.99 -42.78 90.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.111 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 75' ' ' GLY . 5.2 p -54.75 -37.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.439 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.404 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 77.8 m -70.08 -50.17 43.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.31 84.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.98 -42.51 99.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 tt -60.44 -44.82 95.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -62.42 -43.78 98.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.472 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.77 -42.72 90.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.643 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.482 ' O ' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -76.69 -11.99 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.53 -37.28 77.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.97 -34.46 0.56 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.04 115.31 24.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.425 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -132.88 146.35 51.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.407 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.6 m -50.51 148.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.068 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.97 164.23 12.62 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.311 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 tt -131.55 128.65 39.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.88 151.73 41.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -77.6 -159.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -72.02 51.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.75 -118.56 0.66 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.29 4.53 2.3 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -90.04 116.38 28.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.748 0.309 . . . . 0.0 110.39 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.31 89.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -135.69 133.4 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.45 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -71.64 127.93 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.03 0.443 . . . . 0.0 109.894 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.65 152.46 16.56 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.633 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.29 -39.86 27.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.31 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 65.1 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.278 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -103.53 135.96 44.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.184 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.467 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 48.1 t80 -99.89 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.118 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.531 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 4.3 t -113.3 115.43 28.14 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.548 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.467 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 7.2 p -173.53 169.5 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -70.06 -24.42 63.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 m -67.13 143.18 56.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -100.36 170.5 6.58 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.3 Cg_exo -51.96 -40.31 67.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.604 2.203 . . . . 0.0 111.855 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -82.63 45.2 0.96 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.19 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.694 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 3' ' ' LYS . 23.0 ttpt -81.56 120.79 25.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 118.929 -0.557 . . . . 0.0 110.069 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.556 ' C ' ' O ' ' A' ' 2' ' ' LYS . 64.4 tttm -8.39 -81.95 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.341 1.026 . . . . 0.0 111.227 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 2' ' ' LYS . 26.9 m -37.87 134.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 121.222 0.534 . . . . 0.0 110.929 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.552 ' C ' ' H ' ' A' ' 7' ' ' ASN . 12.9 pt-20 -80.23 -13.86 58.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.922 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 66.96 -14.11 0.18 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.669 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 5' ' ' GLU . 41.3 t-20 63.21 41.97 7.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.693 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 9' ' ' LYS . 94.5 m-20 -86.6 -1.83 57.99 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.357 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 10' ' ' PRO . 48.3 tttp -37.5 128.4 0.87 Allowed Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.751 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 9' ' ' LYS . 67.4 Cg_exo -46.9 -172.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.567 2.178 . . . . 0.0 112.132 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.08 -129.23 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.479 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.5 HG13 ' N ' ' A' ' 13' ' ' ARG . 8.6 p -68.63 -41.75 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.5 ' N ' HG13 ' A' ' 12' ' ' VAL . 42.9 ttm180 -83.78 145.55 28.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.344 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -95.42 149.99 20.78 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.446 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.5 mt -42.89 106.52 0.48 Allowed Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.48 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.6 147.16 40.31 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.532 2.154 . . . . 0.0 112.035 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -79.07 -7.93 58.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.564 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 p -85.54 164.47 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -125.9 176.97 6.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.354 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -135.83 139.73 43.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.237 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.09 136.3 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.56 -7.36 6.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.552 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -118.34 128.02 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.7 p -132.47 146.6 52.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.536 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.26 132.89 55.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.169 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.6 141.34 48.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.2 mp -64.56 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -148.92 168.83 22.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.637 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.05 81.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.417 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 m -59.61 -46.83 87.8 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.084 0.469 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -67.64 -28.56 67.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.483 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -64.91 -48.36 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -62.61 -44.89 95.16 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.492 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.68 -45.82 90.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.685 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.98 -44.62 95.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.609 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 m -60.05 -44.71 94.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.327 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.12 -35.84 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.521 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.73 -75.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 40' ' ' SER . 25.4 p -52.59 -43.91 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.789 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 1.4 m 67.73 -63.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.557 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.83 154.55 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.668 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -144.11 148.76 35.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.83 162.21 27.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.63 135.25 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.61 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.12 166.22 17.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.22 -61.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -88.89 84.23 6.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 110.374 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.52 136.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.312 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.561 ' O ' ' N ' ' A' ' 51' ' ' ASP . 20.5 p -108.22 154.27 22.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.406 0.622 . . . . 0.0 109.719 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.047 ' H ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -44.13 -12.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.254 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.651 ' N ' HD22 ' A' ' 50' ' ' LEU . 87.0 m-20 -68.16 -53.4 25.32 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.268 0.556 . . . . 0.0 110.349 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 56' ' ' VAL . 83.2 mt-10 -65.16 -38.99 92.31 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.328 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 57' ' ' VAL . 32.0 mt -61.6 -39.9 92.88 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.031 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.494 HD22 ' CD2' ' A' ' 89' ' ' TYR . 6.6 tp -61.07 -45.12 96.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.158 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -71.49 -34.24 69.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.146 0.498 . . . . 0.0 110.744 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 52' ' ' GLU . 49.6 t -72.38 -53.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.996 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 58' ' ' LEU . 9.6 p -60.59 -43.92 95.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.799 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.538 ' N ' HG13 ' A' ' 57' ' ' VAL . 46.6 tp -60.21 -56.48 20.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.137 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.16 -41.13 62.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.54 82.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.508 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.6 t -63.41 -45.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.549 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.06 -44.17 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.367 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.4 p -61.66 -42.74 99.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.0 m -67.89 -71.14 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.38 88.21 3.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.382 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.524 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.57 -47.87 2.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 66' ' ' SER . 66.9 Cg_endo -80.52 68.5 8.3 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.68 2.254 . . . . 0.0 112.134 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.53 -32.16 47.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.35 -5.77 15.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -72.27 -38.66 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 75' ' ' GLY . 39.0 m80 -103.71 120.81 41.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.219 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 28.4 p-10 -58.32 -42.38 86.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.712 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.693 HG13 HG12 ' A' ' 74' ' ' ILE . 3.8 p -55.09 -29.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.409 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.693 HG12 HG13 ' A' ' 73' ' ' VAL . 49.2 mm -108.49 -12.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -38.35 -62.92 1.03 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.2 p -37.04 -25.06 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.124 0.487 . . . . 0.0 111.006 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' GLY . 63.4 tttm -58.03 -42.71 85.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.139 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 79' ' ' CYS . 5.6 p -56.43 -42.49 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.455 . . . . 0.0 110.314 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.479 ' N ' HG13 ' A' ' 78' ' ' VAL . 87.7 m -62.95 -48.55 78.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.162 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.37 82.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 58' ' ' LEU . 56.5 tp -53.16 -42.34 66.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 82' ' ' LEU . 3.0 tt -60.76 -46.47 90.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.062 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -63.52 -45.49 90.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.52 ' CD2' HD21 ' A' ' 58' ' ' LEU . 3.7 mm? -67.52 -25.55 65.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.773 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.78 -44.23 90.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.364 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.34 -39.11 0.67 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.77 127.14 33.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.265 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 90' ' ' VAL . 2.0 p90 -131.73 -127.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.629 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.599 ' O ' ' CD2' ' A' ' 89' ' ' TYR . 29.1 m -134.44 165.03 32.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 121.097 0.475 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -114.01 144.76 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.677 HD23 ' C ' ' A' ' 92' ' ' LEU . 1.3 tt -131.13 143.18 50.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.989 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.27 163.25 38.76 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.666 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 96' ' ' GLY . 47.4 p30 -74.5 175.9 7.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.529 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.09 26.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -133.66 -70.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.98 -36.04 0.1 OUTLIER Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.71 140.51 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.78 0.324 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 56.4 mp0 -86.66 88.4 7.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.472 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.79 130.64 26.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.48 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.9 mm -61.96 131.74 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.08 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -149.41 170.56 7.47 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.633 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.674 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 50.6 Cg_exo -51.2 -40.14 60.94 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.517 2.144 . . . . 0.0 112.161 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 97.31 5.85 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.573 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -119.41 170.7 8.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.483 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 76.5 t80 -139.68 122.33 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.084 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.536 ' HB2' HD12 ' A' ' 92' ' ' LEU . 12.5 t -122.83 127.53 49.19 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.752 0.657 . . . . 0.0 110.491 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.483 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 84.1 p -172.78 -174.88 1.18 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' ' CG1' ' A' ' 90' ' ' VAL . 86.0 m-85 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.136 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -146.95 172.12 14.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.0 169.98 6.03 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.406 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 63.1 Cg_exo -49.41 -38.28 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.445 2.096 . . . . 0.0 112.054 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 49.2 p-10 -65.6 -30.65 71.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.981 0.419 . . . . 0.0 110.802 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 95.8 m-20 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.53 -99.38 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.687 0.28 . . . . 0.0 110.498 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 4' ' ' VAL . 25.8 tttm -173.65 179.89 1.96 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 3' ' ' LYS . 29.0 m 29.52 -139.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 123.864 0.728 . . . . 0.0 110.429 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -137.92 -13.43 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 110.571 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 72.13 61.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.528 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 64.81 101.02 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.66 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -72.97 144.66 47.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.691 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 10' ' ' PRO . 14.2 ttmm -42.38 118.1 2.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.71 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' LYS . 78.3 Cg_exo -45.36 -179.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.36 2.04 . . . . 0.0 112.591 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -170.38 -87.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.261 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.61 44.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.893 0.378 . . . . 0.0 110.272 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -127.43 165.68 19.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.419 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -62.56 131.18 48.24 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.199 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.563 ' H ' ' CD1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -75.89 157.91 83.14 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.437 -179.15 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -44.04 155.34 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.263 1.975 . . . . 0.0 112.434 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.6 p -64.46 -17.62 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.455 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.8 p -87.06 165.8 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.051 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.593 ' HE ' ' NZ ' ' A' ' 46' ' ' LYS . 43.9 ttm180 -107.7 145.38 33.5 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.297 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.39 137.18 39.16 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.333 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 42' ' ' PHE . 10.9 tp -102.92 142.84 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.309 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -138.88 111.41 7.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.83 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.5 mp -99.76 125.42 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.396 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.06 96.54 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.558 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -151.16 133.97 15.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.203 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 27' ' ' LEU . . . -59.34 109.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -128.06 -67.21 0.82 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.368 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 27' ' ' LEU . 75.5 m-20 -150.88 163.66 38.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.426 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 -62.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.2 m -60.64 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.522 ' CE2' HD11 ' A' ' 35' ' ' LEU . 37.1 t80 -42.78 -44.52 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 110.391 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -61.98 -48.05 82.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.158 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.647 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.45 -45.12 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.176 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 31' ' ' PHE . 84.2 mt -63.04 -42.94 99.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.6 m -61.88 -40.44 95.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.08 -16.14 41.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.459 ' C ' ' SG ' ' A' ' 39' ' ' CYS . . . -93.61 23.62 4.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.611 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 38' ' ' ALA . 2.6 m 75.39 101.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.796 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.45 -34.77 78.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.76 131.22 55.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.684 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.697 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -145.19 124.66 13.13 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.46 0.648 . . . . 0.0 110.901 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.649 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -63.77 135.84 56.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.504 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.1 134.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 0.0 110.58 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.71 164.9 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.3 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.593 ' NZ ' ' HE ' ' A' ' 19' ' ' ARG . 65.2 mttm -94.11 -11.45 30.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.74 11.83 18.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.88 153.02 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.11 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.435 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 57.2 p -99.25 -160.19 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 50' ' ' LEU . 1.9 pt? -63.11 -15.81 57.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 22.0 p-10 -59.99 -52.82 63.76 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.348 0.594 . . . . 0.0 110.589 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -64.03 -40.16 95.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.081 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.43 -45.78 92.86 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.109 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 54' ' ' LEU . 1.8 tt -56.39 -43.72 79.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.34 -49.01 78.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.903 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.31 -43.4 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.383 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 61' ' ' VAL . 76.0 t -63.77 -46.97 93.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.509 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.09 -41.22 99.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.357 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.91 -44.21 94.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.278 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 64' ' ' THR . . . -64.43 -37.15 86.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 57' ' ' VAL . 55.5 t -63.37 -44.78 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.734 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.11 -44.36 60.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.6 p -61.99 -33.35 74.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 60' ' ' ALA . 41.4 p -86.81 -52.25 5.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.434 HD21 ' CE ' ' A' ' 77' ' ' LYS . 34.4 tp -95.04 79.21 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.544 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.87 -46.62 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.646 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.6 Cg_endo -80.74 109.95 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.404 2.069 . . . . 0.0 112.31 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.86 -46.28 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.441 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -67.91 -6.47 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.718 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -73.02 -21.49 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -103.12 98.18 8.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.697 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 25.8 p-10 -62.68 -44.59 95.86 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.412 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.456 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 71.2 t -64.42 -44.96 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.263 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.543 ' C ' ' H ' ' A' ' 76' ' ' THR . 3.3 mt -93.56 9.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -55.54 -1.28 0.18 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.543 ' H ' ' C ' ' A' ' 74' ' ' ILE . 39.9 p -65.7 -31.78 72.97 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.506 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.434 ' CE ' HD21 ' A' ' 65' ' ' LEU . 17.8 ptmt -58.6 -37.59 76.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.201 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.73 -44.13 93.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.32 -38.92 93.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.253 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.32 -54.03 51.41 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.063 0.458 . . . . 0.0 110.687 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.2 mm? -63.24 -40.32 97.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.311 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.7 -42.95 99.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.242 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -61.89 -43.4 98.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.217 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.97 -39.96 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.474 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.9 mt -63.83 -37.88 89.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.513 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.4 79.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.69 -18.54 0.58 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -78.26 56.72 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.782 0.325 . . . . 0.0 110.418 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.52 -168.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.281 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 132.08 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.506 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -75.05 153.22 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.223 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 92' ' ' LEU . 6.6 tt -142.52 122.51 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.468 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.602 ' N ' HD23 ' A' ' 92' ' ' LEU . 41.1 p90 -146.12 151.01 36.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.736 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 96' ' ' GLY . 56.8 p-10 -80.96 175.13 10.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.474 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 41.7 mp0 -62.3 68.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.473 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 94' ' ' ASP . . . -164.97 -79.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' OD1' ' A' ' 98' ' ' ASP . . . 149.7 40.63 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 97' ' ' GLY . 85.6 m-20 -146.98 169.63 18.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.932 0.396 . . . . 0.0 110.529 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.5 mp0 -80.92 91.61 6.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.166 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 101' ' ' ILE . 59.8 t -141.92 162.83 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.444 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.581 ' N ' HG12 ' A' ' 100' ' ' VAL . 4.9 mp -124.1 129.3 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.8 168.93 10.74 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.456 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 81.9 Cg_exo -46.6 -40.2 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.498 2.132 . . . . 0.0 112.203 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.432 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 79.4 mtp180 -113.13 107.12 15.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.473 ' HB2' HD21 ' A' ' 92' ' ' LEU . 11.8 ptt? -139.43 142.99 37.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -96.98 118.85 34.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.32 116.59 25.11 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 t -173.15 178.08 2.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.689 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -60.48 -44.67 95.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.509 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.1 m -55.86 146.1 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.036 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -105.05 170.37 6.05 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.633 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.8 Cg_exo -51.51 -41.28 61.14 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 112.031 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 55.4 t0 -85.32 -9.97 56.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.552 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.539 ' CB ' ' H ' ' A' ' 111' ' ' ALA . 66.1 t0 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.572 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 4' ' ' VAL . 42.9 mmtt -66.76 -76.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.724 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 65.65 -6.93 0.37 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.497 ' H ' ' C ' ' A' ' 2' ' ' LYS . 3.4 m -84.25 152.37 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.399 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 1.3 mp0 -76.51 117.13 17.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.587 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -134.73 154.7 51.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.527 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -56.4 107.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.399 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -118.16 -27.2 6.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.473 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -76.27 152.59 83.98 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.484 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.73 151.58 82.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.633 2.222 . . . . 0.0 112.117 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -53.56 -52.0 61.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.343 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 12' ' ' VAL . 14.9 p -160.84 70.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.05 0.452 . . . . 0.0 110.387 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -154.43 155.71 35.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.4 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -79.6 140.49 37.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.511 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 pt -83.52 152.09 63.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 18' ' ' THR . 55.6 Cg_endo -69.76 157.16 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.731 2.288 . . . . 0.0 112.236 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -75.44 13.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.378 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 16' ' ' PRO . 74.8 p -130.78 162.46 29.49 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -138.27 156.15 47.94 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.148 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -107.97 143.63 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 23' ' ' ILE . 17.5 tt -133.31 140.59 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -126.27 11.77 7.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.5 mp -88.3 101.41 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.961 0.41 . . . . 0.0 110.707 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.516 HG21 ' CD2' ' A' ' 42' ' ' PHE . 75.8 p -141.14 145.98 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.399 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -93.85 138.93 31.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.202 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.64 138.14 41.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 mt -63.2 -39.99 96.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -151.91 176.98 10.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 80.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.513 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 34' ' ' VAL . 97.5 m -61.34 -47.69 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.585 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -68.72 -26.46 65.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.29 -48.53 56.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.3 m -67.1 -41.8 85.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.618 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 30' ' ' THR . 76.3 t -62.36 -47.29 93.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.495 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -63.5 -42.24 98.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.837 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 40' ' ' SER . 78.5 p -62.66 -35.47 79.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -78.69 -34.45 46.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.926 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.04 -92.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.753 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 40' ' ' SER . 14.2 t -65.59 -96.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.713 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER 77.85 -3.79 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.611 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -140.57 115.62 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.516 ' CD2' HG21 ' A' ' 24' ' ' THR . 84.4 m-85 -117.92 129.12 55.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.184 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -91.6 142.26 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.02 121.13 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.432 0.634 . . . . 0.0 110.515 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.476 ' OD1' HG12 ' A' ' 48' ' ' VAL . 19.3 p30 -155.95 171.29 20.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.793 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.22 11.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 45' ' ' ASP . 87.7 m-20 -107.38 0.18 22.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.67 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 49' ' ' THR . 13.5 p -141.24 160.44 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 50' ' ' LEU . 5.2 p -129.94 -70.12 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.226 0.536 . . . . 0.0 110.648 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' N ' ' OG1' ' A' ' 49' ' ' THR . 0.4 OUTLIER -163.16 -33.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -50.21 -43.95 52.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.333 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -68.41 -40.91 81.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.633 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 57' ' ' VAL . 35.6 mt -62.03 -46.26 89.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.72 -36.39 82.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.456 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.81 -52.25 63.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.182 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 57' ' ' VAL . 12.8 p -69.64 -38.59 76.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.532 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 53' ' ' LEU . 43.7 t -59.29 -50.61 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.276 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.69 -50.47 43.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.184 0.516 . . . . 0.0 110.587 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.26 -32.07 69.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.086 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 56' ' ' VAL . . . -69.71 -56.35 7.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 62' ' ' GLU . 30.8 m -67.41 -44.12 87.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.53 ' N ' HG23 ' A' ' 61' ' ' VAL . 8.5 tm-20 -59.35 -46.39 88.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.508 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.9 p -61.77 -51.65 67.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.6 m -60.48 -46.59 89.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.471 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 65' ' ' LEU . 10.3 mp -94.36 57.85 2.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.399 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.612 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.15 -44.02 2.74 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.214 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 66' ' ' SER . 21.5 Cg_exo -64.3 107.59 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.5 2.133 . . . . 0.0 111.859 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.505 ' C ' ' H ' ' A' ' 70' ' ' GLU . 22.0 t -133.84 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -48.5 -11.3 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.466 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 68' ' ' CYS . 79.2 tt0 -73.94 -36.89 64.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.607 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HB3' HG12 ' A' ' 73' ' ' VAL . 96.7 m-70 -132.65 138.99 47.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.9 -43.83 97.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.676 HG13 HG12 ' A' ' 74' ' ' ILE . 2.8 p -45.69 -31.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.318 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.676 HG12 HG13 ' A' ' 73' ' ' VAL . 47.0 mm -108.38 -15.11 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . -46.68 -177.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m 66.74 -31.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 75' ' ' GLY . 47.1 tptt -63.19 -39.15 93.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 79' ' ' CYS . 7.4 p -59.76 -45.23 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.525 ' N ' HG13 ' A' ' 78' ' ' VAL . 75.1 m -64.41 -47.74 78.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.341 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.45 -52.56 64.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.286 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.4 tp -51.29 -40.89 59.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.94 -48.06 82.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.21 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -64.24 -40.96 97.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.355 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.23 -40.63 98.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.89 -19.99 58.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.596 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.64 75.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 88' ' ' ASP . . . 160.33 33.64 0.02 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 80.2 m-20 -149.14 78.03 1.38 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.789 0.328 . . . . 0.0 110.52 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.609 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 1.4 p90 -110.2 -113.34 0.31 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.085 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.447 ' H ' ' HD2' ' A' ' 89' ' ' TYR . 29.4 m -130.8 158.77 43.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.303 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -126.81 157.07 40.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.242 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.17 125.06 24.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.82 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -134.68 153.27 52.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -88.98 -168.31 2.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.431 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 33.2 mp0 -72.93 67.24 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.628 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.23 -59.33 0.21 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.28 -18.79 0.32 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.84 139.71 55.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.672 0.272 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 90.68 6.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.605 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -155.11 135.98 4.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.615 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 49' ' ' THR . 56.6 mt -66.15 132.26 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.27 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.709 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -149.17 173.59 4.11 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.709 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 54.2 Cg_exo -50.66 -40.59 55.68 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.497 2.131 . . . . 0.0 111.842 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.36 90.13 3.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -103.16 145.24 30.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.159 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -113.15 110.21 20.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.138 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.0 p -110.97 113.15 25.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.437 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 p -167.77 164.9 14.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.764 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -72.51 -26.9 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.643 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 p -73.19 154.64 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -90.26 170.12 10.86 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.668 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.3 Cg_exo -51.44 -35.11 53.81 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.46 2.106 . . . . 0.0 112.128 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -79.16 14.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 . . . . . 0 C--O 1.223 -0.332 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.785 -179.876 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -109.17 121.33 44.93 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.74 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -109.34 4.25 22.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.365 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.471 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 18.1 m -85.33 15.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.608 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 57.57 -111.63 0.61 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 4' ' ' VAL . 53.1 m-85 51.79 -117.39 1.13 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.796 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -58.02 -40.93 82.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.206 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -82.86 112.97 20.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.837 0.351 . . . . 0.0 110.397 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -66.95 160.25 71.05 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -46.33 130.82 14.53 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.962 1.774 . . . . 0.0 112.062 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -96.97 35.51 1.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.676 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.47 -130.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.236 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -89.32 -172.76 3.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.511 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.29 139.83 57.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.468 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 mm -41.31 102.12 0.26 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.707 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.95 157.19 23.86 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.439 2.092 . . . . 0.0 112.284 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.9 m -61.75 -40.32 94.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.513 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -88.3 -170.21 2.87 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.225 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -135.08 171.76 13.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -126.45 146.87 49.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.638 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.413 HG13 ' H ' ' A' ' 23' ' ' ILE . 10.7 tp -132.11 141.04 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.317 0.58 . . . . 0.0 110.151 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -138.23 20.05 2.78 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.431 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.413 ' H ' HG13 ' A' ' 21' ' ' ILE . 23.9 mt -114.15 97.32 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.87 0.367 . . . . 0.0 110.839 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -116.19 143.68 45.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.141 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.92 118.33 13.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.443 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.79 118.6 36.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.243 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.78 -40.99 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.604 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.2 t0 -153.69 -178.94 7.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.58 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -62.82 -37.47 86.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -59.21 -48.03 83.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.188 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.16 -4.13 39.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.405 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -85.2 -59.08 2.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.32 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -68.55 -37.29 79.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.926 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 30' ' ' THR . 73.1 t -65.33 -47.45 87.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.07 -41.81 99.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 9.1 t -58.74 -50.25 74.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.58 -34.13 77.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -25.43 60.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.022 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.568 ' C ' ' H ' ' A' ' 41' ' ' GLU . 4.9 t -173.89 -48.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.47 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 36' ' ' SER . 0.4 OUTLIER 59.45 -3.91 0.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.657 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.568 ' H ' ' C ' ' A' ' 39' ' ' CYS . 75.2 mt-10 -144.26 115.79 8.12 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CE1' HG22 ' A' ' 57' ' ' VAL . 80.4 m-85 -121.84 133.57 54.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -95.5 156.68 16.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.975 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 m -134.75 116.7 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.665 0.745 . . . . 0.0 110.775 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' A' ' 47' ' ' ASP . 50.4 t0 -148.2 159.77 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.3 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 50.9 tttm -60.88 12.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.626 ' H ' ' C ' ' A' ' 45' ' ' ASP . 98.2 m-20 -105.34 -37.07 6.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.711 0.291 . . . . 0.0 110.356 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.93 109.06 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.339 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.512 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 27.3 p -86.46 166.05 15.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.336 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -48.29 -44.35 33.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.291 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.512 ' CG ' ' HG1' ' A' ' 49' ' ' THR . 1.5 p-10 -56.82 -44.33 81.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 56' ' ' VAL . 94.9 mt-10 -72.98 -28.59 62.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.289 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.687 ' O ' HG23 ' A' ' 57' ' ' VAL . 55.5 tp -65.3 -54.34 30.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.216 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 55' ' ' ASP . 3.1 pp -67.79 -39.93 83.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.896 0.379 . . . . 0.0 110.287 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 54' ' ' LEU . 16.6 t70 -63.32 -44.39 95.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 52' ' ' GLU . 60.7 t -69.55 -43.12 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.707 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 53' ' ' LEU . 72.1 t -61.98 -47.77 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.455 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 81' ' ' LEU . 8.6 tt -64.05 -53.25 52.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.081 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -52.23 -38.97 59.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.745 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.84 75.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.629 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.27 -48.98 85.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.685 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.78 -37.72 85.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.444 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -60.69 -45.16 95.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.49 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.8 p -72.92 -40.66 65.3 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.751 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -108.26 106.77 17.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.482 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.447 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -79.1 -60.8 0.53 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 178.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 66' ' ' SER . 36.9 Cg_endo -63.15 134.48 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.338 2.025 . . . . 0.0 112.297 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.2 p -134.98 -37.38 0.8 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -67.99 -7.96 33.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.759 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -73.59 -30.34 62.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.715 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 75' ' ' GLY . 60.1 m80 -92.13 108.91 20.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 20.8 p-10 -66.1 -49.12 68.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.339 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 t -66.84 -45.1 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.412 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 mm -95.09 18.79 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.09 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -81.29 -170.62 43.93 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.415 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER 78.32 -26.41 0.18 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 110.552 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER -63.62 -11.02 21.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.163 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.662 HG13 ' N ' ' A' ' 79' ' ' CYS . 7.1 p -71.31 -54.51 17.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 110.304 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.662 ' N ' HG13 ' A' ' 78' ' ' VAL . 98.8 m -69.36 -42.66 74.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.143 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.08 74.63 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.113 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 58' ' ' LEU . 4.7 tt -54.62 -42.15 70.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.166 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.95 -48.71 80.58 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.254 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 87' ' ' GLY . 55.2 t0 -65.52 -43.24 90.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.798 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' ASP . 1.4 mpt_? -62.08 -43.79 98.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.6 -42.84 97.61 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.086 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -9.7 51.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.631 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -154.38 62.45 0.36 Allowed Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 84' ' ' ARG . 96.9 m-20 -36.88 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 110.693 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.503 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 65.5 t80 -87.04 -40.7 14.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.679 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.66 131.52 12.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 98.0 m-85 -109.37 152.25 25.57 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 93' ' ' PHE . 6.1 tt -132.31 122.9 25.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.621 ' N ' HD23 ' A' ' 92' ' ' LEU . 45.2 p90 -142.79 147.68 35.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.52 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.2 t70 -83.91 177.47 8.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.466 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 95.8 mt-10 -70.77 38.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -146.59 -5.71 0.38 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.92 -2.64 73.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 36.4 t0 -93.87 112.86 24.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 110.471 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -53.45 86.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.098 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 69.7 t -145.4 136.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.9 mm -76.09 130.02 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.125 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -150.02 172.0 5.74 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.452 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 52.0 Cg_exo -51.95 -41.52 63.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.354 2.036 . . . . 0.0 111.894 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 1.8 mpt_? -110.46 83.45 1.76 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.188 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -105.19 165.07 11.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.091 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 93' ' ' PHE . 70.6 t80 -134.2 112.51 11.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 21.7 p -115.52 117.08 29.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.623 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.1 t -171.71 175.41 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -66.4 -27.34 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.357 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -61.86 146.46 49.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.473 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -85.62 170.41 13.14 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.1 Cg_exo -50.78 -41.28 55.29 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.542 2.161 . . . . 0.0 112.025 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -60.51 -48.26 82.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.101 0.477 . . . . 0.0 110.849 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.547 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -82.58 104.9 13.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.954 0.407 . . . . 0.0 110.665 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.24 -9.38 42.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.183 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.62 -18.14 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.574 ' O ' ' O ' ' A' ' 7' ' ' ASN . 96.6 mt-10 56.42 67.0 1.06 Allowed 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.639 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.535 ' C ' ' O ' ' A' ' 5' ' ' GLU . 75.1 m-85 -8.77 99.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.815 0.697 . . . . 0.0 112.531 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.574 ' O ' ' O ' ' A' ' 5' ' ' GLU . 97.6 m-20 53.85 168.16 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 121.318 0.58 . . . . 0.0 110.738 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -44.83 148.73 0.5 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.506 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -38.01 152.42 0.15 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.03 -80.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.482 2.121 . . . . 0.0 112.244 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 13' ' ' ARG . 12.6 tptp 58.38 110.8 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.946 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 t 67.12 -45.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 123.525 0.515 . . . . 0.0 110.313 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' LYS . 86.1 mtp180 -57.55 -172.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.543 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -58.11 136.45 57.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.405 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.12 153.11 86.42 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.732 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 18' ' ' THR . 55.9 Cg_endo -69.57 162.12 43.23 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.642 2.228 . . . . 0.0 112.206 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.9 t -65.93 8.99 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.542 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.526 ' H ' ' C ' ' A' ' 16' ' ' PRO . 47.8 p -109.04 168.47 9.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.291 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.45 173.51 8.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.237 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.02 144.17 30.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.053 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.0 pt -136.12 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.753 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.53 121.18 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 23' ' ' ILE . 4.2 mm -94.3 115.88 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.166 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -127.92 100.46 5.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.445 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.53 107.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.34 140.79 46.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.747 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.9 mp -73.7 -41.19 62.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -127.12 -176.78 3.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.63 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.16 82.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -58.69 -52.7 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.414 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' N ' ' OG1' ' A' ' 30' ' ' THR . 85.5 m-85 -69.39 -11.61 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -77.78 -54.89 5.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 p -69.91 -35.34 74.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.914 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' THR . 73.5 t -64.31 -49.89 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.67 -42.22 91.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.835 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.2 p -63.48 -45.65 89.81 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.541 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -68.34 -47.1 68.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.53 -76.1 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.735 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 7.9 t -83.13 72.27 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.9 p -75.78 -26.97 57.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.633 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -172.83 149.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.281 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.507 ' CE2' HG22 ' A' ' 57' ' ' VAL . 6.0 m-85 -130.97 147.01 52.56 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.241 0.543 . . . . 0.0 110.526 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.44 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.38 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.6 132.26 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.904 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 41.7 t0 -145.44 148.62 33.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 20.0 pttp -73.75 20.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 45' ' ' ASP . 13.3 t70 -122.16 16.53 10.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.706 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 101' ' ' ILE . 3.0 m -134.11 161.19 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 109.947 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' ASP . 58.2 p -120.29 134.78 55.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.121 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.679 HD22 ' C ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.86 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.851 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.659 ' N ' HD22 ' A' ' 50' ' ' LEU . 63.1 t0 -67.8 -50.6 55.99 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.37 0.605 . . . . 0.0 110.1 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 56' ' ' VAL . 97.3 mt-10 -67.36 -35.47 79.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.829 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 57' ' ' VAL . 61.4 tp -61.39 -45.54 93.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.774 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.547 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.99 -43.77 97.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.722 -179.525 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.99 -42.6 99.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.729 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 52' ' ' GLU . 66.2 t -67.66 -45.95 83.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.621 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 53' ' ' LEU . 64.5 t -59.85 -45.76 94.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.44 -51.43 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.726 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -60.52 -32.92 71.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.44 -54.48 46.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.952 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.22 -39.08 84.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.6 m -61.61 -49.46 76.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -61.36 -48.73 79.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 65' ' ' LEU . 5.0 tt -108.27 82.17 1.59 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.323 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.606 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.45 -43.93 2.05 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.403 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.8 Cg_exo -61.21 115.18 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.783 2.322 . . . . 0.0 112.091 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 p -133.11 -41.86 0.89 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 71' ' ' HIS . 88.6 tttt -62.09 -37.44 85.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.752 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -75.56 28.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.465 ' H ' ' C ' ' A' ' 69' ' ' LYS . 95.6 m-70 -136.78 143.8 43.4 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.577 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.83 -62.96 1.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.961 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.64 -44.54 89.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.278 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.7 mm -84.51 2.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.971 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.45 -28.4 71.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -8.26 59.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.91 -44.63 94.16 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.409 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 ' N ' ' A' ' 79' ' ' CYS . 11.2 p -57.01 -44.15 82.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.352 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.567 ' N ' HG13 ' A' ' 78' ' ' VAL . 73.5 m -67.75 -49.39 62.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -62.26 -40.71 97.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.57 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.99 -42.4 99.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.09 -42.74 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.096 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.09 -44.51 96.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.674 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.679 HH12 ' HB1' ' A' ' 80' ' ' ALA . 96.4 mtm-85 -65.73 -39.7 91.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -64.64 -37.91 89.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.432 -179.396 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.91 80.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.604 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.64 62.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -172.59 56.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.502 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -101.65 152.58 20.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.962 0.41 . . . . 0.0 110.482 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 34.7 m -48.36 148.01 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.966 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -106.65 164.19 12.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.175 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 92' ' ' LEU . 8.0 tt -127.32 126.82 43.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.845 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.573 ' N ' HD23 ' A' ' 92' ' ' LEU . 31.6 m-85 -137.15 154.9 50.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -84.31 -176.96 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.693 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -71.45 47.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -158.13 -68.17 0.01 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.92 -21.31 0.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -73.78 141.67 46.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.945 0.402 . . . . 0.0 110.62 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.447 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -76.0 93.22 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.403 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.31 153.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.295 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' A' ' 48' ' ' VAL . 77.3 mt -91.47 127.14 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.224 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.02 153.99 19.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.548 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.3 -37.8 25.21 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.181 1.921 . . . . 0.0 112.136 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.425 ' CD ' ' H ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -92.63 54.42 2.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 110.334 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.546 ' HB2' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -103.51 144.34 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.295 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -117.05 122.13 43.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.263 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.432 ' SG ' HD21 ' A' ' 54' ' ' LEU . 12.9 t -113.09 115.0 27.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.536 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 t -173.89 175.71 2.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -75.39 -20.64 58.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.362 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -72.78 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.238 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -98.08 170.68 6.75 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.447 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.9 Cg_exo -52.62 -42.14 64.16 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.654 2.236 . . . . 0.0 112.076 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 67.6 t0 -96.51 48.1 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.566 179.711 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -78.93 136.32 37.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 110.645 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -100.34 -0.14 38.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.511 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 4' ' ' VAL . 9.6 p -111.53 36.41 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.536 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 4' ' ' VAL . 98.1 mt-10 55.94 165.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.311 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -94.38 165.24 12.67 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.581 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -52.13 -82.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.808 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 1.1 p30 166.52 126.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.064 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -43.85 155.99 0.31 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.02 110.62 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.618 2.212 . . . . 0.0 111.759 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -82.24 -85.61 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.212 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 t -72.22 52.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.963 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -153.28 120.28 5.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.253 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -70.82 118.87 14.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.375 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.0 mm -122.91 81.89 50.06 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 120.933 0.397 . . . . 0.0 111.093 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.31 111.41 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.683 2.255 . . . . 0.0 111.301 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -77.85 -10.06 59.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.657 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 p -85.63 170.94 12.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -103.58 136.47 43.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.053 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -104.66 121.92 44.56 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.94 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.03 149.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.431 ' C ' HD12 ' A' ' 23' ' ' ILE . 18.3 ptmt -130.46 20.22 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.963 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.735 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.6 mp -93.49 122.3 44.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.11 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.1 m -142.56 134.48 27.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -97.55 120.34 37.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.096 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -103.82 145.55 29.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.447 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.1 mm? -64.92 -41.66 95.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.816 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -150.12 -174.08 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.91 -37.68 87.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 30' ' ' THR . 1.3 p -59.79 -48.74 80.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.273 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -66.89 -33.95 76.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.589 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.91 -46.54 87.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.436 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -68.32 -41.99 80.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.91 -49.0 85.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.889 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.617 HD11 HG22 ' A' ' 61' ' ' VAL . 4.0 mm? -64.38 -41.07 96.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -59.94 -41.93 92.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -75.14 -31.15 60.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.69 -89.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.0 m -108.99 94.89 5.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.475 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 t -89.29 -11.28 43.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 94.5 mt-10 -145.04 156.56 44.0 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.602 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 8.4 m-85 -143.59 122.61 12.82 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.078 0.466 . . . . 0.0 110.598 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.83 135.43 49.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.381 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.03 132.62 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -58.92 172.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -50.83 -38.38 48.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -147.27 113.9 6.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 49' ' ' THR . 86.9 t -127.88 160.93 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.546 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -96.75 125.65 41.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.658 ' H ' HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -38.35 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.8 m-20 -60.27 -45.94 91.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.216 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 56' ' ' VAL . 37.8 tp10 -63.96 -43.06 96.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.949 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.456 ' O ' HG12 ' A' ' 57' ' ' VAL . 61.9 tp -62.02 -40.26 95.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.04 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.1 -42.76 99.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.277 0.56 . . . . 0.0 110.184 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.3 -39.45 68.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.703 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 52' ' ' GLU . 54.5 t -69.55 -53.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.4 p -55.8 -44.82 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' HG13 ' A' ' 57' ' ' VAL . 58.6 tp -62.04 -52.04 65.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.183 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -54.17 -43.31 70.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.099 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.96 93.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.179 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.617 HG22 HD11 ' A' ' 35' ' ' LEU . 53.1 t -63.23 -43.12 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.252 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -67.53 -36.49 81.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.609 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t -63.03 -52.26 63.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 65' ' ' LEU . 12.1 t -74.75 -38.03 62.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.433 . . . . 0.0 110.547 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' N ' HG23 ' A' ' 64' ' ' THR . 11.2 tp -92.79 33.98 1.11 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.914 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.43 -47.14 2.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 66' ' ' SER . 71.8 Cg_endo -82.5 78.3 3.43 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.452 2.101 . . . . 0.0 112.291 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 33.4 m -133.81 -18.06 2.15 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -68.03 -7.43 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.672 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.33 -38.89 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -101.7 109.87 21.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.225 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 32.8 p-10 -65.78 -36.44 83.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.726 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.56 -57.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.683 ' O ' ' O ' ' A' ' 75' ' ' GLY . 81.6 mt -68.93 -45.0 81.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.683 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . -43.27 -131.27 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 O-C-N 124.053 0.846 . . . . 0.0 111.521 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.429 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 1.3 m 74.22 -36.09 0.32 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.96 -0.729 . . . . 0.0 110.532 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.2 OUTLIER -58.29 -29.47 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.817 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.412 ' O ' HD13 ' A' ' 82' ' ' LEU . 93.6 t -62.4 -48.76 86.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.382 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.13 -37.44 87.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.103 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.42 -43.34 99.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 78' ' ' VAL . 7.7 mp -63.15 -38.02 89.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.794 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.88 -42.05 99.63 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' TYR . 89.0 mtm-85 -62.35 -48.08 81.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.014 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.584 ' O ' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -70.56 -29.9 66.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.173 0.511 . . . . 0.0 110.411 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.16 84.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.43 -50.71 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.321 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.86 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.5 ' CE2' ' O ' ' A' ' 90' ' ' VAL . 26.9 t80 64.55 165.37 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.29 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.5 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 2.9 p -125.2 156.47 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.96 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.445 ' N ' HG22 ' A' ' 90' ' ' VAL . 11.8 m-85 -122.55 138.51 54.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.077 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -108.85 128.83 55.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.4 154.04 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.793 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 44.6 t0 -73.62 176.83 5.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.437 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 11.3 tm-20 -61.12 -42.7 99.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.533 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.62 60.15 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.2 -0.37 87.31 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.5 t0 -89.13 108.83 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.6 0.238 . . . . 0.0 110.472 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -47.1 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.447 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 98' ' ' ASP . 79.6 t -152.84 131.26 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.663 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.781 ' H ' HD12 ' A' ' 101' ' ' ILE . 3.1 mp -60.93 123.88 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.27 170.58 8.01 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.539 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.632 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.3 Cg_exo -51.73 -42.12 58.53 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.269 1.98 . . . . 0.0 112.234 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -105.85 101.5 11.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.226 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 52.1 mtm -104.62 147.05 28.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.324 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -119.02 96.33 5.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.971 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 90' ' ' VAL . 49.2 t -90.24 119.82 30.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.263 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.7 t -161.06 159.74 29.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.608 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 5.5 m-85 -85.52 43.1 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.046 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m -146.6 178.76 8.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.232 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.46 170.69 5.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.518 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.7 Cg_exo -52.14 -39.53 70.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.598 2.199 . . . . 0.0 112.038 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 p30 -87.31 0.58 55.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--O 1.222 -0.388 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.612 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt 41.42 -105.81 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.163 0.506 . . . . 0.0 110.783 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -153.94 2.35 0.25 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.067 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' O ' ' C ' ' A' ' 5' ' ' GLU . 4.5 m -147.74 18.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.477 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 4' ' ' VAL . 5.0 pt-20 30.38 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.83 0.706 . . . . 0.0 110.629 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -130.44 130.98 44.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.255 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 63.33 114.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.506 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -124.68 -179.2 4.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -51.12 151.52 4.71 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.498 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.55 -166.49 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.765 2.31 . . . . 0.0 112.063 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt 75.58 -62.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.995 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 p -70.02 -28.87 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.332 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.53 155.37 47.56 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.753 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -53.56 132.5 40.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.515 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pt -44.5 153.2 0.47 Allowed Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.667 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -44.51 122.84 4.17 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.421 2.081 . . . . 0.0 111.925 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.4 p -108.07 -6.79 16.33 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.519 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -86.43 -176.66 5.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.098 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.497 ' N ' HG23 ' A' ' 18' ' ' THR . 73.2 ttt180 -126.06 150.7 47.96 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.498 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -145.34 126.71 14.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.799 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 42' ' ' PHE . 49.4 pt -140.91 148.56 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.107 0.48 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.602 ' C ' HD12 ' A' ' 23' ' ' ILE . 62.9 mttp -113.43 77.41 1.05 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.791 0.329 . . . . 0.0 110.352 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 22' ' ' LYS . 1.7 mp -110.0 126.42 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.0 m -124.19 126.84 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.364 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 107' ' ' CYS . 85.1 t80 -130.08 134.21 47.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.395 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.84 107.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.441 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.3 -43.59 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.658 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 98.1 m-20 -135.28 -86.36 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.511 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.67 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.582 HG23 ' N ' ' A' ' 31' ' ' PHE . 15.3 t -58.75 -45.55 89.46 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.292 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.582 ' N ' HG23 ' A' ' 30' ' ' THR . 51.6 t80 -61.46 -35.93 79.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.387 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.658 ' CG ' ' H ' ' A' ' 28' ' ' ASP . 90.9 m-20 -62.17 -44.63 96.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.293 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 30' ' ' THR . 78.3 p -62.16 -46.94 86.75 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.631 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.38 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.496 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 39' ' ' CYS . 53.6 tp -61.22 -44.68 96.88 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -60.17 -41.74 93.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 110.157 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.76 -32.25 73.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.07 -76.56 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.99 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.7 t -104.47 96.16 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -111.7 -30.19 7.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.37 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -95.27 141.25 29.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.365 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' ILE . 96.4 m-85 -136.55 133.36 36.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.173 0.511 . . . . 0.0 110.526 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -133.83 143.26 48.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.788 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' OG1' ' A' ' 18' ' ' THR . 1.2 m -145.72 -106.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.781 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.44 ' HA ' ' N ' ' A' ' 19' ' ' ARG . 43.5 p30 -166.85 161.51 15.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -63.64 163.28 11.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 61.49 37.23 16.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.478 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 48' ' ' VAL . 11.0 p -113.69 123.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.13 0.491 . . . . 0.0 110.199 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -83.51 169.92 14.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.375 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -60.81 -40.13 91.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -53.65 -50.34 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.111 0.482 . . . . 0.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.16 -38.08 89.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.313 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.65 -48.8 77.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.296 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.39 -41.18 68.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -62.15 -47.74 83.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.23 -43.36 95.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.133 0.492 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.69 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.82 -45.24 95.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.913 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -55.3 -43.74 75.08 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.97 88.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.465 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.89 -42.02 94.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -69.61 -47.01 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -62.44 -37.1 84.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.76 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -73.65 -69.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.2 mt -103.48 98.57 8.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.556 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -77.85 -47.05 2.31 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.773 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.0 Cg_endo -81.39 137.63 10.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.603 2.202 . . . . 0.0 111.89 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.624 ' SG ' ' NZ ' ' A' ' 77' ' ' LYS . 5.8 m -133.22 -40.25 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.516 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.54 -11.08 60.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.39 -39.03 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.678 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.576 ' O ' ' N ' ' A' ' 75' ' ' GLY . 34.3 m170 -102.29 106.13 16.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.51 -37.95 89.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.25 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.19 -46.55 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.359 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 75' ' ' GLY . 95.7 mt -91.6 -13.67 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -53.93 -158.22 0.01 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.548 HG23 ' C ' ' A' ' 75' ' ' GLY . 2.2 p 69.44 -35.63 0.31 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.092 0.472 . . . . 0.0 110.539 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.624 ' NZ ' ' SG ' ' A' ' 68' ' ' CYS . 21.7 pttp -63.08 -20.47 65.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.306 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 79' ' ' CYS . 9.8 p -65.5 -46.15 90.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.304 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.576 ' N ' HG13 ' A' ' 78' ' ' VAL . 1.6 t -68.85 -47.03 66.97 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.453 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.23 94.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.461 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.97 -43.27 99.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.45 -41.94 99.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.54 -43.81 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.278 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ASP . 96.1 mtt180 -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.135 0.493 . . . . 0.0 110.378 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.92 -42.9 94.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.33 -13.2 55.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.398 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' TYR . . . -149.89 61.41 0.42 Allowed Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' ARG . 88.8 m-20 -38.74 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.508 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -95.0 63.69 2.72 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.356 0.598 . . . . 0.0 110.373 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.9 t -150.91 137.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.33 132.21 41.04 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.219 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -103.65 136.49 43.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.751 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -157.53 148.83 21.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.832 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.63 -164.94 1.25 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 110.468 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.75 -39.83 82.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.78 -34.78 65.52 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.66 60.01 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 100' ' ' VAL . 47.6 t0 -88.16 113.98 24.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -42.57 89.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.658 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 98' ' ' ASP . 9.2 p -144.04 141.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.39 127.65 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.151 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.21 169.67 9.39 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.55 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.684 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 75.5 Cg_exo -45.51 -42.63 18.24 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.426 2.084 . . . . 0.0 112.228 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -99.96 123.85 44.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.82 0.343 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 68.1 mtp -114.81 142.56 46.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -146.15 97.36 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.158 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.522 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.3 t -98.88 115.46 28.89 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.669 0.606 . . . . 0.0 110.923 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 p -171.03 162.11 7.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.649 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 109' ' ' PHE . 1.0 OUTLIER -61.67 -53.34 57.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.361 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.7 p -41.9 148.95 0.15 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.998 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -106.61 161.89 21.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 17.5 Cg_endo -56.62 -31.41 86.99 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.671 2.247 . . . . 0.0 112.081 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -105.02 15.08 28.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.163 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.961 -179.856 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -67.13 128.49 36.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.731 0.3 . . . . 0.0 110.36 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -74.59 -50.16 18.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 5' ' ' GLU . 7.4 p -90.75 154.71 3.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.511 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 4' ' ' VAL . 96.3 mt-10 -67.42 155.54 38.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -69.7 -156.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.459 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 59.46 68.03 0.84 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.814 0.34 . . . . 0.0 110.251 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.429 ' CG ' ' N ' ' A' ' 9' ' ' LYS . 53.6 p-10 -137.52 -131.81 0.13 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.538 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' N ' ' CG ' ' A' ' 8' ' ' ASP . 17.6 ttmm -45.53 127.06 6.31 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.744 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.29 121.63 6.58 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.976 1.784 . . . . 0.0 112.099 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.629 ' O ' ' N ' ' A' ' 13' ' ' ARG . 70.9 mmtt -87.11 -156.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.934 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t 44.97 -81.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 123.302 0.376 . . . . 0.0 110.795 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.629 ' N ' ' O ' ' A' ' 11' ' ' LYS . 89.1 mtm180 -61.91 162.92 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.546 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.51 175.87 0.96 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.653 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.752 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -44.57 163.5 0.19 Allowed Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.352 -179.173 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 15' ' ' ILE . 52.8 Cg_exo -54.12 -137.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 122.404 2.069 . . . . 0.0 112.29 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.0 m -85.46 12.41 8.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.856 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p -86.3 143.59 27.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.184 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' O ' HG12 ' A' ' 44' ' ' VAL . 96.7 mtt180 -131.53 146.16 52.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.479 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.2 140.24 32.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 pt -131.23 146.84 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.18 89.34 2.97 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.4 128.03 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.278 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -66.91 141.34 57.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 8.0 m-85 -115.05 135.19 54.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.321 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.79 142.77 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.639 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt 67.26 46.65 1.43 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.97 0.414 . . . . 0.0 111.35 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -128.0 12.15 6.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.154 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 36.94 -120.25 0.17 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.228 0.537 . . . . 0.0 111.698 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -49.74 -59.77 3.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -40.44 -44.45 2.01 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.838 0.352 . . . . 0.0 110.533 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -56.42 -52.25 65.36 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -68.55 -40.45 80.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.798 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -52.73 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.266 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.17 -42.2 89.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -59.67 -43.52 93.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.74 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -79.26 -26.94 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.69 -72.42 0.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.6 p -152.11 98.91 2.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.531 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 78.4 p -51.39 -30.8 20.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.287 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -85.47 144.95 27.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 40' ' ' SER . 45.6 m-85 -129.6 138.6 51.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.54 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 43.6 tt0 -77.46 136.45 38.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.598 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 19' ' ' ARG . 3.6 p -141.12 155.06 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.454 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' ASP . 45.7 t0 -149.75 146.07 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -40.77 -26.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.607 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' ASP . 11.0 m-20 -138.19 90.99 2.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 49' ' ' THR . 5.0 p -139.05 158.8 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.943 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 51' ' ' ASP . 68.0 p -121.81 137.52 54.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.739 HD23 ' N ' ' A' ' 50' ' ' LEU . 1.7 pt? -37.9 -25.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.432 0.635 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.5 m-20 -58.91 -41.8 88.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.947 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' OE2' ' OE1' ' A' ' 43' ' ' GLU . 80.1 tt0 -64.89 -33.77 76.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.848 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.636 ' O ' HG23 ' A' ' 57' ' ' VAL . 42.9 tp -62.31 -42.84 99.7 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 109.806 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.99 -42.26 76.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.617 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.81 -43.87 91.75 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.173 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 57' ' ' VAL . 8.5 p -72.46 -40.2 63.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.844 0.354 . . . . 0.0 110.688 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 53' ' ' LEU . 48.0 t -61.09 -48.19 90.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.77 -54.07 41.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.755 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 63.7 t0 -52.31 -38.65 59.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.825 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.76 99.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.33 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' LEU . 75.2 t -63.15 -46.25 96.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -66.59 -43.69 84.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.578 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -61.15 -47.47 86.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.5 p -75.2 -75.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' VAL . 68.9 mt -109.5 109.67 20.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.452 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.26 -44.04 2.68 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.074 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' SER . 27.1 Cg_exo -61.15 132.19 40.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.568 2.178 . . . . 0.0 112.118 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 66' ' ' SER . 2.3 m -134.83 -55.44 0.82 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 110.277 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 71' ' ' HIS . 21.2 ptmt -67.53 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.742 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -76.17 13.25 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.482 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' H ' ' C ' ' A' ' 69' ' ' LYS . 97.0 m-70 -126.44 93.4 3.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.442 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -62.12 -34.79 77.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.45 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.07 -45.58 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.287 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 75' ' ' GLY . 51.8 mt -77.72 -60.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.719 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . 46.22 175.82 0.01 OUTLIER Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m 61.96 -23.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.651 -0.323 . . . . 0.0 110.703 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.676 ' H ' ' C ' ' A' ' 75' ' ' GLY . 8.9 tttm -56.69 -62.76 1.51 Allowed 'General case' 0 C--O 1.225 -0.198 0 CA-C-O 121.367 0.603 . . . . 0.0 109.898 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -52.5 -33.34 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.023 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 t -68.22 -50.84 51.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.551 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.13 93.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.82 -42.15 99.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.034 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.81 -43.99 97.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -58.54 -46.69 86.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -64.94 -36.59 84.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.754 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.34 -37.94 85.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.269 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 -24.99 62.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.344 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.18 -65.1 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -174.5 -179.69 1.59 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -158.31 -68.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.572 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.59 157.0 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.543 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 2.5 p90 -144.31 155.3 43.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.784 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.56 154.64 41.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.236 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.47 147.28 27.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.04 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.46 ' C ' ' N ' ' A' ' 96' ' ' GLY . 89.6 m-20 -80.79 167.84 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 104' ' ' ARG . 94.8 mt-10 -52.26 -9.36 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.484 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.46 ' N ' ' C ' ' A' ' 94' ' ' ASP . . . -90.02 -74.52 1.29 Allowed Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.48 -28.19 0.33 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -69.55 137.9 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.412 ' HB3' HD22 ' A' ' 50' ' ' LEU . 97.6 mt-10 -75.35 89.85 2.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -147.87 149.73 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.772 ' N ' HD12 ' A' ' 101' ' ' ILE . 1.8 mp -83.16 129.47 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.079 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -148.33 169.48 9.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.287 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 88.2 Cg_exo -46.23 -45.03 19.1 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.593 2.196 . . . . 0.0 112.601 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 95' ' ' GLU . 74.0 mtp85 -107.31 80.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.508 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -104.23 160.9 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -141.87 114.14 8.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.568 ' SG ' ' CE1' ' A' ' 25' ' ' PHE . 8.9 p -102.7 128.94 49.21 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.964 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 109' ' ' PHE . 40.0 t -175.74 -167.07 0.22 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.223 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.541 ' O ' ' CD2' ' A' ' 109' ' ' PHE . 70.6 t80 -104.12 25.18 10.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.7 m -115.03 160.87 19.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.267 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -109.25 170.41 5.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.522 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.9 Cg_exo -52.41 -40.68 70.61 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.459 2.106 . . . . 0.0 112.378 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.4 p30 -114.16 39.41 2.75 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.639 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -68.33 128.39 36.42 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.668 0.27 . . . . 0.0 110.584 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -81.53 90.6 6.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.315 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 6' ' ' PHE . 2.7 m -146.63 143.38 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.541 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -57.25 -6.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.596 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -44.01 135.05 4.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.34 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 6' ' ' PHE . 1.8 t-20 160.69 -26.15 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 O-C-N 123.818 0.699 . . . . 0.0 110.342 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' ASN . 99.5 m-20 53.85 165.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.025 0.44 . . . . 0.0 110.508 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.72 156.45 80.35 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.798 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.49 14.96 0.88 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.565 2.177 . . . . 0.0 112.172 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.93 -50.46 55.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 12' ' ' VAL . 7.5 p -89.57 19.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.151 0.5 . . . . 0.0 110.775 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.4 mtm105 -137.42 150.07 47.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.917 0.389 . . . . 0.0 110.21 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -53.93 98.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.324 0.583 . . . . 0.0 110.447 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.603 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -43.55 154.72 0.33 Allowed Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.746 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.84 -89.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.416 2.077 . . . . 0.0 112.13 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.9 p -112.75 -1.01 14.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.446 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p -87.01 166.94 14.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -158.45 177.87 10.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.347 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -117.4 141.17 48.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 110.212 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.0 tt -99.16 141.11 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.127 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -132.07 5.41 4.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.23 125.53 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.7 p -138.76 146.56 41.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.81 136.87 56.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.256 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.44 133.33 43.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.062 0.458 . . . . 0.0 110.558 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.3 mp -66.75 -40.39 88.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.716 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 37.0 t0 -159.23 -170.92 3.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.418 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.505 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -59.05 -46.05 89.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.704 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -61.51 -53.21 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.422 ' N ' ' OG1' ' A' ' 30' ' ' THR . 92.7 m-85 -61.42 -27.66 68.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.23 0.538 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.42 -45.0 73.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.975 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -67.98 -36.48 80.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.546 HG21 HD13 ' A' ' 74' ' ' ILE . 76.9 t -62.42 -49.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.467 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.9 -41.62 95.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.99 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 40' ' ' SER . 92.6 p -62.07 -44.46 96.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -75.05 -26.69 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB1' HG22 ' A' ' 61' ' ' VAL . . . -61.01 -28.91 69.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.676 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' GLU . 10.7 p -161.22 -33.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.0 t 69.77 -42.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 39' ' ' CYS . 21.4 pt-20 -154.64 143.16 20.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -134.03 136.07 43.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 110.592 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -67.8 135.85 53.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.433 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.61 134.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.309 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.95 164.37 38.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.615 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 68.9 mmtt -70.66 101.4 2.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 1.5 t70 162.64 -46.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.763 0.665 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -100.14 110.6 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.0 110.597 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -87.53 172.81 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -43.76 -30.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 -51.77 67.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.695 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' VAL . 80.9 mm-40 -65.02 -39.98 94.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.221 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 57' ' ' VAL . 60.1 tp -62.61 -38.95 92.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.966 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.88 -44.01 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.471 . . . . 0.0 110.206 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.53 -34.95 70.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.611 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 52' ' ' GLU . 53.6 t -73.63 -54.51 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 61' ' ' VAL . 9.4 p -55.74 -44.66 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.552 ' N ' HG13 ' A' ' 57' ' ' VAL . 5.6 tt -61.85 -55.3 31.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.63 -42.71 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.8 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.662 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 57' ' ' VAL . 57.8 t -64.92 -46.24 92.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -65.64 -47.19 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.851 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -64.83 -54.03 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.8 m -66.15 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.748 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.3 tp -108.86 81.97 1.53 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.658 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.53 -44.41 2.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.454 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.4 Cg_exo -63.16 119.72 6.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.543 2.162 . . . . 0.0 112.032 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.518 ' SG ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -134.21 -17.89 2.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -66.46 -20.23 65.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.49 28.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.555 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -126.08 160.75 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.492 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -82.43 -65.3 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.42 -47.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.546 HD13 HG21 ' A' ' 34' ' ' VAL . 12.6 mt -65.47 -16.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.061 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.32 3.33 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -82.53 -14.07 55.55 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.299 0.571 . . . . 0.0 110.829 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.434 ' HZ2' HG11 ' A' ' 34' ' ' VAL . 87.1 tttt -54.52 -34.38 61.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.294 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.518 HG22 ' SG ' ' A' ' 68' ' ' CYS . 65.2 t -59.55 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.256 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 85.4 m -61.6 -39.84 92.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.17 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.61 84.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.272 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -60.36 -50.09 74.98 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 -178.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 82' ' ' LEU . 4.1 mm? -61.91 -41.74 98.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.399 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -60.89 -47.15 87.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.216 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -65.7 -40.91 92.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.637 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.23 -22.22 66.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.657 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -40.43 80.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.95 -37.39 0.66 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -84.01 116.33 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.559 0.219 . . . . 0.0 110.461 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -130.92 143.75 50.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.425 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 m -51.5 140.9 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.392 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.89 150.35 24.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.311 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -127.95 127.79 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.778 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -148.02 151.6 36.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.67 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 96' ' ' GLY . 54.0 p-10 -78.67 179.51 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.761 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.81 26.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -130.08 -83.8 0.33 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.43 -26.9 0.12 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -72.46 141.16 48.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.519 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.08 89.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -148.54 136.9 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.559 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mm -77.48 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.483 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -140.46 168.95 12.91 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.8 Cg_exo -51.4 -37.14 60.59 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.544 2.163 . . . . 0.0 112.166 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -129.36 122.79 30.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.52 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.636 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -153.79 149.23 27.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.428 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -87.55 130.82 34.6 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.5 t -126.05 108.4 11.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.15 179.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.417 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' SER . 50.6 p90 -69.34 -40.48 77.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.539 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 109' ' ' PHE . 9.4 t -57.01 149.56 18.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.331 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.683 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -92.77 170.59 8.68 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.643 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.683 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.7 Cg_exo -51.4 -40.39 62.43 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.459 2.106 . . . . 0.0 112.125 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.44 -47.91 84.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.591 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.5 t0 . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.546 -179.773 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -77.8 151.43 34.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.616 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -92.5 -4.15 54.03 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.444 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 6' ' ' PHE . 2.1 t 54.15 21.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.641 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -76.97 38.07 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.489 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' H ' ' C ' ' A' ' 4' ' ' VAL . 80.0 m-85 -108.17 -164.56 0.97 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 6' ' ' PHE . 11.2 m120 61.19 140.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.111 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 50.7 p-10 -95.21 84.96 4.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.128 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -133.62 145.34 55.85 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.012 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.37 -57.06 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.635 2.224 . . . . 0.0 112.244 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -168.85 -161.9 0.35 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.632 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.2 -53.23 46.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.335 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -42.24 114.36 0.55 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.907 0.385 . . . . 0.0 110.186 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -51.09 175.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.089 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.742 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -53.4 164.13 0.86 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.557 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 18' ' ' THR . 34.0 Cg_exo -56.37 148.09 63.88 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.267 1.978 . . . . 0.0 112.119 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.2 p -66.83 8.77 0.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.35 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.508 ' H ' ' C ' ' A' ' 16' ' ' PRO . 58.8 p -87.26 160.52 18.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.221 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -145.65 177.02 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.577 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -145.54 133.72 21.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.452 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.89 149.0 32.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 18.9 mtpp -114.11 68.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.268 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -95.22 125.08 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.268 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 t -161.65 142.37 10.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -129.46 134.19 47.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.404 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.42 143.23 47.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -97.59 -5.14 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.265 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 28.5 t0 -153.42 163.85 39.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.566 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.14 -38.15 89.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -61.25 -45.77 93.16 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.594 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -66.05 -27.82 68.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.437 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -73.44 -40.55 64.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.864 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -66.89 -48.21 69.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.986 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.512 HG23 ' N ' ' A' ' 35' ' ' LEU . 30.8 m -65.33 -42.34 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.513 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.512 ' N ' HG23 ' A' ' 34' ' ' VAL . 37.5 mt -62.94 -43.32 99.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.788 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.5 p -67.6 -43.54 80.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 110.813 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -64.86 -35.52 81.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.65 -58.12 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.805 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.2 m -138.42 94.06 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.686 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.528 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 2.4 p -100.2 -2.73 33.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.342 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -145.75 126.17 14.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -110.94 111.25 22.25 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.159 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.649 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -70.56 156.34 39.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.391 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.04 125.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 47' ' ' ASP . 67.6 m-20 -147.24 149.43 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -72.15 16.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 45' ' ' ASP . 92.4 m-20 -112.07 -3.23 14.79 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -119.19 132.46 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.935 0.398 . . . . 0.0 110.276 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.603 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 72.6 p -101.84 157.52 16.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 51' ' ' ASP . 2.1 pp -48.9 -41.99 35.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.702 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.603 ' CG ' ' HG1' ' A' ' 49' ' ' THR . 1.4 p-10 -59.54 -49.33 78.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 110.337 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -35.52 81.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.316 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' O ' HG12 ' A' ' 57' ' ' VAL . 44.0 tp -61.76 -43.86 98.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.314 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.09 -40.61 98.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.381 0.61 . . . . 0.0 110.073 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.11 -43.61 82.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.855 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.37 -52.38 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.37 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.578 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.6 p -59.0 -46.09 91.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.977 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.578 ' N ' HG13 ' A' ' 57' ' ' VAL . 56.8 tp -65.59 -54.7 24.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.772 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -58.99 -31.69 69.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.845 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.19 -56.46 12.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.366 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.5 HG23 ' N ' ' A' ' 62' ' ' GLU . 34.0 m -69.1 -43.87 81.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.705 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.5 ' N ' HG23 ' A' ' 61' ' ' VAL . 81.6 tt0 -59.06 -44.8 91.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.285 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.7 p -63.05 -45.95 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.67 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -63.34 -52.65 60.91 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.412 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -110.58 73.21 0.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.543 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.01 -46.53 2.8 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.545 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.3 Cg_endo -82.39 107.1 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.353 2.035 . . . . 0.0 111.88 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.538 ' C ' ' H ' ' A' ' 70' ' ' GLU . 2.5 m -133.59 -13.51 2.59 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.252 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -51.02 -6.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.997 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.538 ' H ' ' C ' ' A' ' 68' ' ' CYS . 14.4 pt-20 -72.35 -36.96 68.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.505 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -83.65 156.53 22.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.624 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 19.2 p-10 -76.06 -59.65 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 74' ' ' ILE . 27.4 m -95.48 -44.87 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.554 ' N ' HG23 ' A' ' 73' ' ' VAL . 4.2 mt -70.11 -0.85 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.106 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.472 ' C ' ' N ' ' A' ' 77' ' ' LYS . . . -106.17 -41.08 1.85 Allowed Glycine 0 N--CA 1.465 0.616 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 76' ' ' THR . 55.2 m -48.77 -12.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.472 ' N ' ' C ' ' A' ' 75' ' ' GLY . 21.4 ptmt -56.42 -37.23 69.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.85 -45.67 94.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.803 0.335 . . . . 0.0 110.228 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 82.1 m -64.39 -48.0 77.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.03 82.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.268 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.53 -43.64 98.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.8 -40.7 92.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.65 -50.92 67.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.23 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 89' ' ' TYR . 36.3 ptt180 -69.67 -40.29 76.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 110.642 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.766 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.9 -40.33 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.29 -81.04 1.37 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 84' ' ' ARG . 99.7 m-20 -135.2 97.6 3.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 84' ' ' ARG . 0.3 OUTLIER -55.36 -100.67 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.436 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.5 m -146.38 162.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.524 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.06 142.15 50.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.941 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 93' ' ' PHE . 7.0 tt -122.35 125.63 46.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.306 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.548 ' N ' HD23 ' A' ' 92' ' ' LEU . 91.9 m-85 -128.09 154.29 45.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 23.3 t0 -74.88 177.52 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.5 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.508 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 8.5 tm-20 -47.03 -59.77 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.52 -46.86 91.4 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.24 -13.53 0.82 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.64 141.79 58.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 0.0 110.56 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -76.6 88.33 3.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.545 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -151.02 137.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.33 132.21 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 110.197 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.63 160.89 30.54 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.31 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 22.4 Cg_endo -61.46 -24.69 78.72 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.85 2.367 . . . . 0.0 111.94 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -125.36 57.2 1.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.783 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -102.59 144.65 30.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.012 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.466 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 57.4 t80 -97.34 127.43 43.29 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.308 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.1 p -125.39 112.29 16.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.466 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 5.4 p -171.46 168.76 6.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.772 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 110' ' ' SER . 44.5 p90 -63.5 -47.16 82.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.52 ' N ' ' CG ' ' A' ' 109' ' ' PHE . 17.1 m -59.43 144.14 47.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -77.83 170.64 15.3 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.562 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.5 Cg_exo -51.12 -42.03 54.96 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.383 2.055 . . . . 0.0 111.877 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 46.4 p-10 -88.1 -34.18 18.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 67.7 t0 . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -72.1 98.95 2.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.824 0.345 . . . . 0.0 110.764 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -61.28 -46.53 89.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.614 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.51 134.88 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.57 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -43.23 150.9 0.17 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.681 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -71.58 -59.58 2.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 p30 176.3 116.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.417 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 19.9 p-10 -150.41 -62.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.522 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 20.4 pttm -55.58 147.49 39.57 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.77 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 11' ' ' LYS . 45.2 Cg_endo -70.22 114.21 3.7 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.612 2.208 . . . . 0.0 111.961 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 10' ' ' PRO . 52.9 mtmt 32.38 -112.01 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.476 0.485 . . . . 0.0 110.724 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -133.42 18.71 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.549 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -138.27 137.33 37.36 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.443 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.91 142.43 54.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.501 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.7 mt -110.67 96.78 29.83 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.316 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.1 153.94 32.51 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -72.9 -6.67 46.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.57 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.412 ' HG1' ' HA ' ' A' ' 45' ' ' ASP . 3.0 t -129.17 170.19 13.85 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.57 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -148.81 160.0 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.52 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.63 141.72 33.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 21' ' ' ILE . 12.8 tt -107.33 128.94 61.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.04 16.81 10.84 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.227 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mt -108.05 131.4 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.152 0.501 . . . . 0.0 111.13 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.4 m -141.31 145.25 35.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.474 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 107' ' ' CYS . 87.4 t80 -85.0 114.79 22.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.365 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.95 142.38 46.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.529 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.72 -79.49 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.65 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.73 168.7 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.71 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.762 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.414 ' H ' HG22 ' A' ' 30' ' ' THR . 0.2 OUTLIER -55.85 -57.7 10.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.582 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -65.95 -23.62 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.288 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.48 -46.31 70.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -71.51 -39.32 70.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.494 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' THR . 71.4 t -61.8 -48.22 89.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.271 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.47 -42.92 91.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.967 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 40' ' ' SER . 10.6 t -62.62 -47.94 81.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.502 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.04 -45.75 92.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.727 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.86 65.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.5 t -164.08 78.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' SER . 61.2 p -83.14 -7.22 59.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.294 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -171.16 127.97 0.7 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 43' ' ' GLU . 21.0 t80 -128.76 158.16 39.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.181 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -109.58 116.79 32.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.42 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.82 129.67 75.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.206 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 47' ' ' ASP . 19.6 p-10 -113.94 169.02 9.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.985 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 55.7 mtpt -52.63 86.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.515 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER 167.8 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.449 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.4 t -76.85 129.84 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.311 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLU . 3.8 p -124.18 157.53 34.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -36.54 -39.3 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.646 -179.422 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -63.18 -45.95 89.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.445 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 49' ' ' THR . 46.0 tp10 -66.98 -38.44 86.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 57' ' ' VAL . 5.5 mt -62.45 -43.14 99.53 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 121.078 0.466 . . . . 0.0 110.617 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.619 HD23 ' O ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -67.64 -39.47 84.6 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.315 0.579 . . . . 0.0 110.656 -179.155 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.24 -44.18 80.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.68 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.553 HG13 ' N ' ' A' ' 57' ' ' VAL . 8.4 p -76.64 -45.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.848 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 53' ' ' LEU . 54.0 t -58.33 -47.6 87.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.499 HD21 ' CD1' ' A' ' 81' ' ' LEU . 19.9 tp -64.58 -56.47 13.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.311 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.05 -40.48 58.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.186 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.52 89.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 57' ' ' VAL . 75.7 t -62.2 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.755 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.75 -42.79 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.601 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -63.23 -54.86 30.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.901 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -62.24 -48.76 78.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.541 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.9 tp -108.54 93.57 4.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -79.15 -46.4 1.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.69 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.1 Cg_endo -83.93 116.39 2.15 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.102 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 m -130.64 -34.09 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.556 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -64.57 -28.03 69.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.589 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 70' ' ' GLU . 57.8 mp0 -73.33 -36.37 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 75' ' ' GLY . 92.7 m-70 -91.4 108.67 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.98 -29.85 70.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -59.66 -45.46 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 75' ' ' GLY . 7.0 mt -103.08 -10.75 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.602 ' C ' HG23 ' A' ' 76' ' ' THR . . . -48.09 -177.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.602 HG23 ' C ' ' A' ' 75' ' ' GLY . 2.0 p 73.74 -30.93 0.21 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.353 0.597 . . . . 0.0 110.642 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -62.24 -33.88 75.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.959 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 79' ' ' CYS . 11.3 p -59.68 -42.03 87.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.516 ' N ' HG13 ' A' ' 78' ' ' VAL . 83.2 m -63.43 -50.1 71.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.14 81.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.148 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.499 ' CD1' HD21 ' A' ' 58' ' ' LEU . 37.8 tp -50.99 -41.53 59.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.73 -49.88 75.72 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.141 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.01 -41.99 99.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.35 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -65.83 -41.02 92.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.539 ' C ' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt -62.56 -29.87 70.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.339 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.51 0.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.459 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . 171.14 -74.2 0.1 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 9.9 p-10 176.99 -74.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 1.8 t80 75.81 -71.14 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.1 t -52.9 131.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.337 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.567 ' CZ ' ' O ' ' A' ' 89' ' ' TYR . 37.1 m-85 -120.42 160.41 23.15 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.034 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.651 HD23 ' C ' ' A' ' 92' ' ' LEU . 8.6 tt -123.79 126.78 47.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.425 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.522 ' N ' HD23 ' A' ' 92' ' ' LEU . 62.0 m-85 -130.06 150.54 51.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.767 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -82.82 -158.89 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.457 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.53 -49.69 74.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.437 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.94 -113.22 0.15 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -154.05 45.8 0.56 Allowed Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -124.94 131.39 53.43 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.11 89.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.695 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -158.37 146.52 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 50' ' ' LEU . 13.1 mm -73.45 128.91 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.068 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -144.79 171.27 6.84 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.667 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 76.4 Cg_exo -49.72 -36.74 42.67 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.542 2.161 . . . . 0.0 111.93 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -130.91 131.29 44.4 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.667 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -162.39 167.82 23.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.387 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -139.21 142.17 37.9 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.501 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.9 t -114.28 113.49 24.66 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.0 p -162.22 170.87 18.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.887 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 110' ' ' SER . 44.9 p90 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.513 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 8.4 t -54.91 148.74 12.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.497 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -104.34 170.4 6.13 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.2 Cg_exo -51.32 -40.34 61.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.486 2.124 . . . . 0.0 111.903 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -81.6 35.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.426 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.524 -179.874 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.815 -1.314 . . . . 999.99000000000001 109.815 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.631 ' NZ ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -40.85 164.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.673 -0.264 . . . . 999.99000000000001 110.506 -179.356 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 1.03 ' HZ3' ' N ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -58.48 -153.3 0.0 OUTLIER 'General case' 0 C--N 1.343 0.317 0 C-N-CA 120.352 -0.539 . . . . 999.99000000000001 109.779 -179.699 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.03 ' N ' ' HZ3' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -31.19 -34.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 109.689 -0.485 . . . . 999.99000000000001 109.689 -179.325 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 1.013 ' H ' ' NZ ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 175.93 21.22 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.268 0.627 . . . . 999.99000000000001 112.064 177.692 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.553 ' CD2' ' OE1' ' A' ' 5' ' ' GLU . 22.2 m-85 -135.73 -39.97 0.7 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.332 1.234 . . . . 999.99000000000001 114.332 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.773 ' H ' ' CG ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -179.64 110.3 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 119.56 1.073 . . . . 999.99000000000001 113.851 -178.208 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 7' ' ' ASN . 7.8 t70 100.74 -132.6 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.418 -0.81 . . . . 999.99000000000001 111.458 178.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.579 ' NZ ' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -116.7 153.34 49.13 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 109.223 -0.658 . . . . 999.99000000000001 109.223 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.615 ' HA ' HG22 ' A' ' 4' ' ' VAL . 84.8 Cg_exo -39.39 120.79 0.67 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.239 1.959 . . . . 999.99000000000001 114.093 -178.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HG3' ' H ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -135.49 -83.77 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.266 -0.424 . . . . 999.99000000000001 110.601 179.134 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.88 HG23 ' H ' ' A' ' 13' ' ' ARG . 7.2 m -52.47 -95.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.043 -0.526 . . . . 999.99000000000001 111.378 -179.483 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.88 ' H ' HG23 ' A' ' 12' ' ' VAL . 48.2 ttp85 -39.22 172.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.01 0.433 . . . . 999.99000000000001 110.869 -178.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.512 ' N ' ' CG ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -70.84 138.75 50.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 999.99000000000001 110.015 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.6 mt -66.11 133.42 94.69 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.204 -0.453 . . . . 999.99000000000001 109.866 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 18' ' ' THR . 62.1 Cg_exo -44.81 151.4 0.65 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.615 1.544 . . . . 999.99000000000001 111.526 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 6.0 p -61.47 9.21 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 999.99000000000001 110.025 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.63 ' H ' ' C ' ' A' ' 16' ' ' PRO . 2.9 p -105.41 179.09 4.37 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-O 121.322 0.582 . . . . 999.99000000000001 111.615 -179.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -146.18 169.3 19.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.495 -0.775 . . . . 999.99000000000001 110.835 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -126.18 119.7 28.17 Favored 'General case' 0 C--N 1.267 -2.988 1 O-C-N 114.155 -5.341 . . . . 999.99000000000001 111.2 -174.186 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.585 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -104.25 145.97 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 114.963 -1.017 . . . . 885.66999999999996 110.443 -179.101 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.536 ' N ' HG13 ' A' ' 21' ' ' ILE . 14.1 tttt -134.85 10.67 3.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.142 -0.935 . . . . 999.99000000000001 110.042 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.585 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.4 mp -94.82 110.73 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.09 0.472 . . . . 999.99000000000001 111.354 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -119.63 137.59 53.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.449 -0.796 . . . . 999.99000000000001 109.66 179.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -86.14 114.9 23.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.101 0.477 . . . . 999.99000000000001 110.272 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.91 107.82 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 999.99000000000001 111.048 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.456 HD23 ' N ' ' A' ' 27' ' ' LEU . 6.4 mt -68.95 -40.02 79.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 999.99000000000001 109.536 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -151.62 172.25 16.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.794 -1.093 . . . . 999.99000000000001 109.125 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 32' ' ' ASP . . . -58.2 -26.5 62.87 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.584 -0.447 . . . . 999.99000000000001 109.999 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 32' ' ' ASP . 24.8 m -59.97 -63.89 1.14 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.958 -0.565 . . . . 999.99000000000001 110.287 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.493 ' O ' ' HB3' ' A' ' 35' ' ' LEU . 69.5 m-85 -75.68 16.4 0.39 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 119.091 0.859 . . . . 999.99000000000001 109.636 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.5 t0 -88.65 -64.79 1.09 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.07 -1.456 . . . . 999.99000000000001 107.07 177.038 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.3 p -67.8 -41.37 83.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.256 -0.884 . . . . 999.99000000000001 109.046 177.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.497 HG11 HD22 ' A' ' 65' ' ' LEU . 66.6 t -66.51 -50.3 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 112.787 0.662 . . . . 825.48000000000002 112.787 -178.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 31' ' ' PHE . 12.9 tp -64.96 -41.73 95.22 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.678 -0.809 . . . . 715.35000000000002 110.448 -178.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.54 -44.64 95.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.978 -0.289 . . . . 999.99000000000001 111.411 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -63.18 -45.57 91.16 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.365 0.506 . . . . 999.99000000000001 112.365 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 64' ' ' THR . . . -77.35 -28.28 52.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.227 -0.442 . . . . 999.99000000000001 110.758 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 42' ' ' PHE . 6.9 t -147.66 80.83 1.5 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.398 0.888 . . . . 999.99000000000001 113.398 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 p -91.45 -14.96 29.61 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.834 -0.621 . . . . 999.99000000000001 109.609 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -151.33 144.6 24.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.685 0.994 . . . . 999.99000000000001 113.685 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.581 ' CD2' ' SG ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -140.48 147.44 39.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.168 -0.923 . . . . 999.99000000000001 111.23 177.862 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -110.59 119.12 38.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.736 -0.666 . . . . 999.99000000000001 110.207 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.643 HG12 ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -121.61 111.27 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 114.711 1.374 . . . . 999.99000000000001 114.711 -176.698 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.89 161.11 10.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 105.307 -2.109 . . . . 999.99000000000001 105.307 175.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 17' ' ' SER . 1.2 mtpm? -83.44 35.99 0.52 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 122.403 2.365 . . . . 999.99000000000001 110.376 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -131.94 2.38 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.883 -0.784 . . . . 999.99000000000001 108.883 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.643 ' HB ' HG12 ' A' ' 44' ' ' VAL . 19.0 t -88.63 124.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.498 -0.774 . . . . 999.99000000000001 109.62 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 52' ' ' GLU . 35.0 p -103.19 147.82 26.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 533.5 109.888 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.657 ' N ' HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -33.77 -34.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 304.88 110.938 -178.844 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' THR . 98.3 m-20 -60.7 -48.6 81.04 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 698.47000000000003 110.519 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.9 mt-10 -68.24 -38.14 81.53 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.31 -0.405 . . . . 999.99000000000001 110.385 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.25 -45.83 92.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.142 -0.688 . . . . 499.30000000000001 109.142 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.476 ' CD2' HG23 ' A' ' 90' ' ' VAL . 1.9 mt -63.39 -41.95 98.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.537 -0.756 . . . . 404.06 110.266 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.37 -50.4 73.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.525 -0.761 . . . . 805.60000000000002 111.285 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.8 -36.45 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.821 0.344 . . . . 843.98000000000002 110.925 -179.219 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.38 -48.24 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 353.45999999999998 110.351 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.931 HD11 ' CD1' ' A' ' 81' ' ' LEU . 32.2 tp -63.94 -44.06 93.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.204 -0.907 . . . . 501.13 109.811 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.71 -43.08 97.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.984 -0.553 . . . . 999.99000000000001 111.211 179.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.79 84.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.748 0.309 . . . . 763.22000000000003 110.972 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.7 t -64.24 -42.01 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 599.86000000000001 110.384 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.16 -39.71 93.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 999.99000000000001 109.968 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -42.07 86.07 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.3 -0.409 . . . . 999.99000000000001 111.69 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -75.73 -44.88 39.62 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.598 -0.441 . . . . 999.99000000000001 110.895 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 34' ' ' VAL . 3.0 tp -108.11 71.7 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 999.99000000000001 110.713 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.532 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -78.14 -45.47 2.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 999.99000000000001 110.82 179.42 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 66' ' ' SER . 72.8 Cg_endo -80.42 56.89 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.884 2.39 . . . . 999.99000000000001 113.365 -179.554 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.55 -33.27 25.49 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.935 0.398 . . . . 845.47000000000003 110.318 179.235 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.93 -20.44 65.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.784 -0.644 . . . . 999.99000000000001 111.587 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.79 -38.36 70.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.646 -0.252 . . . . 999.99000000000001 111.451 -178.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -87.78 120.56 29.23 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.95 -0.3 . . . . 999.99000000000001 110.388 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.83 -41.31 97.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.509 0.195 . . . . 999.99000000000001 111.284 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.85 -47.67 92.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 999.99000000000001 110.252 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 75' ' ' GLY . 30.7 mt -81.62 -26.76 9.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 115.975 -0.557 . . . . 999.99000000000001 110.666 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -22.79 -78.93 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 N-CA-C 111.189 -0.764 . . . . 655.89999999999998 111.189 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -25.85 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.942 0.719 . . . . 866.77999999999997 112.942 -178.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -56.02 -29.59 60.6 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.348 -0.22 . . . . 999.99000000000001 110.941 179.635 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 68' ' ' CYS . 2.6 t -68.18 -46.2 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 110.16 -0.311 . . . . 812.96000000000004 110.16 178.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.86 -43.77 97.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.0 -0.545 . . . . 771.90999999999997 110.127 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.08 92.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 483.48000000000002 109.793 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.931 ' CD1' HD11 ' A' ' 58' ' ' LEU . 58.1 tp -62.65 -45.0 94.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.798 -0.637 . . . . 703.45000000000005 110.331 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 82' ' ' LEU . 16.1 tp -62.95 -43.2 99.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.877 -0.601 . . . . 999.99000000000001 110.137 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -64.44 -38.74 92.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.158 -0.474 . . . . 999.99000000000001 110.143 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 97.0 mtt180 -65.73 -39.87 91.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.999 0.428 . . . . 999.99000000000001 110.531 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tp -73.5 -24.52 60.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 985.92999999999995 110.169 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.8 99.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.108 -0.496 . . . . 999.99000000000001 111.941 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.27 -55.79 0.07 OUTLIER Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.238 -0.982 . . . . 999.99000000000001 112.211 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 99.4 m-20 -87.88 115.81 25.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 999.99000000000001 110.119 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.473 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.4 p90 -109.6 -111.36 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.559 -0.291 . . . . 999.99000000000001 110.385 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -150.73 115.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.373 -0.973 . . . . 390.25999999999999 108.373 178.423 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.17 160.55 32.24 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.02 -1.104 . . . . 421.31 108.02 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.938 HD12 ' HB2' ' A' ' 107' ' ' CYS . 3.2 tt -146.49 134.74 21.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 120.002 1.274 . . . . 247.34 107.968 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.08 162.73 37.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.186 -0.606 . . . . 999.99000000000001 112.152 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -77.65 -177.98 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.313 -0.858 . . . . 841.49000000000001 110.719 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -74.69 49.82 0.41 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.06 -0.518 . . . . 999.99000000000001 110.609 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -152.45 -53.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.573 -1.011 . . . . 951.75999999999999 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.49 -19.51 2.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.224 -1.151 . . . . 633.38 110.224 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -70.78 136.93 49.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.34 -0.244 . . . . 774.99000000000001 110.34 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.526 ' HB3' HD21 ' A' ' 50' ' ' LEU . 96.7 mt-10 -74.89 89.93 2.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.898 -0.408 . . . . 691.20000000000005 109.898 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.02 149.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 455.33999999999997 110.502 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.657 HD11 ' N ' ' A' ' 50' ' ' LEU . 4.1 mp -89.86 123.18 41.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.535 -0.543 . . . . 501.24000000000001 109.535 179.131 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -139.48 178.15 1.74 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.83 -0.623 . . . . 635.24000000000001 109.653 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 50.8 Cg_exo -53.74 -35.87 80.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.317 2.011 . . . . 999.99000000000001 111.603 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -121.97 97.9 5.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.94 -0.573 . . . . 999.99000000000001 110.715 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.593 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -116.31 132.2 56.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.045 -0.525 . . . . 524.37 110.542 -179.83 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.489 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 73.8 t80 -92.73 106.07 18.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.367 -0.379 . . . . 650.22000000000003 109.993 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.938 ' HB2' HD12 ' A' ' 92' ' ' LEU . 4.1 t -98.24 118.57 35.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.187 -0.46 . . . . 456.19999999999999 110.942 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.489 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 11.5 t -174.41 168.45 3.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.149 0.499 . . . . 573.24000000000001 110.856 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.588 ' N ' HG12 ' A' ' 90' ' ' VAL . 25.7 p90 -87.79 25.08 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.201 -0.666 . . . . 999.99000000000001 109.201 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.0 m -117.36 121.65 41.7 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.815 -0.63 . . . . 956.63999999999999 110.021 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.74 162.02 2.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.611 -0.722 . . . . 699.55999999999995 110.985 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -46.04 35.48 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.576 2.184 . . . . 999.99000000000001 112.135 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.5 p-10 -74.65 -36.5 62.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.999 0.904 . . . . 999.99000000000001 109.09 177.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 t0 . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 113.624 -1.626 . . . . 999.99000000000001 110.347 179.523 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 2.6 p . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.868 0.366 . . . . 999.99 110.591 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.409 ' O ' HG23 ' A' ' 44' ' ' VAL . 67.3 mtp180 -103.11 137.81 40.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.313 -0.625 . . . . 999.99 109.313 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 97.5 mttt -95.53 114.59 26.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.211 0.529 . . . . 999.99 111.16 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.642 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -100.68 147.1 8.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.268 -0.878 . . . . 885.67 110.178 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' N ' HG13 ' A' ' 21' ' ' ILE . 11.7 tttt -134.78 11.72 3.68 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.667 -0.697 . . . . 999.99 110.783 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.642 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.7 mp -95.85 111.47 26.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.931 0.396 . . . . 999.99 110.697 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.44 130.68 53.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 999.99 110.293 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -78.02 113.19 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.099 0.476 . . . . 999.99 110.41 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.26 107.85 19.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 999.99 110.756 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.4 mt -68.11 -40.06 82.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 999.99 110.181 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -154.08 170.2 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 999.99 109.891 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.97 25.23 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.331 -0.395 . . . . 999.99 110.1 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 32' ' ' ASP . 17.1 m -58.71 -64.68 0.84 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.726 -0.67 . . . . 999.99 110.405 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.509 ' O ' ' HB3' ' A' ' 35' ' ' LEU . 77.9 m-85 -75.93 16.49 0.41 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.357 0.526 . . . . 999.99 109.967 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.0 t0 -88.51 -65.5 1.01 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.65 -0.87 . . . . 999.99 108.65 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.2 p -73.1 -33.51 65.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.471 -0.786 . . . . 999.99 109.7 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.606 HG11 HD22 ' A' ' 65' ' ' LEU . 66.3 t -70.9 -50.1 45.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.077 -0.51 . . . . 825.48 111.457 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 31' ' ' PHE . 16.9 tp -64.05 -41.73 97.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 119.91 -0.716 . . . . 715.35 110.521 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -62.68 -45.65 91.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.353 -0.385 . . . . 999.99 110.937 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -64.35 -39.69 94.38 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.906 0.335 . . . . 999.99 111.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.55 -27.33 31.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 999.99 110.654 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.568 ' HG ' ' HD2' ' A' ' 42' ' ' PHE . 2.9 t -147.78 85.3 1.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 999.99 111.982 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 p -97.13 -16.28 20.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.878 -0.601 . . . . 999.99 110.094 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' CG ' ' HE3' ' A' ' 22' ' ' LYS . 41.4 mt-10 -152.03 144.48 24.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.047 -0.979 . . . . 999.99 112.067 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HD2' ' HG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -142.94 141.76 31.52 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.764 -0.653 . . . . 999.99 111.564 179.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 16.5 pt-20 -105.91 115.31 30.01 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.814 -0.63 . . . . 999.99 110.508 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.544 HG12 ' CB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -119.89 111.95 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.854 0.835 . . . . 999.99 112.644 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 2.2 m-20 -57.73 170.76 0.55 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.014 -1.448 . . . . 999.99 107.667 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -87.89 31.67 0.77 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.295 1.861 . . . . 999.99 110.084 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -133.72 -3.9 2.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 999.99 109.817 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.544 ' CB ' HG12 ' A' ' 44' ' ' VAL . 19.2 t -79.53 126.15 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.877 -0.601 . . . . 999.99 109.996 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' GLU . 19.8 p -103.18 145.66 29.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.907 -0.588 . . . . 533.5 110.178 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.676 ' N ' HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -30.31 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.773 0.671 . . . . 304.88 110.882 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' THR . 97.6 m-20 -60.22 -49.48 77.45 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.326 -0.397 . . . . 698.47 110.598 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.3 mt-10 -66.78 -38.95 87.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 999.99 110.55 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.08 -46.02 92.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.695 -0.483 . . . . 499.3 109.695 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.435 ' CD2' HG23 ' A' ' 90' ' ' VAL . 1.6 mt -63.32 -40.96 98.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 404.06 110.432 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -60.64 -51.52 69.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 805.6 111.064 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.86 -35.8 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.779 0.323 . . . . 843.98 110.795 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.28 -48.04 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.06 -0.518 . . . . 353.46 110.653 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.959 HD11 ' CD1' ' A' ' 81' ' ' LEU . 30.5 tp -65.1 -43.38 92.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 501.13 110.136 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -64.62 -42.08 95.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.931 -0.577 . . . . 999.99 110.78 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . -61.4 -50.95 70.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 763.22 110.828 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.76 -40.82 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 599.86 110.555 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -66.35 -36.91 84.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.927 -0.578 . . . . 999.99 110.36 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -41.78 75.58 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.229 -0.441 . . . . 999.99 111.221 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -74.22 -48.59 27.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.423 -0.353 . . . . 999.99 110.871 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.606 HD22 HG11 ' A' ' 34' ' ' VAL . 3.7 tp -106.23 72.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 999.99 110.438 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -78.23 -49.3 1.89 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 999.99 110.678 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 66' ' ' SER . 59.8 Cg_endo -76.53 63.18 7.22 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.859 2.372 . . . . 999.99 112.423 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -91.86 -31.67 15.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 845.47 110.518 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HB2' HG21 ' A' ' 78' ' ' VAL . 81.0 tttt -65.69 -16.52 63.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 999.99 110.873 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.78 -39.81 66.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.401 -0.363 . . . . 999.99 110.956 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 75' ' ' GLY . 99.0 m-70 -86.73 118.52 26.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 999.99 110.281 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.06 -40.64 94.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 999.99 110.947 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -47.24 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 999.99 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 43.1 mt -83.27 -29.68 8.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.144 -0.48 . . . . 999.99 110.612 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -21.71 -76.03 0.01 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 110.863 -0.895 . . . . 655.9 110.863 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -25.0 -35.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.016 0.48 . . . . 866.78 112.169 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -53.93 -29.75 43.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.267 -0.173 . . . . 999.99 110.606 179.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 69' ' ' LYS . 2.6 t -68.77 -46.9 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.781 0.324 . . . . 812.96 110.389 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 m -61.79 -44.64 96.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.938 -0.574 . . . . 771.91 110.228 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.02 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.962 -0.563 . . . . 483.48 110.224 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.959 ' CD1' HD11 ' A' ' 58' ' ' LEU . 58.3 tp -62.67 -45.31 93.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.078 -0.51 . . . . 703.45 110.479 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 82' ' ' LEU . 16.0 tp -63.2 -43.32 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 999.99 110.345 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.3 -40.08 96.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 999.99 110.43 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 91.7 mtt180 -65.33 -40.0 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 999.99 110.745 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tp -74.94 -19.37 60.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.947 -0.57 . . . . 985.93 110.389 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.76 -45.13 94.12 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.364 -0.38 . . . . 999.99 111.097 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.55 -56.3 0.06 OUTLIER Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.939 -0.648 . . . . 999.99 111.505 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 92.0 m-20 -84.15 112.81 20.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.34 -0.244 . . . . 999.99 110.34 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.505 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.2 p90 -108.62 -110.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.323 . . . . 999.99 110.474 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -151.39 115.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.331 -0.618 . . . . 390.26 109.331 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -73.84 155.27 38.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.262 -0.644 . . . . 421.31 109.262 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.946 HD12 ' HB2' ' A' ' 107' ' ' CYS . 3.8 tt -142.35 135.19 28.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.723 -0.843 . . . . 247.34 108.723 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.51 163.73 32.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.882 0.372 . . . . 999.99 111.011 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -79.49 -175.73 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 841.49 110.36 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.08 50.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.145 -0.479 . . . . 999.99 110.687 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.39 -55.62 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.778 -0.929 . . . . 951.76 110.778 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.76 -20.3 2.18 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.572 -1.011 . . . . 633.38 110.572 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -72.33 136.8 46.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.739 0.304 . . . . 774.99 110.588 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.532 ' HB3' HD21 ' A' ' 50' ' ' LEU . 96.8 mt-10 -74.21 89.83 2.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 691.2 110.28 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.62 151.13 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 455.34 110.456 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.676 HD11 ' N ' ' A' ' 50' ' ' LEU . 4.1 mp -90.45 123.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.546 . . . . 501.24 110.208 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.85 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -141.28 177.49 1.91 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 635.24 110.399 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.85 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 53.2 Cg_exo -51.51 -36.79 60.81 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.704 2.269 . . . . 999.99 111.979 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -123.21 98.0 5.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.212 -0.449 . . . . 999.99 110.499 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.635 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -116.01 134.84 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.536 . . . . 524.37 110.4 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 70.7 t80 -94.87 106.23 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 650.22 110.147 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.946 ' HB2' HD12 ' A' ' 92' ' ' LEU . 4.3 t -98.64 120.76 39.63 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.107 -0.497 . . . . 456.2 110.669 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.509 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 10.4 t -177.38 167.2 2.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.188 0.518 . . . . 573.24 110.738 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.609 ' N ' HG12 ' A' ' 90' ' ' VAL . 26.0 p90 -85.68 26.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 999.99 109.982 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.1 m -119.77 121.1 38.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.259 -0.428 . . . . 956.64 110.552 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -53.54 161.35 1.56 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.854 -0.612 . . . . 699.56 110.418 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.5 Cg_exo -50.58 -47.46 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.558 2.172 . . . . 999.99 112.324 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 24.7 p-10 -72.95 -38.28 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 999.99 110.409 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 114.429 -1.259 . . . . 999.99 110.032 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -113.83 171.3 7.67 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -112.52 147.39 36.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.37 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 21' ' ' ILE . 10.8 tp -108.65 134.29 51.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.05 -2.42 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mt -102.52 122.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.41 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -147.41 144.2 28.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.455 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.55 119.61 23.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.29 36.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -64.88 -40.5 95.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.569 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.3 t0 -156.25 -175.82 5.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -61.1 -42.91 99.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.53 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' VAL . 75.3 m -63.12 -47.56 82.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.563 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.411 ' HB2' ' H ' ' A' ' 28' ' ' ASP . 64.0 m-85 -65.34 -33.46 76.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.447 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -65.46 -51.49 59.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.826 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 t -63.67 -44.86 92.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.749 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 30' ' ' THR . 69.9 t -62.73 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.84 -43.4 96.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.705 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.27 -45.79 91.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.59 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -65.25 -44.39 88.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.728 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.27 -54.52 14.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.472 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 60' ' ' ALA . 60.8 m -118.58 79.22 1.35 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.562 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.46 -37.96 89.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.476 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -172.63 150.48 2.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.604 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -142.12 156.94 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.84 124.66 32.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.985 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 m -124.6 135.64 63.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.093 0.473 . . . . 0.0 110.592 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.24 168.57 19.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.145 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -73.7 161.25 30.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 56.96 33.86 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.678 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -75.14 140.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.242 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 20.3 p -90.76 -71.36 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 172.17 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.771 0.669 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 26.5 p-10 -55.88 -44.46 78.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.919 0.39 . . . . 0.0 110.451 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 79.5 tt0 -64.61 -41.24 96.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.419 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' VAL . 19.3 mt -62.95 -43.64 98.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.83 -43.21 96.88 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.839 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -67.92 -43.05 80.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.022 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.71 -50.48 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 53' ' ' LEU . 76.4 t -57.54 -48.21 83.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 81' ' ' LEU . 54.0 tp -64.92 -55.73 17.52 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.622 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -51.66 -41.82 61.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.304 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.445 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -62.51 -42.44 99.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.588 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 57' ' ' VAL . 53.9 t -63.91 -45.3 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.703 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.59 -42.17 82.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.589 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 t -61.34 -54.37 44.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.794 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.1 p -59.75 -45.42 92.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.152 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -108.01 81.34 1.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.55 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.63 -46.61 4.18 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 66' ' ' SER . 61.1 Cg_endo -81.91 106.4 1.61 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.335 2.023 . . . . 0.0 112.009 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.401 ' SG ' ' CG2' ' A' ' 78' ' ' VAL . 1.4 p -133.25 -42.0 0.88 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.871 0.367 . . . . 0.0 110.208 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -66.9 -22.91 65.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -72.29 -38.64 68.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.732 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 75' ' ' GLY . 77.0 m80 -97.66 125.3 42.36 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.76 -34.98 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.064 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.27 -45.98 95.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.073 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 31.8 mm -88.59 -22.38 6.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.201 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -37.71 -56.18 1.68 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.8 p -46.58 -19.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.722 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 88.9 tttt -62.03 -45.96 91.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.588 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 74.1 t -62.61 -44.53 99.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.57 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 77.9 m -62.0 -49.43 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.78 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 58' ' ' LEU . 5.5 tt -63.28 -44.53 94.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.72 -43.61 98.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 87' ' ' GLY . 33.2 t70 -62.11 -44.27 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 88' ' ' ASP . 87.5 mtm180 -66.83 -36.99 83.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.816 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.21 -46.33 87.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.406 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.21 -49.85 2.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.46 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -69.23 -95.65 0.05 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 83' ' ' ASP . 99.7 m-20 -68.92 -172.11 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.574 0.226 . . . . 0.0 110.495 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CE1' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER 173.45 175.06 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.092 0.472 . . . . 0.0 110.322 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.27 138.29 47.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.436 ' OH ' ' CE1' ' A' ' 89' ' ' TYR . 54.5 m-85 -110.11 151.52 27.14 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.509 ' C ' HD23 ' A' ' 92' ' ' LEU . 7.1 tt -131.29 124.6 30.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.487 ' N ' HD23 ' A' ' 92' ' ' LEU . 82.0 m-85 -132.76 154.68 50.0 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.694 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 97' ' ' GLY . 18.8 p-10 -82.98 177.41 8.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.16 26.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -144.3 -4.6 0.66 Allowed Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.559 ' N ' ' OD1' ' A' ' 94' ' ' ASP . . . 91.75 -6.27 79.73 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 45.1 t0 -86.9 117.19 25.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.791 0.329 . . . . 0.0 110.464 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 100' ' ' VAL . 95.6 mt-10 -55.6 86.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.521 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 99' ' ' GLU . 67.7 t -156.83 134.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.47 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 101' ' ' ILE . 1.6 mp -68.92 131.44 33.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.678 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -146.06 172.0 5.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.582 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.1 Cg_exo -51.46 -35.69 56.1 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.598 2.199 . . . . 0.0 111.812 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' A' ' 103' ' ' PRO . 1.5 mpt_? -118.63 74.23 0.96 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.002 0.43 . . . . 0.0 110.392 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -104.79 148.69 26.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.165 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.485 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 57.3 t80 -116.82 124.89 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.48 ' SG ' ' CD1' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -123.5 110.36 14.98 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.485 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 7.1 p -168.38 169.3 10.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.804 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 109' ' ' PHE . 30.1 t80 -62.46 -47.36 84.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -59.34 145.69 42.44 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.403 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.675 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -80.58 170.79 14.26 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.443 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.675 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.3 Cg_exo -51.32 -42.29 55.1 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.526 2.15 . . . . 0.0 111.84 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.05 -41.11 97.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.02 0.438 . . . . 0.0 110.755 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.762 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 110.438 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' OG1' ' A' ' 18' ' ' THR . 33.7 ptt180 -139.24 167.18 22.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.358 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -116.17 146.7 42.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 21' ' ' ILE . 8.3 tt -130.26 122.4 53.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.36 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -99.42 121.5 41.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.922 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.17 115.0 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.165 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -154.54 117.8 4.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -134.11 138.65 45.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.958 0.409 . . . . 0.0 110.425 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 143.11 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.6 mt -139.78 -79.72 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 21.9 p-10 -156.94 -62.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.583 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.513 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -178.11 -68.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.453 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -62.02 -51.21 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -69.73 -20.77 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.352 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.89 -52.86 17.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 36' ' ' SER . 78.1 p -68.46 -41.54 80.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.634 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 30' ' ' THR . 70.5 t -63.08 -45.63 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.71 -42.63 99.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 78.3 p -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.74 -41.2 96.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.678 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.486 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -59.31 -24.15 63.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.634 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 38' ' ' ALA . 8.5 m -162.42 63.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.569 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.4 p -68.49 -18.77 64.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.519 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -174.45 139.43 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 156.15 46.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.086 0.469 . . . . 0.0 110.181 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -119.51 113.83 21.34 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.973 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.58 133.82 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.255 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.42 141.1 28.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.317 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 64.3 tttp -47.56 101.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.94 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD2' ' C ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER 163.38 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.712 0.632 . . . . 0.0 110.3 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.76 136.91 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 110.454 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -92.42 155.52 17.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.05 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -42.65 -37.73 1.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.22 -43.59 95.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.211 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -65.61 -35.36 80.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 57' ' ' VAL . 18.6 mt -61.53 -46.83 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.53 -41.58 98.46 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.452 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -43.14 99.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.93 -45.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-O 120.955 0.407 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 53' ' ' LEU . 54.6 t -58.04 -48.37 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.894 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.7 -53.67 47.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.98 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -49.86 -42.6 47.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.829 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.93 -49.66 74.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.942 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.59 -48.06 90.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.247 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' HA ' HD23 ' A' ' 65' ' ' LEU . 14.8 mm-40 -45.32 -53.39 8.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.398 0.618 . . . . 0.0 110.414 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 t -60.08 -43.44 95.48 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.5 p -86.04 14.34 6.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.118 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.73 -24.01 23.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 110.212 179.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.479 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -41.33 -49.96 8.82 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.582 -178.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 66' ' ' SER . 50.2 Cg_exo -53.04 -39.75 78.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.149 1.899 . . . . 0.0 112.218 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.8 m -68.02 -34.28 76.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.597 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -60.92 -30.45 70.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.517 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.62 -33.64 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.475 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 75' ' ' GLY . 97.8 m-70 -97.05 118.49 33.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.238 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.0 p-10 -68.5 -35.38 77.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 78.1 t -61.57 -47.85 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 76' ' ' THR . 58.6 mt -88.42 -34.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.391 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -39.89 -21.75 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' ILE . 46.2 p -54.76 -29.73 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.103 0.478 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -32.89 66.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 65' ' ' LEU . 91.7 t -62.09 -46.17 97.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.43 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 94.2 m -63.66 -39.13 93.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.8 -43.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.82 -41.45 99.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.4 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.58 -41.9 99.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.566 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 87' ' ' GLY . 40.0 t0 -62.19 -43.11 99.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -69.5 -37.61 77.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.518 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.61 -43.11 99.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.464 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.68 -12.15 22.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.556 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -119.78 57.17 0.57 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 63.51 98.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.086 0.469 . . . . 0.0 110.504 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -55.29 -100.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.12 162.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.157 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -116.29 139.77 50.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.861 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.87 132.58 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -140.98 154.78 46.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.644 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -85.13 -162.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.564 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -73.01 51.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.566 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.43 -90.15 0.08 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.5 -29.07 0.02 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.31 139.93 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -80.96 90.24 5.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -146.61 138.52 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.516 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.749 HD12 ' N ' ' A' ' 101' ' ' ILE . 2.5 mp -71.47 131.66 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -145.8 172.56 5.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.631 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 53.3 Cg_exo -51.17 -36.29 55.18 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.559 2.173 . . . . 0.0 112.162 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -132.73 103.09 5.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -122.55 148.42 45.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.214 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -101.79 119.9 39.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.06 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.32 112.97 20.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.476 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 t -177.34 168.77 2.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.847 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 -45.48 93.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.6 p -59.14 147.06 36.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.281 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -87.53 170.07 12.75 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.457 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 54.8 Cg_exo -50.15 -43.97 40.22 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.414 2.076 . . . . 0.0 111.931 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 31.5 p-10 -90.07 -37.84 13.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.97 0.415 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 61.2 t0 . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.545 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 2.3 t . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.778 0.323 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 44' ' ' VAL . 84.8 mtp180 -105.26 140.95 37.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.957 0.408 . . . . 0.0 110.292 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -105.53 148.6 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.133 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.2 tp -127.69 135.12 63.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.307 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -137.8 -35.23 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.817 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.3 140.52 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.263 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -155.26 144.76 21.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.35 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.39 137.84 55.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 116.11 22.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.584 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.418 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 54.1 mt -62.06 -42.86 99.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.456 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 61.8 m-20 -158.77 20.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 28' ' ' ASP . . . 73.81 -51.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m -61.36 -53.53 55.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.285 0.565 . . . . 0.0 110.696 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -71.24 -27.33 63.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.922 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.89 -44.51 97.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.255 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.0 p -70.35 -42.21 72.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.29 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.7 -48.88 86.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.383 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.37 -40.73 96.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.498 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 40' ' ' SER . 75.1 m -56.3 -43.38 78.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.09 89.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.502 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.34 2.7 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.861 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 18.2 p -174.45 54.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.108 0.48 . . . . 0.0 110.286 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 36' ' ' SER . 78.0 p -60.11 -36.97 78.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.754 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -136.59 125.67 24.47 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.453 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -129.82 131.63 46.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.48 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -91.48 126.67 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.15 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 19' ' ' ARG . 47.1 t -122.48 126.19 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.115 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -48.84 160.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 22.6 pttm -59.72 -50.03 75.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.036 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 49.9 t0 -91.63 90.36 7.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -147.71 128.23 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.275 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -90.48 151.67 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.228 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -48.69 -32.86 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.375 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -51.11 71.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.289 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 56' ' ' VAL . 82.4 tt0 -64.66 -41.71 95.92 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.71 HD13 ' C ' ' A' ' 53' ' ' LEU . 2.8 tm? -61.78 -50.72 71.22 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.599 HD11 ' NH2' ' A' ' 84' ' ' ARG . 60.8 tp -50.73 -41.72 56.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.14 -35.8 71.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 52' ' ' GLU . 44.4 t -69.7 -51.78 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 58' ' ' LEU . 14.8 p -61.39 -42.7 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.908 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.521 ' N ' HG13 ' A' ' 57' ' ' VAL . 57.4 tp -60.45 -54.5 44.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.28 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -53.89 -41.72 67.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.88 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.31 -46.66 82.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.543 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.84 -43.71 97.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.437 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.564 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -62.63 -44.08 97.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.822 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.2 p -68.53 -64.81 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.725 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.41 83.35 2.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.569 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -74.87 -45.73 5.06 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.322 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.8 Cg_endo -83.25 114.32 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.599 2.2 . . . . 0.0 111.987 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.76 -19.39 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.0 -9.84 48.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.759 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.55 -38.5 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.472 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.1 m-70 -103.16 124.58 48.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.3 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.6 p-10 -60.58 -34.98 74.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.353 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.513 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 82.9 t -62.32 -47.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 45.9 mt -82.45 -23.37 9.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -34.91 -61.01 0.64 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -40.05 -24.38 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.95 0.405 . . . . 0.0 110.784 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 66.0 tttm -58.67 -45.39 89.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.213 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.1 t -57.4 -44.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.37 -46.52 88.3 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.73 -38.5 91.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.242 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.39 -42.7 99.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -62.35 -45.92 91.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 0.0 110.09 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.93 -45.48 94.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.599 ' NH2' HD11 ' A' ' 54' ' ' LEU . 83.1 mtp180 -66.08 -39.43 90.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.076 0.465 . . . . 0.0 110.751 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.88 -29.25 69.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.44 59.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.498 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 168.62 -65.35 0.18 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 89' ' ' TYR . 28.0 t70 -173.89 176.0 2.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.548 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.545 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 t80 -175.18 -68.53 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.3 m -66.1 133.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.308 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 65.4 m-85 -116.87 145.89 43.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.617 ' C ' HD23 ' A' ' 92' ' ' LEU . 7.7 tt -117.02 125.73 51.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.509 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.57 ' N ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -126.37 152.26 46.54 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.284 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 46.6 t0 -74.52 179.16 4.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.165 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 80.5 mm-40 -65.68 -37.54 86.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.66 -3.47 87.0 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.61 78.97 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.1 t0 -88.5 111.08 21.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -50.62 87.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.306 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 76.0 t -152.87 130.8 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.521 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.59 134.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.031 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -155.59 171.82 6.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.579 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 58.0 Cg_exo -50.83 -38.07 56.53 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.414 2.076 . . . . 0.0 111.993 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -130.86 131.79 44.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.315 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.533 ' HB2' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -153.4 173.87 15.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.02 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -117.98 109.73 16.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.343 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.8 t -107.55 115.74 30.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.534 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 t -172.59 177.34 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.527 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -89.72 40.85 1.01 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.617 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.2 m -136.91 116.1 12.54 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.449 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.609 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -61.96 170.38 2.08 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.541 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 49.0 Cg_exo -54.45 -43.13 61.66 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.428 2.085 . . . . 0.0 112.267 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -93.79 12.73 24.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.583 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.529 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 C--O 1.229 0.025 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' VAL . 62.6 ttp180 -110.53 151.83 27.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -112.42 144.96 40.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.069 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tp -119.32 142.8 32.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -130.74 -15.21 3.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.37 126.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 110.567 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 m -138.13 137.61 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.384 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.8 131.25 50.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.213 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.77 137.1 43.09 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.552 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.9 mm? -63.89 -41.42 97.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -159.59 179.07 9.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.83 83.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.499 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -63.2 -50.85 68.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.513 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -70.31 -22.69 62.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.65 -52.65 50.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 0.0 110.346 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -67.87 -44.6 76.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.34 -46.45 95.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.27 -43.55 97.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.592 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.3 t -60.58 -42.74 97.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -63.61 -44.47 93.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.549 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.17 -78.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 31.6 t -87.14 64.34 8.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.5 t -62.33 -41.28 98.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -154.28 148.11 25.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 81.8 t80 -150.28 150.12 31.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.495 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 16.7 pt-20 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.238 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 19' ' ' ARG . 65.4 t -127.89 133.27 67.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.116 0.484 . . . . 0.0 110.472 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 48' ' ' VAL . 91.5 m-20 -81.2 170.08 16.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.228 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.81 152.23 20.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.086 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.12 41.55 10.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.587 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.625 HG12 ' N ' ' A' ' 49' ' ' THR . 62.7 t -89.22 166.85 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.625 ' N ' HG12 ' A' ' 48' ' ' VAL . 31.0 m -121.71 129.33 52.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.26 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -37.61 -27.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.697 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 49' ' ' THR . 64.2 t0 -60.03 -46.92 87.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.055 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 80.7 mm-40 -64.88 -41.95 95.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.367 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.469 ' O ' HG12 ' A' ' 57' ' ' VAL . 51.2 tp -62.59 -41.36 98.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.213 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.83 -44.61 95.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.754 0.788 . . . . 0.0 110.367 -178.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.36 -42.49 68.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.543 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' GLU . 56.0 t -66.72 -51.27 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.071 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.549 HG13 ' N ' ' A' ' 58' ' ' LEU . 9.3 p -58.17 -43.93 86.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' N ' HG13 ' A' ' 57' ' ' VAL . 58.1 tp -60.06 -52.22 66.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.257 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.79 -31.53 71.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.16 -54.42 41.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.17 -38.58 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.722 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.5 -44.77 81.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.2 p -62.1 -44.8 95.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.434 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.418 ' C ' HD12 ' A' ' 65' ' ' LEU . 22.0 p -61.17 -49.21 78.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 65' ' ' LEU . 10.8 mp -101.35 109.49 21.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.254 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.43 -48.11 3.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.5 Cg_endo -80.69 138.04 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.637 2.224 . . . . 0.0 111.881 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.8 m -130.99 -77.79 0.53 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.586 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.2 -5.73 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.466 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -72.36 0.96 8.71 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.342 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -130.26 102.92 6.42 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.269 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -66.17 -39.54 89.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.597 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.01 -47.58 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.731 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 75' ' ' GLY . 97.2 mt -67.42 -56.04 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.911 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . 31.95 -155.93 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m 71.84 -50.62 0.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 110.377 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -63.68 -25.29 68.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.338 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.32 -50.33 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.6 m -69.37 -37.65 77.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.44 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.66 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.955 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.19 -47.26 85.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.876 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.03 -40.29 96.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.12 0.486 . . . . 0.0 110.437 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -61.43 -46.27 90.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.713 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -43.22 97.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.256 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.33 -24.35 64.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.498 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.12 32.87 2.28 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 89' ' ' TYR . 97.7 m-20 -78.69 -53.5 7.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 48.5 p90 42.61 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.653 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.8 m -142.08 168.13 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.158 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.4 137.76 38.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.046 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 92' ' ' LEU . 2.5 pp -134.57 139.96 45.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.625 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -151.94 164.11 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.819 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 96' ' ' GLY . 52.4 p-10 -76.58 178.0 7.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.277 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.38 26.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -118.7 -70.07 0.35 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.79 -24.91 0.23 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.97 123.21 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.27 92.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.478 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.94 135.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.655 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.51 132.8 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.339 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -161.27 172.0 6.26 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.663 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 52.2 Cg_exo -52.19 -42.97 56.55 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.592 2.195 . . . . 0.0 111.785 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.72 78.24 1.33 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.062 0.458 . . . . 0.0 110.038 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -106.08 134.46 49.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.405 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -104.47 97.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 108' ' ' SER . 11.9 t -95.38 124.32 39.35 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.511 0.507 . . . . 0.0 110.597 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 107' ' ' CYS . 69.1 m -168.95 170.21 9.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.56 48.53 1.53 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.97 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 t -140.61 168.58 19.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.115 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -100.98 170.38 6.63 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.3 Cg_exo -51.75 -39.3 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.586 2.191 . . . . 0.0 111.837 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -81.47 40.35 0.57 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.982 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.413 HG22 ' OD1' ' A' ' 45' ' ' ASP . 43.2 p . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 120.708 0.289 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.405 ' NH2' ' NZ ' ' A' ' 46' ' ' LYS . 43.2 ttm180 -127.95 149.23 50.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.229 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.08 135.61 46.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.13 138.5 37.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.441 ' C ' HD12 ' A' ' 23' ' ' ILE . 77.0 tttt -95.24 115.35 27.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.768 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.781 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.8 mp -94.57 108.64 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.458 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -137.08 102.02 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.507 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -161.06 107.17 1.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.16 151.15 49.45 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.168 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.2 28.09 8.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 33.8 t0 -146.03 -143.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.307 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.499 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -131.52 -64.66 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.525 HG23 ' N ' ' A' ' 31' ' ' PHE . 14.7 t -58.03 -42.76 86.02 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.393 0.616 . . . . 0.0 110.399 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.525 ' N ' HG23 ' A' ' 30' ' ' THR . 52.2 t80 -68.16 -22.98 64.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.507 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -76.3 -44.42 37.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.993 0.425 . . . . 0.0 111.135 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -63.27 -45.73 90.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.843 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 35' ' ' LEU . 20.6 m -65.28 -40.19 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.398 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -61.72 -51.02 70.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.841 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -62.6 -45.34 93.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.04 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.02 -44.56 84.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.91 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 7.5 t -89.31 79.75 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.414 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -82.19 -9.04 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.321 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -172.7 127.97 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.135 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.29 139.84 45.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -119.52 115.89 24.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.267 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.36 156.15 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.768 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' OD1' HG22 ' A' ' 18' ' ' THR . 92.6 m-20 -87.57 171.69 10.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.207 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 48' ' ' VAL . 68.6 mttm -60.85 -59.49 5.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 46' ' ' LYS . 98.4 m-20 -34.09 -34.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' LYS . 21.3 t -59.55 133.13 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 p -106.72 147.42 29.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.241 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -38.88 -35.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.55 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.14 -51.83 67.91 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.114 0.483 . . . . 0.0 110.146 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.561 ' O ' HG22 ' A' ' 56' ' ' VAL . 85.1 tt0 -63.68 -34.92 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.046 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.47 ' O ' HG12 ' A' ' 57' ' ' VAL . 54.6 tp -62.68 -40.02 95.78 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.534 0.521 . . . . 0.0 110.442 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.265 0.555 . . . . 0.0 111.077 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -69.4 -46.68 66.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.669 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.644 HG23 ' N ' ' A' ' 57' ' ' VAL . 29.2 m -69.82 -49.72 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.644 ' N ' HG23 ' A' ' 56' ' ' VAL . 9.8 p -57.39 -45.61 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.569 ' N ' HG13 ' A' ' 57' ' ' VAL . 55.5 tp -60.94 -53.56 55.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.12 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -53.62 -39.79 65.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.59 -52.05 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.498 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.465 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 66.7 t -64.26 -47.31 90.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.47 -45.29 76.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.352 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.0 p -62.46 -45.61 92.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.714 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.8 m -53.31 -51.95 60.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.586 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.4 OUTLIER -108.29 68.43 0.7 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.366 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.56 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.94 -47.05 2.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.4 Cg_endo -81.08 85.07 1.86 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.569 2.179 . . . . 0.0 112.333 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.4 m -133.49 -10.04 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.591 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.09 -27.12 68.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.12 -36.75 69.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.579 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 75' ' ' GLY . 80.8 m80 -76.61 126.08 30.36 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.89 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.46 -43.98 92.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.53 -44.68 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.11 17.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.429 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -74.55 -62.13 2.96 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -57.12 -9.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.95 0.405 . . . . 0.0 110.064 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' GLY . 49.7 tptt -59.7 -51.77 68.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.626 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -57.61 -48.53 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 110.032 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.4 m -57.18 -34.57 68.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.103 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.94 93.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.493 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.04 -44.9 95.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.596 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.76 -44.64 92.83 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.41 -43.86 97.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.416 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mtt180 -67.92 -41.7 82.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.761 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.77 -20.75 66.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.425 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.52 -35.53 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.704 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -63.43 0.04 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' ARG . 67.5 t0 -79.15 119.54 22.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.652 0.263 . . . . 0.0 110.424 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -120.47 -100.25 0.43 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.741 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -144.3 141.92 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 110.501 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -93.54 132.68 37.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.966 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 92' ' ' LEU . 6.5 tt -120.8 121.68 38.69 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.534 ' N ' HD23 ' A' ' 92' ' ' LEU . 53.2 p90 -154.62 149.54 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.676 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.6 p30 -93.65 -176.56 4.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.522 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.59 42.56 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -139.96 -16.38 0.5 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.65 -7.78 78.06 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 100' ' ' VAL . 51.9 t0 -96.91 111.03 23.41 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 40.3 mp0 -53.66 88.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 98' ' ' ASP . 6.3 p -146.73 153.54 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.8 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 101' ' ' ILE . 2.0 mp -77.46 129.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 110.329 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.679 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.49 173.6 4.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.738 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.679 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 66.5 Cg_exo -50.49 -38.21 53.45 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.437 2.091 . . . . 0.0 111.807 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 102.56 12.63 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 109.863 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.6 mtp -103.19 137.55 41.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.49 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -138.03 104.09 5.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 28.2 p -111.53 110.62 21.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.463 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 m -158.87 165.62 33.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 95.9 m-85 -61.09 -30.25 70.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -63.56 152.67 38.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.262 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.41 170.62 5.29 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.0 Cg_exo -51.76 -40.9 64.69 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.63 2.22 . . . . 0.0 112.015 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 113' ' ' ASP . 67.6 t0 -96.84 45.76 1.05 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.417 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.455 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.908 0.385 . . . . 0.0 110.297 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.594 ' N ' ' OG1' ' A' ' 18' ' ' THR . 15.0 ptm180 -105.84 143.39 34.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.179 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -107.84 146.56 32.1 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.749 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.23 48.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -137.33 -3.11 1.96 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.898 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.42 126.65 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.6 p -149.33 146.28 27.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -62.11 116.58 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.004 0.43 . . . . 0.0 110.171 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.68 112.49 15.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.4 mp -67.09 -42.52 84.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.525 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' ASP . 71.4 m-20 -151.82 151.11 30.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.53 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.95 -51.33 66.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.9 m -61.7 -49.03 78.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.726 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -64.96 -30.64 71.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' ASP . 64.8 t0 -64.43 -50.29 68.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.528 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 t -62.46 -44.61 96.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.542 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.3 -44.95 94.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.62 -45.16 94.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.71 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' SER . 44.1 t -61.74 -44.4 96.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.57 -35.48 80.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.672 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.97 87.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.784 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.4 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 62.7 m -123.95 -63.07 1.24 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.861 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.6 p 72.92 1.68 4.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.481 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -170.63 146.51 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.88 100.07 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' A' ' 19' ' ' ARG . 10.8 tp10 -77.42 117.81 19.26 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 18' ' ' THR . 75.9 t -127.24 132.43 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.002 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.54 172.28 0.51 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HZ2' ' C ' ' A' ' 18' ' ' THR . 60.1 mttp -89.38 19.97 4.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.563 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -148.08 54.69 1.04 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.425 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.58 144.08 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 110.536 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -96.41 146.56 24.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -43.18 -34.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.411 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -48.64 -47.46 40.37 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 56' ' ' VAL . 30.4 tp10 -64.07 -36.21 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.546 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 57' ' ' VAL . 39.9 tp -60.87 -43.92 97.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.325 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 89' ' ' TYR . 10.8 mp -62.35 -44.03 97.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.463 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.61 -34.41 75.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 52' ' ' GLU . 40.7 t -73.15 -51.57 25.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.626 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 53' ' ' LEU . 72.4 t -55.55 -45.93 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 58' ' ' LEU . 59.4 tp -61.69 -55.02 34.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.254 0.549 . . . . 0.0 110.293 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.41 -30.85 65.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.4 ' HB1' ' SG ' ' A' ' 39' ' ' CYS . . . -64.29 -55.45 21.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.345 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 62' ' ' GLU . 5.3 p -64.34 -40.51 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.844 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 61' ' ' VAL . 44.4 tt0 -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.9 t -62.63 -48.46 79.28 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.484 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.9 m -67.26 -71.96 0.18 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.8 tp -101.07 83.09 2.45 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -72.79 -46.04 9.06 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.4 Cg_endo -81.69 104.27 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.619 2.213 . . . . 0.0 111.888 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 2.8 m -133.59 -23.32 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -64.91 -30.69 71.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.396 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -72.0 -37.21 69.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 75' ' ' GLY . 72.2 m80 -78.67 115.74 18.56 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.495 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -60.37 -29.99 69.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.04 -45.57 98.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 74' ' ' ILE . 28.7 mt -106.91 -1.71 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 110.344 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -51.87 169.85 0.48 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 m 70.98 -22.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.474 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 75' ' ' GLY . 50.2 tptt -63.72 -45.81 88.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.22 -45.05 84.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.131 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 84.1 m -63.42 -41.17 98.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.73 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.48 95.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.15 -42.16 96.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.62 -42.93 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.728 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 87' ' ' GLY . 97.8 m-20 -64.15 -42.86 96.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mtt180 -70.36 -38.74 74.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -61.94 -44.51 96.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.671 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.13 -45.47 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -66.46 -74.31 0.55 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 84' ' ' ARG . 44.8 t0 -164.35 165.26 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.098 0.475 . . . . 0.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.435 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 27.3 p90 -132.78 146.4 51.81 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.901 0.381 . . . . 0.0 110.508 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.5 m -53.51 132.08 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.589 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -86.06 144.37 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.116 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tt -117.46 136.37 53.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.622 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 25.9 p90 -155.12 166.45 33.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.767 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 12.3 t70 -73.03 -156.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.531 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 98.5 mt-10 -66.86 -53.0 36.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.601 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.88 -98.15 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.33 22.54 0.18 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -89.22 113.7 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.806 0.336 . . . . 0.0 110.607 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 55.4 mp0 -73.33 89.45 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -164.65 142.65 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.777 HD12 ' H ' ' A' ' 101' ' ' ILE . 2.7 mp -59.11 131.79 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.019 0.437 . . . . 0.0 110.01 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -154.84 173.8 4.47 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.727 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 61.4 Cg_exo -49.29 -37.85 40.89 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.562 2.175 . . . . 0.0 112.172 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -92.26 121.61 33.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 110.087 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 87.5 mmm -104.12 139.58 39.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.49 96.78 1.07 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.5 t -111.16 118.86 37.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.545 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -164.94 171.45 14.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.697 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 110' ' ' SER . 92.0 m-85 -61.32 -44.67 96.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.287 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' PHE . 70.7 m -37.75 159.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -109.08 170.26 5.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.668 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 61.2 Cg_exo -48.54 -42.77 34.91 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.559 2.173 . . . . 0.0 112.158 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 37.1 p-10 -96.75 -32.42 12.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 66.8 t0 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -131.51 165.12 24.29 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -133.03 144.55 50.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.202 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.27 140.67 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 109.996 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.473 ' H ' HD12 ' A' ' 23' ' ' ILE . 74.3 tttt -135.82 26.9 3.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.579 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.816 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.2 mp -97.94 118.63 44.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 146.13 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -91.51 129.38 37.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.364 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.59 113.44 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -149.21 88.07 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.553 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.2 m-20 165.25 -20.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.593 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 28' ' ' ASP . . . 77.17 -71.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.532 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 34' ' ' VAL . 12.8 m -61.51 -50.03 74.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.372 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -72.63 -23.3 60.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.79 -51.15 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.369 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -65.25 -45.27 85.28 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.393 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 30' ' ' THR . 91.4 t -61.91 -45.47 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.367 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.58 -41.0 98.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -58.5 -42.44 87.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -79.96 -21.02 44.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.744 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.32 67.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 41' ' ' GLU . 5.9 t -163.44 -84.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.42 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 67.84 -8.99 0.49 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 -179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 8.7 tm-20 -146.97 135.51 21.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 64.1 t80 -142.12 146.82 35.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.535 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 56.0 mp0 -86.46 150.97 23.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.359 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.56 124.64 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' ASP . 1.3 m-20 -141.95 139.58 32.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.448 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 70.9 mmtt -50.94 85.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.421 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.6 m-20 173.81 -31.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.386 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 m -106.13 111.63 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 110.333 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 p -86.36 167.32 14.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -41.08 -35.06 0.51 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.531 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.36 -48.72 80.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.414 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.553 ' O ' HG22 ' A' ' 56' ' ' VAL . 56.3 mp0 -65.2 -34.4 78.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.633 ' O ' HD23 ' A' ' 53' ' ' LEU . 1.3 tt -60.79 -40.76 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.148 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.17 -35.88 71.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.542 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.56 -46.17 60.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.625 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.637 HG23 ' N ' ' A' ' 57' ' ' VAL . 28.2 m -68.63 -49.41 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.188 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.637 ' N ' HG23 ' A' ' 56' ' ' VAL . 8.2 p -59.67 -46.6 93.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.214 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' N ' HG13 ' A' ' 57' ' ' VAL . 52.3 tp -63.28 -57.21 11.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.358 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -51.61 -38.42 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.692 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.1 79.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.61 -46.29 96.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -62.56 -40.06 95.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.297 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.0 t -59.86 -50.28 74.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.548 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.6 p -59.13 -65.75 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.35 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -107.95 80.68 1.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.847 0.356 . . . . 0.0 110.421 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.65 -45.84 12.7 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.426 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.7 Cg_endo -83.81 84.67 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.761 2.307 . . . . 0.0 111.875 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.4 m -87.03 -17.82 32.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.86 -5.44 16.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -72.37 -38.54 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' GLY . 58.2 m-70 -110.13 126.54 54.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.47 -38.74 91.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.72 -48.15 88.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' ' C ' ' A' ' 75' ' ' GLY . 68.5 mt -80.49 -31.04 12.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.163 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 78' ' ' VAL . . . -34.65 -57.47 0.75 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 m -39.43 -28.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.433 0.635 . . . . 0.0 110.945 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 75' ' ' GLY . 27.9 tptp -60.92 -40.27 92.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 75' ' ' GLY . 2.9 p -56.03 -39.61 58.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.433 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 1.2 t -66.26 -48.7 69.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.23 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.41 87.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.282 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.86 -45.48 93.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.45 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -61.82 -43.17 99.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.43 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.49 -42.76 78.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.056 0.455 . . . . 0.0 110.71 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.49 -20.29 64.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.455 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.42 82.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.561 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.34 -54.23 0.09 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.23 117.97 12.46 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.459 ' O ' ' CE1' ' A' ' 91' ' ' TYR . 37.0 p90 -123.53 141.96 51.49 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 110.558 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 90' ' ' VAL . 4.5 t -50.89 125.14 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.18 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 3.4 m-85 -82.55 153.89 25.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.285 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.41 130.37 47.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.563 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.87 155.81 42.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 42.6 t0 -73.17 -178.62 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.365 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.484 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 24.8 tp10 -74.67 38.45 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.491 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.49 -59.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.63 0.24 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.63 140.69 58.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.625 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.84 88.44 4.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.55 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.3 t -150.07 134.16 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.741 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 86.7 mt -70.7 132.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.314 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.8 170.81 7.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 60.0 Cg_exo -49.51 -38.82 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.403 2.069 . . . . 0.0 112.305 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -125.16 126.54 45.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -150.81 166.14 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.212 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -113.12 118.54 35.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.431 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.514 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 14.9 p -105.12 122.78 46.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.71 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.0 t -171.98 166.85 6.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.674 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.431 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 48.9 p90 -73.44 -26.12 60.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.532 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.8 p -95.27 169.82 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.472 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -98.83 162.26 22.19 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.266 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 40.6 Cg_endo -67.63 -21.59 45.37 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.701 2.267 . . . . 0.0 112.057 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -149.28 65.44 1.02 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.422 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.853 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -105.04 165.18 11.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.117 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -130.95 135.33 47.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.65 133.01 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -119.57 22.13 11.79 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.9 mp -84.93 136.87 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.481 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -135.86 132.47 36.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.347 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 107' ' ' CYS . 73.6 t80 -109.83 114.7 28.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.209 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.83 147.75 48.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.469 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.0 mt -97.95 -63.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 8.6 t70 -84.68 173.71 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.63 -36.7 84.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 34' ' ' VAL . 1.2 p -61.99 -54.4 42.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.683 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.449 ' N ' ' OG1' ' A' ' 30' ' ' THR . 67.0 m-85 -60.25 -20.03 57.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.544 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -76.58 -49.04 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.5 p -73.47 -35.14 65.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 30' ' ' THR . 85.1 t -64.41 -51.81 63.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.58 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.55 -41.93 83.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.749 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -61.52 -45.43 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.853 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.84 -45.87 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.979 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 40' ' ' SER . . . -73.66 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 14.5 p -71.33 45.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.592 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 38' ' ' ALA . 4.4 p -59.13 -28.62 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.372 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.78 140.24 19.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.12 137.75 41.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.55 120.07 30.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.266 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.3 m -144.3 162.46 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.369 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -89.79 170.41 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.628 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -78.65 39.22 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 66.1 t0 -118.22 -25.95 6.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.532 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 48' ' ' VAL . 3.8 m -79.03 128.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 0.0 110.709 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.9 p -85.0 158.38 20.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.386 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -46.98 -38.46 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.243 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.12 -46.75 89.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 56' ' ' VAL . 95.6 mt-10 -68.29 -35.16 77.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.312 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 57' ' ' VAL . 58.7 tp -63.46 -43.83 96.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -39.32 87.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 0.0 110.511 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -71.43 -43.55 66.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.775 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 52' ' ' GLU . 55.2 t -67.16 -51.48 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.058 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.0 p -58.57 -44.71 89.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' HG13 ' A' ' 57' ' ' VAL . 47.5 tp -61.33 -55.6 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.287 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.42 -33.61 65.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.866 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.92 -51.1 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.76 -43.19 93.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -62.75 -46.87 86.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.621 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.1 t -60.2 -49.28 78.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.604 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -58.84 -45.79 89.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.183 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.41 76.47 1.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.991 0.424 . . . . 0.0 110.407 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.59 -43.68 11.95 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.099 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 66' ' ' SER . 37.7 Cg_exo -60.21 110.18 0.74 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.404 2.069 . . . . 0.0 111.835 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 66' ' ' SER . 3.4 m -133.9 -58.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.552 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -68.5 -9.38 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.58 -42.84 61.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.421 ' O ' ' N ' ' A' ' 75' ' ' GLY . 4.5 t-80 -106.36 134.53 49.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -61.73 -35.54 78.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.545 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.25 -48.0 89.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.449 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 77' ' ' LYS . 57.4 mt -82.54 -27.01 8.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.933 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -34.05 -59.02 0.62 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -42.7 -23.76 0.05 OUTLIER 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.289 0.566 . . . . 0.0 110.947 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 74' ' ' ILE . 88.7 tttt -58.99 -42.78 90.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.111 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 75' ' ' GLY . 5.2 p -54.75 -37.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.439 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.404 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 77.8 m -70.08 -50.17 43.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.31 84.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.98 -42.51 99.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 tt -60.44 -44.82 95.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -62.42 -43.78 98.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.472 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.77 -42.72 90.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.643 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.482 ' O ' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -76.69 -11.99 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.53 -37.28 77.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.97 -34.46 0.56 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.04 115.31 24.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.425 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -132.88 146.35 51.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.407 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.6 m -50.51 148.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.068 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.97 164.23 12.62 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.311 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 tt -131.55 128.65 39.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.88 151.73 41.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -77.6 -159.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -72.02 51.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.75 -118.56 0.66 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.29 4.53 2.3 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -90.04 116.38 28.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.748 0.309 . . . . 0.0 110.39 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.31 89.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -135.69 133.4 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.45 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -71.64 127.93 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.03 0.443 . . . . 0.0 109.894 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.65 152.46 16.56 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.633 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.29 -39.86 27.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.31 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 65.1 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.278 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -103.53 135.96 44.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.184 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.467 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 48.1 t80 -99.89 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.118 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.531 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 4.3 t -113.3 115.43 28.14 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.548 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.467 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 7.2 p -173.53 169.5 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -70.06 -24.42 63.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 m -67.13 143.18 56.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -100.36 170.5 6.58 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.3 Cg_exo -51.96 -40.31 67.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.604 2.203 . . . . 0.0 111.855 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -82.63 45.2 0.96 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.19 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.694 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.521 -0.149 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -125.9 176.97 6.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.354 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -135.83 139.73 43.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.237 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.09 136.3 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.56 -7.36 6.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.552 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -118.34 128.02 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.7 p -132.47 146.6 52.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.536 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.26 132.89 55.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.169 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.6 141.34 48.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.2 mp -64.56 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -148.92 168.83 22.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.637 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.05 81.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.417 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 m -59.61 -46.83 87.8 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.084 0.469 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -67.64 -28.56 67.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.483 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -64.91 -48.36 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -62.61 -44.89 95.16 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.492 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.68 -45.82 90.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.685 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.98 -44.62 95.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.609 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 m -60.05 -44.71 94.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.327 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.12 -35.84 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.521 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.73 -75.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 40' ' ' SER . 25.4 p -52.59 -43.91 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.789 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 1.4 m 67.73 -63.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.557 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.83 154.55 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.668 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -144.11 148.76 35.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.83 162.21 27.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.63 135.25 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.61 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.12 166.22 17.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.22 -61.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -88.89 84.23 6.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 110.374 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.52 136.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.312 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.561 ' O ' ' N ' ' A' ' 51' ' ' ASP . 20.5 p -108.22 154.27 22.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.406 0.622 . . . . 0.0 109.719 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.047 ' H ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -44.13 -12.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.254 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.651 ' N ' HD22 ' A' ' 50' ' ' LEU . 87.0 m-20 -68.16 -53.4 25.32 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.268 0.556 . . . . 0.0 110.349 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 56' ' ' VAL . 83.2 mt-10 -65.16 -38.99 92.31 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.328 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 57' ' ' VAL . 32.0 mt -61.6 -39.9 92.88 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.031 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.494 HD22 ' CD2' ' A' ' 89' ' ' TYR . 6.6 tp -61.07 -45.12 96.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.158 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -71.49 -34.24 69.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.146 0.498 . . . . 0.0 110.744 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 52' ' ' GLU . 49.6 t -72.38 -53.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.996 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 58' ' ' LEU . 9.6 p -60.59 -43.92 95.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.799 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.538 ' N ' HG13 ' A' ' 57' ' ' VAL . 46.6 tp -60.21 -56.48 20.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.137 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.16 -41.13 62.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.54 82.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.508 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.6 t -63.41 -45.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.549 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.06 -44.17 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.367 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.4 p -61.66 -42.74 99.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.0 m -67.89 -71.14 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.38 88.21 3.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.382 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.524 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.57 -47.87 2.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 66' ' ' SER . 66.9 Cg_endo -80.52 68.5 8.3 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.68 2.254 . . . . 0.0 112.134 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.53 -32.16 47.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.35 -5.77 15.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -72.27 -38.66 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 75' ' ' GLY . 39.0 m80 -103.71 120.81 41.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.219 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 28.4 p-10 -58.32 -42.38 86.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.712 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.693 HG13 HG12 ' A' ' 74' ' ' ILE . 3.8 p -55.09 -29.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.409 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.693 HG12 HG13 ' A' ' 73' ' ' VAL . 49.2 mm -108.49 -12.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -38.35 -62.92 1.03 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.2 p -37.04 -25.06 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.124 0.487 . . . . 0.0 111.006 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' GLY . 63.4 tttm -58.03 -42.71 85.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.139 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 79' ' ' CYS . 5.6 p -56.43 -42.49 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.455 . . . . 0.0 110.314 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.479 ' N ' HG13 ' A' ' 78' ' ' VAL . 87.7 m -62.95 -48.55 78.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.162 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.37 82.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 58' ' ' LEU . 56.5 tp -53.16 -42.34 66.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.641 ' O ' HD23 ' A' ' 82' ' ' LEU . 3.0 tt -60.76 -46.47 90.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.062 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -63.52 -45.49 90.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.52 ' CD2' HD21 ' A' ' 58' ' ' LEU . 3.7 mm? -67.52 -25.55 65.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.773 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.78 -44.23 90.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.364 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.34 -39.11 0.67 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.77 127.14 33.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.265 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 90' ' ' VAL . 2.0 p90 -131.73 -127.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.629 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.599 ' O ' ' CD2' ' A' ' 89' ' ' TYR . 29.1 m -134.44 165.03 32.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 121.097 0.475 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -114.01 144.76 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.677 ' C ' HD23 ' A' ' 92' ' ' LEU . 1.3 tt -131.13 143.18 50.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.989 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.27 163.25 38.76 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.666 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 96' ' ' GLY . 47.4 p30 -74.5 175.9 7.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.529 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.09 26.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -133.66 -70.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.98 -36.04 0.1 OUTLIER Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.71 140.51 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.78 0.324 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.4 mp0 -86.66 88.4 7.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.472 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.79 130.64 26.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.48 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.9 mm -61.96 131.74 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.08 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -149.41 170.56 7.47 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.633 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.674 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 50.6 Cg_exo -51.2 -40.14 60.94 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.517 2.144 . . . . 0.0 112.161 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 97.31 5.85 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.573 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -119.41 170.7 8.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.483 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 76.5 t80 -139.68 122.33 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.084 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.536 ' HB2' HD12 ' A' ' 92' ' ' LEU . 12.5 t -122.83 127.53 49.19 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.752 0.657 . . . . 0.0 110.491 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.483 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 84.1 p -172.78 -174.88 1.18 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' ' CG1' ' A' ' 90' ' ' VAL . 86.0 m-85 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.136 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -146.95 172.12 14.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.0 169.98 6.03 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.406 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 63.1 Cg_exo -49.41 -38.28 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.445 2.096 . . . . 0.0 112.054 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 49.2 p-10 -65.6 -30.65 71.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.981 0.419 . . . . 0.0 110.802 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 95.8 m-20 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.8 p . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.593 ' HE ' ' NZ ' ' A' ' 46' ' ' LYS . 43.9 ttm180 -107.7 145.38 33.5 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.297 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.39 137.18 39.16 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.333 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 42' ' ' PHE . 10.9 tp -102.92 142.84 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.309 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -138.88 111.41 7.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.83 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.5 mp -99.76 125.42 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.396 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.06 96.54 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.558 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -151.16 133.97 15.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.203 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 27' ' ' LEU . . . -59.34 109.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -128.06 -67.21 0.82 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.368 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 27' ' ' LEU . 75.5 m-20 -150.88 163.66 38.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.426 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 -62.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.2 m -60.64 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.522 ' CE2' HD11 ' A' ' 35' ' ' LEU . 37.1 t80 -42.78 -44.52 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 110.391 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -61.98 -48.05 82.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.158 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.647 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.45 -45.12 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.176 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 31' ' ' PHE . 84.2 mt -63.04 -42.94 99.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.6 m -61.88 -40.44 95.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.08 -16.14 41.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.459 ' C ' ' SG ' ' A' ' 39' ' ' CYS . . . -93.61 23.62 4.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.611 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 38' ' ' ALA . 2.6 m 75.39 101.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.796 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.45 -34.77 78.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.76 131.22 55.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.684 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.697 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -145.19 124.66 13.13 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.46 0.648 . . . . 0.0 110.901 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.649 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -63.77 135.84 56.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.504 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.1 134.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 0.0 110.58 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.71 164.9 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.3 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.593 ' NZ ' ' HE ' ' A' ' 19' ' ' ARG . 65.2 mttm -94.11 -11.45 30.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.74 11.83 18.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.88 153.02 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.11 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.435 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 57.2 p -99.25 -160.19 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 50' ' ' LEU . 1.9 pt? -63.11 -15.81 57.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 22.0 p-10 -59.99 -52.82 63.76 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.348 0.594 . . . . 0.0 110.589 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -64.03 -40.16 95.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.081 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.43 -45.78 92.86 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.109 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.605 ' O ' HD23 ' A' ' 54' ' ' LEU . 1.8 tt -56.39 -43.72 79.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.34 -49.01 78.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.903 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.31 -43.4 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.383 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 61' ' ' VAL . 76.0 t -63.77 -46.97 93.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.509 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.09 -41.22 99.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.357 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.91 -44.21 94.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.278 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 64' ' ' THR . . . -64.43 -37.15 86.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 57' ' ' VAL . 55.5 t -63.37 -44.78 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.734 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.11 -44.36 60.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.6 p -61.99 -33.35 74.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 60' ' ' ALA . 41.4 p -86.81 -52.25 5.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.434 HD21 ' CE ' ' A' ' 77' ' ' LYS . 34.4 tp -95.04 79.21 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.544 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.87 -46.62 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.646 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.6 Cg_endo -80.74 109.95 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.404 2.069 . . . . 0.0 112.31 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.86 -46.28 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.441 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -67.91 -6.47 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.718 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -73.02 -21.49 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -103.12 98.18 8.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.697 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 25.8 p-10 -62.68 -44.59 95.86 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.412 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.456 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 71.2 t -64.42 -44.96 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.263 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.543 ' C ' ' H ' ' A' ' 76' ' ' THR . 3.3 mt -93.56 9.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -55.54 -1.28 0.18 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.543 ' H ' ' C ' ' A' ' 74' ' ' ILE . 39.9 p -65.7 -31.78 72.97 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.506 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.434 ' CE ' HD21 ' A' ' 65' ' ' LEU . 17.8 ptmt -58.6 -37.59 76.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.201 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.73 -44.13 93.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.32 -38.92 93.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.253 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.32 -54.03 51.41 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.063 0.458 . . . . 0.0 110.687 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.2 mm? -63.24 -40.32 97.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.311 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.7 -42.95 99.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.242 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -61.89 -43.4 98.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.217 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.97 -39.96 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.474 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.9 mt -63.83 -37.88 89.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.513 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.4 79.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.69 -18.54 0.58 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -78.26 56.72 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.782 0.325 . . . . 0.0 110.418 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.52 -168.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.281 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 132.08 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.506 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -75.05 153.22 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.223 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.607 ' C ' HD23 ' A' ' 92' ' ' LEU . 6.6 tt -142.52 122.51 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.468 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.602 ' N ' HD23 ' A' ' 92' ' ' LEU . 41.1 p90 -146.12 151.01 36.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.736 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 96' ' ' GLY . 56.8 p-10 -80.96 175.13 10.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.474 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 41.7 mp0 -62.3 68.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.473 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 94' ' ' ASP . . . -164.97 -79.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' OD1' ' A' ' 98' ' ' ASP . . . 149.7 40.63 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 97' ' ' GLY . 85.6 m-20 -146.98 169.63 18.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.932 0.396 . . . . 0.0 110.529 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.5 mp0 -80.92 91.61 6.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.166 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 101' ' ' ILE . 59.8 t -141.92 162.83 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.444 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.581 ' N ' HG12 ' A' ' 100' ' ' VAL . 4.9 mp -124.1 129.3 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.8 168.93 10.74 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.456 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 81.9 Cg_exo -46.6 -40.2 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.498 2.132 . . . . 0.0 112.203 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.432 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 79.4 mtp180 -113.13 107.12 15.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.473 ' HB2' HD21 ' A' ' 92' ' ' LEU . 11.8 ptt? -139.43 142.99 37.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -96.98 118.85 34.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.32 116.59 25.11 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 t -173.15 178.08 2.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.689 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -60.48 -44.67 95.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.509 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.1 m -55.86 146.1 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.036 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -105.05 170.37 6.05 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.633 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.8 Cg_exo -51.51 -41.28 61.14 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 112.031 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 113' ' ' ASP . 55.4 t0 -85.32 -9.97 56.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.552 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.539 ' CB ' ' H ' ' A' ' 111' ' ' ALA . 66.1 t0 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.572 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 120.782 0.325 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -138.27 156.15 47.94 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.148 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -107.97 143.63 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 23' ' ' ILE . 17.5 tt -133.31 140.59 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -126.27 11.77 7.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.68 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.5 mp -88.3 101.41 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.961 0.41 . . . . 0.0 110.707 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.516 HG21 ' CD2' ' A' ' 42' ' ' PHE . 75.8 p -141.14 145.98 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.399 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -93.85 138.93 31.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.202 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.64 138.14 41.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 mt -63.2 -39.99 96.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -151.91 176.98 10.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 80.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.513 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 34' ' ' VAL . 97.5 m -61.34 -47.69 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.585 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -68.72 -26.46 65.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.29 -48.53 56.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.3 m -67.1 -41.8 85.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.618 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 30' ' ' THR . 76.3 t -62.36 -47.29 93.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.495 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -63.5 -42.24 98.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.837 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 40' ' ' SER . 78.5 p -62.66 -35.47 79.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -78.69 -34.45 46.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.926 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.04 -92.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.753 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 40' ' ' SER . 14.2 t -65.59 -96.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.713 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER 77.85 -3.79 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.611 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -140.57 115.62 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.516 ' CD2' HG21 ' A' ' 24' ' ' THR . 84.4 m-85 -117.92 129.12 55.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.184 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -91.6 142.26 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.02 121.13 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.432 0.634 . . . . 0.0 110.515 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.476 ' OD1' HG12 ' A' ' 48' ' ' VAL . 19.3 p30 -155.95 171.29 20.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.793 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.22 11.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 45' ' ' ASP . 87.7 m-20 -107.38 0.18 22.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.67 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 49' ' ' THR . 13.5 p -141.24 160.44 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 50' ' ' LEU . 5.2 p -129.94 -70.12 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.226 0.536 . . . . 0.0 110.648 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' N ' ' OG1' ' A' ' 49' ' ' THR . 0.4 OUTLIER -163.16 -33.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -50.21 -43.95 52.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.333 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -68.41 -40.91 81.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.633 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 57' ' ' VAL . 35.6 mt -62.03 -46.26 89.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.72 -36.39 82.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.456 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.81 -52.25 63.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.182 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 57' ' ' VAL . 12.8 p -69.64 -38.59 76.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.532 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 53' ' ' LEU . 43.7 t -59.29 -50.61 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.276 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.69 -50.47 43.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.184 0.516 . . . . 0.0 110.587 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.26 -32.07 69.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.086 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 56' ' ' VAL . . . -69.71 -56.35 7.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 62' ' ' GLU . 30.8 m -67.41 -44.12 87.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.53 ' N ' HG23 ' A' ' 61' ' ' VAL . 8.5 tm-20 -59.35 -46.39 88.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.508 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.9 p -61.77 -51.65 67.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.6 m -60.48 -46.59 89.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.471 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 65' ' ' LEU . 10.3 mp -94.36 57.85 2.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.399 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.612 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.15 -44.02 2.74 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.214 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 66' ' ' SER . 21.5 Cg_exo -64.3 107.59 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.5 2.133 . . . . 0.0 111.859 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.505 ' C ' ' H ' ' A' ' 70' ' ' GLU . 22.0 t -133.84 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -48.5 -11.3 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.466 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 68' ' ' CYS . 79.2 tt0 -73.94 -36.89 64.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.607 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HB3' HG12 ' A' ' 73' ' ' VAL . 67.4 m80 -132.65 138.99 47.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.9 -43.83 97.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.676 HG13 HG12 ' A' ' 74' ' ' ILE . 2.8 p -45.69 -31.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.318 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.676 HG12 HG13 ' A' ' 73' ' ' VAL . 47.0 mm -108.38 -15.11 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . -46.68 -177.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m 66.74 -31.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 75' ' ' GLY . 47.1 tptt -63.19 -39.15 93.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 79' ' ' CYS . 7.4 p -59.76 -45.23 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.525 ' N ' HG13 ' A' ' 78' ' ' VAL . 75.1 m -64.41 -47.74 78.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.341 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.45 -52.56 64.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.286 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.4 tp -51.29 -40.89 59.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.94 -48.06 82.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.21 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -64.24 -40.96 97.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.355 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.23 -40.63 98.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.89 -19.99 58.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.596 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.64 75.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 88' ' ' ASP . . . 160.33 33.64 0.02 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 80.2 m-20 -149.14 78.03 1.38 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.789 0.328 . . . . 0.0 110.52 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.4 p90 -110.2 -113.34 0.31 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.085 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.447 ' H ' ' HD2' ' A' ' 89' ' ' TYR . 29.4 m -130.8 158.77 43.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.303 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -126.81 157.07 40.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.242 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.17 125.06 24.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.82 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -134.68 153.27 52.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -88.98 -168.31 2.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.431 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 33.2 mp0 -72.93 67.24 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.628 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.23 -59.33 0.21 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.28 -18.79 0.32 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.84 139.71 55.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.672 0.272 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 90.68 6.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.605 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -155.11 135.98 4.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.615 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 49' ' ' THR . 56.6 mt -66.15 132.26 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.27 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.709 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -149.17 173.59 4.11 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.709 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 54.2 Cg_exo -50.66 -40.59 55.68 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.497 2.131 . . . . 0.0 111.842 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.36 90.13 3.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -103.16 145.24 30.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.159 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -113.15 110.21 20.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.138 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.0 p -110.97 113.15 25.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.437 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 p -167.77 164.9 14.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.764 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -72.51 -26.9 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.643 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 p -73.19 154.64 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -90.26 170.12 10.86 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.668 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.3 Cg_exo -51.44 -35.11 53.81 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.46 2.106 . . . . 0.0 112.128 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -79.16 14.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 . . . . . 0 C--O 1.223 -0.332 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.785 -179.876 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -135.08 171.76 13.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -126.45 146.87 49.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.638 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.413 HG13 ' H ' ' A' ' 23' ' ' ILE . 10.7 tp -132.11 141.04 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.317 0.58 . . . . 0.0 110.151 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -138.23 20.05 2.78 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.431 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.413 ' H ' HG13 ' A' ' 21' ' ' ILE . 23.9 mt -114.15 97.32 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.87 0.367 . . . . 0.0 110.839 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -116.19 143.68 45.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.141 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.92 118.33 13.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.443 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.79 118.6 36.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.243 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.78 -40.99 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.604 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.2 t0 -153.69 -178.94 7.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.58 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -62.82 -37.47 86.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -59.21 -48.03 83.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.188 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.16 -4.13 39.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.405 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -85.2 -59.08 2.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.32 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -68.55 -37.29 79.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.926 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 30' ' ' THR . 73.1 t -65.33 -47.45 87.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.07 -41.81 99.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 9.1 t -58.74 -50.25 74.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.58 -34.13 77.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -25.43 60.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.022 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.568 ' C ' ' H ' ' A' ' 41' ' ' GLU . 4.9 t -173.89 -48.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.47 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 36' ' ' SER . 0.4 OUTLIER 59.45 -3.91 0.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.657 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.568 ' H ' ' C ' ' A' ' 39' ' ' CYS . 75.2 mt-10 -144.26 115.79 8.12 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CE1' HG22 ' A' ' 57' ' ' VAL . 80.4 m-85 -121.84 133.57 54.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -95.5 156.68 16.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.975 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 m -134.75 116.7 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.665 0.745 . . . . 0.0 110.775 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' A' ' 47' ' ' ASP . 50.4 t0 -148.2 159.77 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.3 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 50.9 tttm -60.88 12.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.626 ' H ' ' C ' ' A' ' 45' ' ' ASP . 98.2 m-20 -105.34 -37.07 6.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.711 0.291 . . . . 0.0 110.356 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.93 109.06 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.339 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.512 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 27.3 p -86.46 166.05 15.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.336 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -48.29 -44.35 33.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.291 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.512 ' CG ' ' HG1' ' A' ' 49' ' ' THR . 1.5 p-10 -56.82 -44.33 81.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 56' ' ' VAL . 94.9 mt-10 -72.98 -28.59 62.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.289 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.687 ' O ' HG23 ' A' ' 57' ' ' VAL . 55.5 tp -65.3 -54.34 30.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.216 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 55' ' ' ASP . 3.1 pp -67.79 -39.93 83.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.896 0.379 . . . . 0.0 110.287 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 54' ' ' LEU . 16.6 t70 -63.32 -44.39 95.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 52' ' ' GLU . 60.7 t -69.55 -43.12 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.707 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 53' ' ' LEU . 72.1 t -61.98 -47.77 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.455 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 81' ' ' LEU . 8.6 tt -64.05 -53.25 52.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.081 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -52.23 -38.97 59.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.745 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.84 75.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.629 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.27 -48.98 85.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.685 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.78 -37.72 85.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.444 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -60.69 -45.16 95.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.49 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.8 p -72.92 -40.66 65.3 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.751 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -108.26 106.77 17.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.482 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.447 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -79.1 -60.8 0.53 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 178.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 66' ' ' SER . 36.9 Cg_endo -63.15 134.48 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.338 2.025 . . . . 0.0 112.297 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.2 p -134.98 -37.38 0.8 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -67.99 -7.96 33.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.759 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -73.59 -30.34 62.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.715 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 75' ' ' GLY . 60.1 m80 -92.13 108.91 20.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 20.8 p-10 -66.1 -49.12 68.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.339 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 t -66.84 -45.1 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.412 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 mm -95.09 18.79 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.09 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -81.29 -170.62 43.93 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.415 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER 78.32 -26.41 0.18 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 110.552 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER -63.62 -11.02 21.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.163 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.662 HG13 ' N ' ' A' ' 79' ' ' CYS . 7.1 p -71.31 -54.51 17.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 110.304 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.662 ' N ' HG13 ' A' ' 78' ' ' VAL . 98.8 m -69.36 -42.66 74.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.143 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.08 74.63 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.113 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 58' ' ' LEU . 4.7 tt -54.62 -42.15 70.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.166 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.95 -48.71 80.58 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.254 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 87' ' ' GLY . 55.2 t0 -65.52 -43.24 90.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.798 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' ASP . 1.4 mpt_? -62.08 -43.79 98.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.6 -42.84 97.61 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.086 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -9.7 51.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.631 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -154.38 62.45 0.36 Allowed Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 84' ' ' ARG . 96.9 m-20 -36.88 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 110.693 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.503 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 65.5 t80 -87.04 -40.7 14.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.679 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.66 131.52 12.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 98.0 m-85 -109.37 152.25 25.57 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 93' ' ' PHE . 6.1 tt -132.31 122.9 25.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.621 ' N ' HD23 ' A' ' 92' ' ' LEU . 45.2 p90 -142.79 147.68 35.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.52 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.2 t70 -83.91 177.47 8.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.466 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 95.8 mt-10 -70.77 38.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -146.59 -5.71 0.38 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.92 -2.64 73.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 36.4 t0 -93.87 112.86 24.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 110.471 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -53.45 86.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.098 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 69.7 t -145.4 136.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.9 mm -76.09 130.02 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.125 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -150.02 172.0 5.74 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.452 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 52.0 Cg_exo -51.95 -41.52 63.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.354 2.036 . . . . 0.0 111.894 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 1.8 mpt_? -110.46 83.45 1.76 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.188 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -105.19 165.07 11.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.091 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 93' ' ' PHE . 70.6 t80 -134.2 112.51 11.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 21.7 p -115.52 117.08 29.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.623 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.1 t -171.71 175.41 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -66.4 -27.34 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.357 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -61.86 146.46 49.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.473 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -85.62 170.41 13.14 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.1 Cg_exo -50.78 -41.28 55.29 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.542 2.161 . . . . 0.0 112.025 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -60.51 -48.26 82.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.101 0.477 . . . . 0.0 110.849 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.547 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.67 0.271 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.45 173.51 8.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.237 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.02 144.17 30.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.053 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.0 pt -136.12 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.753 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.53 121.18 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 23' ' ' ILE . 4.2 mm -94.3 115.88 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.166 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -127.92 100.46 5.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.445 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.53 107.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.34 140.79 46.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.747 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.9 mp -73.7 -41.19 62.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -127.12 -176.78 3.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.63 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.16 82.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -58.69 -52.7 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.414 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' N ' ' OG1' ' A' ' 30' ' ' THR . 85.5 m-85 -69.39 -11.61 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -77.78 -54.89 5.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 p -69.91 -35.34 74.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.914 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' THR . 73.5 t -64.31 -49.89 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.67 -42.22 91.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.835 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.2 p -63.48 -45.65 89.81 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.541 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -68.34 -47.1 68.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.53 -76.1 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.735 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 7.9 t -83.13 72.27 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.9 p -75.78 -26.97 57.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.633 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -172.83 149.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.281 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.507 ' CE2' HG22 ' A' ' 57' ' ' VAL . 6.0 m-85 -130.97 147.01 52.56 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.241 0.543 . . . . 0.0 110.526 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.44 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.38 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.6 132.26 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.904 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 41.7 t0 -145.44 148.62 33.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 20.0 pttp -73.75 20.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 45' ' ' ASP . 13.3 t70 -122.16 16.53 10.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.706 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 101' ' ' ILE . 3.0 m -134.11 161.19 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 109.947 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' ASP . 58.2 p -120.29 134.78 55.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.121 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.679 HD22 ' C ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.86 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.851 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.659 ' N ' HD22 ' A' ' 50' ' ' LEU . 63.1 t0 -67.8 -50.6 55.99 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.37 0.605 . . . . 0.0 110.1 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 56' ' ' VAL . 97.3 mt-10 -67.36 -35.47 79.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.829 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 57' ' ' VAL . 61.4 tp -61.39 -45.54 93.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.774 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.99 -43.77 97.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.722 -179.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.99 -42.6 99.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.729 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 52' ' ' GLU . 66.2 t -67.66 -45.95 83.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.621 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 53' ' ' LEU . 64.5 t -59.85 -45.76 94.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.44 -51.43 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.726 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -60.52 -32.92 71.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.44 -54.48 46.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.952 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.22 -39.08 84.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.6 m -61.61 -49.46 76.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -61.36 -48.73 79.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 65' ' ' LEU . 5.0 tt -108.27 82.17 1.59 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.323 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.606 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.45 -43.93 2.05 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.403 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.8 Cg_exo -61.21 115.18 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.783 2.322 . . . . 0.0 112.091 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 p -133.11 -41.86 0.89 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 71' ' ' HIS . 88.6 tttt -62.09 -37.44 85.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.752 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -75.56 28.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.465 ' H ' ' C ' ' A' ' 69' ' ' LYS . 95.6 m-70 -136.78 143.8 43.4 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.577 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.83 -62.96 1.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.961 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.64 -44.54 89.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.278 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.7 mm -84.51 2.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.971 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.45 -28.4 71.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -8.26 59.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.91 -44.63 94.16 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.409 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 ' N ' ' A' ' 79' ' ' CYS . 11.2 p -57.01 -44.15 82.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.352 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.567 ' N ' HG13 ' A' ' 78' ' ' VAL . 73.5 m -67.75 -49.39 62.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -62.26 -40.71 97.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.57 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.99 -42.4 99.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.09 -42.74 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.096 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.09 -44.51 96.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.674 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.679 HH12 ' HB1' ' A' ' 80' ' ' ALA . 96.4 mtm-85 -65.73 -39.7 91.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.588 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -64.64 -37.91 89.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.432 -179.396 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.91 80.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.604 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.64 62.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -172.59 56.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.502 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -101.65 152.58 20.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.962 0.41 . . . . 0.0 110.482 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 34.7 m -48.36 148.01 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.966 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -106.65 164.19 12.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.175 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 92' ' ' LEU . 8.0 tt -127.32 126.82 43.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.845 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.573 ' N ' HD23 ' A' ' 92' ' ' LEU . 31.6 m-85 -137.15 154.9 50.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -84.31 -176.96 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.693 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -71.45 47.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -158.13 -68.17 0.01 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.92 -21.31 0.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -73.78 141.67 46.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.945 0.402 . . . . 0.0 110.62 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -76.0 93.22 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.403 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.31 153.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.295 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' A' ' 48' ' ' VAL . 77.3 mt -91.47 127.14 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.224 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.02 153.99 19.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.548 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.3 -37.8 25.21 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.181 1.921 . . . . 0.0 112.136 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.425 ' CD ' ' H ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -92.63 54.42 2.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 110.334 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.546 ' HB2' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -103.51 144.34 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.295 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -117.05 122.13 43.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.263 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.432 ' SG ' HD21 ' A' ' 54' ' ' LEU . 12.9 t -113.09 115.0 27.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.536 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 t -173.89 175.71 2.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -75.39 -20.64 58.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.362 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -72.78 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.238 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -98.08 170.68 6.75 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.447 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.9 Cg_exo -52.62 -42.14 64.16 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.654 2.236 . . . . 0.0 112.076 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 113' ' ' ASP . 67.6 t0 -96.51 48.1 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.566 179.711 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.231 0.091 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -103.58 136.47 43.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.053 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -104.66 121.92 44.56 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.94 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.03 149.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.431 ' C ' HD12 ' A' ' 23' ' ' ILE . 18.3 ptmt -130.46 20.22 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.963 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.735 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.6 mp -93.49 122.3 44.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.11 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.1 m -142.56 134.48 27.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -97.55 120.34 37.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.096 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -103.82 145.55 29.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.447 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.1 mm? -64.92 -41.66 95.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.816 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -150.12 -174.08 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.91 -37.68 87.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.477 ' H ' HG23 ' A' ' 30' ' ' THR . 1.3 p -59.79 -48.74 80.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.273 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -66.89 -33.95 76.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.589 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.91 -46.54 87.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.436 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -68.32 -41.99 80.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.91 -49.0 85.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.889 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.617 HD11 HG22 ' A' ' 61' ' ' VAL . 4.0 mm? -64.38 -41.07 96.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -59.94 -41.93 92.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -75.14 -31.15 60.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.69 -89.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.0 m -108.99 94.89 5.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.475 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 t -89.29 -11.28 43.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 94.5 mt-10 -145.04 156.56 44.0 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.602 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 8.4 m-85 -143.59 122.61 12.82 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.078 0.466 . . . . 0.0 110.598 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.83 135.43 49.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.381 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.03 132.62 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -58.92 172.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -50.83 -38.38 48.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -147.27 113.9 6.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 49' ' ' THR . 86.9 t -127.88 160.93 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.546 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -96.75 125.65 41.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.658 ' H ' HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -38.35 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.8 m-20 -60.27 -45.94 91.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.216 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 56' ' ' VAL . 37.8 tp10 -63.96 -43.06 96.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.949 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.456 ' O ' HG12 ' A' ' 57' ' ' VAL . 61.9 tp -62.02 -40.26 95.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.04 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.1 -42.76 99.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.277 0.56 . . . . 0.0 110.184 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.3 -39.45 68.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.703 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 52' ' ' GLU . 54.5 t -69.55 -53.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.4 p -55.8 -44.82 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' HG13 ' A' ' 57' ' ' VAL . 58.6 tp -62.04 -52.04 65.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.183 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -54.17 -43.31 70.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.099 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.96 93.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.179 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.617 HG22 HD11 ' A' ' 35' ' ' LEU . 53.1 t -63.23 -43.12 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.252 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -67.53 -36.49 81.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.609 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t -63.03 -52.26 63.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 65' ' ' LEU . 12.1 t -74.75 -38.03 62.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.433 . . . . 0.0 110.547 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.427 ' N ' HG23 ' A' ' 64' ' ' THR . 11.2 tp -92.79 33.98 1.11 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.914 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.43 -47.14 2.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 66' ' ' SER . 71.8 Cg_endo -82.5 78.3 3.43 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.452 2.101 . . . . 0.0 112.291 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 33.4 m -133.81 -18.06 2.15 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -68.03 -7.43 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.672 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.33 -38.89 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -101.7 109.87 21.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.225 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 32.8 p-10 -65.78 -36.44 83.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.726 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.56 -57.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.683 ' O ' ' O ' ' A' ' 75' ' ' GLY . 81.6 mt -68.93 -45.0 81.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.683 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . -43.27 -131.27 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 O-C-N 124.053 0.846 . . . . 0.0 111.521 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.429 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 1.3 m 74.22 -36.09 0.32 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.96 -0.729 . . . . 0.0 110.532 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.2 OUTLIER -58.29 -29.47 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.817 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.412 ' O ' HD13 ' A' ' 82' ' ' LEU . 93.6 t -62.4 -48.76 86.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.382 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.13 -37.44 87.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.103 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.42 -43.34 99.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 78' ' ' VAL . 7.7 mp -63.15 -38.02 89.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.794 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.88 -42.05 99.63 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' TYR . 89.0 mtm-85 -62.35 -48.08 81.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.014 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.584 ' O ' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -70.56 -29.9 66.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.173 0.511 . . . . 0.0 110.411 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.16 84.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.43 -50.71 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.321 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.86 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.5 ' CE2' ' O ' ' A' ' 90' ' ' VAL . 26.9 t80 64.55 165.37 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.29 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.5 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 2.9 p -125.2 156.47 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.96 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.445 ' N ' HG22 ' A' ' 90' ' ' VAL . 11.8 m-85 -122.55 138.51 54.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.077 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -108.85 128.83 55.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.4 154.04 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.793 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 44.6 t0 -73.62 176.83 5.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.437 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 11.3 tm-20 -61.12 -42.7 99.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.533 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.62 60.15 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.2 -0.37 87.31 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.5 t0 -89.13 108.83 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.6 0.238 . . . . 0.0 110.472 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -47.1 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.447 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 98' ' ' ASP . 79.6 t -152.84 131.26 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.663 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.781 HD12 ' H ' ' A' ' 101' ' ' ILE . 3.1 mp -60.93 123.88 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.27 170.58 8.01 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.539 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.632 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.3 Cg_exo -51.73 -42.12 58.53 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.269 1.98 . . . . 0.0 112.234 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -105.85 101.5 11.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.226 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 52.1 mtm -104.62 147.05 28.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.324 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -119.02 96.33 5.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.971 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 90' ' ' VAL . 49.2 t -90.24 119.82 30.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.263 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.7 t -161.06 159.74 29.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.608 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 5.5 m-85 -85.52 43.1 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.046 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m -146.6 178.76 8.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.232 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.46 170.69 5.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.518 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.7 Cg_exo -52.14 -39.53 70.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.598 2.199 . . . . 0.0 112.038 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 p30 -87.31 0.58 55.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--O 1.222 -0.388 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.612 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.217 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.497 ' N ' HG23 ' A' ' 18' ' ' THR . 73.2 ttt180 -126.06 150.7 47.96 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.498 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -145.34 126.71 14.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.799 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 42' ' ' PHE . 49.4 pt -140.91 148.56 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.107 0.48 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.602 ' C ' HD12 ' A' ' 23' ' ' ILE . 62.9 mttp -113.43 77.41 1.05 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.791 0.329 . . . . 0.0 110.352 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 22' ' ' LYS . 1.7 mp -110.0 126.42 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.0 m -124.19 126.84 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.364 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 107' ' ' CYS . 85.1 t80 -130.08 134.21 47.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.395 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.84 107.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.441 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.3 -43.59 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.658 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 98.1 m-20 -135.28 -86.36 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.511 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.67 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.582 HG23 ' N ' ' A' ' 31' ' ' PHE . 15.3 t -58.75 -45.55 89.46 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.292 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.582 ' N ' HG23 ' A' ' 30' ' ' THR . 51.6 t80 -61.46 -35.93 79.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.387 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.658 ' CG ' ' H ' ' A' ' 28' ' ' ASP . 90.9 m-20 -62.17 -44.63 96.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.293 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 30' ' ' THR . 78.3 p -62.16 -46.94 86.75 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.631 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.38 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.496 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 39' ' ' CYS . 53.6 tp -61.22 -44.68 96.88 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -60.17 -41.74 93.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 110.157 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.76 -32.25 73.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.07 -76.56 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.99 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.7 t -104.47 96.16 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -111.7 -30.19 7.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.37 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -95.27 141.25 29.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.365 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' ILE . 96.4 m-85 -136.55 133.36 36.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.173 0.511 . . . . 0.0 110.526 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -133.83 143.26 48.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.788 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' OG1' ' A' ' 18' ' ' THR . 1.2 m -145.72 -106.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.781 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.44 ' HA ' ' N ' ' A' ' 19' ' ' ARG . 43.5 p30 -166.85 161.51 15.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -63.64 163.28 11.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 61.49 37.23 16.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.478 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 48' ' ' VAL . 11.0 p -113.69 123.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.13 0.491 . . . . 0.0 110.199 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -83.51 169.92 14.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.375 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.693 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -60.81 -40.13 91.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -53.65 -50.34 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.111 0.482 . . . . 0.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.16 -38.08 89.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.313 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.65 -48.8 77.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.296 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.39 -41.18 68.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -62.15 -47.74 83.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.23 -43.36 95.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.133 0.492 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.69 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.82 -45.24 95.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.913 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -55.3 -43.74 75.08 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.97 88.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.465 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.89 -42.02 94.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -69.61 -47.01 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -62.44 -37.1 84.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.76 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -73.65 -69.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.2 mt -103.48 98.57 8.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.556 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -77.85 -47.05 2.31 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.773 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.0 Cg_endo -81.39 137.63 10.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.603 2.202 . . . . 0.0 111.89 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.624 ' SG ' ' NZ ' ' A' ' 77' ' ' LYS . 5.8 m -133.22 -40.25 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.516 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.54 -11.08 60.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.39 -39.03 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.678 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.576 ' O ' ' N ' ' A' ' 75' ' ' GLY . 34.3 m170 -102.29 106.13 16.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.51 -37.95 89.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.25 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.19 -46.55 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.359 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 75' ' ' GLY . 95.7 mt -91.6 -13.67 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -53.93 -158.22 0.01 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.548 HG23 ' C ' ' A' ' 75' ' ' GLY . 2.2 p 69.44 -35.63 0.31 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.092 0.472 . . . . 0.0 110.539 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.624 ' NZ ' ' SG ' ' A' ' 68' ' ' CYS . 21.7 pttp -63.08 -20.47 65.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.306 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 79' ' ' CYS . 9.8 p -65.5 -46.15 90.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.304 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.576 ' N ' HG13 ' A' ' 78' ' ' VAL . 1.6 t -68.85 -47.03 66.97 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.453 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.23 94.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.461 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.97 -43.27 99.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.45 -41.94 99.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.54 -43.81 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.278 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ASP . 96.1 mtt180 -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.135 0.493 . . . . 0.0 110.378 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.92 -42.9 94.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.33 -13.2 55.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.398 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' TYR . . . -149.89 61.41 0.42 Allowed Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' ARG . 88.8 m-20 -38.74 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.508 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -95.0 63.69 2.72 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.356 0.598 . . . . 0.0 110.373 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.9 t -150.91 137.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.33 132.21 41.04 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.219 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -103.65 136.49 43.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.751 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -157.53 148.83 21.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.832 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.63 -164.94 1.25 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 110.468 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.75 -39.83 82.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.78 -34.78 65.52 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.66 60.01 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 100' ' ' VAL . 47.6 t0 -88.16 113.98 24.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -42.57 89.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.658 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 98' ' ' ASP . 9.2 p -144.04 141.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.39 127.65 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.151 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.21 169.67 9.39 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.55 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.684 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 75.5 Cg_exo -45.51 -42.63 18.24 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.426 2.084 . . . . 0.0 112.228 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -99.96 123.85 44.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.82 0.343 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 68.1 mtp -114.81 142.56 46.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -146.15 97.36 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.158 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.522 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.3 t -98.88 115.46 28.89 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.669 0.606 . . . . 0.0 110.923 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 p -171.03 162.11 7.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.649 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 109' ' ' PHE . 1.0 OUTLIER -61.67 -53.34 57.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.361 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.7 p -41.9 148.95 0.15 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.998 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -106.61 161.89 21.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 17.5 Cg_endo -56.62 -31.41 86.99 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.671 2.247 . . . . 0.0 112.081 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -105.02 15.08 28.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.163 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.961 -179.856 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.861 0.363 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.509 ' O ' HG12 ' A' ' 44' ' ' VAL . 96.7 mtt180 -131.53 146.16 52.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.479 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.2 140.24 32.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 pt -131.23 146.84 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.18 89.34 2.97 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.4 128.03 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.278 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -66.91 141.34 57.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 8.0 m-85 -115.05 135.19 54.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.321 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.79 142.77 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.639 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt 67.26 46.65 1.43 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.97 0.414 . . . . 0.0 111.35 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -128.0 12.15 6.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.154 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 36.94 -120.25 0.17 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.228 0.537 . . . . 0.0 111.698 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -49.74 -59.77 3.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -40.44 -44.45 2.01 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.838 0.352 . . . . 0.0 110.533 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -56.42 -52.25 65.36 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -68.55 -40.45 80.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.798 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -52.73 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.266 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.17 -42.2 89.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -59.67 -43.52 93.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.74 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -79.26 -26.94 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.69 -72.42 0.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 23.6 p -152.11 98.91 2.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.531 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 78.4 p -51.39 -30.8 20.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.287 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -85.47 144.95 27.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 40' ' ' SER . 45.6 m-85 -129.6 138.6 51.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.54 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 43.6 tt0 -77.46 136.45 38.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.598 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 19' ' ' ARG . 3.6 p -141.12 155.06 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.454 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' ASP . 45.7 t0 -149.75 146.07 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -40.77 -26.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.607 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' ASP . 11.0 m-20 -138.19 90.99 2.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 49' ' ' THR . 5.0 p -139.05 158.8 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.943 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 51' ' ' ASP . 68.0 p -121.81 137.52 54.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.739 ' N ' HD23 ' A' ' 50' ' ' LEU . 1.7 pt? -37.9 -25.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.432 0.635 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.5 m-20 -58.91 -41.8 88.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.947 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' OE2' ' OE1' ' A' ' 43' ' ' GLU . 80.1 tt0 -64.89 -33.77 76.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.848 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.636 ' O ' HG23 ' A' ' 57' ' ' VAL . 42.9 tp -62.31 -42.84 99.7 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 109.806 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.99 -42.26 76.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.617 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.81 -43.87 91.75 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.173 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 57' ' ' VAL . 8.5 p -72.46 -40.2 63.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.844 0.354 . . . . 0.0 110.688 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 53' ' ' LEU . 48.0 t -61.09 -48.19 90.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.77 -54.07 41.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.755 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 63.7 t0 -52.31 -38.65 59.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.825 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.76 99.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.33 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' LEU . 75.2 t -63.15 -46.25 96.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -66.59 -43.69 84.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.578 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -61.15 -47.47 86.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.5 p -75.2 -75.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' VAL . 68.9 mt -109.5 109.67 20.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.452 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.26 -44.04 2.68 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.074 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' SER . 27.1 Cg_exo -61.15 132.19 40.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.568 2.178 . . . . 0.0 112.118 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 66' ' ' SER . 2.3 m -134.83 -55.44 0.82 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 110.277 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 71' ' ' HIS . 21.2 ptmt -67.53 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.742 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -76.17 13.25 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.482 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' H ' ' C ' ' A' ' 69' ' ' LYS . 97.0 m-70 -126.44 93.4 3.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.442 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -62.12 -34.79 77.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.45 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.07 -45.58 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.287 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 75' ' ' GLY . 51.8 mt -77.72 -60.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.719 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . 46.22 175.82 0.01 OUTLIER Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m 61.96 -23.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.651 -0.323 . . . . 0.0 110.703 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.676 ' H ' ' C ' ' A' ' 75' ' ' GLY . 8.9 tttm -56.69 -62.76 1.51 Allowed 'General case' 0 C--O 1.225 -0.198 0 CA-C-O 121.367 0.603 . . . . 0.0 109.898 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -52.5 -33.34 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.023 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 t -68.22 -50.84 51.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.551 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.13 93.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.82 -42.15 99.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.034 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.81 -43.99 97.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -58.54 -46.69 86.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -64.94 -36.59 84.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.754 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.34 -37.94 85.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.269 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 -24.99 62.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.344 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.18 -65.1 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -174.5 -179.69 1.59 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -158.31 -68.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.572 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.59 157.0 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.543 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 2.5 p90 -144.31 155.3 43.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.784 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.56 154.64 41.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.236 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.47 147.28 27.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.04 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.46 ' C ' ' N ' ' A' ' 96' ' ' GLY . 89.6 m-20 -80.79 167.84 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 104' ' ' ARG . 94.8 mt-10 -52.26 -9.36 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.484 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.46 ' N ' ' C ' ' A' ' 94' ' ' ASP . . . -90.02 -74.52 1.29 Allowed Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.48 -28.19 0.33 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -69.55 137.9 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.412 ' HB3' HD22 ' A' ' 50' ' ' LEU . 97.6 mt-10 -75.35 89.85 2.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -147.87 149.73 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.772 HD12 ' N ' ' A' ' 101' ' ' ILE . 1.8 mp -83.16 129.47 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.079 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -148.33 169.48 9.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.287 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 88.2 Cg_exo -46.23 -45.03 19.1 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.593 2.196 . . . . 0.0 112.601 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 95' ' ' GLU . 74.0 mtp85 -107.31 80.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.508 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -104.23 160.9 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -141.87 114.14 8.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.568 ' SG ' ' CE1' ' A' ' 25' ' ' PHE . 8.9 p -102.7 128.94 49.21 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.964 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 109' ' ' PHE . 40.0 t -175.74 -167.07 0.22 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.223 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.541 ' O ' ' CD2' ' A' ' 109' ' ' PHE . 70.6 t80 -104.12 25.18 10.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.7 m -115.03 160.87 19.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.267 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -109.25 170.41 5.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.522 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.9 Cg_exo -52.41 -40.68 70.61 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.459 2.106 . . . . 0.0 112.378 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.4 p30 -114.16 39.41 2.75 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.639 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.778 0.323 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -158.45 177.87 10.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.347 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -117.4 141.17 48.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 110.212 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.0 tt -99.16 141.11 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.127 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -132.07 5.41 4.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.23 125.53 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.7 p -138.76 146.56 41.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.81 136.87 56.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.256 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.44 133.33 43.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.062 0.458 . . . . 0.0 110.558 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.3 mp -66.75 -40.39 88.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.716 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 37.0 t0 -159.23 -170.92 3.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.418 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.505 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -59.05 -46.05 89.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.704 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -61.51 -53.21 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.422 ' N ' ' OG1' ' A' ' 30' ' ' THR . 92.7 m-85 -61.42 -27.66 68.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.23 0.538 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.42 -45.0 73.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.975 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -67.98 -36.48 80.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.546 HG21 HD13 ' A' ' 74' ' ' ILE . 76.9 t -62.42 -49.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.467 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.9 -41.62 95.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.99 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 40' ' ' SER . 92.6 p -62.07 -44.46 96.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -75.05 -26.69 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB1' HG22 ' A' ' 61' ' ' VAL . . . -61.01 -28.91 69.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.676 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' GLU . 10.7 p -161.22 -33.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.0 t 69.77 -42.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 39' ' ' CYS . 21.4 pt-20 -154.64 143.16 20.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -134.03 136.07 43.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 110.592 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -67.8 135.85 53.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.433 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.61 134.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.309 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.95 164.37 38.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.615 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 68.9 mmtt -70.66 101.4 2.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 1.5 t70 162.64 -46.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.763 0.665 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -100.14 110.6 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.0 110.597 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -87.53 172.81 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -43.76 -30.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 -51.77 67.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.695 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' VAL . 80.9 mm-40 -65.02 -39.98 94.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.221 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 57' ' ' VAL . 60.1 tp -62.61 -38.95 92.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.966 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.88 -44.01 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.471 . . . . 0.0 110.206 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.53 -34.95 70.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.611 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 52' ' ' GLU . 53.6 t -73.63 -54.51 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 61' ' ' VAL . 9.4 p -55.74 -44.66 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.552 ' N ' HG13 ' A' ' 57' ' ' VAL . 5.6 tt -61.85 -55.3 31.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.63 -42.71 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.8 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.662 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 57' ' ' VAL . 57.8 t -64.92 -46.24 92.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -65.64 -47.19 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.851 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -64.83 -54.03 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.8 m -66.15 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.748 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.3 tp -108.86 81.97 1.53 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.658 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.53 -44.41 2.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.454 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.4 Cg_exo -63.16 119.72 6.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.543 2.162 . . . . 0.0 112.032 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.518 ' SG ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -134.21 -17.89 2.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -66.46 -20.23 65.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.49 28.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.555 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -126.08 160.75 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.492 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -82.43 -65.3 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.42 -47.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.546 HD13 HG21 ' A' ' 34' ' ' VAL . 12.6 mt -65.47 -16.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.061 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.32 3.33 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -82.53 -14.07 55.55 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.299 0.571 . . . . 0.0 110.829 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.434 ' HZ2' HG11 ' A' ' 34' ' ' VAL . 87.1 tttt -54.52 -34.38 61.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.294 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.518 HG22 ' SG ' ' A' ' 68' ' ' CYS . 65.2 t -59.55 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.256 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 85.4 m -61.6 -39.84 92.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.17 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.61 84.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.272 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.559 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -60.36 -50.09 74.98 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 -178.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 82' ' ' LEU . 4.1 mm? -61.91 -41.74 98.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.399 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -60.89 -47.15 87.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.216 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -65.7 -40.91 92.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.637 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.23 -22.22 66.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.657 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -40.43 80.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.95 -37.39 0.66 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -84.01 116.33 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.559 0.219 . . . . 0.0 110.461 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -130.92 143.75 50.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.425 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 m -51.5 140.9 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.392 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.89 150.35 24.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.311 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -127.95 127.79 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.778 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -148.02 151.6 36.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.67 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 96' ' ' GLY . 54.0 p-10 -78.67 179.51 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.761 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.81 26.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -130.08 -83.8 0.33 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.43 -26.9 0.12 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -72.46 141.16 48.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.519 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.08 89.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -148.54 136.9 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.559 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mm -77.48 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.483 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -140.46 168.95 12.91 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.8 Cg_exo -51.4 -37.14 60.59 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.544 2.163 . . . . 0.0 112.166 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -129.36 122.79 30.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.52 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.636 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -153.79 149.23 27.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.428 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -87.55 130.82 34.6 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.5 t -126.05 108.4 11.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.15 179.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.417 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' SER . 50.6 p90 -69.34 -40.48 77.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.539 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 109' ' ' PHE . 9.4 t -57.01 149.56 18.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.331 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.683 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -92.77 170.59 8.68 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.643 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.683 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.7 Cg_exo -51.4 -40.39 62.43 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.459 2.106 . . . . 0.0 112.125 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.44 -47.91 84.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.591 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.5 t0 . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.546 -179.773 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.866 0.365 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -145.65 177.02 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.577 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -145.54 133.72 21.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.452 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.89 149.0 32.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 18.9 mtpp -114.11 68.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.268 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -95.22 125.08 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.268 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 t -161.65 142.37 10.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -129.46 134.19 47.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.404 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.42 143.23 47.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -97.59 -5.14 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.265 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 28.5 t0 -153.42 163.85 39.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.566 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.14 -38.15 89.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -61.25 -45.77 93.16 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.594 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -66.05 -27.82 68.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.437 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -73.44 -40.55 64.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.864 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -66.89 -48.21 69.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.986 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.512 HG23 ' N ' ' A' ' 35' ' ' LEU . 30.8 m -65.33 -42.34 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.513 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.512 ' N ' HG23 ' A' ' 34' ' ' VAL . 37.5 mt -62.94 -43.32 99.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.788 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.5 p -67.6 -43.54 80.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 110.813 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -64.86 -35.52 81.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.65 -58.12 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.805 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.2 m -138.42 94.06 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.686 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.528 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 2.4 p -100.2 -2.73 33.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.342 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -145.75 126.17 14.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -110.94 111.25 22.25 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.159 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.649 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -70.56 156.34 39.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.391 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.04 125.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 47' ' ' ASP . 67.6 m-20 -147.24 149.43 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -72.15 16.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 45' ' ' ASP . 92.4 m-20 -112.07 -3.23 14.79 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -119.19 132.46 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.935 0.398 . . . . 0.0 110.276 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.603 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 72.6 p -101.84 157.52 16.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 51' ' ' ASP . 2.1 pp -48.9 -41.99 35.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.702 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.603 ' CG ' ' HG1' ' A' ' 49' ' ' THR . 1.4 p-10 -59.54 -49.33 78.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 110.337 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -35.52 81.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.316 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.474 ' O ' HG12 ' A' ' 57' ' ' VAL . 44.0 tp -61.76 -43.86 98.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.314 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.09 -40.61 98.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.381 0.61 . . . . 0.0 110.073 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.11 -43.61 82.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.855 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.37 -52.38 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.37 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.578 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.6 p -59.0 -46.09 91.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.977 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.578 ' N ' HG13 ' A' ' 57' ' ' VAL . 56.8 tp -65.59 -54.7 24.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.772 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -58.99 -31.69 69.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.845 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.19 -56.46 12.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.366 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.5 HG23 ' N ' ' A' ' 62' ' ' GLU . 34.0 m -69.1 -43.87 81.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.705 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.5 ' N ' HG23 ' A' ' 61' ' ' VAL . 81.6 tt0 -59.06 -44.8 91.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.285 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.7 p -63.05 -45.95 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.67 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -63.34 -52.65 60.91 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.412 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -110.58 73.21 0.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.543 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.01 -46.53 2.8 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.545 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.3 Cg_endo -82.39 107.1 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.353 2.035 . . . . 0.0 111.88 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.538 ' C ' ' H ' ' A' ' 70' ' ' GLU . 2.5 m -133.59 -13.51 2.59 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.252 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -51.02 -6.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.997 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.538 ' H ' ' C ' ' A' ' 68' ' ' CYS . 14.4 pt-20 -72.35 -36.96 68.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.505 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -83.65 156.53 22.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.624 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 19.2 p-10 -76.06 -59.65 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 74' ' ' ILE . 27.4 m -95.48 -44.87 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.554 ' N ' HG23 ' A' ' 73' ' ' VAL . 4.2 mt -70.11 -0.85 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.106 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.472 ' C ' ' N ' ' A' ' 77' ' ' LYS . . . -106.17 -41.08 1.85 Allowed Glycine 0 N--CA 1.465 0.616 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 76' ' ' THR . 55.2 m -48.77 -12.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.472 ' N ' ' C ' ' A' ' 75' ' ' GLY . 21.4 ptmt -56.42 -37.23 69.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.85 -45.67 94.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.803 0.335 . . . . 0.0 110.228 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 82.1 m -64.39 -48.0 77.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.03 82.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.268 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.53 -43.64 98.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.8 -40.7 92.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.65 -50.92 67.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.23 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 89' ' ' TYR . 36.3 ptt180 -69.67 -40.29 76.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 110.642 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.766 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.9 -40.33 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.29 -81.04 1.37 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 84' ' ' ARG . 99.7 m-20 -135.2 97.6 3.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 84' ' ' ARG . 0.3 OUTLIER -55.36 -100.67 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.436 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.5 m -146.38 162.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.524 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.06 142.15 50.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.941 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 93' ' ' PHE . 7.0 tt -122.35 125.63 46.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.306 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.548 ' N ' HD23 ' A' ' 92' ' ' LEU . 91.9 m-85 -128.09 154.29 45.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 23.3 t0 -74.88 177.52 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.5 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.508 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 8.5 tm-20 -47.03 -59.77 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.52 -46.86 91.4 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.24 -13.53 0.82 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.64 141.79 58.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 0.0 110.56 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -76.6 88.33 3.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.545 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -151.02 137.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.33 132.21 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 110.197 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.63 160.89 30.54 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.31 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 22.4 Cg_endo -61.46 -24.69 78.72 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.85 2.367 . . . . 0.0 111.94 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -125.36 57.2 1.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.783 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -102.59 144.65 30.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.012 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.466 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 57.4 t80 -97.34 127.43 43.29 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.308 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.1 p -125.39 112.29 16.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.466 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 5.4 p -171.46 168.76 6.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.772 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 110' ' ' SER . 44.5 p90 -63.5 -47.16 82.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.52 ' N ' ' CG ' ' A' ' 109' ' ' PHE . 17.1 m -59.43 144.14 47.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -77.83 170.64 15.3 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.562 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.5 Cg_exo -51.12 -42.03 54.96 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.383 2.055 . . . . 0.0 111.877 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 46.4 p-10 -88.1 -34.18 18.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 67.7 t0 . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.412 ' HG1' ' HA ' ' A' ' 45' ' ' ASP . 3.0 t . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.891 0.377 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -148.81 160.0 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.52 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.63 141.72 33.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 21' ' ' ILE . 12.8 tt -107.33 128.94 61.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.04 16.81 10.84 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.227 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mt -108.05 131.4 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.152 0.501 . . . . 0.0 111.13 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.4 m -141.31 145.25 35.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.474 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 107' ' ' CYS . 87.4 t80 -85.0 114.79 22.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.365 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.95 142.38 46.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.529 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.72 -79.49 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.65 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.73 168.7 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.71 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.762 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.414 ' H ' HG22 ' A' ' 30' ' ' THR . 0.2 OUTLIER -55.85 -57.7 10.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.582 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -65.95 -23.62 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.288 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.48 -46.31 70.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -71.51 -39.32 70.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.494 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' THR . 71.4 t -61.8 -48.22 89.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.271 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.47 -42.92 91.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.967 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 40' ' ' SER . 10.6 t -62.62 -47.94 81.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.502 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.04 -45.75 92.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.727 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.86 65.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.5 t -164.08 78.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' SER . 61.2 p -83.14 -7.22 59.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.294 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -171.16 127.97 0.7 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 43' ' ' GLU . 21.0 t80 -128.76 158.16 39.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.181 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -109.58 116.79 32.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.42 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.82 129.67 75.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.206 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 47' ' ' ASP . 19.6 p-10 -113.94 169.02 9.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.985 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 55.7 mtpt -52.63 86.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.515 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER 167.8 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.449 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.4 t -76.85 129.84 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.311 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLU . 3.8 p -124.18 157.53 34.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.571 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -36.54 -39.3 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.646 -179.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -63.18 -45.95 89.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.445 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 49' ' ' THR . 46.0 tp10 -66.98 -38.44 86.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 57' ' ' VAL . 5.5 mt -62.45 -43.14 99.53 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 121.078 0.466 . . . . 0.0 110.617 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.619 ' O ' HD23 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -67.64 -39.47 84.6 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.315 0.579 . . . . 0.0 110.656 -179.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.24 -44.18 80.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.68 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.553 HG13 ' N ' ' A' ' 57' ' ' VAL . 8.4 p -76.64 -45.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.848 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 53' ' ' LEU . 54.0 t -58.33 -47.6 87.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.499 HD21 ' CD1' ' A' ' 81' ' ' LEU . 19.9 tp -64.58 -56.47 13.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.311 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.05 -40.48 58.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.186 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.52 89.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 57' ' ' VAL . 75.7 t -62.2 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.755 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.75 -42.79 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.601 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -63.23 -54.86 30.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.901 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -62.24 -48.76 78.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.541 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.9 tp -108.54 93.57 4.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -79.15 -46.4 1.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.69 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.1 Cg_endo -83.93 116.39 2.15 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.102 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 m -130.64 -34.09 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.556 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -64.57 -28.03 69.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.589 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 70' ' ' GLU . 57.8 mp0 -73.33 -36.37 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 75' ' ' GLY . 92.7 m-70 -91.4 108.67 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.98 -29.85 70.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -59.66 -45.46 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 75' ' ' GLY . 7.0 mt -103.08 -10.75 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.602 ' C ' HG23 ' A' ' 76' ' ' THR . . . -48.09 -177.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.602 HG23 ' C ' ' A' ' 75' ' ' GLY . 2.0 p 73.74 -30.93 0.21 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.353 0.597 . . . . 0.0 110.642 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -62.24 -33.88 75.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.959 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 79' ' ' CYS . 11.3 p -59.68 -42.03 87.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.516 ' N ' HG13 ' A' ' 78' ' ' VAL . 83.2 m -63.43 -50.1 71.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.14 81.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.148 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.499 ' CD1' HD21 ' A' ' 58' ' ' LEU . 37.8 tp -50.99 -41.53 59.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.73 -49.88 75.72 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.141 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.01 -41.99 99.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.35 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -65.83 -41.02 92.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.539 ' C ' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt -62.56 -29.87 70.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.339 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.51 0.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.459 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . 171.14 -74.2 0.1 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 9.9 p-10 176.99 -74.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 1.8 t80 75.81 -71.14 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.1 t -52.9 131.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.337 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.567 ' CZ ' ' O ' ' A' ' 89' ' ' TYR . 37.1 m-85 -120.42 160.41 23.15 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.034 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.651 ' C ' HD23 ' A' ' 92' ' ' LEU . 8.6 tt -123.79 126.78 47.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.425 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.522 ' N ' HD23 ' A' ' 92' ' ' LEU . 62.0 m-85 -130.06 150.54 51.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.767 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -82.82 -158.89 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.457 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.53 -49.69 74.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.437 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.94 -113.22 0.15 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -154.05 45.8 0.56 Allowed Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -124.94 131.39 53.43 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.11 89.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.695 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -158.37 146.52 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 50' ' ' LEU . 13.1 mm -73.45 128.91 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.068 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -144.79 171.27 6.84 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.667 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 76.4 Cg_exo -49.72 -36.74 42.67 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.542 2.161 . . . . 0.0 111.93 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -130.91 131.29 44.4 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.667 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -162.39 167.82 23.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.387 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -139.21 142.17 37.9 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.501 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.9 t -114.28 113.49 24.66 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.0 p -162.22 170.87 18.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.887 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 110' ' ' SER . 44.9 p90 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.513 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 8.4 t -54.91 148.74 12.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.497 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -104.34 170.4 6.13 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.2 Cg_exo -51.32 -40.34 61.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.486 2.124 . . . . 0.0 111.903 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -81.6 35.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.426 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.524 -179.874 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 121.322 0.582 . . . . 999.99 111.615 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -146.18 169.3 19.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.495 -0.775 . . . . 999.99 110.835 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -126.18 119.7 28.17 Favored 'General case' 0 C--N 1.267 -2.988 1 O-C-N 114.155 -5.341 . . . . 999.99 111.2 -174.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.585 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -104.25 145.97 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 114.963 -1.017 . . . . 885.67 110.443 -179.101 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.536 ' N ' HG13 ' A' ' 21' ' ' ILE . 14.1 tttt -134.85 10.67 3.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.142 -0.935 . . . . 999.99 110.042 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.585 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.4 mp -94.82 110.73 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.09 0.472 . . . . 999.99 111.354 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -119.63 137.59 53.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.449 -0.796 . . . . 999.99 109.66 179.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -86.14 114.9 23.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.101 0.477 . . . . 999.99 110.272 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.91 107.82 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 999.99 111.048 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.456 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.4 mt -68.95 -40.02 79.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 999.99 109.536 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -151.62 172.25 16.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.794 -1.093 . . . . 999.99 109.125 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 32' ' ' ASP . . . -58.2 -26.5 62.87 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.584 -0.447 . . . . 999.99 109.999 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 32' ' ' ASP . 24.8 m -59.97 -63.89 1.14 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.958 -0.565 . . . . 999.99 110.287 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.493 ' O ' ' HB3' ' A' ' 35' ' ' LEU . 69.5 m-85 -75.68 16.4 0.39 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 119.091 0.859 . . . . 999.99 109.636 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.5 t0 -88.65 -64.79 1.09 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.07 -1.456 . . . . 999.99 107.07 177.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.3 p -67.8 -41.37 83.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.256 -0.884 . . . . 999.99 109.046 177.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.497 HG11 HD22 ' A' ' 65' ' ' LEU . 66.6 t -66.51 -50.3 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 112.787 0.662 . . . . 825.48 112.787 -178.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 31' ' ' PHE . 12.9 tp -64.96 -41.73 95.22 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.678 -0.809 . . . . 715.35 110.448 -178.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.54 -44.64 95.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.978 -0.289 . . . . 999.99 111.411 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -63.18 -45.57 91.16 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.365 0.506 . . . . 999.99 112.365 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 64' ' ' THR . . . -77.35 -28.28 52.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.227 -0.442 . . . . 999.99 110.758 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 42' ' ' PHE . 6.9 t -147.66 80.83 1.5 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.398 0.888 . . . . 999.99 113.398 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 p -91.45 -14.96 29.61 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.834 -0.621 . . . . 999.99 109.609 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -151.33 144.6 24.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.685 0.994 . . . . 999.99 113.685 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.581 ' CD2' ' SG ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -140.48 147.44 39.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.168 -0.923 . . . . 999.99 111.23 177.862 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -110.59 119.12 38.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.736 -0.666 . . . . 999.99 110.207 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.643 HG12 ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -121.61 111.27 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 114.711 1.374 . . . . 999.99 114.711 -176.698 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.89 161.11 10.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 105.307 -2.109 . . . . 999.99 105.307 175.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -83.44 35.99 0.52 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 122.403 2.365 . . . . 999.99 110.376 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -131.94 2.38 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.883 -0.784 . . . . 999.99 108.883 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.643 ' HB ' HG12 ' A' ' 44' ' ' VAL . 19.0 t -88.63 124.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.498 -0.774 . . . . 999.99 109.62 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 52' ' ' GLU . 35.0 p -103.19 147.82 26.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 533.5 109.888 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.657 ' N ' HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -33.77 -34.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 304.88 110.938 -178.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' THR . 98.3 m-20 -60.7 -48.6 81.04 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 698.47 110.519 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.9 mt-10 -68.24 -38.14 81.53 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.31 -0.405 . . . . 999.99 110.385 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.25 -45.83 92.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.142 -0.688 . . . . 499.3 109.142 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.476 ' CD2' HG23 ' A' ' 90' ' ' VAL . 1.9 mt -63.39 -41.95 98.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.537 -0.756 . . . . 404.06 110.266 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.37 -50.4 73.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.525 -0.761 . . . . 805.6 111.285 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.8 -36.45 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.821 0.344 . . . . 843.98 110.925 -179.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.38 -48.24 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 353.46 110.351 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.931 HD11 ' CD1' ' A' ' 81' ' ' LEU . 32.2 tp -63.94 -44.06 93.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.204 -0.907 . . . . 501.13 109.811 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.71 -43.08 97.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.984 -0.553 . . . . 999.99 111.211 179.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.79 84.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.748 0.309 . . . . 763.22 110.972 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.7 t -64.24 -42.01 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 599.86 110.384 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.16 -39.71 93.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 999.99 109.968 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -42.07 86.07 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.3 -0.409 . . . . 999.99 111.69 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -75.73 -44.88 39.62 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.598 -0.441 . . . . 999.99 110.895 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 34' ' ' VAL . 3.0 tp -108.11 71.7 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 999.99 110.713 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.532 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -78.14 -45.47 2.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 999.99 110.82 179.42 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 66' ' ' SER . 72.8 Cg_endo -80.42 56.89 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.884 2.39 . . . . 999.99 113.365 -179.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.55 -33.27 25.49 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.935 0.398 . . . . 845.47 110.318 179.235 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.93 -20.44 65.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.784 -0.644 . . . . 999.99 111.587 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.79 -38.36 70.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.646 -0.252 . . . . 999.99 111.451 -178.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -87.78 120.56 29.23 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.95 -0.3 . . . . 999.99 110.388 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.83 -41.31 97.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.509 0.195 . . . . 999.99 111.284 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.85 -47.67 92.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 999.99 110.252 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 75' ' ' GLY . 30.7 mt -81.62 -26.76 9.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 115.975 -0.557 . . . . 999.99 110.666 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -22.79 -78.93 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 N-CA-C 111.189 -0.764 . . . . 655.9 111.189 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -25.85 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.942 0.719 . . . . 866.78 112.942 -178.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -56.02 -29.59 60.6 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.348 -0.22 . . . . 999.99 110.941 179.635 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 68' ' ' CYS . 2.6 t -68.18 -46.2 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 110.16 -0.311 . . . . 812.96 110.16 178.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.86 -43.77 97.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.0 -0.545 . . . . 771.91 110.127 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.08 92.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 483.48 109.793 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.931 ' CD1' HD11 ' A' ' 58' ' ' LEU . 58.1 tp -62.65 -45.0 94.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.798 -0.637 . . . . 703.45 110.331 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 82' ' ' LEU . 16.1 tp -62.95 -43.2 99.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.877 -0.601 . . . . 999.99 110.137 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -64.44 -38.74 92.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.158 -0.474 . . . . 999.99 110.143 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 97.0 mtt180 -65.73 -39.87 91.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.999 0.428 . . . . 999.99 110.531 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tp -73.5 -24.52 60.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 985.93 110.169 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.8 99.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.108 -0.496 . . . . 999.99 111.941 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.27 -55.79 0.07 OUTLIER Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.238 -0.982 . . . . 999.99 112.211 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 99.4 m-20 -87.88 115.81 25.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 999.99 110.119 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.473 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.4 p90 -109.6 -111.36 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.559 -0.291 . . . . 999.99 110.385 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -150.73 115.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.373 -0.973 . . . . 390.26 108.373 178.423 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.17 160.55 32.24 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.02 -1.104 . . . . 421.31 108.02 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.938 HD12 ' HB2' ' A' ' 107' ' ' CYS . 3.2 tt -146.49 134.74 21.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 120.002 1.274 . . . . 247.34 107.968 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.08 162.73 37.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.186 -0.606 . . . . 999.99 112.152 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -77.65 -177.98 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.313 -0.858 . . . . 841.49 110.719 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -74.69 49.82 0.41 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.06 -0.518 . . . . 999.99 110.609 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -152.45 -53.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.573 -1.011 . . . . 951.76 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.49 -19.51 2.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.224 -1.151 . . . . 633.38 110.224 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -70.78 136.93 49.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.34 -0.244 . . . . 774.99 110.34 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.526 ' HB3' HD21 ' A' ' 50' ' ' LEU . 96.7 mt-10 -74.89 89.93 2.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.898 -0.408 . . . . 691.2 109.898 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.02 149.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 455.34 110.502 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.657 HD11 ' N ' ' A' ' 50' ' ' LEU . 4.1 mp -89.86 123.18 41.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.535 -0.543 . . . . 501.24 109.535 179.131 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -139.48 178.15 1.74 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.83 -0.623 . . . . 635.24 109.653 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 50.8 Cg_exo -53.74 -35.87 80.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.317 2.011 . . . . 999.99 111.603 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -121.97 97.9 5.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.94 -0.573 . . . . 999.99 110.715 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.593 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -116.31 132.2 56.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.045 -0.525 . . . . 524.37 110.542 -179.83 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.489 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 73.8 t80 -92.73 106.07 18.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.367 -0.379 . . . . 650.22 109.993 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.938 ' HB2' HD12 ' A' ' 92' ' ' LEU . 4.1 t -98.24 118.57 35.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.187 -0.46 . . . . 456.2 110.942 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.489 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 11.5 t -174.41 168.45 3.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.149 0.499 . . . . 573.24 110.856 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.588 ' N ' HG12 ' A' ' 90' ' ' VAL . 25.7 p90 -87.79 25.08 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.201 -0.666 . . . . 999.99 109.201 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.0 m -117.36 121.65 41.7 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.815 -0.63 . . . . 956.64 110.021 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.74 162.02 2.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.611 -0.722 . . . . 699.56 110.985 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -46.04 35.48 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.576 2.184 . . . . 999.99 112.135 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.5 p-10 -74.65 -36.5 62.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.999 0.904 . . . . 999.99 109.09 177.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 t0 . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 113.624 -1.626 . . . . 999.99 110.347 179.523 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.455 -1.458 . . . . 999.99 109.455 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.671 ' CD ' ' HD2' ' A' ' 3' ' ' LYS . 6.6 tptt 89.11 -77.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.819 0.364 . . . . 999.99 110.706 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 1.056 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER 128.31 -138.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 O-C-N 124.341 1.025 . . . . 999.99 109.894 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.056 HG13 ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 174.89 27.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.574 0 O-C-N 123.838 0.711 . . . . 999.99 112.399 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.526 ' H ' ' HG2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -152.75 22.11 0.6 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.256 0.55 . . . . 999.99 110.538 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.2 172.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.936 -1.029 . . . . 999.99 111.532 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.529 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -115.42 -174.3 2.49 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.441 -1.318 . . . . 999.99 107.441 178.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.76 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 14.5 m-20 68.54 170.35 0.28 Allowed 'General case' 0 C--O 1.207 -1.146 0 CA-C-O 116.888 -1.529 . . . . 999.99 107.227 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.933 ' O ' ' C ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -27.22 142.3 0.05 OUTLIER Pre-proline 0 CA--C 1.479 -1.771 0 CA-C-O 113.768 -3.015 . . . . 999.99 108.609 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 1.591 ' CB ' ' CG ' ' A' ' 10' ' ' PRO 0.432 5.9 Cg_exo -55.08 178.3 0.09 OUTLIER 'Trans proline' 2 N--CA 2.068 35.282 3 C-N-CA 134.299 10.0 . . . . 999.99 128.721 179.226 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.729 ' HD3' ' N ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER 42.98 -108.63 0.12 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 109.758 -3.383 . . . . 999.99 107.648 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.729 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 25.6 t -49.36 -24.25 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 105.611 -1.996 . . . . 999.99 105.611 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.933 ' C ' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -173.78 114.56 0.21 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 113.722 -3.037 . . . . 999.99 111.288 178.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.418 ' CB ' ' CA ' ' A' ' 10' ' ' PRO 0.455 0.9 OUTLIER -179.74 -175.77 0.34 Allowed 'General case' 2 N--CA 1.634 8.739 0 O-C-N 127.822 3.201 . . . . 999.99 113.96 172.029 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.495 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -142.71 163.11 40.6 Favored Pre-proline 0 N--CA 1.44 -0.964 0 CA-C-N 112.743 -2.026 . . . . 999.99 109.19 173.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.673 ' C ' ' H ' ' A' ' 18' ' ' THR . 86.7 Cg_exo -41.58 146.84 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.361 2.04 . . . . 999.99 112.346 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.58 17.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.315 0.579 . . . . 999.99 110.985 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.673 ' H ' ' C ' ' A' ' 16' ' ' PRO . 2.6 p -116.41 158.53 23.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.074 -0.966 . . . . 999.99 110.591 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.409 ' O ' HG23 ' A' ' 44' ' ' VAL . 67.3 mtp180 -103.11 137.81 40.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.313 -0.625 . . . . 999.99 109.313 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 97.5 mttt -95.53 114.59 26.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.211 0.529 . . . . 999.99 111.16 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.642 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -100.68 147.1 8.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.268 -0.878 . . . . 885.67 110.178 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' N ' HG13 ' A' ' 21' ' ' ILE . 11.7 tttt -134.78 11.72 3.68 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.667 -0.697 . . . . 999.99 110.783 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.642 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.7 mp -95.85 111.47 26.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.931 0.396 . . . . 999.99 110.697 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.44 130.68 53.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.733 -0.667 . . . . 999.99 110.293 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -78.02 113.19 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.099 0.476 . . . . 999.99 110.41 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.26 107.85 19.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 999.99 110.756 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.4 mt -68.11 -40.06 82.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 999.99 110.181 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -154.08 170.2 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 999.99 109.891 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.97 25.23 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.331 -0.395 . . . . 999.99 110.1 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 32' ' ' ASP . 17.1 m -58.71 -64.68 0.84 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.726 -0.67 . . . . 999.99 110.405 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.509 ' O ' ' HB3' ' A' ' 35' ' ' LEU . 77.9 m-85 -75.93 16.49 0.41 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.357 0.526 . . . . 999.99 109.967 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.0 t0 -88.51 -65.5 1.01 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.65 -0.87 . . . . 999.99 108.65 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.2 p -73.1 -33.51 65.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.471 -0.786 . . . . 999.99 109.7 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.606 HG11 HD22 ' A' ' 65' ' ' LEU . 66.3 t -70.9 -50.1 45.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.077 -0.51 . . . . 825.48 111.457 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 31' ' ' PHE . 16.9 tp -64.05 -41.73 97.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 119.91 -0.716 . . . . 715.35 110.521 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -62.68 -45.65 91.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.353 -0.385 . . . . 999.99 110.937 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -64.35 -39.69 94.38 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.906 0.335 . . . . 999.99 111.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.55 -27.33 31.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 999.99 110.654 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.568 ' HG ' ' HD2' ' A' ' 42' ' ' PHE . 2.9 t -147.78 85.3 1.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 999.99 111.982 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 p -97.13 -16.28 20.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.878 -0.601 . . . . 999.99 110.094 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' CG ' ' HE3' ' A' ' 22' ' ' LYS . 41.4 mt-10 -152.03 144.48 24.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.047 -0.979 . . . . 999.99 112.067 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HD2' ' HG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -142.94 141.76 31.52 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.764 -0.653 . . . . 999.99 111.564 179.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 16.5 pt-20 -105.91 115.31 30.01 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.814 -0.63 . . . . 999.99 110.508 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.544 HG12 ' CB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -119.89 111.95 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.854 0.835 . . . . 999.99 112.644 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 2.2 m-20 -57.73 170.76 0.55 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.014 -1.448 . . . . 999.99 107.667 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -87.89 31.67 0.77 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-N 121.295 1.861 . . . . 999.99 110.084 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -133.72 -3.9 2.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 999.99 109.817 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.544 ' CB ' HG12 ' A' ' 44' ' ' VAL . 19.2 t -79.53 126.15 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.877 -0.601 . . . . 999.99 109.996 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' GLU . 19.8 p -103.18 145.66 29.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.907 -0.588 . . . . 533.5 110.178 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.676 ' N ' HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -30.31 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.773 0.671 . . . . 304.88 110.882 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' THR . 97.6 m-20 -60.22 -49.48 77.45 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.326 -0.397 . . . . 698.47 110.598 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.3 mt-10 -66.78 -38.95 87.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 999.99 110.55 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.08 -46.02 92.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.695 -0.483 . . . . 499.3 109.695 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.435 ' CD2' HG23 ' A' ' 90' ' ' VAL . 1.6 mt -63.32 -40.96 98.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 404.06 110.432 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -60.64 -51.52 69.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 805.6 111.064 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.86 -35.8 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.779 0.323 . . . . 843.98 110.795 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.28 -48.04 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.06 -0.518 . . . . 353.46 110.653 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.959 HD11 ' CD1' ' A' ' 81' ' ' LEU . 30.5 tp -65.1 -43.38 92.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 501.13 110.136 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -64.62 -42.08 95.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.931 -0.577 . . . . 999.99 110.78 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . -61.4 -50.95 70.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 763.22 110.828 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.76 -40.82 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 599.86 110.555 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -66.35 -36.91 84.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.927 -0.578 . . . . 999.99 110.36 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -41.78 75.58 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.229 -0.441 . . . . 999.99 111.221 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -74.22 -48.59 27.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.423 -0.353 . . . . 999.99 110.871 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.606 HD22 HG11 ' A' ' 34' ' ' VAL . 3.7 tp -106.23 72.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 999.99 110.438 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -78.23 -49.3 1.89 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 999.99 110.678 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 66' ' ' SER . 59.8 Cg_endo -76.53 63.18 7.22 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.859 2.372 . . . . 999.99 112.423 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -91.86 -31.67 15.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 845.47 110.518 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HB2' HG21 ' A' ' 78' ' ' VAL . 81.0 tttt -65.69 -16.52 63.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 999.99 110.873 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.78 -39.81 66.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.401 -0.363 . . . . 999.99 110.956 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 75' ' ' GLY . 99.0 m-70 -86.73 118.52 26.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 999.99 110.281 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.06 -40.64 94.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 999.99 110.947 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -47.24 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 999.99 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 43.1 mt -83.27 -29.68 8.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.144 -0.48 . . . . 999.99 110.612 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -21.71 -76.03 0.01 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 110.863 -0.895 . . . . 655.9 110.863 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -25.0 -35.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.016 0.48 . . . . 866.78 112.169 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -53.93 -29.75 43.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.267 -0.173 . . . . 999.99 110.606 179.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 69' ' ' LYS . 2.6 t -68.77 -46.9 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.781 0.324 . . . . 812.96 110.389 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 m -61.79 -44.64 96.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.938 -0.574 . . . . 771.91 110.228 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.02 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.962 -0.563 . . . . 483.48 110.224 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.959 ' CD1' HD11 ' A' ' 58' ' ' LEU . 58.3 tp -62.67 -45.31 93.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.078 -0.51 . . . . 703.45 110.479 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 82' ' ' LEU . 16.0 tp -63.2 -43.32 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 999.99 110.345 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.3 -40.08 96.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.021 -0.536 . . . . 999.99 110.43 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 91.7 mtt180 -65.33 -40.0 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 999.99 110.745 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tp -74.94 -19.37 60.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.947 -0.57 . . . . 985.93 110.389 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.76 -45.13 94.12 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.364 -0.38 . . . . 999.99 111.097 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.55 -56.3 0.06 OUTLIER Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.939 -0.648 . . . . 999.99 111.505 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 92.0 m-20 -84.15 112.81 20.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.34 -0.244 . . . . 999.99 110.34 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.505 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.2 p90 -108.62 -110.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.323 . . . . 999.99 110.474 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -151.39 115.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.331 -0.618 . . . . 390.26 109.331 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -73.84 155.27 38.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.262 -0.644 . . . . 421.31 109.262 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.946 HD12 ' HB2' ' A' ' 107' ' ' CYS . 3.8 tt -142.35 135.19 28.39 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.723 -0.843 . . . . 247.34 108.723 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.51 163.73 32.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.882 0.372 . . . . 999.99 111.011 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -79.49 -175.73 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 841.49 110.36 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.08 50.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.145 -0.479 . . . . 999.99 110.687 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.39 -55.62 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.778 -0.929 . . . . 951.76 110.778 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.76 -20.3 2.18 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.572 -1.011 . . . . 633.38 110.572 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -72.33 136.8 46.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.739 0.304 . . . . 774.99 110.588 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.532 ' HB3' HD21 ' A' ' 50' ' ' LEU . 96.8 mt-10 -74.21 89.83 2.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 691.2 110.28 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -148.62 151.13 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 455.34 110.456 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.676 HD11 ' N ' ' A' ' 50' ' ' LEU . 4.1 mp -90.45 123.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.546 . . . . 501.24 110.208 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.85 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -141.28 177.49 1.91 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 635.24 110.399 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.85 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 53.2 Cg_exo -51.51 -36.79 60.81 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.704 2.269 . . . . 999.99 111.979 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -123.21 98.0 5.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.212 -0.449 . . . . 999.99 110.499 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.635 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -116.01 134.84 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.536 . . . . 524.37 110.4 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 70.7 t80 -94.87 106.23 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 650.22 110.147 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.946 ' HB2' HD12 ' A' ' 92' ' ' LEU . 4.3 t -98.64 120.76 39.63 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.107 -0.497 . . . . 456.2 110.669 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.509 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 10.4 t -177.38 167.2 2.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.188 0.518 . . . . 573.24 110.738 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.609 ' N ' HG12 ' A' ' 90' ' ' VAL . 26.0 p90 -85.68 26.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 999.99 109.982 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.1 m -119.77 121.1 38.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.259 -0.428 . . . . 956.64 110.552 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -53.54 161.35 1.56 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.854 -0.612 . . . . 699.56 110.418 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.5 Cg_exo -50.58 -47.46 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.558 2.172 . . . . 999.99 112.324 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 24.7 p-10 -72.95 -38.28 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 999.99 110.409 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 114.429 -1.259 . . . . 999.99 110.032 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -76.54 144.11 39.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.316 . . . . 0.0 110.333 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -133.14 -4.76 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.488 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.635 HG13 ' N ' ' A' ' 5' ' ' GLU . 7.1 p -77.24 -52.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.992 0.425 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.635 ' N ' HG13 ' A' ' 4' ' ' VAL . 85.8 mt-10 -153.74 150.82 28.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.771 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -102.38 125.47 49.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -173.18 52.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.553 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 9' ' ' LYS . 35.1 t0 43.97 -167.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.36 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 2.8 mptm? -46.03 157.32 0.41 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.745 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.22 156.32 62.42 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.325 2.017 . . . . 0.0 112.06 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -128.13 144.58 51.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.105 0.479 . . . . 0.0 110.327 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t 57.67 47.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -152.48 150.62 29.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.422 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -57.68 131.96 51.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.409 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 pt -66.95 154.24 92.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.824 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.44 -164.11 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.593 2.195 . . . . 0.0 111.92 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -74.95 1.36 13.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.49 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.9 p -85.25 169.6 13.64 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.322 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -113.83 171.3 7.67 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -112.52 147.39 36.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.37 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 21' ' ' ILE . 10.8 tp -108.65 134.29 51.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.05 -2.42 1.87 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mt -102.52 122.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.41 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -147.41 144.2 28.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.455 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -81.55 119.61 23.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.29 36.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -64.88 -40.5 95.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.569 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.3 t0 -156.25 -175.82 5.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -61.1 -42.91 99.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.53 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' VAL . 75.3 m -63.12 -47.56 82.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.563 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.411 ' HB2' ' H ' ' A' ' 28' ' ' ASP . 64.0 m-85 -65.34 -33.46 76.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.447 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -65.46 -51.49 59.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.826 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 t -63.67 -44.86 92.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.749 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 30' ' ' THR . 69.9 t -62.73 -47.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.52 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.84 -43.4 96.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.705 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.27 -45.79 91.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.59 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -65.25 -44.39 88.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.728 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.27 -54.52 14.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.472 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 60' ' ' ALA . 60.8 m -118.58 79.22 1.35 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.562 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.46 -37.96 89.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.476 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -172.63 150.48 2.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.604 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -142.12 156.94 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.84 124.66 32.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.985 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 m -124.6 135.64 63.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.093 0.473 . . . . 0.0 110.592 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.24 168.57 19.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.145 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -73.7 161.25 30.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 56.96 33.86 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.678 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -75.14 140.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.242 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 20.3 p -90.76 -71.36 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 172.17 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.771 0.669 . . . . 0.0 110.812 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 26.5 p-10 -55.88 -44.46 78.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.919 0.39 . . . . 0.0 110.451 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 79.5 tt0 -64.61 -41.24 96.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.419 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' VAL . 19.3 mt -62.95 -43.64 98.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.695 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.83 -43.21 96.88 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.839 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -67.92 -43.05 80.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.022 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.71 -50.48 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 53' ' ' LEU . 76.4 t -57.54 -48.21 83.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 81' ' ' LEU . 54.0 tp -64.92 -55.73 17.52 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.622 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -51.66 -41.82 61.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.304 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.445 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -62.51 -42.44 99.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.588 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 57' ' ' VAL . 53.9 t -63.91 -45.3 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.703 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.59 -42.17 82.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.589 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 t -61.34 -54.37 44.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.794 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.1 p -59.75 -45.42 92.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.152 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -108.01 81.34 1.48 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.55 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.63 -46.61 4.18 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 66' ' ' SER . 61.1 Cg_endo -81.91 106.4 1.61 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.335 2.023 . . . . 0.0 112.009 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.401 ' SG ' ' CG2' ' A' ' 78' ' ' VAL . 1.4 p -133.25 -42.0 0.88 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.871 0.367 . . . . 0.0 110.208 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -66.9 -22.91 65.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -72.29 -38.64 68.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.732 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 75' ' ' GLY . 77.0 m80 -97.66 125.3 42.36 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.76 -34.98 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.064 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.27 -45.98 95.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.073 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 31.8 mm -88.59 -22.38 6.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.201 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -37.71 -56.18 1.68 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.8 p -46.58 -19.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.722 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 88.9 tttt -62.03 -45.96 91.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.588 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 74.1 t -62.61 -44.53 99.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.57 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 77.9 m -62.0 -49.43 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.78 91.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 58' ' ' LEU . 5.5 tt -63.28 -44.53 94.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.72 -43.61 98.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 87' ' ' GLY . 33.2 t70 -62.11 -44.27 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 88' ' ' ASP . 87.5 mtm180 -66.83 -36.99 83.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.816 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.21 -46.33 87.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.406 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.21 -49.85 2.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.46 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -69.23 -95.65 0.05 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 83' ' ' ASP . 99.7 m-20 -68.92 -172.11 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.574 0.226 . . . . 0.0 110.495 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CE1' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER 173.45 175.06 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.092 0.472 . . . . 0.0 110.322 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.27 138.29 47.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.436 ' OH ' ' CE1' ' A' ' 89' ' ' TYR . 54.5 m-85 -110.11 151.52 27.14 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.509 ' C ' HD23 ' A' ' 92' ' ' LEU . 7.1 tt -131.29 124.6 30.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.487 ' N ' HD23 ' A' ' 92' ' ' LEU . 82.0 m-85 -132.76 154.68 50.0 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.694 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 97' ' ' GLY . 18.8 p-10 -82.98 177.41 8.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.16 26.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -144.3 -4.6 0.66 Allowed Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.559 ' N ' ' OD1' ' A' ' 94' ' ' ASP . . . 91.75 -6.27 79.73 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 45.1 t0 -86.9 117.19 25.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.791 0.329 . . . . 0.0 110.464 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 100' ' ' VAL . 95.6 mt-10 -55.6 86.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.521 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 99' ' ' GLU . 67.7 t -156.83 134.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.47 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 101' ' ' ILE . 1.6 mp -68.92 131.44 33.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.678 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -146.06 172.0 5.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.582 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.1 Cg_exo -51.46 -35.69 56.1 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.598 2.199 . . . . 0.0 111.812 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' A' ' 103' ' ' PRO . 1.5 mpt_? -118.63 74.23 0.96 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.002 0.43 . . . . 0.0 110.392 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -104.79 148.69 26.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.165 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.485 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 57.3 t80 -116.82 124.89 50.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.326 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.48 ' SG ' ' CD1' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -123.5 110.36 14.98 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.485 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 7.1 p -168.38 169.3 10.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.804 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 109' ' ' PHE . 30.1 t80 -62.46 -47.36 84.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -59.34 145.69 42.44 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.403 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.675 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -80.58 170.79 14.26 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.443 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.675 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.3 Cg_exo -51.32 -42.29 55.1 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.526 2.15 . . . . 0.0 111.84 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.05 -41.11 97.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.02 0.438 . . . . 0.0 110.755 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.762 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -82.82 159.54 22.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 110.6 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -43.32 -45.08 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 4' ' ' VAL . 8.1 p -97.31 126.47 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.337 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.42 179.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.431 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASP . 33.3 m-85 -158.6 60.6 0.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.459 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 6' ' ' PHE . 8.4 m120 32.83 -91.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.083 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' PHE . 52.1 p-10 -143.8 -170.88 3.42 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.742 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -80.84 148.22 64.31 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.666 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.93 76.7 1.19 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.469 2.112 . . . . 0.0 112.327 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.0 -39.28 89.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.32 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -71.66 -73.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.495 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -56.62 171.64 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.527 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.14 139.63 56.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.455 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.3 161.59 62.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.653 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -55.02 144.67 67.45 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.317 2.011 . . . . 0.0 112.088 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.6 t -101.65 9.02 41.45 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.573 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -111.14 -179.94 3.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.438 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' OG1' ' A' ' 18' ' ' THR . 33.7 ptt180 -139.24 167.18 22.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.358 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -116.17 146.7 42.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 21' ' ' ILE . 8.3 tt -130.26 122.4 53.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.36 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -99.42 121.5 41.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.922 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.17 115.0 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.165 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -154.54 117.8 4.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -134.11 138.65 45.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.958 0.409 . . . . 0.0 110.425 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 143.11 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.6 mt -139.78 -79.72 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 21.9 p-10 -156.94 -62.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.583 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.513 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -178.11 -68.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.453 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -62.02 -51.21 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -69.73 -20.77 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.352 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.89 -52.86 17.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 36' ' ' SER . 78.1 p -68.46 -41.54 80.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.634 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 30' ' ' THR . 70.5 t -63.08 -45.63 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.71 -42.63 99.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 78.3 p -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.74 -41.2 96.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.678 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.486 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -59.31 -24.15 63.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.634 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 38' ' ' ALA . 8.5 m -162.42 63.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.569 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 36' ' ' SER . 85.4 p -68.49 -18.77 64.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.519 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -174.45 139.43 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.536 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 156.15 46.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.086 0.469 . . . . 0.0 110.181 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -119.51 113.83 21.34 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.973 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.58 133.82 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.255 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.42 141.1 28.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.317 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 64.3 tttp -47.56 101.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.94 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD2' ' C ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER 163.38 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.712 0.632 . . . . 0.0 110.3 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.76 136.91 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 110.454 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -92.42 155.52 17.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.05 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -42.65 -37.73 1.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.22 -43.59 95.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.211 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -65.61 -35.36 80.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.435 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 57' ' ' VAL . 18.6 mt -61.53 -46.83 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.53 -41.58 98.46 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.452 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.06 -43.14 99.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.93 -45.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-O 120.955 0.407 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 53' ' ' LEU . 54.6 t -58.04 -48.37 84.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.894 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.7 -53.67 47.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.98 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -49.86 -42.6 47.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.829 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.93 -49.66 74.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.942 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.59 -48.06 90.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.247 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' HA ' HD23 ' A' ' 65' ' ' LEU . 14.8 mm-40 -45.32 -53.39 8.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.398 0.618 . . . . 0.0 110.414 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 t -60.08 -43.44 95.48 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.5 p -86.04 14.34 6.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.118 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.73 -24.01 23.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 110.212 179.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.479 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -41.33 -49.96 8.82 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.582 -178.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 66' ' ' SER . 50.2 Cg_exo -53.04 -39.75 78.67 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.149 1.899 . . . . 0.0 112.218 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.8 m -68.02 -34.28 76.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.597 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -60.92 -30.45 70.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.517 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.62 -33.64 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.475 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 75' ' ' GLY . 97.8 m-70 -97.05 118.49 33.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.238 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.0 p-10 -68.5 -35.38 77.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 78.1 t -61.57 -47.85 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 76' ' ' THR . 58.6 mt -88.42 -34.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.391 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -39.89 -21.75 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' ILE . 46.2 p -54.76 -29.73 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.103 0.478 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -32.89 66.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 65' ' ' LEU . 91.7 t -62.09 -46.17 97.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.43 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 94.2 m -63.66 -39.13 93.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.8 -43.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.82 -41.45 99.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.4 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.58 -41.9 99.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.566 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 87' ' ' GLY . 40.0 t0 -62.19 -43.11 99.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -69.5 -37.61 77.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.518 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.61 -43.11 99.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.464 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.68 -12.15 22.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.556 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -119.78 57.17 0.57 Allowed Glycine 0 N--CA 1.463 0.471 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 63.51 98.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.086 0.469 . . . . 0.0 110.504 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -55.29 -100.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.12 162.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.157 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -116.29 139.77 50.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.861 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.87 132.58 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -140.98 154.78 46.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.644 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -85.13 -162.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.564 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -73.01 51.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.566 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.43 -90.15 0.08 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.5 -29.07 0.02 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.31 139.93 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -80.96 90.24 5.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -146.61 138.52 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.516 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.749 HD12 ' N ' ' A' ' 101' ' ' ILE . 2.5 mp -71.47 131.66 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -145.8 172.56 5.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.631 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 53.3 Cg_exo -51.17 -36.29 55.18 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.559 2.173 . . . . 0.0 112.162 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -132.73 103.09 5.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.372 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -122.55 148.42 45.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.214 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -101.79 119.9 39.51 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.06 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.32 112.97 20.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.476 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 t -177.34 168.77 2.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.847 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 -45.48 93.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.6 p -59.14 147.06 36.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.281 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -87.53 170.07 12.75 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.457 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 54.8 Cg_exo -50.15 -43.97 40.22 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.414 2.076 . . . . 0.0 111.931 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 31.5 p-10 -90.07 -37.84 13.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.97 0.415 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 61.2 t0 . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.545 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 4' ' ' VAL . 46.5 mttp -65.26 -76.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? 65.87 -7.82 0.35 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.594 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' A' ' 2' ' ' LYS . 19.6 m -86.93 -163.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.01 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -109.95 150.99 27.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.04 0.448 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -156.42 81.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.488 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -149.13 85.11 1.46 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.831 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.05 176.83 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.098 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.58 153.38 39.23 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.557 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 12' ' ' VAL . 47.1 Cg_endo -67.94 -93.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.676 2.251 . . . . 0.0 111.991 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ARG . 65.0 tttm 41.92 -88.46 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.716 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 10' ' ' PRO . 16.1 m -71.21 21.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.532 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' LYS . 61.1 ttp180 -155.54 156.71 35.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.453 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.03 139.81 58.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 110.499 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -74.86 160.47 80.68 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.44 -178.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.55 142.33 60.19 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.129 1.886 . . . . 0.0 112.184 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m -78.6 4.52 13.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.453 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 2.3 t -162.09 153.73 18.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.523 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 44' ' ' VAL . 84.8 mtp180 -105.26 140.95 37.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.957 0.408 . . . . 0.0 110.292 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -105.53 148.6 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.133 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.2 tp -127.69 135.12 63.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.307 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -137.8 -35.23 0.65 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.817 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.3 140.52 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.263 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -155.26 144.76 21.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.35 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.39 137.84 55.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 116.11 22.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.584 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.418 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 54.1 mt -62.06 -42.86 99.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.456 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 61.8 m-20 -158.77 20.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.589 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 28' ' ' ASP . . . 73.81 -51.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m -61.36 -53.53 55.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.285 0.565 . . . . 0.0 110.696 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -71.24 -27.33 63.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.922 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.89 -44.51 97.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.255 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.0 p -70.35 -42.21 72.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.29 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.7 -48.88 86.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.383 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.37 -40.73 96.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.498 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 40' ' ' SER . 75.1 m -56.3 -43.38 78.86 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.09 89.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.502 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.34 2.7 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.861 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 18.2 p -174.45 54.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.108 0.48 . . . . 0.0 110.286 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 36' ' ' SER . 78.0 p -60.11 -36.97 78.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.754 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -136.59 125.67 24.47 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.453 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -129.82 131.63 46.22 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.48 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -91.48 126.67 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.15 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 19' ' ' ARG . 47.1 t -122.48 126.19 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.115 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -48.84 160.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 22.6 pttm -59.72 -50.03 75.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.036 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 49.9 t0 -91.63 90.36 7.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -147.71 128.23 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.275 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -90.48 151.67 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.228 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -48.69 -32.86 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.375 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -51.11 71.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 110.289 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 56' ' ' VAL . 82.4 tt0 -64.66 -41.71 95.92 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.71 HD13 ' C ' ' A' ' 53' ' ' LEU . 2.8 tm? -61.78 -50.72 71.22 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.599 HD11 ' NH2' ' A' ' 84' ' ' ARG . 60.8 tp -50.73 -41.72 56.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.14 -35.8 71.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 52' ' ' GLU . 44.4 t -69.7 -51.78 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 58' ' ' LEU . 14.8 p -61.39 -42.7 94.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.908 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.521 ' N ' HG13 ' A' ' 57' ' ' VAL . 57.4 tp -60.45 -54.5 44.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.28 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -53.89 -41.72 67.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.88 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.31 -46.66 82.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.543 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.84 -43.71 97.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.437 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.564 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -62.63 -44.08 97.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.822 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.2 p -68.53 -64.81 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.725 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.41 83.35 2.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.569 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -74.87 -45.73 5.06 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.322 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.8 Cg_endo -83.25 114.32 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.599 2.2 . . . . 0.0 111.987 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.76 -19.39 2.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.0 -9.84 48.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.759 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.55 -38.5 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.472 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.1 m-70 -103.16 124.58 48.85 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.3 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 40.6 p-10 -60.58 -34.98 74.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.353 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.513 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 82.9 t -62.32 -47.81 91.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.242 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 77' ' ' LYS . 45.9 mt -82.45 -23.37 9.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.002 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -34.91 -61.01 0.64 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -40.05 -24.38 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.95 0.405 . . . . 0.0 110.784 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 66.0 tttm -58.67 -45.39 89.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.213 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.1 t -57.4 -44.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.7 m -62.37 -46.52 88.3 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.73 -38.5 91.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.242 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.39 -42.7 99.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -62.35 -45.92 91.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.33 0.586 . . . . 0.0 110.09 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.93 -45.48 94.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.599 ' NH2' HD11 ' A' ' 54' ' ' LEU . 83.1 mtp180 -66.08 -39.43 90.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.076 0.465 . . . . 0.0 110.751 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.88 -29.25 69.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.44 59.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.498 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 168.62 -65.35 0.18 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 89' ' ' TYR . 28.0 t70 -173.89 176.0 2.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.548 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.545 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 1.9 t80 -175.18 -68.53 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.594 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.3 m -66.1 133.06 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.308 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 65.4 m-85 -116.87 145.89 43.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.617 ' C ' HD23 ' A' ' 92' ' ' LEU . 7.7 tt -117.02 125.73 51.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.509 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.57 ' N ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -126.37 152.26 46.54 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.284 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 46.6 t0 -74.52 179.16 4.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.165 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 80.5 mm-40 -65.68 -37.54 86.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.66 -3.47 87.0 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.61 78.97 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.1 t0 -88.5 111.08 21.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -50.62 87.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.306 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 76.0 t -152.87 130.8 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.521 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.59 134.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.031 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -155.59 171.82 6.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.579 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 58.0 Cg_exo -50.83 -38.07 56.53 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.414 2.076 . . . . 0.0 111.993 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -130.86 131.79 44.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.315 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.533 ' HB2' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -153.4 173.87 15.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.02 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -117.98 109.73 16.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.343 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.8 t -107.55 115.74 30.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.534 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 t -172.59 177.34 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.527 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -89.72 40.85 1.01 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.617 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.2 m -136.91 116.1 12.54 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.449 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.609 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -61.96 170.38 2.08 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.541 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 49.0 Cg_exo -54.45 -43.13 61.66 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.428 2.085 . . . . 0.0 112.267 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -93.79 12.73 24.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.583 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.529 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -69.31 141.03 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.996 0.427 . . . . 0.0 110.209 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -114.48 -12.89 12.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.721 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 5' ' ' GLU . 35.9 m -114.94 -14.34 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.784 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 4' ' ' VAL . 48.0 mp0 43.53 98.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -82.68 138.28 34.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.943 0.401 . . . . 0.0 110.39 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -95.54 13.98 24.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.335 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 50.14 -171.02 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.284 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 pttm -109.31 118.64 50.46 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.563 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.25 65.19 7.93 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.412 2.075 . . . . 0.0 112.151 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -102.85 62.63 0.82 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.931 0.396 . . . . 0.0 110.281 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -168.29 -26.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -146.9 152.25 38.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.574 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -67.64 137.42 55.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.268 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -44.63 157.14 0.32 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.537 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -42.22 129.53 4.57 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.396 2.064 . . . . 0.0 112.031 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 95.6 p -88.29 -4.55 58.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.581 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 p -86.08 167.09 15.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.979 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' VAL . 62.6 ttp180 -110.53 151.83 27.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -112.42 144.96 40.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.069 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tp -119.32 142.8 32.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -130.74 -15.21 3.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -104.37 126.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 110.567 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 m -138.13 137.61 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.384 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.8 131.25 50.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.213 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.77 137.1 43.09 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.552 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.9 mm? -63.89 -41.42 97.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -159.59 179.07 9.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.83 83.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.499 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -63.2 -50.85 68.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.513 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -70.31 -22.69 62.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.65 -52.65 50.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 0.0 110.346 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -67.87 -44.6 76.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.34 -46.45 95.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.27 -43.55 97.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.592 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.3 t -60.58 -42.74 97.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -63.61 -44.47 93.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.549 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.17 -78.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 31.6 t -87.14 64.34 8.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.5 t -62.33 -41.28 98.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -154.28 148.11 25.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 81.8 t80 -150.28 150.12 31.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.495 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 16.7 pt-20 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.238 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 19' ' ' ARG . 65.4 t -127.89 133.27 67.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.116 0.484 . . . . 0.0 110.472 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 48' ' ' VAL . 91.5 m-20 -81.2 170.08 16.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.228 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.81 152.23 20.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.086 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.12 41.55 10.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.587 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.625 HG12 ' N ' ' A' ' 49' ' ' THR . 62.7 t -89.22 166.85 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.625 ' N ' HG12 ' A' ' 48' ' ' VAL . 31.0 m -121.71 129.33 52.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.26 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -37.61 -27.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.697 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 49' ' ' THR . 64.2 t0 -60.03 -46.92 87.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.055 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 80.7 mm-40 -64.88 -41.95 95.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.367 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.469 ' O ' HG12 ' A' ' 57' ' ' VAL . 51.2 tp -62.59 -41.36 98.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.213 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.83 -44.61 95.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.754 0.788 . . . . 0.0 110.367 -178.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.36 -42.49 68.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.543 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' GLU . 56.0 t -66.72 -51.27 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.071 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.549 HG13 ' N ' ' A' ' 58' ' ' LEU . 9.3 p -58.17 -43.93 86.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' N ' HG13 ' A' ' 57' ' ' VAL . 58.1 tp -60.06 -52.22 66.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.257 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.79 -31.53 71.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.16 -54.42 41.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.17 -38.58 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.722 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.5 -44.77 81.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.2 p -62.1 -44.8 95.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.434 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.418 ' C ' HD12 ' A' ' 65' ' ' LEU . 22.0 p -61.17 -49.21 78.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 65' ' ' LEU . 10.8 mp -101.35 109.49 21.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.254 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.54 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.43 -48.11 3.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.11 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.5 Cg_endo -80.69 138.04 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.637 2.224 . . . . 0.0 111.881 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.8 m -130.99 -77.79 0.53 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.586 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.2 -5.73 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.466 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -72.36 0.96 8.71 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.342 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -130.26 102.92 6.42 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.269 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -66.17 -39.54 89.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.597 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.01 -47.58 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.731 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 75' ' ' GLY . 97.2 mt -67.42 -56.04 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.911 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . 31.95 -155.93 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m 71.84 -50.62 0.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.136 0.493 . . . . 0.0 110.377 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -63.68 -25.29 68.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.338 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.32 -50.33 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 92.6 m -69.37 -37.65 77.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.44 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.66 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.955 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.19 -47.26 85.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.876 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.03 -40.29 96.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.12 0.486 . . . . 0.0 110.437 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -61.43 -46.27 90.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.9 -38.36 86.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.713 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -43.22 97.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.256 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.33 -24.35 64.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.498 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.12 32.87 2.28 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 89' ' ' TYR . 97.7 m-20 -78.69 -53.5 7.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 48.5 p90 42.61 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.653 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.8 m -142.08 168.13 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.158 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.4 137.76 38.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.046 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 92' ' ' LEU . 2.5 pp -134.57 139.96 45.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.625 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -151.94 164.11 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.819 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 96' ' ' GLY . 52.4 p-10 -76.58 178.0 7.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.277 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.38 26.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -118.7 -70.07 0.35 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.79 -24.91 0.23 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.97 123.21 28.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.27 92.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.478 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.94 135.69 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.655 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.51 132.8 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.339 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -161.27 172.0 6.26 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.663 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 52.2 Cg_exo -52.19 -42.97 56.55 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.592 2.195 . . . . 0.0 111.785 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.72 78.24 1.33 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.062 0.458 . . . . 0.0 110.038 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -106.08 134.46 49.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.405 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -104.47 97.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 108' ' ' SER . 11.9 t -95.38 124.32 39.35 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.511 0.507 . . . . 0.0 110.597 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 107' ' ' CYS . 69.1 m -168.95 170.21 9.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.56 48.53 1.53 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.97 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 t -140.61 168.58 19.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.115 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -100.98 170.38 6.63 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.3 Cg_exo -51.75 -39.3 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.586 2.191 . . . . 0.0 111.837 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -81.47 40.35 0.57 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.982 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 3' ' ' LYS . 9.8 tptp -76.71 165.62 24.5 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.346 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 99.2 mttt -133.28 -32.92 1.15 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.621 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.03 -172.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.196 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' O ' ' OE1' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -116.5 136.97 52.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.264 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -104.07 -173.68 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.089 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -130.67 130.04 43.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.09 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -81.26 83.79 6.77 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.106 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -135.27 146.53 58.45 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.84 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.5 129.73 13.97 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.207 1.938 . . . . 0.0 112.142 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -61.14 -61.2 2.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.537 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 12' ' ' VAL . 16.7 m -82.84 -129.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.337 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' VAL . 39.0 ptt180 -51.95 -172.02 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.247 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -112.7 125.37 54.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.143 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 pt -109.45 156.84 38.82 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -61.18 152.37 72.39 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.524 2.149 . . . . 0.0 112.291 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 m -72.01 -16.94 62.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.293 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.413 HG22 ' OD1' ' A' ' 45' ' ' ASP . 43.2 p -89.79 -174.51 4.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.338 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.405 ' NH2' ' NZ ' ' A' ' 46' ' ' LYS . 43.2 ttm180 -127.95 149.23 50.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.229 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.08 135.61 46.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.13 138.5 37.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' C ' HD12 ' A' ' 23' ' ' ILE . 77.0 tttt -95.24 115.35 27.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.768 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.781 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.8 mp -94.57 108.64 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.458 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -137.08 102.02 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.507 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -161.06 107.17 1.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.16 151.15 49.45 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.168 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.6 mt -118.2 28.09 8.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.551 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 33.8 t0 -146.03 -143.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.307 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.499 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -131.52 -64.66 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.525 HG23 ' N ' ' A' ' 31' ' ' PHE . 14.7 t -58.03 -42.76 86.02 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.393 0.616 . . . . 0.0 110.399 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.525 ' N ' HG23 ' A' ' 30' ' ' THR . 52.2 t80 -68.16 -22.98 64.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.507 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -76.3 -44.42 37.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.993 0.425 . . . . 0.0 111.135 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -63.27 -45.73 90.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.843 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 35' ' ' LEU . 20.6 m -65.28 -40.19 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.398 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -61.72 -51.02 70.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.841 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -62.6 -45.34 93.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.04 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.02 -44.56 84.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.91 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 7.5 t -89.31 79.75 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.414 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -82.19 -9.04 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.321 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -172.7 127.97 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.135 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.29 139.84 45.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -119.52 115.89 24.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.267 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.36 156.15 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.768 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' OD1' HG22 ' A' ' 18' ' ' THR . 92.6 m-20 -87.57 171.69 10.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.207 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 48' ' ' VAL . 68.6 mttm -60.85 -59.49 5.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 46' ' ' LYS . 98.4 m-20 -34.09 -34.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' LYS . 21.3 t -59.55 133.13 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 p -106.72 147.42 29.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.241 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -38.88 -35.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.55 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -60.14 -51.83 67.91 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.114 0.483 . . . . 0.0 110.146 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.561 ' O ' HG22 ' A' ' 56' ' ' VAL . 85.1 tt0 -63.68 -34.92 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.046 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.47 ' O ' HG12 ' A' ' 57' ' ' VAL . 54.6 tp -62.68 -40.02 95.78 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.534 0.521 . . . . 0.0 110.442 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.265 0.555 . . . . 0.0 111.077 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -69.4 -46.68 66.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.669 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.644 HG23 ' N ' ' A' ' 57' ' ' VAL . 29.2 m -69.82 -49.72 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.644 ' N ' HG23 ' A' ' 56' ' ' VAL . 9.8 p -57.39 -45.61 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.569 ' N ' HG13 ' A' ' 57' ' ' VAL . 55.5 tp -60.94 -53.56 55.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.12 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -53.62 -39.79 65.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.59 -52.05 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.498 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.465 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 66.7 t -64.26 -47.31 90.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.47 -45.29 76.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.352 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.0 p -62.46 -45.61 92.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.714 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.8 m -53.31 -51.95 60.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.586 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.4 OUTLIER -108.29 68.43 0.7 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.366 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.56 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.94 -47.05 2.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 66' ' ' SER . 67.4 Cg_endo -81.08 85.07 1.86 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.569 2.179 . . . . 0.0 112.333 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.4 m -133.49 -10.04 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.591 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.09 -27.12 68.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.12 -36.75 69.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.579 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 75' ' ' GLY . 80.8 m80 -76.61 126.08 30.36 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.89 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.46 -43.98 92.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.4 t -63.53 -44.68 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.11 17.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.429 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -74.55 -62.13 2.96 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -57.12 -9.34 0.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.95 0.405 . . . . 0.0 110.064 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' GLY . 49.7 tptt -59.7 -51.77 68.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.626 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -57.61 -48.53 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 110.032 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.4 m -57.18 -34.57 68.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.103 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.33 -41.94 93.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.493 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.04 -44.9 95.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.596 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.76 -44.64 92.83 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.41 -43.86 97.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.416 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mtt180 -67.92 -41.7 82.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.761 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.77 -20.75 66.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.425 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.52 -35.53 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.704 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -63.43 0.04 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' ARG . 67.5 t0 -79.15 119.54 22.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.652 0.263 . . . . 0.0 110.424 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -120.47 -100.25 0.43 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.741 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -144.3 141.92 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 110.501 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -93.54 132.68 37.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.966 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 92' ' ' LEU . 6.5 tt -120.8 121.68 38.69 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.534 ' N ' HD23 ' A' ' 92' ' ' LEU . 53.2 p90 -154.62 149.54 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.676 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 96' ' ' GLY . 56.6 p30 -93.65 -176.56 4.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.522 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.59 42.56 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -139.96 -16.38 0.5 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.65 -7.78 78.06 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 100' ' ' VAL . 51.9 t0 -96.91 111.03 23.41 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 40.3 mp0 -53.66 88.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 98' ' ' ASP . 6.3 p -146.73 153.54 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.8 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 101' ' ' ILE . 2.0 mp -77.46 129.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 110.329 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.679 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.49 173.6 4.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.738 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.679 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 66.5 Cg_exo -50.49 -38.21 53.45 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.437 2.091 . . . . 0.0 111.807 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.93 102.56 12.63 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 109.863 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 93.6 mtp -103.19 137.55 41.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.49 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -138.03 104.09 5.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 28.2 p -111.53 110.62 21.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.463 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 m -158.87 165.62 33.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.466 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 95.9 m-85 -61.09 -30.25 70.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.2 p -63.56 152.67 38.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.262 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.41 170.62 5.29 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.0 Cg_exo -51.76 -40.9 64.69 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.63 2.22 . . . . 0.0 112.015 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 113' ' ' ASP . 67.6 t0 -96.84 45.76 1.05 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.417 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.455 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' C ' ' H ' ' A' ' 4' ' ' VAL . 3.5 mmmm -85.38 -6.81 59.19 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 122.87 -0.194 . . . . 0.0 110.797 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 65.81 -35.6 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.659 0.599 . . . . 0.0 110.54 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 4' ' ' VAL . 11.9 p -103.36 12.95 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 121.031 0.443 . . . . 0.0 110.587 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 97.8 mt-10 49.94 -111.66 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.364 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 5' ' ' GLU . 96.5 m-85 -158.5 -102.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.592 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 8' ' ' ASP . 14.2 m120 49.5 30.29 3.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.473 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 7' ' ' ASN . 99.6 m-20 37.17 -106.48 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.559 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 11' ' ' LYS . 6.6 ptmt -93.66 152.75 41.03 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.625 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -39.51 -18.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.83 2.353 . . . . 0.0 112.493 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 9' ' ' LYS . 73.7 tttt 71.14 -50.16 0.68 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.83 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 13' ' ' ARG . 33.7 m -63.93 -46.32 94.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.65 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.564 ' N ' HG23 ' A' ' 12' ' ' VAL . 88.1 mtm180 -144.4 154.97 43.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.563 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -59.26 145.67 42.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.508 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.8 pt -44.72 150.09 0.73 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.701 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.52 145.76 59.53 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.689 2.259 . . . . 0.0 112.331 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.4 p -68.86 -39.47 79.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.716 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -105.79 -175.69 2.87 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.297 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.594 ' N ' ' OG1' ' A' ' 18' ' ' THR . 15.0 ptm180 -105.84 143.39 34.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.179 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -107.84 146.56 32.1 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.749 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.23 48.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -137.33 -3.11 1.96 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.898 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.42 126.65 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.6 p -149.33 146.28 27.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -62.11 116.58 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.004 0.43 . . . . 0.0 110.171 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.68 112.49 15.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.4 mp -67.09 -42.52 84.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.525 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' ASP . 71.4 m-20 -151.82 151.11 30.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.53 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.95 -51.33 66.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.9 m -61.7 -49.03 78.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.726 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -64.96 -30.64 71.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' ASP . 64.8 t0 -64.43 -50.29 68.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.528 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 t -62.46 -44.61 96.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.542 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.3 -44.95 94.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.624 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.62 -45.16 94.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.71 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' SER . 44.1 t -61.74 -44.4 96.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.57 -35.48 80.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.672 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.97 87.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.784 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.4 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 62.7 m -123.95 -63.07 1.24 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.861 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.6 p 72.92 1.68 4.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.481 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -170.63 146.51 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.88 100.07 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' A' ' 19' ' ' ARG . 10.8 tp10 -77.42 117.81 19.26 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 18' ' ' THR . 75.9 t -127.24 132.43 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.002 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.54 172.28 0.51 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HZ2' ' C ' ' A' ' 18' ' ' THR . 60.1 mttp -89.38 19.97 4.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.563 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -148.08 54.69 1.04 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.425 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.58 144.08 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 110.536 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -96.41 146.56 24.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -43.18 -34.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.411 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -48.64 -47.46 40.37 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 56' ' ' VAL . 30.4 tp10 -64.07 -36.21 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.546 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 57' ' ' VAL . 39.9 tp -60.87 -43.92 97.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.325 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 89' ' ' TYR . 10.8 mp -62.35 -44.03 97.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.463 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.61 -34.41 75.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 52' ' ' GLU . 40.7 t -73.15 -51.57 25.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.626 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 53' ' ' LEU . 72.4 t -55.55 -45.93 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 58' ' ' LEU . 59.4 tp -61.69 -55.02 34.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.254 0.549 . . . . 0.0 110.293 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.41 -30.85 65.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.4 ' HB1' ' SG ' ' A' ' 39' ' ' CYS . . . -64.29 -55.45 21.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.345 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 62' ' ' GLU . 5.3 p -64.34 -40.51 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.844 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 61' ' ' VAL . 44.4 tt0 -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.959 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.9 t -62.63 -48.46 79.28 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.484 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.9 m -67.26 -71.96 0.18 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.8 tp -101.07 83.09 2.45 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -72.79 -46.04 9.06 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 66' ' ' SER . 57.4 Cg_endo -81.69 104.27 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.619 2.213 . . . . 0.0 111.888 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 2.8 m -133.59 -23.32 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -64.91 -30.69 71.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.396 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -72.0 -37.21 69.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 75' ' ' GLY . 72.2 m80 -78.67 115.74 18.56 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.495 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -60.37 -29.99 69.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.04 -45.57 98.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 74' ' ' ILE . 28.7 mt -106.91 -1.71 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 110.344 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -51.87 169.85 0.48 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 m 70.98 -22.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.474 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 75' ' ' GLY . 50.2 tptt -63.72 -45.81 88.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.22 -45.05 84.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.131 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 84.1 m -63.42 -41.17 98.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.73 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.48 95.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.15 -42.16 96.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.62 -42.93 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.728 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 87' ' ' GLY . 97.8 m-20 -64.15 -42.86 96.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mtt180 -70.36 -38.74 74.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.626 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -61.94 -44.51 96.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.671 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.13 -45.47 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.591 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -66.46 -74.31 0.55 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 84' ' ' ARG . 44.8 t0 -164.35 165.26 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.098 0.475 . . . . 0.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.435 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 27.3 p90 -132.78 146.4 51.81 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.901 0.381 . . . . 0.0 110.508 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.5 m -53.51 132.08 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.589 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -86.06 144.37 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.116 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tt -117.46 136.37 53.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.622 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 25.9 p90 -155.12 166.45 33.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.767 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 12.3 t70 -73.03 -156.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.531 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 98.5 mt-10 -66.86 -53.0 36.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.601 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.88 -98.15 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.33 22.54 0.18 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -89.22 113.7 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.806 0.336 . . . . 0.0 110.607 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 55.4 mp0 -73.33 89.45 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -164.65 142.65 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.777 HD12 ' H ' ' A' ' 101' ' ' ILE . 2.7 mp -59.11 131.79 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.019 0.437 . . . . 0.0 110.01 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -154.84 173.8 4.47 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.727 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 61.4 Cg_exo -49.29 -37.85 40.89 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.562 2.175 . . . . 0.0 112.172 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -92.26 121.61 33.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 110.087 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 87.5 mmm -104.12 139.58 39.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.49 96.78 1.07 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.5 t -111.16 118.86 37.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.545 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -164.94 171.45 14.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.697 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 110' ' ' SER . 92.0 m-85 -61.32 -44.67 96.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.287 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' PHE . 70.7 m -37.75 159.32 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -109.08 170.26 5.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.668 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 61.2 Cg_exo -48.54 -42.77 34.91 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.559 2.173 . . . . 0.0 112.158 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 37.1 p-10 -96.75 -32.42 12.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 66.8 t0 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 3' ' ' LYS . 6.1 tmtt? -70.16 119.8 14.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.028 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 2' ' ' LYS . 67.9 mttm -43.33 169.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.452 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 3' ' ' LYS . 33.2 m 36.21 -151.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 O-C-N 123.369 0.418 . . . . 0.0 110.481 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -140.32 139.59 35.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -51.71 140.77 18.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.284 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.71 83.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.612 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -117.68 35.76 4.57 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.489 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -132.63 158.91 74.48 Favored Pre-proline 0 N--CA 1.458 -0.061 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' VAL . 60.8 Cg_endo -74.18 -86.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.469 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 tttm 64.67 -70.85 0.08 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.314 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 10' ' ' PRO . 11.3 m -64.11 -35.65 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.297 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -76.44 163.16 27.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.555 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -56.35 141.3 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.222 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.73 86.48 24.21 Favored Pre-proline 0 N--CA 1.468 0.457 0 O-C-N 123.41 0.444 . . . . 0.0 110.231 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.55 144.54 84.44 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.728 2.285 . . . . 0.0 111.764 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.0 m -114.63 16.44 17.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.507 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -129.46 167.18 18.22 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.388 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -131.51 165.12 24.29 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -133.03 144.55 50.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.202 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.27 140.67 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 109.996 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.473 ' H ' HD12 ' A' ' 23' ' ' ILE . 74.3 tttt -135.82 26.9 3.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.579 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.816 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.2 mp -97.94 118.63 44.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.871 0.367 . . . . 0.0 110.412 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 146.13 35.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -91.51 129.38 37.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.364 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.59 113.44 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -149.21 88.07 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.553 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.2 m-20 165.25 -20.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.593 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 28' ' ' ASP . . . 77.17 -71.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.532 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 34' ' ' VAL . 12.8 m -61.51 -50.03 74.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.372 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -72.63 -23.3 60.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.79 -51.15 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.369 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -65.25 -45.27 85.28 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.393 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 30' ' ' THR . 91.4 t -61.91 -45.47 98.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.367 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.58 -41.0 98.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -58.5 -42.44 87.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -79.96 -21.02 44.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.744 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.32 67.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 41' ' ' GLU . 5.9 t -163.44 -84.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.42 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 67.84 -8.99 0.49 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 -179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 8.7 tm-20 -146.97 135.51 21.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' GLU . 64.1 t80 -142.12 146.82 35.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.535 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 56.0 mp0 -86.46 150.97 23.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.359 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.56 124.64 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' ASP . 1.3 m-20 -141.95 139.58 32.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.448 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 70.9 mmtt -50.94 85.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.421 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.6 m-20 173.81 -31.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.386 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 m -106.13 111.63 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 110.333 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 p -86.36 167.32 14.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -41.08 -35.06 0.51 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.531 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.36 -48.72 80.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.414 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.553 ' O ' HG22 ' A' ' 56' ' ' VAL . 56.3 mp0 -65.2 -34.4 78.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.633 ' O ' HD23 ' A' ' 53' ' ' LEU . 1.3 tt -60.79 -40.76 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.148 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.17 -35.88 71.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.542 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.56 -46.17 60.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.625 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.637 HG23 ' N ' ' A' ' 57' ' ' VAL . 28.2 m -68.63 -49.41 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.188 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.637 ' N ' HG23 ' A' ' 56' ' ' VAL . 8.2 p -59.67 -46.6 93.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.214 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' N ' HG13 ' A' ' 57' ' ' VAL . 52.3 tp -63.28 -57.21 11.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.358 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -51.61 -38.42 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.692 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.1 79.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.607 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.61 -46.29 96.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -62.56 -40.06 95.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.297 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.0 t -59.86 -50.28 74.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.548 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.6 p -59.13 -65.75 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.35 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.0 mt -107.95 80.68 1.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.847 0.356 . . . . 0.0 110.421 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.65 -45.84 12.7 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.426 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.7 Cg_endo -83.81 84.67 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.761 2.307 . . . . 0.0 111.875 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.4 m -87.03 -17.82 32.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.86 -5.44 16.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -72.37 -38.54 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' GLY . 58.2 m-70 -110.13 126.54 54.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.47 -38.74 91.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.576 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.72 -48.15 88.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' ' C ' ' A' ' 75' ' ' GLY . 68.5 mt -80.49 -31.04 12.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.163 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 78' ' ' VAL . . . -34.65 -57.47 0.75 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 m -39.43 -28.36 0.04 OUTLIER 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.433 0.635 . . . . 0.0 110.945 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 75' ' ' GLY . 27.9 tptp -60.92 -40.27 92.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 75' ' ' GLY . 2.9 p -56.03 -39.61 58.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.433 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 1.2 t -66.26 -48.7 69.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.23 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.41 87.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.282 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.86 -45.48 93.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.45 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -61.82 -43.17 99.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.43 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.49 -42.76 78.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.056 0.455 . . . . 0.0 110.71 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.49 -20.29 64.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.455 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.42 82.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.561 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.34 -54.23 0.09 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.23 117.97 12.46 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.459 ' O ' ' CE1' ' A' ' 91' ' ' TYR . 37.0 p90 -123.53 141.96 51.49 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 110.558 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 90' ' ' VAL . 4.5 t -50.89 125.14 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.18 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 89' ' ' TYR . 3.4 m-85 -82.55 153.89 25.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.285 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.41 130.37 47.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.563 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.87 155.81 42.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.624 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 42.6 t0 -73.17 -178.62 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.365 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.484 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 24.8 tp10 -74.67 38.45 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.491 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.49 -59.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.63 0.24 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.63 140.69 58.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.625 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.84 88.44 4.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.55 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.3 t -150.07 134.16 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.741 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 86.7 mt -70.7 132.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.314 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.8 170.81 7.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 60.0 Cg_exo -49.51 -38.82 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.403 2.069 . . . . 0.0 112.305 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -125.16 126.54 45.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -150.81 166.14 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.212 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -113.12 118.54 35.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.431 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.514 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 14.9 p -105.12 122.78 46.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.71 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.0 t -171.98 166.85 6.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.674 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.431 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 48.9 p90 -73.44 -26.12 60.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.532 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.8 p -95.27 169.82 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.472 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -98.83 162.26 22.19 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.266 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 40.6 Cg_endo -67.63 -21.59 45.37 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.701 2.267 . . . . 0.0 112.057 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -149.28 65.44 1.02 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.422 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.853 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -69.74 134.77 48.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.99 0.424 . . . . 0.0 110.85 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -103.0 -28.41 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.501 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.58 -42.26 87.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.468 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.52 ' O ' ' C ' ' A' ' 6' ' ' PHE . 98.2 mt-10 58.62 67.8 0.89 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.255 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.52 ' C ' ' O ' ' A' ' 5' ' ' GLU . 74.2 m-85 -19.0 109.46 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.23 0.956 . . . . 0.0 110.702 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -38.46 -50.45 1.53 Allowed 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 123.397 0.435 . . . . 0.0 110.514 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -55.84 118.46 4.61 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.167 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -65.72 144.29 98.83 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.976 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.24 145.18 48.14 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.687 2.258 . . . . 0.0 112.306 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 13' ' ' ARG . 59.3 mttp -94.18 -50.78 5.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.25 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 12' ' ' VAL . 8.4 p -73.13 43.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.045 0.45 . . . . 0.0 110.634 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 11' ' ' LYS . 35.7 ttm180 -157.48 158.17 35.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.436 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -71.43 134.2 46.45 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.012 0.434 . . . . 0.0 110.617 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 pt -82.23 156.46 69.06 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.647 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -44.29 162.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.437 2.091 . . . . 0.0 112.314 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.7 t -63.1 -7.86 6.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.663 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 p -107.17 168.43 9.22 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.332 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -105.04 165.18 11.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.117 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -130.95 135.33 47.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.268 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.65 133.01 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.359 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -119.57 22.13 11.79 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.9 mp -84.93 136.87 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.481 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -135.86 132.47 36.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.347 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 107' ' ' CYS . 73.6 t80 -109.83 114.7 28.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.209 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.83 147.75 48.4 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.469 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.0 mt -97.95 -63.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 8.6 t70 -84.68 173.71 10.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.728 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.63 -36.7 84.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 34' ' ' VAL . 1.2 p -61.99 -54.4 42.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.683 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.449 ' N ' ' OG1' ' A' ' 30' ' ' THR . 67.0 m-85 -60.25 -20.03 57.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.544 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -76.58 -49.04 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.5 p -73.47 -35.14 65.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 30' ' ' THR . 85.1 t -64.41 -51.81 63.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.58 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.55 -41.93 83.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.749 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -61.52 -45.43 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.853 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.84 -45.87 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.979 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 40' ' ' SER . . . -73.66 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 14.5 p -71.33 45.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.592 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 38' ' ' ALA . 4.4 p -59.13 -28.62 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.372 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.78 140.24 19.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.12 137.75 41.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.55 120.07 30.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.266 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.3 m -144.3 162.46 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.369 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -89.79 170.41 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.628 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -78.65 39.22 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 66.1 t0 -118.22 -25.95 6.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.532 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 48' ' ' VAL . 3.8 m -79.03 128.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 0.0 110.709 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.9 p -85.0 158.38 20.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.386 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -46.98 -38.46 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.243 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.12 -46.75 89.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.297 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 56' ' ' VAL . 95.6 mt-10 -68.29 -35.16 77.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.312 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 57' ' ' VAL . 58.7 tp -63.46 -43.83 96.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -39.32 87.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 0.0 110.511 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -71.43 -43.55 66.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.775 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 52' ' ' GLU . 55.2 t -67.16 -51.48 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.058 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.564 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.0 p -58.57 -44.71 89.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' HG13 ' A' ' 57' ' ' VAL . 47.5 tp -61.33 -55.6 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.287 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.42 -33.61 65.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.866 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.92 -51.1 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.76 -43.19 93.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -62.75 -46.87 86.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.621 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.1 t -60.2 -49.28 78.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.604 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -58.84 -45.79 89.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.183 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.41 76.47 1.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.991 0.424 . . . . 0.0 110.407 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -71.59 -43.68 11.95 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.099 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 66' ' ' SER . 37.7 Cg_exo -60.21 110.18 0.74 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.404 2.069 . . . . 0.0 111.835 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 66' ' ' SER . 3.4 m -133.9 -58.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.552 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -68.5 -9.38 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.58 -42.84 61.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.421 ' O ' ' N ' ' A' ' 75' ' ' GLY . 4.5 t-80 -106.36 134.53 49.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -61.73 -35.54 78.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.545 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.25 -48.0 89.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.449 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 77' ' ' LYS . 57.4 mt -82.54 -27.01 8.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.933 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -34.05 -59.02 0.62 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -42.7 -23.76 0.05 OUTLIER 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.289 0.566 . . . . 0.0 110.947 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 74' ' ' ILE . 88.7 tttt -58.99 -42.78 90.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.111 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 75' ' ' GLY . 5.2 p -54.75 -37.57 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.439 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.404 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 77.8 m -70.08 -50.17 43.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.31 84.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.98 -42.51 99.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 tt -60.44 -44.82 95.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -62.42 -43.78 98.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.472 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.77 -42.72 90.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.643 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.482 ' O ' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -76.69 -11.99 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.562 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.53 -37.28 77.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.97 -34.46 0.56 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.04 115.31 24.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.425 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -132.88 146.35 51.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.407 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.6 m -50.51 148.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.068 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.97 164.23 12.62 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.311 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 tt -131.55 128.65 39.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.88 151.73 41.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -77.6 -159.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -72.02 51.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.75 -118.56 0.66 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.29 4.53 2.3 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -90.04 116.38 28.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.748 0.309 . . . . 0.0 110.39 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.31 89.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -135.69 133.4 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.45 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -71.64 127.93 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.03 0.443 . . . . 0.0 109.894 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.65 152.46 16.56 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.633 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.29 -39.86 27.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.31 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 65.1 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.278 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -103.53 135.96 44.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.184 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.467 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 48.1 t80 -99.89 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.118 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.531 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 4.3 t -113.3 115.43 28.14 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.548 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.467 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 7.2 p -173.53 169.5 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -70.06 -24.42 63.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 m -67.13 143.18 56.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -100.36 170.5 6.58 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.3 Cg_exo -51.96 -40.31 67.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.604 2.203 . . . . 0.0 111.855 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -82.63 45.2 0.96 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.19 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.694 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 3' ' ' LYS . 23.0 ttpt -81.56 120.79 25.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 118.929 -0.557 . . . . 0.0 110.069 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.556 ' C ' ' O ' ' A' ' 2' ' ' LYS . 64.4 tttm -8.39 -81.95 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.341 1.026 . . . . 0.0 111.227 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 2' ' ' LYS . 26.9 m -37.87 134.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 121.222 0.534 . . . . 0.0 110.929 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.552 ' C ' ' H ' ' A' ' 7' ' ' ASN . 12.9 pt-20 -80.23 -13.86 58.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.922 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 66.96 -14.11 0.18 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.669 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 5' ' ' GLU . 41.3 t-20 63.21 41.97 7.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.693 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 9' ' ' LYS . 94.5 m-20 -86.6 -1.83 57.99 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.357 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 10' ' ' PRO . 48.3 tttp -37.5 128.4 0.87 Allowed Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.751 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 9' ' ' LYS . 67.4 Cg_exo -46.9 -172.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.567 2.178 . . . . 0.0 112.132 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.08 -129.23 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.479 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.5 HG13 ' N ' ' A' ' 13' ' ' ARG . 8.6 p -68.63 -41.75 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.5 ' N ' HG13 ' A' ' 12' ' ' VAL . 42.9 ttm180 -83.78 145.55 28.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.344 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -95.42 149.99 20.78 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.446 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.5 mt -42.89 106.52 0.48 Allowed Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.48 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.6 147.16 40.31 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.532 2.154 . . . . 0.0 112.035 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -79.07 -7.93 58.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.564 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 p -85.54 164.47 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -125.9 176.97 6.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.354 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -135.83 139.73 43.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.237 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.09 136.3 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.56 -7.36 6.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.552 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.0 mp -118.34 128.02 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.7 p -132.47 146.6 52.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.536 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.26 132.89 55.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.169 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.6 141.34 48.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.766 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.2 mp -64.56 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -148.92 168.83 22.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.637 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.07 -48.05 81.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.417 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 m -59.61 -46.83 87.8 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.084 0.469 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -67.64 -28.56 67.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.483 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -64.91 -48.36 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -62.61 -44.89 95.16 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.492 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.68 -45.82 90.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.685 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.98 -44.62 95.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.609 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 m -60.05 -44.71 94.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.327 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.12 -35.84 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.521 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.73 -75.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 40' ' ' SER . 25.4 p -52.59 -43.91 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.789 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 1.4 m 67.73 -63.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.557 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.83 154.55 2.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.668 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -144.11 148.76 35.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.83 162.21 27.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.457 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.63 135.25 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.61 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.12 166.22 17.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.22 -61.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.661 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -88.89 84.23 6.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 110.374 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.52 136.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.312 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.561 ' O ' ' N ' ' A' ' 51' ' ' ASP . 20.5 p -108.22 154.27 22.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.406 0.622 . . . . 0.0 109.719 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.047 ' H ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -44.13 -12.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.254 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.651 ' N ' HD22 ' A' ' 50' ' ' LEU . 87.0 m-20 -68.16 -53.4 25.32 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.268 0.556 . . . . 0.0 110.349 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 56' ' ' VAL . 83.2 mt-10 -65.16 -38.99 92.31 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.328 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 57' ' ' VAL . 32.0 mt -61.6 -39.9 92.88 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.031 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.494 HD22 ' CD2' ' A' ' 89' ' ' TYR . 6.6 tp -61.07 -45.12 96.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.158 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -71.49 -34.24 69.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.146 0.498 . . . . 0.0 110.744 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 52' ' ' GLU . 49.6 t -72.38 -53.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.996 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 58' ' ' LEU . 9.6 p -60.59 -43.92 95.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.799 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.538 ' N ' HG13 ' A' ' 57' ' ' VAL . 46.6 tp -60.21 -56.48 20.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.137 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.16 -41.13 62.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.54 82.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.508 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.6 t -63.41 -45.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.549 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.06 -44.17 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.367 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.4 p -61.66 -42.74 99.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.0 m -67.89 -71.14 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.8 tp -99.38 88.21 3.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.382 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.524 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.57 -47.87 2.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 179.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 66' ' ' SER . 66.9 Cg_endo -80.52 68.5 8.3 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.68 2.254 . . . . 0.0 112.134 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.53 -32.16 47.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -67.35 -5.77 15.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.714 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -72.27 -38.66 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 75' ' ' GLY . 39.0 m80 -103.71 120.81 41.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.219 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 28.4 p-10 -58.32 -42.38 86.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.712 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.693 HG13 HG12 ' A' ' 74' ' ' ILE . 3.8 p -55.09 -29.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.409 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.693 HG12 HG13 ' A' ' 73' ' ' VAL . 49.2 mm -108.49 -12.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -38.35 -62.92 1.03 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.2 p -37.04 -25.06 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.124 0.487 . . . . 0.0 111.006 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' GLY . 63.4 tttm -58.03 -42.71 85.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.139 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 79' ' ' CYS . 5.6 p -56.43 -42.49 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.455 . . . . 0.0 110.314 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.479 ' N ' HG13 ' A' ' 78' ' ' VAL . 87.7 m -62.95 -48.55 78.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.162 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.27 -48.37 82.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 58' ' ' LEU . 56.5 tp -53.16 -42.34 66.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.641 ' O ' HD23 ' A' ' 82' ' ' LEU . 3.0 tt -60.76 -46.47 90.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.062 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.529 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -63.52 -45.49 90.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.52 ' CD2' HD21 ' A' ' 58' ' ' LEU . 3.7 mm? -67.52 -25.55 65.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.773 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.78 -44.23 90.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.364 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.34 -39.11 0.67 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.77 127.14 33.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.265 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CD2' ' O ' ' A' ' 90' ' ' VAL . 2.0 p90 -131.73 -127.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.629 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.599 ' O ' ' CD2' ' A' ' 89' ' ' TYR . 29.1 m -134.44 165.03 32.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 121.097 0.475 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -114.01 144.76 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.677 ' C ' HD23 ' A' ' 92' ' ' LEU . 1.3 tt -131.13 143.18 50.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.989 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.27 163.25 38.76 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.666 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 96' ' ' GLY . 47.4 p30 -74.5 175.9 7.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.529 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.09 26.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -133.66 -70.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.98 -36.04 0.1 OUTLIER Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.71 140.51 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.78 0.324 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.4 mp0 -86.66 88.4 7.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.472 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.79 130.64 26.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.48 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.9 mm -61.96 131.74 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.08 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -149.41 170.56 7.47 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.633 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.674 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 50.6 Cg_exo -51.2 -40.14 60.94 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.517 2.144 . . . . 0.0 112.161 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 97.31 5.85 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.573 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -119.41 170.7 8.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.483 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 76.5 t80 -139.68 122.33 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.084 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.536 ' HB2' HD12 ' A' ' 92' ' ' LEU . 12.5 t -122.83 127.53 49.19 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.752 0.657 . . . . 0.0 110.491 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.483 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 84.1 p -172.78 -174.88 1.18 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' ' CG1' ' A' ' 90' ' ' VAL . 86.0 m-85 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.136 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -146.95 172.12 14.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.0 169.98 6.03 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.406 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 63.1 Cg_exo -49.41 -38.28 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.445 2.096 . . . . 0.0 112.054 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 49.2 p-10 -65.6 -30.65 71.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.981 0.419 . . . . 0.0 110.802 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 95.8 m-20 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.453 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.53 -99.38 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.687 0.28 . . . . 0.0 110.498 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 4' ' ' VAL . 25.8 tttm -173.65 179.89 1.96 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 3' ' ' LYS . 29.0 m 29.52 -139.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 123.864 0.728 . . . . 0.0 110.429 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -137.92 -13.43 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 110.571 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 72.13 61.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.528 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 1.7 m120 64.81 101.02 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.66 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -72.97 144.66 47.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.691 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 10' ' ' PRO . 14.2 ttmm -42.38 118.1 2.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.71 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' LYS . 78.3 Cg_exo -45.36 -179.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.36 2.04 . . . . 0.0 112.591 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -170.38 -87.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.261 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.61 44.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.893 0.378 . . . . 0.0 110.272 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -127.43 165.68 19.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.419 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -62.56 131.18 48.24 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.199 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.563 ' CD1' ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -75.89 157.91 83.14 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.437 -179.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -44.04 155.34 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.263 1.975 . . . . 0.0 112.434 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.6 p -64.46 -17.62 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.455 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.8 p -87.06 165.8 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.051 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.593 ' HE ' ' NZ ' ' A' ' 46' ' ' LYS . 43.9 ttm180 -107.7 145.38 33.5 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.297 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.39 137.18 39.16 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.333 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 42' ' ' PHE . 10.9 tp -102.92 142.84 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.309 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -138.88 111.41 7.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.83 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.5 mp -99.76 125.42 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.396 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.06 96.54 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.558 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -151.16 133.97 15.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.203 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 27' ' ' LEU . . . -59.34 109.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -128.06 -67.21 0.82 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.368 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 27' ' ' LEU . 75.5 m-20 -150.88 163.66 38.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.426 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 -62.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.2 m -60.64 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.522 ' CE2' HD11 ' A' ' 35' ' ' LEU . 37.1 t80 -42.78 -44.52 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 110.391 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -61.98 -48.05 82.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.158 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.647 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.45 -45.12 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.176 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 31' ' ' PHE . 84.2 mt -63.04 -42.94 99.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.814 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.6 m -61.88 -40.44 95.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.08 -16.14 41.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.459 ' C ' ' SG ' ' A' ' 39' ' ' CYS . . . -93.61 23.62 4.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.611 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 38' ' ' ALA . 2.6 m 75.39 101.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.796 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -64.45 -34.77 78.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.76 131.22 55.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.684 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.697 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -145.19 124.66 13.13 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.46 0.648 . . . . 0.0 110.901 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.649 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -63.77 135.84 56.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.504 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.1 134.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 0.0 110.58 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.71 164.9 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.3 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.593 ' NZ ' ' HE ' ' A' ' 19' ' ' ARG . 65.2 mttm -94.11 -11.45 30.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.74 11.83 18.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.88 153.02 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.11 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.435 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 57.2 p -99.25 -160.19 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 50' ' ' LEU . 1.9 pt? -63.11 -15.81 57.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 22.0 p-10 -59.99 -52.82 63.76 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.348 0.594 . . . . 0.0 110.589 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -64.03 -40.16 95.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.081 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.43 -45.78 92.86 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.109 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.605 ' O ' HD23 ' A' ' 54' ' ' LEU . 1.8 tt -56.39 -43.72 79.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.34 -49.01 78.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.903 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.31 -43.4 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.383 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 61' ' ' VAL . 76.0 t -63.77 -46.97 93.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.509 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.09 -41.22 99.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.357 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.91 -44.21 94.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.278 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 64' ' ' THR . . . -64.43 -37.15 86.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 57' ' ' VAL . 55.5 t -63.37 -44.78 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.734 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.11 -44.36 60.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.6 p -61.99 -33.35 74.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 60' ' ' ALA . 41.4 p -86.81 -52.25 5.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.434 HD21 ' CE ' ' A' ' 77' ' ' LYS . 34.4 tp -95.04 79.21 3.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.457 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.544 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -77.87 -46.62 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.646 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.6 Cg_endo -80.74 109.95 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.404 2.069 . . . . 0.0 112.31 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.86 -46.28 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.441 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -67.91 -6.47 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.718 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -73.02 -21.49 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -103.12 98.18 8.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.697 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 25.8 p-10 -62.68 -44.59 95.86 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.412 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.456 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 71.2 t -64.42 -44.96 97.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.263 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.543 ' C ' ' H ' ' A' ' 76' ' ' THR . 3.3 mt -93.56 9.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -55.54 -1.28 0.18 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.543 ' H ' ' C ' ' A' ' 74' ' ' ILE . 39.9 p -65.7 -31.78 72.97 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.506 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.434 ' CE ' HD21 ' A' ' 65' ' ' LEU . 17.8 ptmt -58.6 -37.59 76.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.201 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.73 -44.13 93.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.32 -38.92 93.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.253 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.32 -54.03 51.41 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.063 0.458 . . . . 0.0 110.687 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.2 mm? -63.24 -40.32 97.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.311 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.7 -42.95 99.63 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.242 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -61.89 -43.4 98.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.217 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.97 -39.96 95.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.474 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.9 mt -63.83 -37.88 89.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.513 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.4 79.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.69 -18.54 0.58 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -78.26 56.72 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.782 0.325 . . . . 0.0 110.418 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.52 -168.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.281 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 132.08 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.506 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -75.05 153.22 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.223 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.607 ' C ' HD23 ' A' ' 92' ' ' LEU . 6.6 tt -142.52 122.51 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.468 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.602 ' N ' HD23 ' A' ' 92' ' ' LEU . 41.1 p90 -146.12 151.01 36.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.736 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 96' ' ' GLY . 56.8 p-10 -80.96 175.13 10.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.474 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 41.7 mp0 -62.3 68.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.473 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 94' ' ' ASP . . . -164.97 -79.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' OD1' ' A' ' 98' ' ' ASP . . . 149.7 40.63 0.03 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 97' ' ' GLY . 85.6 m-20 -146.98 169.63 18.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.932 0.396 . . . . 0.0 110.529 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.5 mp0 -80.92 91.61 6.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.166 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 101' ' ' ILE . 59.8 t -141.92 162.83 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.444 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.581 ' N ' HG12 ' A' ' 100' ' ' VAL . 4.9 mp -124.1 129.3 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.8 168.93 10.74 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.456 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 81.9 Cg_exo -46.6 -40.2 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.498 2.132 . . . . 0.0 112.203 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.432 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 79.4 mtp180 -113.13 107.12 15.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.473 ' HB2' HD21 ' A' ' 92' ' ' LEU . 11.8 ptt? -139.43 142.99 37.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -96.98 118.85 34.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.32 116.59 25.11 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 t -173.15 178.08 2.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.689 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -60.48 -44.67 95.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.509 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.1 m -55.86 146.1 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.036 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -105.05 170.37 6.05 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.633 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.8 Cg_exo -51.51 -41.28 61.14 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 112.031 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 113' ' ' ASP . 55.4 t0 -85.32 -9.97 56.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.552 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.539 ' CB ' ' H ' ' A' ' 111' ' ' ALA . 66.1 t0 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.572 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 4' ' ' VAL . 42.9 mmtt -66.76 -76.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.724 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 65.65 -6.93 0.37 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.497 ' H ' ' C ' ' A' ' 2' ' ' LYS . 3.4 m -84.25 152.37 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.399 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.506 ' N ' ' OE1' ' A' ' 5' ' ' GLU . 1.3 mp0 -76.51 117.13 17.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.587 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -134.73 154.7 51.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.527 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -56.4 107.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.399 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -118.16 -27.2 6.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.473 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -76.27 152.59 83.98 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.484 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.73 151.58 82.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.633 2.222 . . . . 0.0 112.117 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -53.56 -52.0 61.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.343 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.698 ' O ' HG13 ' A' ' 12' ' ' VAL . 14.9 p -160.84 70.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.05 0.452 . . . . 0.0 110.387 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -154.43 155.71 35.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.4 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -79.6 140.49 37.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.511 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 pt -83.52 152.09 63.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 18' ' ' THR . 55.6 Cg_endo -69.76 157.16 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.731 2.288 . . . . 0.0 112.236 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -75.44 13.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.378 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 16' ' ' PRO . 74.8 p -130.78 162.46 29.49 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -138.27 156.15 47.94 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.148 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -107.97 143.63 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 23' ' ' ILE . 17.5 tt -133.31 140.59 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.214 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -126.27 11.77 7.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.68 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.5 mp -88.3 101.41 11.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.961 0.41 . . . . 0.0 110.707 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.516 HG21 ' CD2' ' A' ' 42' ' ' PHE . 75.8 p -141.14 145.98 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.399 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -93.85 138.93 31.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.202 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.64 138.14 41.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 mt -63.2 -39.99 96.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -151.91 176.98 10.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.65 80.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.513 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 34' ' ' VAL . 97.5 m -61.34 -47.69 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.585 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -68.72 -26.46 65.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -70.29 -48.53 56.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.3 m -67.1 -41.8 85.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.618 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 30' ' ' THR . 76.3 t -62.36 -47.29 93.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.495 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.1 mt -63.5 -42.24 98.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.837 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 40' ' ' SER . 78.5 p -62.66 -35.47 79.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -78.69 -34.45 46.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.926 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.04 -92.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.753 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 40' ' ' SER . 14.2 t -65.59 -96.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.713 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER 77.85 -3.79 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.611 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -140.57 115.62 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.194 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.516 ' CD2' HG21 ' A' ' 24' ' ' THR . 84.4 m-85 -117.92 129.12 55.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.184 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -91.6 142.26 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.426 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.02 121.13 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.432 0.634 . . . . 0.0 110.515 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.476 ' OD1' HG12 ' A' ' 48' ' ' VAL . 19.3 p30 -155.95 171.29 20.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.793 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.22 11.92 0.85 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 45' ' ' ASP . 87.7 m-20 -107.38 0.18 22.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.67 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 49' ' ' THR . 13.5 p -141.24 160.44 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 50' ' ' LEU . 5.2 p -129.94 -70.12 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.226 0.536 . . . . 0.0 110.648 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' N ' ' OG1' ' A' ' 49' ' ' THR . 0.4 OUTLIER -163.16 -33.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -50.21 -43.95 52.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.333 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -68.41 -40.91 81.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.633 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 57' ' ' VAL . 35.6 mt -62.03 -46.26 89.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.72 -36.39 82.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.456 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.81 -52.25 63.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.182 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 57' ' ' VAL . 12.8 p -69.64 -38.59 76.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.532 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 53' ' ' LEU . 43.7 t -59.29 -50.61 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.276 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.69 -50.47 43.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.184 0.516 . . . . 0.0 110.587 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.26 -32.07 69.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.086 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 56' ' ' VAL . . . -69.71 -56.35 7.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.248 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 62' ' ' GLU . 30.8 m -67.41 -44.12 87.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.53 ' N ' HG23 ' A' ' 61' ' ' VAL . 8.5 tm-20 -59.35 -46.39 88.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.508 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.9 p -61.77 -51.65 67.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.6 m -60.48 -46.59 89.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.471 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 65' ' ' LEU . 10.3 mp -94.36 57.85 2.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.399 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.612 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.15 -44.02 2.74 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.214 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 66' ' ' SER . 21.5 Cg_exo -64.3 107.59 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.5 2.133 . . . . 0.0 111.859 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.505 ' C ' ' H ' ' A' ' 70' ' ' GLU . 22.0 t -133.84 -80.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.915 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -48.5 -11.3 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.466 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 68' ' ' CYS . 79.2 tt0 -73.94 -36.89 64.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.607 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HB3' HG12 ' A' ' 73' ' ' VAL . 67.4 m80 -132.65 138.99 47.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -62.9 -43.83 97.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.676 HG13 HG12 ' A' ' 74' ' ' ILE . 2.8 p -45.69 -31.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.318 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.676 HG12 HG13 ' A' ' 73' ' ' VAL . 47.0 mm -108.38 -15.11 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . -46.68 -177.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m 66.74 -31.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 75' ' ' GLY . 47.1 tptt -63.19 -39.15 93.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 79' ' ' CYS . 7.4 p -59.76 -45.23 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.525 ' N ' HG13 ' A' ' 78' ' ' VAL . 75.1 m -64.41 -47.74 78.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.341 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.45 -52.56 64.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.286 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.4 tp -51.29 -40.89 59.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.94 -48.06 82.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.21 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -64.24 -40.96 97.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.355 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.23 -40.63 98.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.89 -19.99 58.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.596 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.64 75.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 88' ' ' ASP . . . 160.33 33.64 0.02 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 80.2 m-20 -149.14 78.03 1.38 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.789 0.328 . . . . 0.0 110.52 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.4 p90 -110.2 -113.34 0.31 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.085 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.447 ' H ' ' HD2' ' A' ' 89' ' ' TYR . 29.4 m -130.8 158.77 43.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.303 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -126.81 157.07 40.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.242 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.17 125.06 24.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.82 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -134.68 153.27 52.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -88.98 -168.31 2.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.431 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 33.2 mp0 -72.93 67.24 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.628 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.23 -59.33 0.21 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.28 -18.79 0.32 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.84 139.71 55.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.672 0.272 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.94 90.68 6.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.605 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -155.11 135.98 4.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.615 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 49' ' ' THR . 56.6 mt -66.15 132.26 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.27 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.709 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -149.17 173.59 4.11 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.709 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 54.2 Cg_exo -50.66 -40.59 55.68 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.497 2.131 . . . . 0.0 111.842 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.36 90.13 3.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -103.16 145.24 30.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.159 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -113.15 110.21 20.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.138 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.0 p -110.97 113.15 25.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.437 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 p -167.77 164.9 14.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.764 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -72.51 -26.9 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.643 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.7 p -73.19 154.64 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -90.26 170.12 10.86 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.668 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.3 Cg_exo -51.44 -35.11 53.81 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.46 2.106 . . . . 0.0 112.128 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -79.16 14.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.486 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 . . . . . 0 C--O 1.223 -0.332 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.785 -179.876 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -109.17 121.33 44.93 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.74 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -109.34 4.25 22.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.365 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.471 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 18.1 m -85.33 15.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.608 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 57.57 -111.63 0.61 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 4' ' ' VAL . 53.1 m-85 51.79 -117.39 1.13 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.796 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -58.02 -40.93 82.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.206 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -82.86 112.97 20.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.837 0.351 . . . . 0.0 110.397 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -66.95 160.25 71.05 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -46.33 130.82 14.53 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.962 1.774 . . . . 0.0 112.062 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -96.97 35.51 1.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.676 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.47 -130.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.236 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -89.32 -172.76 3.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.511 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.29 139.83 57.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.468 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 mm -41.31 102.12 0.26 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.707 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.95 157.19 23.86 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.439 2.092 . . . . 0.0 112.284 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.9 m -61.75 -40.32 94.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.513 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -88.3 -170.21 2.87 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.225 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -135.08 171.76 13.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -126.45 146.87 49.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.638 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.413 HG13 ' H ' ' A' ' 23' ' ' ILE . 10.7 tp -132.11 141.04 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.317 0.58 . . . . 0.0 110.151 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -138.23 20.05 2.78 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.431 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.413 ' H ' HG13 ' A' ' 21' ' ' ILE . 23.9 mt -114.15 97.32 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.87 0.367 . . . . 0.0 110.839 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -116.19 143.68 45.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.141 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.92 118.33 13.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.443 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.79 118.6 36.61 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.243 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.78 -40.99 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.604 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 32.2 t0 -153.69 -178.94 7.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.58 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -62.82 -37.47 86.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -59.21 -48.03 83.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.188 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.16 -4.13 39.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.405 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -85.2 -59.08 2.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.32 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -68.55 -37.29 79.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.926 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 30' ' ' THR . 73.1 t -65.33 -47.45 87.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.07 -41.81 99.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 9.1 t -58.74 -50.25 74.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.58 -34.13 77.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -25.43 60.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.022 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.568 ' C ' ' H ' ' A' ' 41' ' ' GLU . 4.9 t -173.89 -48.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.47 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 36' ' ' SER . 0.4 OUTLIER 59.45 -3.91 0.09 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.657 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.568 ' H ' ' C ' ' A' ' 39' ' ' CYS . 75.2 mt-10 -144.26 115.79 8.12 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CE1' HG22 ' A' ' 57' ' ' VAL . 80.4 m-85 -121.84 133.57 54.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -95.5 156.68 16.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.975 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 m -134.75 116.7 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.665 0.745 . . . . 0.0 110.775 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' A' ' 47' ' ' ASP . 50.4 t0 -148.2 159.77 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.3 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 50.9 tttm -60.88 12.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.626 ' H ' ' C ' ' A' ' 45' ' ' ASP . 98.2 m-20 -105.34 -37.07 6.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.711 0.291 . . . . 0.0 110.356 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.93 109.06 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.339 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.512 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 27.3 p -86.46 166.05 15.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.336 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -48.29 -44.35 33.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.291 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.512 ' CG ' ' HG1' ' A' ' 49' ' ' THR . 1.5 p-10 -56.82 -44.33 81.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 56' ' ' VAL . 94.9 mt-10 -72.98 -28.59 62.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.289 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.687 ' O ' HG23 ' A' ' 57' ' ' VAL . 55.5 tp -65.3 -54.34 30.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.216 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 55' ' ' ASP . 3.1 pp -67.79 -39.93 83.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.896 0.379 . . . . 0.0 110.287 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 54' ' ' LEU . 16.6 t70 -63.32 -44.39 95.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 52' ' ' GLU . 60.7 t -69.55 -43.12 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.707 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 53' ' ' LEU . 72.1 t -61.98 -47.77 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.455 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 81' ' ' LEU . 8.6 tt -64.05 -53.25 52.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.081 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -52.23 -38.97 59.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.745 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.84 75.39 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.629 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.27 -48.98 85.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.685 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.78 -37.72 85.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.444 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -60.69 -45.16 95.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.49 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.8 p -72.92 -40.66 65.3 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.751 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -108.26 106.77 17.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.482 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.447 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -79.1 -60.8 0.53 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 178.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 66' ' ' SER . 36.9 Cg_endo -63.15 134.48 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.338 2.025 . . . . 0.0 112.297 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.2 p -134.98 -37.38 0.8 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -67.99 -7.96 33.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.759 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -73.59 -30.34 62.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.715 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 75' ' ' GLY . 60.1 m80 -92.13 108.91 20.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 20.8 p-10 -66.1 -49.12 68.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.339 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 t -66.84 -45.1 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.412 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 mm -95.09 18.79 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.09 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -81.29 -170.62 43.93 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.415 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER 78.32 -26.41 0.18 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 110.552 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER -63.62 -11.02 21.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.163 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.662 HG13 ' N ' ' A' ' 79' ' ' CYS . 7.1 p -71.31 -54.51 17.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 110.304 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.662 ' N ' HG13 ' A' ' 78' ' ' VAL . 98.8 m -69.36 -42.66 74.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.143 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.08 74.63 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.113 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.719 HD11 HD21 ' A' ' 58' ' ' LEU . 4.7 tt -54.62 -42.15 70.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.166 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.95 -48.71 80.58 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.254 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 87' ' ' GLY . 55.2 t0 -65.52 -43.24 90.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.798 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' ASP . 1.4 mpt_? -62.08 -43.79 98.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.6 -42.84 97.61 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.086 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -9.7 51.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.631 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -154.38 62.45 0.36 Allowed Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 84' ' ' ARG . 96.9 m-20 -36.88 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 110.693 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.503 ' O ' ' CE2' ' A' ' 91' ' ' TYR . 65.5 t80 -87.04 -40.7 14.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.679 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.66 131.52 12.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE2' ' O ' ' A' ' 89' ' ' TYR . 98.0 m-85 -109.37 152.25 25.57 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 93' ' ' PHE . 6.1 tt -132.31 122.9 25.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.621 ' N ' HD23 ' A' ' 92' ' ' LEU . 45.2 p90 -142.79 147.68 35.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.52 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 96' ' ' GLY . 39.2 t70 -83.91 177.47 8.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.466 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 95.8 mt-10 -70.77 38.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -146.59 -5.71 0.38 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.92 -2.64 73.83 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' VAL . 36.4 t0 -93.87 112.86 24.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 110.471 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -53.45 86.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.098 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 98' ' ' ASP . 69.7 t -145.4 136.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.9 mm -76.09 130.02 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.125 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -150.02 172.0 5.74 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.452 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 52.0 Cg_exo -51.95 -41.52 63.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.354 2.036 . . . . 0.0 111.894 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 1.8 mpt_? -110.46 83.45 1.76 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.188 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -105.19 165.07 11.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.091 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 93' ' ' PHE . 70.6 t80 -134.2 112.51 11.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 21.7 p -115.52 117.08 29.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.623 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.1 t -171.71 175.41 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -66.4 -27.34 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.357 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -61.86 146.46 49.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.473 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -85.62 170.41 13.14 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.1 Cg_exo -50.78 -41.28 55.29 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.542 2.161 . . . . 0.0 112.025 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -60.51 -48.26 82.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.101 0.477 . . . . 0.0 110.849 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.547 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -82.58 104.9 13.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.954 0.407 . . . . 0.0 110.665 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.24 -9.38 42.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.183 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.62 -18.14 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.574 ' O ' ' O ' ' A' ' 7' ' ' ASN . 96.6 mt-10 56.42 67.0 1.06 Allowed 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.639 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.535 ' C ' ' O ' ' A' ' 5' ' ' GLU . 75.1 m-85 -8.77 99.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.815 0.697 . . . . 0.0 112.531 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.574 ' O ' ' O ' ' A' ' 5' ' ' GLU . 97.6 m-20 53.85 168.16 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 121.318 0.58 . . . . 0.0 110.738 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -44.83 148.73 0.5 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.506 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -38.01 152.42 0.15 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.03 -80.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.482 2.121 . . . . 0.0 112.244 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 13' ' ' ARG . 12.6 tptp 58.38 110.8 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.946 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 t 67.12 -45.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 123.525 0.515 . . . . 0.0 110.313 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' LYS . 86.1 mtp180 -57.55 -172.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.543 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -58.11 136.45 57.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.405 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.12 153.11 86.42 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.732 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 18' ' ' THR . 55.9 Cg_endo -69.57 162.12 43.23 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.642 2.228 . . . . 0.0 112.206 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.9 t -65.93 8.99 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.542 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.526 ' H ' ' C ' ' A' ' 16' ' ' PRO . 47.8 p -109.04 168.47 9.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.291 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.45 173.51 8.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.237 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.02 144.17 30.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.053 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.0 pt -136.12 146.77 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.753 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.53 121.18 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 23' ' ' ILE . 4.2 mm -94.3 115.88 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.166 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -127.92 100.46 5.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.445 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.53 107.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.34 140.79 46.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.747 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.9 mp -73.7 -41.19 62.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -127.12 -176.78 3.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.63 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.16 82.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -58.69 -52.7 64.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.414 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' N ' ' OG1' ' A' ' 30' ' ' THR . 85.5 m-85 -69.39 -11.61 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -77.78 -54.89 5.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 p -69.91 -35.34 74.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.914 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' THR . 73.5 t -64.31 -49.89 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.67 -42.22 91.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.835 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.2 p -63.48 -45.65 89.81 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.541 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -68.34 -47.1 68.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.53 -76.1 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.735 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 7.9 t -83.13 72.27 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.9 p -75.78 -26.97 57.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.633 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -172.83 149.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.281 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.507 ' CE2' HG22 ' A' ' 57' ' ' VAL . 6.0 m-85 -130.97 147.01 52.56 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.241 0.543 . . . . 0.0 110.526 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.44 169.45 18.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.38 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.6 132.26 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.904 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 41.7 t0 -145.44 148.62 33.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 20.0 pttp -73.75 20.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 45' ' ' ASP . 13.3 t70 -122.16 16.53 10.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.706 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 101' ' ' ILE . 3.0 m -134.11 161.19 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 109.947 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' ASP . 58.2 p -120.29 134.78 55.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.121 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.679 HD22 ' C ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -39.86 -17.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.851 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.659 ' N ' HD22 ' A' ' 50' ' ' LEU . 63.1 t0 -67.8 -50.6 55.99 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.37 0.605 . . . . 0.0 110.1 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 56' ' ' VAL . 97.3 mt-10 -67.36 -35.47 79.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.829 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 57' ' ' VAL . 61.4 tp -61.39 -45.54 93.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.774 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.99 -43.77 97.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.722 -179.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.99 -42.6 99.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.729 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 52' ' ' GLU . 66.2 t -67.66 -45.95 83.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.621 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 53' ' ' LEU . 64.5 t -59.85 -45.76 94.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.44 -51.43 69.52 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.726 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -60.52 -32.92 71.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.44 -54.48 46.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.952 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.22 -39.08 84.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.585 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.304 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.6 m -61.61 -49.46 76.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -61.36 -48.73 79.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 65' ' ' LEU . 5.0 tt -108.27 82.17 1.59 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.323 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.606 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.45 -43.93 2.05 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.403 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.8 Cg_exo -61.21 115.18 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.783 2.322 . . . . 0.0 112.091 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 p -133.11 -41.86 0.89 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 71' ' ' HIS . 88.6 tttt -62.09 -37.44 85.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.752 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -75.56 28.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.465 ' H ' ' C ' ' A' ' 69' ' ' LYS . 95.6 m-70 -136.78 143.8 43.4 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.577 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.83 -62.96 1.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.961 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.64 -44.54 89.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.278 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.7 mm -84.51 2.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.971 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.45 -28.4 71.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -8.26 59.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.91 -44.63 94.16 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.409 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 ' N ' ' A' ' 79' ' ' CYS . 11.2 p -57.01 -44.15 82.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.352 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.567 ' N ' HG13 ' A' ' 78' ' ' VAL . 73.5 m -67.75 -49.39 62.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -62.26 -40.71 97.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.57 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.99 -42.4 99.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.09 -42.74 99.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.096 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.09 -44.51 96.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.674 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.679 HH12 ' HB1' ' A' ' 80' ' ' ALA . 96.4 mtm-85 -65.73 -39.7 91.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.588 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -64.64 -37.91 89.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.432 -179.396 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.91 80.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.604 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.64 62.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -172.59 56.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.502 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -101.65 152.58 20.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.962 0.41 . . . . 0.0 110.482 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 34.7 m -48.36 148.01 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.966 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -106.65 164.19 12.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.175 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 92' ' ' LEU . 8.0 tt -127.32 126.82 43.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.845 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.573 ' N ' HD23 ' A' ' 92' ' ' LEU . 31.6 m-85 -137.15 154.9 50.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -84.31 -176.96 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.693 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -71.45 47.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -158.13 -68.17 0.01 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.92 -21.31 0.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -73.78 141.67 46.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.945 0.402 . . . . 0.0 110.62 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -76.0 93.22 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.403 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.31 153.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.295 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' A' ' 48' ' ' VAL . 77.3 mt -91.47 127.14 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.224 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.02 153.99 19.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.548 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.3 -37.8 25.21 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.181 1.921 . . . . 0.0 112.136 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.425 ' CD ' ' H ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -92.63 54.42 2.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 110.334 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.546 ' HB2' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -103.51 144.34 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.295 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -117.05 122.13 43.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.263 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.432 ' SG ' HD21 ' A' ' 54' ' ' LEU . 12.9 t -113.09 115.0 27.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.536 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 t -173.89 175.71 2.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -75.39 -20.64 58.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.362 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -72.78 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.238 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -98.08 170.68 6.75 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.447 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.9 Cg_exo -52.62 -42.14 64.16 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.654 2.236 . . . . 0.0 112.076 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 113' ' ' ASP . 67.6 t0 -96.51 48.1 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 67.6 t0 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.566 179.711 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -78.93 136.32 37.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 110.645 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -100.34 -0.14 38.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.511 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 4' ' ' VAL . 9.6 p -111.53 36.41 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.536 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 4' ' ' VAL . 98.1 mt-10 55.94 165.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.311 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -94.38 165.24 12.67 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.581 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -52.13 -82.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.808 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 1.1 p30 166.52 126.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.064 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -43.85 155.99 0.31 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.02 110.62 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.618 2.212 . . . . 0.0 111.759 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -82.24 -85.61 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.212 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 t -72.22 52.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.963 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -153.28 120.28 5.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.253 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -70.82 118.87 14.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.375 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.0 mm -122.91 81.89 50.06 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 120.933 0.397 . . . . 0.0 111.093 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.31 111.41 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.683 2.255 . . . . 0.0 111.301 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -77.85 -10.06 59.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.657 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 p -85.63 170.94 12.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -103.58 136.47 43.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.053 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -104.66 121.92 44.56 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.94 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 pp -100.03 149.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.431 ' C ' HD12 ' A' ' 23' ' ' ILE . 18.3 ptmt -130.46 20.22 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.963 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.735 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.6 mp -93.49 122.3 44.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.11 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.1 m -142.56 134.48 27.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -97.55 120.34 37.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.096 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -103.82 145.55 29.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.447 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.1 mm? -64.92 -41.66 95.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.816 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -150.12 -174.08 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.91 -37.68 87.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.477 ' H ' HG23 ' A' ' 30' ' ' THR . 1.3 p -59.79 -48.74 80.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.273 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -66.89 -33.95 76.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.589 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -58.91 -46.54 87.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.436 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -68.32 -41.99 80.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.91 -49.0 85.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.889 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.617 HD11 HG22 ' A' ' 61' ' ' VAL . 4.0 mm? -64.38 -41.07 96.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -59.94 -41.93 92.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -75.14 -31.15 60.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.69 -89.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.0 m -108.99 94.89 5.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.475 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 t -89.29 -11.28 43.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 94.5 mt-10 -145.04 156.56 44.0 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.602 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 8.4 m-85 -143.59 122.61 12.82 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.078 0.466 . . . . 0.0 110.598 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.83 135.43 49.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.381 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.0 t -136.03 132.62 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -58.92 172.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -50.83 -38.38 48.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -147.27 113.9 6.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 49' ' ' THR . 86.9 t -127.88 160.93 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.431 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.546 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -96.75 125.65 41.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.658 ' H ' HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -38.35 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.8 m-20 -60.27 -45.94 91.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.216 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 56' ' ' VAL . 37.8 tp10 -63.96 -43.06 96.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.949 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.456 ' O ' HG12 ' A' ' 57' ' ' VAL . 61.9 tp -62.02 -40.26 95.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.04 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.1 -42.76 99.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.277 0.56 . . . . 0.0 110.184 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.3 -39.45 68.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.703 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 52' ' ' GLU . 54.5 t -69.55 -53.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.011 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.4 p -55.8 -44.82 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' HG13 ' A' ' 57' ' ' VAL . 58.6 tp -62.04 -52.04 65.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.183 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -54.17 -43.31 70.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.099 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.96 93.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.179 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.617 HG22 HD11 ' A' ' 35' ' ' LEU . 53.1 t -63.23 -43.12 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.252 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -67.53 -36.49 81.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.609 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t -63.03 -52.26 63.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 65' ' ' LEU . 12.1 t -74.75 -38.03 62.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.433 . . . . 0.0 110.547 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' N ' HG23 ' A' ' 64' ' ' THR . 11.2 tp -92.79 33.98 1.11 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.914 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.43 -47.14 2.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 66' ' ' SER . 71.8 Cg_endo -82.5 78.3 3.43 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.452 2.101 . . . . 0.0 112.291 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 33.4 m -133.81 -18.06 2.15 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -68.03 -7.43 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.672 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.33 -38.89 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -101.7 109.87 21.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.225 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 32.8 p-10 -65.78 -36.44 83.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.726 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.56 -57.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.683 ' O ' ' O ' ' A' ' 75' ' ' GLY . 81.6 mt -68.93 -45.0 81.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.683 ' O ' ' O ' ' A' ' 74' ' ' ILE . . . -43.27 -131.27 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 O-C-N 124.053 0.846 . . . . 0.0 111.521 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.429 ' CB ' ' O ' ' A' ' 75' ' ' GLY . 1.3 m 74.22 -36.09 0.32 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.96 -0.729 . . . . 0.0 110.532 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.2 OUTLIER -58.29 -29.47 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.817 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.412 ' O ' HD13 ' A' ' 82' ' ' LEU . 93.6 t -62.4 -48.76 86.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.382 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.13 -37.44 87.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.103 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.42 -43.34 99.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 78' ' ' VAL . 7.7 mp -63.15 -38.02 89.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.794 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.88 -42.05 99.63 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' TYR . 89.0 mtm-85 -62.35 -48.08 81.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.014 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.584 ' O ' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -70.56 -29.9 66.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.173 0.511 . . . . 0.0 110.411 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.16 84.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.43 -50.71 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.321 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.86 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.5 ' CE2' ' O ' ' A' ' 90' ' ' VAL . 26.9 t80 64.55 165.37 0.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.29 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.5 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 2.9 p -125.2 156.47 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.96 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.445 ' N ' HG22 ' A' ' 90' ' ' VAL . 11.8 m-85 -122.55 138.51 54.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.077 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -108.85 128.83 55.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.4 154.04 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.793 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 44.6 t0 -73.62 176.83 5.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.437 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 11.3 tm-20 -61.12 -42.7 99.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.533 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.53 0.62 60.15 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.2 -0.37 87.31 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 100' ' ' VAL . 44.5 t0 -89.13 108.83 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.6 0.238 . . . . 0.0 110.472 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -47.1 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.447 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 98' ' ' ASP . 79.6 t -152.84 131.26 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.663 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.781 HD12 ' H ' ' A' ' 101' ' ' ILE . 3.1 mp -60.93 123.88 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.27 170.58 8.01 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.539 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.632 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.3 Cg_exo -51.73 -42.12 58.53 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.269 1.98 . . . . 0.0 112.234 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -105.85 101.5 11.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.226 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 52.1 mtm -104.62 147.05 28.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.324 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -119.02 96.33 5.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.971 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 90' ' ' VAL . 49.2 t -90.24 119.82 30.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.263 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.7 t -161.06 159.74 29.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.608 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 5.5 m-85 -85.52 43.1 1.0 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.046 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m -146.6 178.76 8.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.232 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -108.46 170.69 5.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.518 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 50.7 Cg_exo -52.14 -39.53 70.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.598 2.199 . . . . 0.0 112.038 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 p30 -87.31 0.58 55.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--O 1.222 -0.388 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.612 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt 41.42 -105.81 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.163 0.506 . . . . 0.0 110.783 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -153.94 2.35 0.25 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.067 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' O ' ' C ' ' A' ' 5' ' ' GLU . 4.5 m -147.74 18.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.477 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 4' ' ' VAL . 5.0 pt-20 30.38 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.83 0.706 . . . . 0.0 110.629 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -130.44 130.98 44.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.255 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 63.33 114.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.506 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -124.68 -179.2 4.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -51.12 151.52 4.71 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.498 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.55 -166.49 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.765 2.31 . . . . 0.0 112.063 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt 75.58 -62.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.995 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 p -70.02 -28.87 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.332 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.53 155.37 47.56 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.753 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -53.56 132.5 40.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.515 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pt -44.5 153.2 0.47 Allowed Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.667 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -44.51 122.84 4.17 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.421 2.081 . . . . 0.0 111.925 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.4 p -108.07 -6.79 16.33 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.519 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -86.43 -176.66 5.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.098 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.497 ' N ' HG23 ' A' ' 18' ' ' THR . 73.2 ttt180 -126.06 150.7 47.96 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.498 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -145.34 126.71 14.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.799 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 42' ' ' PHE . 49.4 pt -140.91 148.56 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.107 0.48 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.602 ' C ' HD12 ' A' ' 23' ' ' ILE . 62.9 mttp -113.43 77.41 1.05 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.791 0.329 . . . . 0.0 110.352 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 22' ' ' LYS . 1.7 mp -110.0 126.42 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.0 m -124.19 126.84 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.364 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 107' ' ' CYS . 85.1 t80 -130.08 134.21 47.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.395 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.84 107.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.441 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.3 -43.59 60.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.658 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 98.1 m-20 -135.28 -86.36 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.511 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.67 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.582 HG23 ' N ' ' A' ' 31' ' ' PHE . 15.3 t -58.75 -45.55 89.46 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.292 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.582 ' N ' HG23 ' A' ' 30' ' ' THR . 51.6 t80 -61.46 -35.93 79.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.387 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.658 ' CG ' ' H ' ' A' ' 28' ' ' ASP . 90.9 m-20 -62.17 -44.63 96.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.293 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 30' ' ' THR . 78.3 p -62.16 -46.94 86.75 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.631 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.38 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.496 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 39' ' ' CYS . 53.6 tp -61.22 -44.68 96.88 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -60.17 -41.74 93.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 110.157 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.76 -32.25 73.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.07 -76.56 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.99 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 35' ' ' LEU . 3.7 t -104.47 96.16 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -111.7 -30.19 7.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.37 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -95.27 141.25 29.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.365 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' ILE . 96.4 m-85 -136.55 133.36 36.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.173 0.511 . . . . 0.0 110.526 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -133.83 143.26 48.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.788 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' OG1' ' A' ' 18' ' ' THR . 1.2 m -145.72 -106.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.781 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.44 ' HA ' ' N ' ' A' ' 19' ' ' ARG . 43.5 p30 -166.85 161.51 15.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -63.64 163.28 11.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 61.49 37.23 16.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.478 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 48' ' ' VAL . 11.0 p -113.69 123.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.13 0.491 . . . . 0.0 110.199 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -83.51 169.92 14.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.375 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.693 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -60.81 -40.13 91.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -53.65 -50.34 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.111 0.482 . . . . 0.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.16 -38.08 89.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.313 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.65 -48.8 77.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.296 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.39 -41.18 68.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -62.15 -47.74 83.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.23 -43.36 95.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.133 0.492 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.69 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.82 -45.24 95.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.913 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -55.3 -43.74 75.08 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.97 88.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.465 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.89 -42.02 94.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -69.61 -47.01 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -62.44 -37.1 84.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.76 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -73.65 -69.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.2 mt -103.48 98.57 8.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.556 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -77.85 -47.05 2.31 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.773 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.0 Cg_endo -81.39 137.63 10.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.603 2.202 . . . . 0.0 111.89 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.624 ' SG ' ' NZ ' ' A' ' 77' ' ' LYS . 5.8 m -133.22 -40.25 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.516 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.54 -11.08 60.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.39 -39.03 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.678 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.576 ' O ' ' N ' ' A' ' 75' ' ' GLY . 34.3 m170 -102.29 106.13 16.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -63.51 -37.95 89.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.25 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.19 -46.55 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.359 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 75' ' ' GLY . 95.7 mt -91.6 -13.67 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 71' ' ' HIS . . . -53.93 -158.22 0.01 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.548 HG23 ' C ' ' A' ' 75' ' ' GLY . 2.2 p 69.44 -35.63 0.31 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.092 0.472 . . . . 0.0 110.539 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.624 ' NZ ' ' SG ' ' A' ' 68' ' ' CYS . 21.7 pttp -63.08 -20.47 65.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.306 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 79' ' ' CYS . 9.8 p -65.5 -46.15 90.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.304 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.576 ' N ' HG13 ' A' ' 78' ' ' VAL . 1.6 t -68.85 -47.03 66.97 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.453 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.23 94.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.461 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.97 -43.27 99.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.45 -41.94 99.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.54 -43.81 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.278 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ASP . 96.1 mtt180 -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.135 0.493 . . . . 0.0 110.378 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.92 -42.9 94.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.33 -13.2 55.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.398 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' TYR . . . -149.89 61.41 0.42 Allowed Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' ARG . 88.8 m-20 -38.74 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.508 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -95.0 63.69 2.72 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.356 0.598 . . . . 0.0 110.373 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.9 t -150.91 137.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.33 132.21 41.04 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.029 0.442 . . . . 0.0 110.219 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -103.65 136.49 43.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.751 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -157.53 148.83 21.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.832 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.63 -164.94 1.25 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 110.468 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.75 -39.83 82.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.78 -34.78 65.52 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.66 60.01 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 100' ' ' VAL . 47.6 t0 -88.16 113.98 24.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -42.57 89.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.658 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 98' ' ' ASP . 9.2 p -144.04 141.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.39 127.65 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.151 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -153.21 169.67 9.39 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.55 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.684 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 75.5 Cg_exo -45.51 -42.63 18.24 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.426 2.084 . . . . 0.0 112.228 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -99.96 123.85 44.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.82 0.343 . . . . 0.0 110.196 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 68.1 mtp -114.81 142.56 46.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -146.15 97.36 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.158 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.522 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.3 t -98.88 115.46 28.89 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.669 0.606 . . . . 0.0 110.923 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 p -171.03 162.11 7.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.649 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 109' ' ' PHE . 1.0 OUTLIER -61.67 -53.34 57.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.361 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.7 p -41.9 148.95 0.15 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.998 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -106.61 161.89 21.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 17.5 Cg_endo -56.62 -31.41 86.99 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.671 2.247 . . . . 0.0 112.081 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -105.02 15.08 28.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.163 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.961 -179.856 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -67.13 128.49 36.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.731 0.3 . . . . 0.0 110.36 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -74.59 -50.16 18.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 5' ' ' GLU . 7.4 p -90.75 154.71 3.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.511 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 4' ' ' VAL . 96.3 mt-10 -67.42 155.54 38.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -69.7 -156.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.459 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 m120 59.46 68.03 0.84 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.814 0.34 . . . . 0.0 110.251 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.429 ' CG ' ' N ' ' A' ' 9' ' ' LYS . 53.6 p-10 -137.52 -131.81 0.13 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.538 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' N ' ' CG ' ' A' ' 8' ' ' ASP . 17.6 ttmm -45.53 127.06 6.31 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.744 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.29 121.63 6.58 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.976 1.784 . . . . 0.0 112.099 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.629 ' O ' ' N ' ' A' ' 13' ' ' ARG . 70.9 mmtt -87.11 -156.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.934 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t 44.97 -81.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 123.302 0.376 . . . . 0.0 110.795 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.629 ' N ' ' O ' ' A' ' 11' ' ' LYS . 89.1 mtm180 -61.91 162.92 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.546 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.51 175.87 0.96 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.653 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.752 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -44.57 163.5 0.19 Allowed Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.352 -179.173 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 15' ' ' ILE . 52.8 Cg_exo -54.12 -137.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 122.404 2.069 . . . . 0.0 112.29 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.0 m -85.46 12.41 8.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.856 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p -86.3 143.59 27.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.184 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' O ' HG12 ' A' ' 44' ' ' VAL . 96.7 mtt180 -131.53 146.16 52.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.479 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.2 140.24 32.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 pt -131.23 146.84 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.18 89.34 2.97 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.4 128.03 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.278 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -66.91 141.34 57.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 8.0 m-85 -115.05 135.19 54.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.321 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.79 142.77 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.639 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt 67.26 46.65 1.43 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.97 0.414 . . . . 0.0 111.35 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -128.0 12.15 6.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.154 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 36.94 -120.25 0.17 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.228 0.537 . . . . 0.0 111.698 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -49.74 -59.77 3.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -40.44 -44.45 2.01 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.838 0.352 . . . . 0.0 110.533 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -56.42 -52.25 65.36 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -68.55 -40.45 80.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.798 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -52.73 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.266 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.17 -42.2 89.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -59.67 -43.52 93.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.74 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -79.26 -26.94 42.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.69 -72.42 0.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 39' ' ' CYS . 23.6 p -152.11 98.91 2.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.531 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 78.4 p -51.39 -30.8 20.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.287 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -85.47 144.95 27.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.161 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 40' ' ' SER . 45.6 m-85 -129.6 138.6 51.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.54 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 43.6 tt0 -77.46 136.45 38.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.598 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 19' ' ' ARG . 3.6 p -141.12 155.06 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.454 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' ASP . 45.7 t0 -149.75 146.07 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -40.77 -26.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.607 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' ASP . 11.0 m-20 -138.19 90.99 2.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 49' ' ' THR . 5.0 p -139.05 158.8 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.943 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 51' ' ' ASP . 68.0 p -121.81 137.52 54.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.739 ' N ' HD23 ' A' ' 50' ' ' LEU . 1.7 pt? -37.9 -25.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.432 0.635 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 49' ' ' THR . 99.5 m-20 -58.91 -41.8 88.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.947 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' OE2' ' OE1' ' A' ' 43' ' ' GLU . 80.1 tt0 -64.89 -33.77 76.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.848 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.636 ' O ' HG23 ' A' ' 57' ' ' VAL . 42.9 tp -62.31 -42.84 99.7 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 109.806 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.99 -42.26 76.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.617 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.81 -43.87 91.75 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.173 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 57' ' ' VAL . 8.5 p -72.46 -40.2 63.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.844 0.354 . . . . 0.0 110.688 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 53' ' ' LEU . 48.0 t -61.09 -48.19 90.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.77 -54.07 41.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.755 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 63.7 t0 -52.31 -38.65 59.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.825 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.76 99.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.33 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' LEU . 75.2 t -63.15 -46.25 96.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.555 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -66.59 -43.69 84.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.578 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -61.15 -47.47 86.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.5 p -75.2 -75.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' VAL . 68.9 mt -109.5 109.67 20.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.452 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -77.26 -44.04 2.68 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.074 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' SER . 27.1 Cg_exo -61.15 132.19 40.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.568 2.178 . . . . 0.0 112.118 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 66' ' ' SER . 2.3 m -134.83 -55.44 0.82 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 110.277 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 71' ' ' HIS . 21.2 ptmt -67.53 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.742 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -76.17 13.25 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.482 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' H ' ' C ' ' A' ' 69' ' ' LYS . 97.0 m-70 -126.44 93.4 3.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.442 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -62.12 -34.79 77.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.45 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.07 -45.58 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.287 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 75' ' ' GLY . 51.8 mt -77.72 -60.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.719 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 77' ' ' LYS . . . 46.22 175.82 0.01 OUTLIER Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 m 61.96 -23.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.651 -0.323 . . . . 0.0 110.703 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.676 ' H ' ' C ' ' A' ' 75' ' ' GLY . 8.9 tttm -56.69 -62.76 1.51 Allowed 'General case' 0 C--O 1.225 -0.198 0 CA-C-O 121.367 0.603 . . . . 0.0 109.898 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -52.5 -33.34 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.023 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 t -68.22 -50.84 51.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.551 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.13 93.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.82 -42.15 99.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.034 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.81 -43.99 97.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -58.54 -46.69 86.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.257 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -64.94 -36.59 84.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.754 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.34 -37.94 85.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.269 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 -24.99 62.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.344 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.18 -65.1 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -174.5 -179.69 1.59 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -158.31 -68.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.572 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.59 157.0 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.543 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 2.5 p90 -144.31 155.3 43.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.784 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.56 154.64 41.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.236 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.47 147.28 27.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.04 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.46 ' C ' ' N ' ' A' ' 96' ' ' GLY . 89.6 m-20 -80.79 167.84 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 104' ' ' ARG . 94.8 mt-10 -52.26 -9.36 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.484 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.46 ' N ' ' C ' ' A' ' 94' ' ' ASP . . . -90.02 -74.52 1.29 Allowed Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.48 -28.19 0.33 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -69.55 137.9 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.412 ' HB3' HD22 ' A' ' 50' ' ' LEU . 97.6 mt-10 -75.35 89.85 2.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.387 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -147.87 149.73 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.772 HD12 ' N ' ' A' ' 101' ' ' ILE . 1.8 mp -83.16 129.47 37.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.079 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -148.33 169.48 9.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.287 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 88.2 Cg_exo -46.23 -45.03 19.1 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.593 2.196 . . . . 0.0 112.601 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 95' ' ' GLU . 74.0 mtp85 -107.31 80.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.508 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -104.23 160.9 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.238 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -141.87 114.14 8.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.568 ' SG ' ' CE1' ' A' ' 25' ' ' PHE . 8.9 p -102.7 128.94 49.21 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.964 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 109' ' ' PHE . 40.0 t -175.74 -167.07 0.22 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.223 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.541 ' O ' ' CD2' ' A' ' 109' ' ' PHE . 70.6 t80 -104.12 25.18 10.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.7 m -115.03 160.87 19.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.267 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -109.25 170.41 5.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.522 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.9 Cg_exo -52.41 -40.68 70.61 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.459 2.106 . . . . 0.0 112.378 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.4 p30 -114.16 39.41 2.75 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.639 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -68.33 128.39 36.42 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.668 0.27 . . . . 0.0 110.584 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -81.53 90.6 6.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.315 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 6' ' ' PHE . 2.7 m -146.63 143.38 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.541 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -57.25 -6.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.596 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -44.01 135.05 4.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.34 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 6' ' ' PHE . 1.8 t-20 160.69 -26.15 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 O-C-N 123.818 0.699 . . . . 0.0 110.342 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' ASN . 99.5 m-20 53.85 165.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.025 0.44 . . . . 0.0 110.508 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.72 156.45 80.35 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.798 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.49 14.96 0.88 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.565 2.177 . . . . 0.0 112.172 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.93 -50.46 55.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.227 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 12' ' ' VAL . 7.5 p -89.57 19.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.151 0.5 . . . . 0.0 110.775 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.4 mtm105 -137.42 150.07 47.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.917 0.389 . . . . 0.0 110.21 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -53.93 98.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.324 0.583 . . . . 0.0 110.447 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.603 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -43.55 154.72 0.33 Allowed Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.746 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.84 -89.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.416 2.077 . . . . 0.0 112.13 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.9 p -112.75 -1.01 14.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.446 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p -87.01 166.94 14.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -158.45 177.87 10.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.347 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -117.4 141.17 48.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 110.212 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.0 tt -99.16 141.11 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.127 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -132.07 5.41 4.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.23 125.53 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.7 p -138.76 146.56 41.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.592 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.81 136.87 56.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.256 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.44 133.33 43.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.062 0.458 . . . . 0.0 110.558 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 27' ' ' LEU . 10.3 mp -66.75 -40.39 88.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.716 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 29' ' ' ALA . 37.0 t0 -159.23 -170.92 3.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.418 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.505 ' H ' ' CG ' ' A' ' 28' ' ' ASP . . . -59.05 -46.05 89.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.704 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -61.51 -53.21 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.422 ' N ' ' OG1' ' A' ' 30' ' ' THR . 92.7 m-85 -61.42 -27.66 68.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.23 0.538 . . . . 0.0 110.313 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.42 -45.0 73.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.975 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -67.98 -36.48 80.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.546 HG21 HD13 ' A' ' 74' ' ' ILE . 76.9 t -62.42 -49.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.467 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.9 -41.62 95.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.99 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 40' ' ' SER . 92.6 p -62.07 -44.46 96.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -75.05 -26.69 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB1' HG22 ' A' ' 61' ' ' VAL . . . -61.01 -28.91 69.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.676 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' GLU . 10.7 p -161.22 -33.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 36' ' ' SER . 2.0 t 69.77 -42.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 39' ' ' CYS . 21.4 pt-20 -154.64 143.16 20.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.471 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -134.03 136.07 43.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 110.592 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -67.8 135.85 53.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.433 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.61 134.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.309 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.95 164.37 38.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.615 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 68.9 mmtt -70.66 101.4 2.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 1.5 t70 162.64 -46.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.763 0.665 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -100.14 110.6 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.0 110.597 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -87.53 172.81 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 pp -43.76 -30.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.582 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 -51.77 67.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.695 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' VAL . 80.9 mm-40 -65.02 -39.98 94.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.221 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 57' ' ' VAL . 60.1 tp -62.61 -38.95 92.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.966 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.88 -44.01 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.471 . . . . 0.0 110.206 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.53 -34.95 70.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.611 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 52' ' ' GLU . 53.6 t -73.63 -54.51 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 61' ' ' VAL . 9.4 p -55.74 -44.66 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.552 ' N ' HG13 ' A' ' 57' ' ' VAL . 5.6 tt -61.85 -55.3 31.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.63 -42.71 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.8 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.87 95.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.662 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 57' ' ' VAL . 57.8 t -64.92 -46.24 92.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -65.64 -47.19 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.851 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -64.83 -54.03 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.8 m -66.15 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.748 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.3 tp -108.86 81.97 1.53 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.658 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -78.53 -44.41 2.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.454 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 66' ' ' SER . 24.4 Cg_exo -63.16 119.72 6.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.543 2.162 . . . . 0.0 112.032 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.518 ' SG ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -134.21 -17.89 2.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -66.46 -20.23 65.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.49 28.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.555 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -126.08 160.75 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.492 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -82.43 -65.3 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.42 -47.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.546 HD13 HG21 ' A' ' 34' ' ' VAL . 12.6 mt -65.47 -16.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.061 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.32 3.33 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -82.53 -14.07 55.55 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.299 0.571 . . . . 0.0 110.829 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.434 ' HZ2' HG11 ' A' ' 34' ' ' VAL . 87.1 tttt -54.52 -34.38 61.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.294 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.518 HG22 ' SG ' ' A' ' 68' ' ' CYS . 65.2 t -59.55 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.256 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 85.4 m -61.6 -39.84 92.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.17 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.61 84.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.272 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.559 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -60.36 -50.09 74.98 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 -178.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 82' ' ' LEU . 4.1 mm? -61.91 -41.74 98.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.399 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -60.89 -47.15 87.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.216 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -65.7 -40.91 92.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.637 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.23 -22.22 66.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.657 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -40.43 80.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.95 -37.39 0.66 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -84.01 116.33 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.559 0.219 . . . . 0.0 110.461 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -130.92 143.75 50.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.425 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 m -51.5 140.9 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.392 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.89 150.35 24.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.311 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -127.95 127.79 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.778 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -148.02 151.6 36.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.67 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 96' ' ' GLY . 54.0 p-10 -78.67 179.51 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.761 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -66.81 26.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -130.08 -83.8 0.33 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.43 -26.9 0.12 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -72.46 141.16 48.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.519 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.08 89.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -148.54 136.9 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.559 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mm -77.48 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.483 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -140.46 168.95 12.91 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 51.8 Cg_exo -51.4 -37.14 60.59 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.544 2.163 . . . . 0.0 112.166 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -129.36 122.79 30.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.52 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.636 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -153.79 149.23 27.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.428 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -87.55 130.82 34.6 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.574 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.5 t -126.05 108.4 11.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.15 179.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.417 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.451 ' CD2' ' N ' ' A' ' 110' ' ' SER . 50.6 p90 -69.34 -40.48 77.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.539 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' A' ' 109' ' ' PHE . 9.4 t -57.01 149.56 18.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.331 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.683 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -92.77 170.59 8.68 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.643 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.683 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 51.7 Cg_exo -51.4 -40.39 62.43 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.459 2.106 . . . . 0.0 112.125 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.44 -47.91 84.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.591 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.5 t0 . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.546 -179.773 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -77.8 151.43 34.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.616 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -92.5 -4.15 54.03 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.444 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 6' ' ' PHE . 2.1 t 54.15 21.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.641 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -76.97 38.07 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.489 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' H ' ' C ' ' A' ' 4' ' ' VAL . 80.0 m-85 -108.17 -164.56 0.97 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 6' ' ' PHE . 11.2 m120 61.19 140.28 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.111 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 50.7 p-10 -95.21 84.96 4.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.128 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -133.62 145.34 55.85 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.012 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.37 -57.06 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.635 2.224 . . . . 0.0 112.244 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -168.85 -161.9 0.35 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.632 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.2 -53.23 46.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.335 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -42.24 114.36 0.55 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.907 0.385 . . . . 0.0 110.186 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -51.09 175.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.089 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.742 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -53.4 164.13 0.86 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.557 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 18' ' ' THR . 34.0 Cg_exo -56.37 148.09 63.88 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.267 1.978 . . . . 0.0 112.119 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.2 p -66.83 8.77 0.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.35 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.508 ' H ' ' C ' ' A' ' 16' ' ' PRO . 58.8 p -87.26 160.52 18.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.221 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -145.65 177.02 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.577 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -145.54 133.72 21.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.452 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.89 149.0 32.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' A' ' 40' ' ' SER . 18.9 mtpp -114.11 68.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.268 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -95.22 125.08 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.268 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 t -161.65 142.37 10.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -129.46 134.19 47.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.404 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.42 143.23 47.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -97.59 -5.14 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.265 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 29' ' ' ALA . 28.5 t0 -153.42 163.85 39.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.566 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 28' ' ' ASP . . . -65.14 -38.15 89.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -61.25 -45.77 93.16 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.594 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -66.05 -27.82 68.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.437 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -73.44 -40.55 64.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.864 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.1 p -66.89 -48.21 69.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.986 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.512 HG23 ' N ' ' A' ' 35' ' ' LEU . 30.8 m -65.33 -42.34 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.513 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.512 ' N ' HG23 ' A' ' 34' ' ' VAL . 37.5 mt -62.94 -43.32 99.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.788 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.5 p -67.6 -43.54 80.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.024 0.44 . . . . 0.0 110.813 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -64.86 -35.52 81.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.65 -58.12 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.805 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.2 m -138.42 94.06 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.686 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.528 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 2.4 p -100.2 -2.73 33.19 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.342 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -145.75 126.17 14.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -110.94 111.25 22.25 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.159 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.649 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.4 pm0 -70.56 156.34 39.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.391 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.04 125.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 47' ' ' ASP . 67.6 m-20 -147.24 149.43 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -72.15 16.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 45' ' ' ASP . 92.4 m-20 -112.07 -3.23 14.79 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -119.19 132.46 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.935 0.398 . . . . 0.0 110.276 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.603 ' HG1' ' CG ' ' A' ' 51' ' ' ASP . 72.6 p -101.84 157.52 16.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 51' ' ' ASP . 2.1 pp -48.9 -41.99 35.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.702 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.603 ' CG ' ' HG1' ' A' ' 49' ' ' THR . 1.4 p-10 -59.54 -49.33 78.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 110.337 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -35.52 81.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.316 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' O ' HG12 ' A' ' 57' ' ' VAL . 44.0 tp -61.76 -43.86 98.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.314 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.09 -40.61 98.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.381 0.61 . . . . 0.0 110.073 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.11 -43.61 82.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.855 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.37 -52.38 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.37 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.578 HG13 ' N ' ' A' ' 58' ' ' LEU . 8.6 p -59.0 -46.09 91.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.977 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.578 ' N ' HG13 ' A' ' 57' ' ' VAL . 56.8 tp -65.59 -54.7 24.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.772 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -58.99 -31.69 69.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.845 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.19 -56.46 12.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.366 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.5 HG23 ' N ' ' A' ' 62' ' ' GLU . 34.0 m -69.1 -43.87 81.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.705 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.5 ' N ' HG23 ' A' ' 61' ' ' VAL . 81.6 tt0 -59.06 -44.8 91.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.285 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.7 p -63.05 -45.95 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.67 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -63.34 -52.65 60.91 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.412 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -110.58 73.21 0.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.543 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -77.01 -46.53 2.8 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.545 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.3 Cg_endo -82.39 107.1 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.353 2.035 . . . . 0.0 111.88 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.538 ' C ' ' H ' ' A' ' 70' ' ' GLU . 2.5 m -133.59 -13.51 2.59 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.252 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -51.02 -6.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.997 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.538 ' H ' ' C ' ' A' ' 68' ' ' CYS . 14.4 pt-20 -72.35 -36.96 68.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.505 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -83.65 156.53 22.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.624 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 19.2 p-10 -76.06 -59.65 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 74' ' ' ILE . 27.4 m -95.48 -44.87 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.554 ' N ' HG23 ' A' ' 73' ' ' VAL . 4.2 mt -70.11 -0.85 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.106 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.472 ' C ' ' N ' ' A' ' 77' ' ' LYS . . . -106.17 -41.08 1.85 Allowed Glycine 0 N--CA 1.465 0.616 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 76' ' ' THR . 55.2 m -48.77 -12.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.472 ' N ' ' C ' ' A' ' 75' ' ' GLY . 21.4 ptmt -56.42 -37.23 69.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.85 -45.67 94.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.803 0.335 . . . . 0.0 110.228 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 82.1 m -64.39 -48.0 77.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.03 82.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.268 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.53 -43.64 98.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.8 -40.7 92.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.65 -50.92 67.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.23 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 89' ' ' TYR . 36.3 ptt180 -69.67 -40.29 76.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 110.642 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.25 -40.13 95.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.766 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.9 -40.33 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.29 -81.04 1.37 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 84' ' ' ARG . 99.7 m-20 -135.2 97.6 3.76 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 84' ' ' ARG . 0.3 OUTLIER -55.36 -100.67 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.436 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.5 m -146.38 162.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.524 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.06 142.15 50.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.941 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 93' ' ' PHE . 7.0 tt -122.35 125.63 46.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.306 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.548 ' N ' HD23 ' A' ' 92' ' ' LEU . 91.9 m-85 -128.09 154.29 45.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 95' ' ' GLU . 23.3 t0 -74.88 177.52 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.5 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.508 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 8.5 tm-20 -47.03 -59.77 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.548 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.52 -46.86 91.4 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.24 -13.53 0.82 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.64 141.79 58.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 0.0 110.56 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -76.6 88.33 3.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.545 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -151.02 137.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.33 132.21 30.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 110.197 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -152.63 160.89 30.54 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.31 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 22.4 Cg_endo -61.46 -24.69 78.72 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.85 2.367 . . . . 0.0 111.94 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -125.36 57.2 1.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.783 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -102.59 144.65 30.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.012 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.466 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 57.4 t80 -97.34 127.43 43.29 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.308 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 32.1 p -125.39 112.29 16.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.466 ' OG ' ' CZ ' ' A' ' 106' ' ' TYR . 5.4 p -171.46 168.76 6.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.772 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 110' ' ' SER . 44.5 p90 -63.5 -47.16 82.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.52 ' N ' ' CG ' ' A' ' 109' ' ' PHE . 17.1 m -59.43 144.14 47.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -77.83 170.64 15.3 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.562 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.5 Cg_exo -51.12 -42.03 54.96 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.383 2.055 . . . . 0.0 111.877 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 46.4 p-10 -88.1 -34.18 18.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 67.7 t0 . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.649 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -72.1 98.95 2.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.824 0.345 . . . . 0.0 110.764 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -61.28 -46.53 89.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.614 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.51 134.88 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.57 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -43.23 150.9 0.17 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.681 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -71.58 -59.58 2.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 p30 176.3 116.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.417 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 19.9 p-10 -150.41 -62.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.522 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 20.4 pttm -55.58 147.49 39.57 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.77 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 11' ' ' LYS . 45.2 Cg_endo -70.22 114.21 3.7 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.612 2.208 . . . . 0.0 111.961 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 10' ' ' PRO . 52.9 mtmt 32.38 -112.01 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.476 0.485 . . . . 0.0 110.724 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -133.42 18.71 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.549 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -138.27 137.33 37.36 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.443 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.91 142.43 54.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.501 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.7 mt -110.67 96.78 29.83 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.316 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.1 153.94 32.51 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -72.9 -6.67 46.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.57 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.412 ' HG1' ' HA ' ' A' ' 45' ' ' ASP . 3.0 t -129.17 170.19 13.85 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.57 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -148.81 160.0 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.52 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.63 141.72 33.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 21' ' ' ILE . 12.8 tt -107.33 128.94 61.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.04 16.81 10.84 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.227 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mt -108.05 131.4 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.152 0.501 . . . . 0.0 111.13 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.4 m -141.31 145.25 35.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.474 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 107' ' ' CYS . 87.4 t80 -85.0 114.79 22.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.365 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.95 142.38 46.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.529 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.72 -79.49 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.65 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.73 168.7 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.71 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.762 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.414 ' H ' HG22 ' A' ' 30' ' ' THR . 0.2 OUTLIER -55.85 -57.7 10.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.582 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -65.95 -23.62 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.288 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.48 -46.31 70.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -71.51 -39.32 70.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.494 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' THR . 71.4 t -61.8 -48.22 89.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.271 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.47 -42.92 91.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.967 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 40' ' ' SER . 10.6 t -62.62 -47.94 81.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.502 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.04 -45.75 92.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.727 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.86 65.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.5 t -164.08 78.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' SER . 61.2 p -83.14 -7.22 59.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.294 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -171.16 127.97 0.7 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 43' ' ' GLU . 21.0 t80 -128.76 158.16 39.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.181 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -109.58 116.79 32.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.42 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.82 129.67 75.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.206 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 47' ' ' ASP . 19.6 p-10 -113.94 169.02 9.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.985 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' C ' ' OD2' ' A' ' 47' ' ' ASP . 55.7 mtpt -52.63 86.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.515 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER 167.8 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.449 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.4 t -76.85 129.84 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.311 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 52' ' ' GLU . 3.8 p -124.18 157.53 34.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.571 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -36.54 -39.3 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.646 -179.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -63.18 -45.95 89.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.445 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 49' ' ' THR . 46.0 tp10 -66.98 -38.44 86.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 57' ' ' VAL . 5.5 mt -62.45 -43.14 99.53 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 121.078 0.466 . . . . 0.0 110.617 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.619 ' O ' HD23 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -67.64 -39.47 84.6 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.315 0.579 . . . . 0.0 110.656 -179.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.24 -44.18 80.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.68 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.553 HG13 ' N ' ' A' ' 57' ' ' VAL . 8.4 p -76.64 -45.57 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.848 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 53' ' ' LEU . 54.0 t -58.33 -47.6 87.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.499 HD21 ' CD1' ' A' ' 81' ' ' LEU . 19.9 tp -64.58 -56.47 13.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.311 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.05 -40.48 58.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.186 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.52 89.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 57' ' ' VAL . 75.7 t -62.2 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.755 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.75 -42.79 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.601 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -63.23 -54.86 30.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.901 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -62.24 -48.76 78.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.541 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.9 tp -108.54 93.57 4.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -79.15 -46.4 1.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.69 179.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 66' ' ' SER . 60.1 Cg_endo -83.93 116.39 2.15 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.102 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 m -130.64 -34.09 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.556 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -64.57 -28.03 69.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.589 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 70' ' ' GLU . 57.8 mp0 -73.33 -36.37 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 75' ' ' GLY . 92.7 m-70 -91.4 108.67 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.217 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.98 -29.85 70.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -59.66 -45.46 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 75' ' ' GLY . 7.0 mt -103.08 -10.75 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.602 ' C ' HG23 ' A' ' 76' ' ' THR . . . -48.09 -177.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.602 HG23 ' C ' ' A' ' 75' ' ' GLY . 2.0 p 73.74 -30.93 0.21 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.353 0.597 . . . . 0.0 110.642 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -62.24 -33.88 75.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.959 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 79' ' ' CYS . 11.3 p -59.68 -42.03 87.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.516 ' N ' HG13 ' A' ' 78' ' ' VAL . 83.2 m -63.43 -50.1 71.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.235 0.54 . . . . 0.0 110.006 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.14 81.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.148 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.499 ' CD1' HD21 ' A' ' 58' ' ' LEU . 37.8 tp -50.99 -41.53 59.65 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.6 tp -60.73 -49.88 75.72 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.141 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.01 -41.99 99.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.35 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -65.83 -41.02 92.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.539 ' C ' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt -62.56 -29.87 70.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.339 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.51 0.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.459 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . 171.14 -74.2 0.1 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 9.9 p-10 176.99 -74.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.33 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 91' ' ' TYR . 1.8 t80 75.81 -71.14 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.1 t -52.9 131.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.337 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.567 ' CZ ' ' O ' ' A' ' 89' ' ' TYR . 37.1 m-85 -120.42 160.41 23.15 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.034 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.651 ' C ' HD23 ' A' ' 92' ' ' LEU . 8.6 tt -123.79 126.78 47.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.425 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.522 ' N ' HD23 ' A' ' 92' ' ' LEU . 62.0 m-85 -130.06 150.54 51.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.767 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -82.82 -158.89 0.29 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.457 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.53 -49.69 74.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.437 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.94 -113.22 0.15 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -154.05 45.8 0.56 Allowed Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -124.94 131.39 53.43 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.502 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -70.11 89.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.695 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -158.37 146.52 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 50' ' ' LEU . 13.1 mm -73.45 128.91 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.068 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -144.79 171.27 6.84 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.667 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 76.4 Cg_exo -49.72 -36.74 42.67 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.542 2.161 . . . . 0.0 111.93 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -130.91 131.29 44.4 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.667 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -162.39 167.82 23.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.387 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -139.21 142.17 37.9 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.501 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.9 t -114.28 113.49 24.66 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.0 p -162.22 170.87 18.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.887 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 110' ' ' SER . 44.9 p90 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.513 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 8.4 t -54.91 148.74 12.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.497 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 112' ' ' PRO . . . -104.34 170.4 6.13 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.493 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 111' ' ' ALA . 52.2 Cg_exo -51.32 -40.34 61.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.486 2.124 . . . . 0.0 111.903 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -81.6 35.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.426 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.2 t0 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.524 -179.874 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.815 -1.314 . . . . 999.99 109.815 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.631 ' NZ ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -40.85 164.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.673 -0.264 . . . . 999.99 110.506 -179.356 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 1.03 ' HZ3' ' N ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -58.48 -153.3 0.0 OUTLIER 'General case' 0 C--N 1.343 0.317 0 C-N-CA 120.352 -0.539 . . . . 999.99 109.779 -179.699 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.03 ' N ' ' HZ3' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -31.19 -34.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 109.689 -0.485 . . . . 999.99 109.689 -179.325 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 1.013 ' H ' ' NZ ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 175.93 21.22 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.268 0.627 . . . . 999.99 112.064 177.692 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.553 ' CD2' ' OE1' ' A' ' 5' ' ' GLU . 22.2 m-85 -135.73 -39.97 0.7 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.332 1.234 . . . . 999.99 114.332 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.773 ' H ' ' CG ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -179.64 110.3 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 119.56 1.073 . . . . 999.99 113.851 -178.208 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 7' ' ' ASN . 7.8 t70 100.74 -132.6 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.418 -0.81 . . . . 999.99 111.458 178.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.579 ' NZ ' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -116.7 153.34 49.13 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 109.223 -0.658 . . . . 999.99 109.223 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.615 ' HA ' HG22 ' A' ' 4' ' ' VAL . 84.8 Cg_exo -39.39 120.79 0.67 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.239 1.959 . . . . 999.99 114.093 -178.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HG3' ' H ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -135.49 -83.77 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.266 -0.424 . . . . 999.99 110.601 179.134 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.88 HG23 ' H ' ' A' ' 13' ' ' ARG . 7.2 m -52.47 -95.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.043 -0.526 . . . . 999.99 111.378 -179.483 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.88 ' H ' HG23 ' A' ' 12' ' ' VAL . 48.2 ttp85 -39.22 172.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.01 0.433 . . . . 999.99 110.869 -178.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.512 ' N ' ' CG ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -70.84 138.75 50.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 999.99 110.015 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.6 mt -66.11 133.42 94.69 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.204 -0.453 . . . . 999.99 109.866 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 18' ' ' THR . 62.1 Cg_exo -44.81 151.4 0.65 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.615 1.544 . . . . 999.99 111.526 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 6.0 p -61.47 9.21 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 999.99 110.025 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.63 ' H ' ' C ' ' A' ' 16' ' ' PRO . 2.9 p -105.41 179.09 4.37 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-O 121.322 0.582 . . . . 999.99 111.615 -179.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -146.18 169.3 19.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.495 -0.775 . . . . 999.99 110.835 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -126.18 119.7 28.17 Favored 'General case' 0 C--N 1.267 -2.988 1 O-C-N 114.155 -5.341 . . . . 999.99 111.2 -174.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.585 HG13 ' H ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -104.25 145.97 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 114.963 -1.017 . . . . 885.67 110.443 -179.101 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.536 ' N ' HG13 ' A' ' 21' ' ' ILE . 14.1 tttt -134.85 10.67 3.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.142 -0.935 . . . . 999.99 110.042 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.585 ' H ' HG13 ' A' ' 21' ' ' ILE . 4.4 mp -94.82 110.73 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.09 0.472 . . . . 999.99 111.354 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -119.63 137.59 53.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.449 -0.796 . . . . 999.99 109.66 179.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -86.14 114.9 23.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.101 0.477 . . . . 999.99 110.272 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.91 107.82 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 999.99 111.048 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.456 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.4 mt -68.95 -40.02 79.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 999.99 109.536 178.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -151.62 172.25 16.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.794 -1.093 . . . . 999.99 109.125 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 32' ' ' ASP . . . -58.2 -26.5 62.87 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.584 -0.447 . . . . 999.99 109.999 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 32' ' ' ASP . 24.8 m -59.97 -63.89 1.14 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.958 -0.565 . . . . 999.99 110.287 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.493 ' O ' ' HB3' ' A' ' 35' ' ' LEU . 69.5 m-85 -75.68 16.4 0.39 Allowed 'General case' 0 C--N 1.349 0.587 0 CA-C-N 119.091 0.859 . . . . 999.99 109.636 178.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.5 t0 -88.65 -64.79 1.09 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.07 -1.456 . . . . 999.99 107.07 177.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.3 p -67.8 -41.37 83.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.256 -0.884 . . . . 999.99 109.046 177.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.497 HG11 HD22 ' A' ' 65' ' ' LEU . 66.6 t -66.51 -50.3 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 112.787 0.662 . . . . 825.48 112.787 -178.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 31' ' ' PHE . 12.9 tp -64.96 -41.73 95.22 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.678 -0.809 . . . . 715.35 110.448 -178.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -62.54 -44.64 95.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.978 -0.289 . . . . 999.99 111.411 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -63.18 -45.57 91.16 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.365 0.506 . . . . 999.99 112.365 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 64' ' ' THR . . . -77.35 -28.28 52.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.227 -0.442 . . . . 999.99 110.758 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 42' ' ' PHE . 6.9 t -147.66 80.83 1.5 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.398 0.888 . . . . 999.99 113.398 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.1 p -91.45 -14.96 29.61 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.834 -0.621 . . . . 999.99 109.609 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -151.33 144.6 24.74 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.685 0.994 . . . . 999.99 113.685 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.581 ' CD2' ' SG ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -140.48 147.44 39.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.168 -0.923 . . . . 999.99 111.23 177.862 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -110.59 119.12 38.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.736 -0.666 . . . . 999.99 110.207 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.643 HG12 ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -121.61 111.27 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 114.711 1.374 . . . . 999.99 114.711 -176.698 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.89 161.11 10.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 105.307 -2.109 . . . . 999.99 105.307 175.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 17' ' ' SER . 1.2 mtpm? -83.44 35.99 0.52 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 122.403 2.365 . . . . 999.99 110.376 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -131.94 2.38 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.883 -0.784 . . . . 999.99 108.883 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.643 ' HB ' HG12 ' A' ' 44' ' ' VAL . 19.0 t -88.63 124.99 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.498 -0.774 . . . . 999.99 109.62 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 52' ' ' GLU . 35.0 p -103.19 147.82 26.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 533.5 109.888 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.657 ' N ' HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -33.77 -34.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.761 -0.654 . . . . 304.88 110.938 -178.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' THR . 98.3 m-20 -60.7 -48.6 81.04 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 698.47 110.519 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.9 mt-10 -68.24 -38.14 81.53 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.31 -0.405 . . . . 999.99 110.385 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.25 -45.83 92.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.142 -0.688 . . . . 499.3 109.142 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.476 ' CD2' HG23 ' A' ' 90' ' ' VAL . 1.9 mt -63.39 -41.95 98.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.537 -0.756 . . . . 404.06 110.266 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.37 -50.4 73.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.525 -0.761 . . . . 805.6 111.285 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.8 -36.45 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.821 0.344 . . . . 843.98 110.925 -179.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.38 -48.24 88.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 353.46 110.351 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.931 HD11 ' CD1' ' A' ' 81' ' ' LEU . 32.2 tp -63.94 -44.06 93.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.204 -0.907 . . . . 501.13 109.811 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.71 -43.08 97.62 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.984 -0.553 . . . . 999.99 111.211 179.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.79 84.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.748 0.309 . . . . 763.22 110.972 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.7 t -64.24 -42.01 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 599.86 110.384 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.16 -39.71 93.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 999.99 109.968 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -42.07 86.07 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.3 -0.409 . . . . 999.99 111.69 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -75.73 -44.88 39.62 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.598 -0.441 . . . . 999.99 110.895 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 34' ' ' VAL . 3.0 tp -108.11 71.7 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 999.99 110.713 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.532 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -78.14 -45.47 2.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 999.99 110.82 179.42 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 66' ' ' SER . 72.8 Cg_endo -80.42 56.89 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.884 2.39 . . . . 999.99 113.365 -179.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.55 -33.27 25.49 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.935 0.398 . . . . 845.47 110.318 179.235 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.93 -20.44 65.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.784 -0.644 . . . . 999.99 111.587 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.79 -38.36 70.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.646 -0.252 . . . . 999.99 111.451 -178.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' A' ' 75' ' ' GLY . 98.8 m-70 -87.78 120.56 29.23 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.95 -0.3 . . . . 999.99 110.388 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.83 -41.31 97.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.509 0.195 . . . . 999.99 111.284 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.85 -47.67 92.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 999.99 110.252 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.529 ' O ' ' C ' ' A' ' 75' ' ' GLY . 30.7 mt -81.62 -26.76 9.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 115.975 -0.557 . . . . 999.99 110.666 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 77' ' ' LYS . . . -22.79 -78.93 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 N-CA-C 111.189 -0.764 . . . . 655.9 111.189 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -25.85 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.942 0.719 . . . . 866.78 112.942 -178.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -56.02 -29.59 60.6 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.348 -0.22 . . . . 999.99 110.941 179.635 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 68' ' ' CYS . 2.6 t -68.18 -46.2 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 110.16 -0.311 . . . . 812.96 110.16 178.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.86 -43.77 97.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.0 -0.545 . . . . 771.91 110.127 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.08 92.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 483.48 109.793 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.931 ' CD1' HD11 ' A' ' 58' ' ' LEU . 58.1 tp -62.65 -45.0 94.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.798 -0.637 . . . . 703.45 110.331 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 82' ' ' LEU . 16.1 tp -62.95 -43.2 99.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.877 -0.601 . . . . 999.99 110.137 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -64.44 -38.74 92.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.158 -0.474 . . . . 999.99 110.143 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 97.0 mtt180 -65.73 -39.87 91.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.999 0.428 . . . . 999.99 110.531 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tp -73.5 -24.52 60.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 985.93 110.169 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.8 99.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.108 -0.496 . . . . 999.99 111.941 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.27 -55.79 0.07 OUTLIER Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.238 -0.982 . . . . 999.99 112.211 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 99.4 m-20 -87.88 115.81 25.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.119 -0.326 . . . . 999.99 110.119 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.473 ' HD2' ' H ' ' A' ' 90' ' ' VAL . 1.4 p90 -109.6 -111.36 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.559 -0.291 . . . . 999.99 110.385 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -150.73 115.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.373 -0.973 . . . . 390.26 108.373 178.423 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.17 160.55 32.24 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.02 -1.104 . . . . 421.31 108.02 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.938 HD12 ' HB2' ' A' ' 107' ' ' CYS . 3.2 tt -146.49 134.74 21.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 120.002 1.274 . . . . 247.34 107.968 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.08 162.73 37.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.186 -0.606 . . . . 999.99 112.152 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -77.65 -177.98 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.313 -0.858 . . . . 841.49 110.719 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -74.69 49.82 0.41 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.06 -0.518 . . . . 999.99 110.609 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -152.45 -53.98 0.01 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.573 -1.011 . . . . 951.76 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.49 -19.51 2.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.224 -1.151 . . . . 633.38 110.224 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -70.78 136.93 49.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.34 -0.244 . . . . 774.99 110.34 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.526 ' HB3' HD21 ' A' ' 50' ' ' LEU . 96.7 mt-10 -74.89 89.93 2.38 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.898 -0.408 . . . . 691.2 109.898 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.02 149.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 455.34 110.502 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.657 HD11 ' N ' ' A' ' 50' ' ' LEU . 4.1 mp -89.86 123.18 41.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.535 -0.543 . . . . 501.24 109.535 179.131 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -139.48 178.15 1.74 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.83 -0.623 . . . . 635.24 109.653 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 50.8 Cg_exo -53.74 -35.87 80.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.317 2.011 . . . . 999.99 111.603 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -121.97 97.9 5.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.94 -0.573 . . . . 999.99 110.715 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.593 ' HB2' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -116.31 132.2 56.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.045 -0.525 . . . . 524.37 110.542 -179.83 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.489 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 73.8 t80 -92.73 106.07 18.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.367 -0.379 . . . . 650.22 109.993 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.938 ' HB2' HD12 ' A' ' 92' ' ' LEU . 4.1 t -98.24 118.57 35.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.187 -0.46 . . . . 456.2 110.942 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.489 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 11.5 t -174.41 168.45 3.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.149 0.499 . . . . 573.24 110.856 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.588 ' N ' HG12 ' A' ' 90' ' ' VAL . 25.7 p90 -87.79 25.08 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.201 -0.666 . . . . 999.99 109.201 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.0 m -117.36 121.65 41.7 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.815 -0.63 . . . . 956.64 110.021 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.74 162.02 2.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.611 -0.722 . . . . 699.56 110.985 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.28 -46.04 35.48 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.576 2.184 . . . . 999.99 112.135 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.5 p-10 -74.65 -36.5 62.87 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.999 0.904 . . . . 999.99 109.09 177.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 t0 . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 113.624 -1.626 . . . . 999.99 110.347 179.523 . . . . . . . . 0 0 . 1 stop_ save_